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The following thesis summarizes my work on translational GTPases and the mechanism of eukaryal 
translation initiation, which was performed at the University of Göttingen under the supervision of 
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“Structural insight into the recognition of amino-acylated initiator tRNA by eIF5B in the 80S 
initiation complex”, Kuhle, B. and Ficner, R., 2014, BMC Structural Biology, accepted. 
“Translation initiation factor eIF3b contains a nine-bladed beta-propeller and interacts with 
the 40S ribosomal subunit”, Liu, Y., Neumann, P., Kuhle, B., Monecke, T., Schell, S., Chari, A., & 
Ficner, R., 2014, Structure, 22: 1-8. 
 
“Analysis of the interaction network between eIF2 and eIF5 and its implications for the process 
of eukaryal translation initiation”, Kuhle, B., Valerius, O. and Ficner, R., 2014, manuscript in 
preparation. 
“Analysis of the interaction network between eIF2 and eIF2Bε and its implications for the 
mechanism of nucleotide exchange”, Kuhle, B., Valerius, O. and Ficner, R., 2014, manuscript in 
preparation. 
“The crystal structures of eIF2Bβ and eIF2Bδ provide new insights into the regulatory 
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Translation, the process of mRNA-encoded protein biosynthesis, is one of the fundamental 
processes that are universally conserved in extant cellular life. In all its major stages, namely 
initiation, elongation, termination and recycling, translation depends on a dynamic interplay 
between the ribosome as the principle place of protein synthesis, mRNA, tRNAs and a number of 
accessory proteins called translation factors. A subgroup of these translation factors belongs to the 
universally conserved family of translational GTPases (trGTPases) that use the free energy of GTP 
hydrolysis to ensure the necessary speed and accuracy of protein synthesis on the ribosome. One 
of the most complex processes supported by trGTPases, namely by the eukaryal translation 
initiation factors 2 (eIF2) and 5B (eIF5B), is the intricate mechanism of cap-dependent translation 
initiation in eukaryal cells. 
The current thesis focuses on the structural and functional characterization of the trGTPases 
eIF2 and eIF5B. The first part of this thesis (chapters 2-4) is dedicated to eIF2, a structurally 
unusually complex trGTPase that is responsible for the GTP-dependent delivery of the unique 
initiator tRNA to the ribosome, and the auxiliary initiation factors that regulate the guanine-
nucleotide cycle of eIF2, namely the specialized GTPase activating protein (GAP) eIF5 and the 
guanine-nucleotide exchange factor (GEF) eIF2B. The second part of the thesis (chapters 5-7) 
encompasses a structural and functional analysis of eIF5B, a universally conserved trGTPase that 
catalyzes ribosomal subunit joining in a GTP-dependent manner to form elongation-competent 
ribosomes. 
Throughout the thesis, the methodological focus lies on the specific mechanistic aspects of 
eIF2 and eIF5B function during translation initiation. Both initiation factors will thereby be treated 
individually in their respective functional contexts of the initiation process, with each of the six 
chapters dedicated to particular questions at hand. The natural framework for the analysis of the 





in the historical settings of molecular evolution as a compromise between the innovative processes 
of structural adaption to biological constellations and the conservative preservation of underlying 
functional principles. Based on this framework, the specific findings for either trGTPase are used 
for generalizations in the larger context of translation as an evolved process. 
 
The first chapter forms a general introduction into the mechanism of translation, with a particular 
focus on the processes that underlie translation initiation in eukarya, to provide an overview of the 
general mechanistic settings into which eIF2 and eIF5B are placed. More specific introductions into 
the particular questions addressed in the present work are given individually in each chapter. 
Chapter 2 focuses on the analysis of the interaction network between eIF2 and its 
multifunctional effector protein eIF5. A combination of complimentary high- and low-resolution 
structural approaches with mutational and biochemical methods is used to show how eIF5 forms 
three main contacts with the eIF2 complex, and how these interactions affect the contacts of both 
proteins with initiation factors eIF1 and eIF3c. A high-resolution crystal structure of theeIF2β N-
terminal tail in complex with the eIF5-CTD and Trp quenching experiments showhowthe 
recruitment of eIF5 to its substrate eIF2 is mediated by a flexible peptide-domain interaction that 
provides the means for the dynamic interplay between eIF2, eIF5 and other eIFs in the course of 
the initiation process. A second interaction was found to be formed between the eIF5-NTDand the 
GTP-binding eIF2γ subunit. Finally, the third interaction occurs between the eIF5-CTD and eIF2γ 
next to the nucleotide binding pocket, indicating that this contact might be responsible for the 
previously reported function of eIF5 in stabilizing the bound guanine-nucleotide on eIF2. Together, 
the presented findings provide a more complete and refined picture of the intricate interactions 
between eIF2 and eIF5 that play central roles at various stages of the initiation process.  
Chapter 3 focuses on the interactions between eIF2 and the catalytic ε-subunit of its GEF 
eIF2B. A combination of structural and biochemical methods was used to gain insight into the 
interactions between eIF2Bε and its substrate eIF2 to understand the molecular basis for 
nucleotide exchange. This analysisindicatesthat the catalytic eIF2Bε-CTD contacts its substrate eIF2 
via two main interfaces: a nucleotide-independent high-affinity interaction with the eIF2β subunit, 




destabilization of the bound nucleotide, most likely in a manner analogous to the mechanisms 
used by other GEFs. One of the central aspects of the presented findings is their qualitative 
comparison to those reported for the eIF2·eIF5 interaction in chapter 2. The observation of a high 
degree of structural and functional similarities between the regions in eIF2Bε and eIF5 that contact 
eIF2 to modulate its affinity to guanine nucleotides results in the hypothesis that these 
similaritiesare not merely the result of mechanistic analogies between both proteins but might in 
fact be the result of an evolutionary homology. 
Chapter 4 focuses on structural aspects of the regulatory subcomplex of the eIF2-specific 
exchange factor eIF2B which is composed of subunits α, β and δ and which is involved in the 
regulation of translation by modulating the exchange activity of the eIF2B complex. In this chapter 
the first high-resolution crystal structures of the isolated eIF2Bβ and eIF2Bδ subunits are presented 
together with a protocol for the recombinant purification and in vitro reconstitution of the 
complete eIF2Bαβδ complex from the fungus Chaetomium thermophilum. 
In chapter 5, the question is addressed how GTP binding and hydrolysis by eIF5B mediate its 
catalytic role during ribosomal subunit joining. Six high resolution crystal structures of eIF5B in its 
apo, GDP- and GTP-bound form are presented. Together with an analysis of the thermodynamics 
of nucleotide binding, they provide a detailed picture of the nucleotide cycle performed by eIF5B. 
The data suggest that GTP binding induces significant conformational changes in eIF5B that 
activate the factor for ribosome binding and subunit joining. Based on these observations, a 
domain release mechanism for eIF5B activation is proposed, which represents a novel variation 
from the classical paradigm of GTPase function and suggests a unified picture of subunit joining by 
a/eIF5B and its bacterial ortholog IF2. 
Chapter 6 addresses the specific aspect of how domain IV in eIF5B and IF2 interacts with the 
acceptor stem of the initiator tRNA in the ribosomal context, an interaction that is central to 
subunit joining as the last checkpoint for the formation of functional ribosomes. A reinterpretation 
of a 6.6 Å resolution cryo-EM structure of the yeast 80S initiation complex using the newly 
determined crystal structures of eIF5B from C. thermophilum shows that eIF5B domain IV interacts 
extensively with the initiator tRNA, which includes direct recognition of the methionylated 3’ CCA-





structurally homologous translational β barrel folds in eIF5B/IF2 and EF-Tu/aIF2γ and their 
interactions with tRNAs. 
Chapter 7 is dedicated to the presentation of the hypothesis of monovalent cation (M+) 
dependency among trGTPases, according to which an M+ ion acts as structural and catalytic 
cofactor in trGTPases. The fundament for this hypothesis is formed by biochemical and high-
resolution structural data that demonstrate that eIF5B, the archaeal elongation factor aEF1A and 
its bacterial ortholog EF-Tu in their GTP-bound form coordinate an M+ in their active sites. In 
sequence and structure, the coordination shell for the M+ ion is highly conserved among trGTPases 
from bacteria to human, suggesting a universal mechanism of M+-dependent conformational 
switching and GTP-hydrolysis among trGTPases, which provides considerable explanatory power 
for previously unresolved questions concerning the function and evolution of trGTPases. 
Chapter 8 finally forms a brief synopsis for the presented findings and gives an outlook into 


















The metabolism of living organisms depends on an intricate network of mutually interdependent 
reactions that serve the accumulation of energy and the synthesis of cell material. As functionally 
most versatile macro molecules, proteins play the central role as catalysts of chemical reactions, 
for cellular transport or as storage molecules. The synthesis of functional proteins according to 
genetically encoded information thus constitutes one of the key processes in the metabolism of 
extant cellular life. 
During the biosynthesis of proteins, the flow of the genetic information follows a common 
principle in all living cells, consisting of two major steps: In the first step, called transcription, the 
DNA-encoded genetic information is copied to a messenger RNA (mRNA), representing a short-
lived mobile version of the genetic information. In the second step, called translation, this mRNA 
serves as template for protein synthesis, during which the triplet codons of the mRNA are 
translated into amino-acids that become covalently condensed into the growing polypeptide chain. 
The principle site of protein synthesis is the ribosome, a large multi-protein-RNA complex, whose 
activity is complemented by an apparatus of additional proteins, the so-called translation factors 
that ensure the necessary accuracy and speed during the four major stages of translation: 
initiation, elongation, termination and recycling. As the critical step of the information flow, in 
which the level of the genetic information intersects with the functional level of proteins, 
translation thus depends on the concerted interplay between ribonucleic acids and proteins. The 
key role of this process for cellular life becomes apparent from the universal evolutionary 
conservation of the translation machinery in the three domains of life, indicating that the 
underlying principles of extant protein synthesis evolved long before the onset of speciation. 
 




1.1 The ribosome and the universal mechanism of translation 
Protein synthesis is carried out by the ribosome, a large ribonucleo-protein assembly of 2.5 and 4 
MDa in size in bacteria/archaea and eukarya, respectively, composed of about two-thirds 
ribosomal RNA (rRNA) and one-third protein (Fig. 1.1) [2-4]. The overall architecture as well as the 
structural and functional core of the ribosome is universally conserved throughout evolution from 
bacteria to human [5, 6]. The Ribosome comprises two subunits: The small subunit (30S in 
bacteria/archaea, 40S in eukarya) contains the mRNA binding channel and decoding center (DC), 
and is responsible for fidelity and processivity of the translation process. The large subunit (50S in 
bacteria/archaea, 60S in eukarya) contains the peptidyl transferase center (PTC), which constitutes 
the active site for peptide bond formation on the ribosome from which the nascent peptide chain 
is ultimately released through an exit tunnel at the back of the large subunit. Together, small and 
large ribosomal subunits form the complete 70S or 80S ribosome in bacteria/archaea and eukarya, 
respectively, that becomes reversibly assembled on mRNAs for protein synthesis [7].  
The delivery of amino-acids to the ribosome occurs through transfer RNAs (tRNAs) which 
successively bind to three tRNA binding sites that are shared between both subunits: the amino-
acyl (A), peptidyl (P), and exit (E) site. The A site accommodates the incoming amino-acylated tRNA 
(aa-tRNA) with its anticodon stem-loop (ASL) oriented toward the mRNA in the DC of the small 
ribosomal subunit, while the acceptor end with the attached amino-acyl group is positioned next 
to the PTC of the large subunit (Fig. 1.1). The P site accommodates the peptidyl-tRNA from which 
the nascent peptide chain is transferred to the A site tRNA. Finally, the E site binds the deacylated 
tRNA before it dissociates from the ribosome [7, 8].  
Like the ribosome itself, the principles that underlie the process of ribosomal protein 
synthesis with its subdivision into initiation, elongation, termination, and recycling are one of the 
major commonalities of cellular life (Fig. 1.2) [7].  
The initiation phase covers all the steps between the dissociation of the ribosomal subunits 
after a previous translation cycle and its reassembly at the start site of an mRNA with a unique 
charged initiator tRNA in its P site, a process that is supported by a set of auxiliary initiation factors 
(IFs). The major steps that have to be accomplished by the initiation machinery are the recruitment 
of the initiator tRNA and the mRNA to the small ribosomal subunit, identification of the correct 





Figure 1.1: Structure of the Ribosome. Overall structure of the 
bacterial 70S ribosome with mRNA (black) in the decoding center 
(DC), and tRNAs in A-, P- and E-site (green, red and yellow, 
respectively) (PDB: 2WDL, 2WDK). The ribosomal RNA (rRNA) and 
ribosomal proteins are shown in light blue and dark blue for the 
large 50S ribosomal subunit, and in beige and brown for the small 
30S subunit, respectively. The acceptor ends of A- and P-site tRNAs 
are positioned in the peptidyl-transferase center (PTC) of the 50S 
subunit, while the anticodon loop of the P site tRNA occupies the 
DC of the 30S subunit. 
 
start site for translation, and finally the 
joining of the two ribosomal subunits 
at the start site. The ultimate result is 
the formation of an elongation-
competent ribosome, ready to accept 
the first elongator aa-tRNA for peptide 
bond formation [7, 9]. The critical 
importance of this process lies in the 
fact that it sets the reading frame for 
the subsequent elongation phase and 
thus decides over the functionality of 
the synthesized protein. 
The elongation phase of 
translation is a dynamic cyclic process 
in which tRNAs deliver amino-acids to 
the ribosome as specified by the mRNA 
template and sequentially move 
through the ribosome from the A site 
to the P site and finally to the E site, 
thereby adding their amino-acid to the 
nascent polypeptide chain (Fig. 1.2). 
The first step of this cycle is the binding of an aa-tRNA to the ribosomal A site to form a cognate 
codon-anticodon interaction with the mRNA in the DC of the small subunit. This is followed by 
peptide bond formation in the PTC between the aa-tRNA in the A site and the peptide attached to 
the P site-bound tRNA, accompanied by transfer of the peptidyl group to the A site aa-tRNA. 
Subsequently, in a series of coordinated movements, the mRNA-tRNA complex is translocated by 
one codon on the ribosome, thereby moving the deacylated tRNA to the E site, while the newly 
formed peptidyl-tRNA is moved from the A to the P site, leaving the A site free for a new aa-tRNA. 
In all domains of life, this elongation cycle is supported by two ubiquitous translational GTPases, 




namely elongation factors (EFs) 1A/EF-Tu and 2/EF-G, which are responsible for the delivery of 
cognate aa-tRNAs to the ribosome and to promote the translocation of the mRNA-tRNA complex 




Figure 1.2: Schematic presentation of the basic processes of translation in the three domains of life. The process of 
translation can be subdivided into initiation, elongation, termination, and recycling. During initiation, the two 
ribosomal subunits and the specialized initiator tRNA (blue) are recruited to the mRNA to assemble the 70S/80S 
ribosome with the initiator tRNA positioned in the P site, base paired to the AUG start codon (light green). The 70S/80S 
ribosome then enters the elongation phase, a cyclic process during which tRNAs (aa-tRNA) deliver amino-acids to the 
ribosome and move through the ribosome from the A (green) to the P (red) and finally to the E site (yellow), thereby 
adding their amino-acid to the nascent polypeptide chain as specified by the mRNA template. Translation is terminated 
upon the encounter of a stop codon (red ‘stop’) on the mRNA, which results in the release of the synthesized protein 
and finally in the recycling of the ribosome by dissociation into the individual subunits. During all its stages, the 
translation process is supported by translation factors, including a number of translational GTPases to ensure the 
necessary accuracy and speed (not shown for clarity). 
 
Termination of the translation process occurs upon the encounter of an in-frame stop codon 
in the mRNA, which is recognized by specialized release factors (RFs) to catalyze the hydrolysis of 
the newly synthesized polypeptide chain from the P site-tRNA. The translation cycle ends in the 
recycling step with the dissociation of the two ribosomal subunits, which become thus available for 
a new round of translation initiation (Fig. 1.2) [7, 11]. 
 
 





Figure 1.3: Schematic presentation of cap-dependent translation initiation. The mechanism of eukaryal translation 
initiation covers all steps between dissociation of the 80S ribosome from a preceding translation cycle and its 
reassembly at the start codon of an mRNA. The initiation process starts with the formation of the eIF2·GTP·Met-tRNAi 
TC, which is subsequently recruited to the 40S subunit with the help of eIFs 1, 1A, 3 and 5 to form the 43S pre-IC. The 
43S pre-IC then attaches to the 5’ proximal region of the mRNA through interactions with the cap binding complex 
eIF4F and facilitated by the helicase eIF4A. Once bound, the 43S pre-IC starts to scan the 5’-UTR of the mRNA in a 5’-
to-3’ direction until it reaches the correct AUG start codon. Recognition of the start codon arrests the scanning process 
and results in the displacement of eIF1 and the eIF5-stimulated hydrolysis of eIF2-bound GTP. eIF2·GDP then 
dissociates from the pre-IC together with eIFs 1, 5, 3 and 4F. Joining of the 60S subunit is finally promoted by 
eIF5B·GTP, followed by ribosome-induced GTP hydrolysis on eIF5B and the dissociation of eIF5B·GDP and eIF1A to yield 
the elongation-competent 80S ribosome. The figure was modified from Hinnebusch & Lorsch [12]. 




1.2 Translation initiation 
Among the different steps of the translation process, translation initiation incurred by far the most 
extensive divergence in the three domains of life. Hereby, the main differences are found in the 
mechanisms by which the initiator tRNA and mRNA are recruited to the small ribosomal subunit 
and the recognition of the correct start site [9, 13]. In prokayotes, mRNA recruitment entails the 
direct recognition of the translation initiation region by the 30S subunit through annealing of the 
Shine-Dalgarno (SD) motif on the mRNA with the complementary anti-SD sequence at the 3’ end of 
the 16S rRNA, placing the start codon directly in the ribosomal P site [13, 14]. In bacteria, this 
process, together with the recruitment of the initiator tRNA and joining of the 50S subunit is 
modulated by three monomeric accessory initiation factors, namely IF1, IF2 and IF3 [15]. In 
eukarya binding of most mRNAs to the 40S subunit does not rely on direct mRNA-rRNA 
recognition, but instead involves the recruitment of the 40S subunit to the capped mRNA 5’ end 
and a subsequent scanning of the mRNA in the 3’ direction until the correct start site is 
encountered. Although eukaryal cells contain orthologs of bacterial IF1 and IF2 as well as a 
functional counterpart to IF3, the eukaryal initiation machinery relies on at least 9 additional 
initiation factors (eIFs) (Table 1.1), many of which are multimeric protein complexes, that together 
mediate the recruitment of initiator tRNA and mRNA to the 40S subunit, scanning, start codon 
recognition and finally the joining of the 60S subunit [9, 16]. 
 
1.2.1 Cap-dependent translation initiation in eukarya 
Cap-dependent translation initiation in eukarya can be subdivided into several, partly parallel 
occurring steps that are orchestrated by the concerted action of the initiation factors (Fig. 1.3) [9, 
12, 16]. In a first step, the heterotrimeric GTPase eIF2 in its GTP-bound form specifically recognizes 
and binds the methionylated initiator tRNA (Met-tRNAi) to form a ternary complex (TC). Supported 
by eIFs 1, 1A, 5 and the multisubunit eIF3 complex, the TC binds to the 40S subunit to form the 43S  
pre-initiation complex (pre-IC), placing the Met-tRNAi in the ribosomal P site. The 43S pre-IC is then 
recruited to the 5’-7-mthylguanosine cap of the mRNA in a way facilitated by eIF3, the poly(A) 
binding protein (PABP) and the multimeric cap-binding complex eIF4F. Once attached to the 5’ 
proximal region of the mRNA, the pre-IC starts to scan the 5’ untranslated region (5’ UTR) in a 5’-3’  











Function of the eukaryal homolog 
eIF1 aIF1 IF3* Promotes binding of the eIF2·GTP·Met-tRNAi complex to the 40S 
subunit together with eIF1A; promotes ribosomal scanning and 
ensures the fidelity of start codon recognition; prevents premature 
accommodation of Met-tRNAi in the P site; its dissociation is 
coupled to eIF5-induced GTP hydrolysis by eIF2 and Pi release. 
eIF1A aIF1A IF1 Promotes binding of the eIF2·GTP·Met-tRNAi complex to the 40S 
subunit together with eIF1; stimulates ribosomal scanning and 
promotes start codon recognition cooperatively with eIF1. 
eIF2        aIF2  Consists of three subunits (eIF2αβγ); specifically recognizes Met-
tRNAi to form an eIF2·GTP·Met-tRNAi TC; recruits Met-tRNAi to the 
P site of the 40S subunit; hydrolyzes GTP upon start codon 
recognition. 
eIF2B         Consists of five subunits (eIF2Bαβγδε); guanosine-nucleotide 
exchange factor (GEF) that promotes exchange of GDP against GTP 
on eIF2. 
eIF3                    Consists of 13 subunits in mammals; interacts with eIF1, eIF5 and 
eIF2 to form a multi-factor complex; stimulates recruitment of the 
eIF2·GTP·Met-tRNAi TC to the 40S subunit; promotes attachment of 
43S pre-IC to mRNA; is involved in ribosome dissociation and anti-
association, preventing premature joining of 40S and 60S subunits. 
eIF4A aIF4A  ATP-dependent DEAD-box RNA helicase that unwinds secondary 
structures in the 5’ leader of the mRNA. 
eIF4B   Enhances the ATPase and helicase activity of eIF4A 
eIF4E   Binds to the 5′-cap structure of the mRNA 
eIF4H   Homologous to the N-terminal domain of eIF4B; enhances the 
ATPase and helicase activity of eIF4A 
eIF5   Binds eIF1, eIF2 and eIF3; forms nucleation point for the MFC; 
promotes recruitment of eIF2·GTP·Met-tRNAi TC to the 40S subunit 
and stimulates start codon recognition; acts as GTPase activating 
protein (GAP) that induces hydrolysis of eIF2-bound GTP upon start 
codon recognition. 
eIF5B aIF5B IF2 Ribosome-dependent GTPase that catalyzes ribosomal subunit 
joining 
eIF6   Anti-association factor that binds the 60S subunit and prevents its 
association to the 40S subunit. 
* The grouping of IF3 with a/eIF1 is based on their functional homology and the structural similarity of a/eIF1 to the 
C-terminal domain of IF3 [17, 18] and not on a common evolutionary descent. 




direction for the AUG start codon. This process is supported by the small monomeric eIFs 1 and 1A, 
which bind close to the mRNA channel of the 40S subunit and stabilize the 43S pre-IC in an ‘open’ 
conformation that is competent for processive movement along the mRNA, thereby allowing the P 
site-bound Met-tRNAi to sample each of the successive mRNA triplets by using complementarity 
with its anticodon[19-21]. Base-pairing between anticodon of the Met-tRNAi and the AUG start 
codon in the ribosomal P site arrests the scanning process and triggers rearrangements within the 
pre-IC involving eIFs 1, 1A, 2 and 5 that result in the irreversible hydrolysis of the eIF2-bound GTP 
by the gated release of the orthophosphate (Pi) from eIF2, triggered by the GTPase activating 
protein (GAP) eIF5. Conversion of eIF2 to its GDP-bound form commits the pre-IC to the 
downstream events of the initiation process: The inactive eIF2⋅GDP has a reduced affinity to the 
Met-tRNAi, resulting in its release together with eIF5 and eIF1 from the 40S subunit. Joining of the 
60S ribosomal subunit is finally catalyzed by the ribosome-dependent GTPase eIF5B. Supported by 
eIF1A, eIF5B binds to the scanning-arrested 43S pre-IC in a GTP-dependent manner and promotes 
the association of the large 60S ribosomal subunit. 60S binding triggers the GTPase activity in 
eIF5B, resulting in the concerted dissociation of eIF5B⋅GDP and eIF1A from the 80S initiation 
complex (IC) which is thus ready to enter the elongation phase of translation. 
 
1.3 GTPases involved in translation 
Translation is one of the most fundamental cellular processes that are regulated by guanine 
nucleotide-binding (G) proteins (GTPases). Apart from translation, G proteins such as the small Ras-
like GTPases or Gα proteins are involved in a wide variety of mechanisms from signal transduction 
to nucleocytoplasmic transport. The unifying characteristic of G proteins, which share a common 
evolutionary origin[22], is their function as molecular switches that alternate between an ‘inactive’ 
GDP-bound state and a structurally distinct ‘active’ GTP-bound state, characterized by the 
interaction of two conserved dynamic structural elements, switch 1 and switch 2, with the γ-
phosphate of the bound GTP molecule (Fig. 1.4A) [23-25]. Only the active GTP-bound conformation 
of the G protein is able to interact productively with effector molecules or complexes and is 
therefore a prerequisite for its biological function (Fig. 1.4B). Conversion of the active to the 
inactive state to ‘switch off’ the G protein requires the hydrolysis of the bound GTP molecule, 




which is achieved by stimulation of the usually low intrinsic GTPase activity. Common features of 
these activation mechanisms are the stabilization of the catalytic machinery of the GTPase in a 
conformation that is productive for GTP hydrolysis and the introduction of additional catalytic 






Figure 1.4: G proteins as molecular switches. A) Crystal structure of human Ras (light blue; PDB: 5P21) bound to 
GDPNP. Ras belongs to the family of small GTPases that consist only of the G domain itself. The phosphate binding loop 
(P loop), switch 1 and switch 2 are colored in light red, magenta and dark red, respectively. Switch 1 and switch 2 are 
highly conserved structural elements that specifically recognize the nucleotide state of the G domain by forming direct 
contacts to the GTP γ-phosphate; both switch elements become thus stabilized in a defined conformation that renders 
the G domain active for interactions with effector molecules. B) Schematic presentation of the conventional guanine-
nucleotide cycle of G proteins. To convert the ‘inactive’ form of the G protein to its ‘active’ state, GDP has to be 
replaced by GTP; in some cases (e.g. Ras, EF-Tu and eIF2γ) this step is accelerated by guanine-nucleotide exchange 
factors (GEFs). GTP-binding induces the ‘active’ conformation of the G domain, in which it binds to effector molecules 
and is able to carry out its biological function in the cell. The GTPase reaction to convert the G protein back to its GDP-
bound form is usually slow and has to be accelerated by external factors that complement and/or stabilize the active 
site (here indicated by the collective term GAP for GTPase activating protein). 
 






In all its basic sub-processes from initiation to ribosome recycling, the translation apparatus 
depends on auxiliary trGTPases (Table 1.2). Three of these factors, namely initiation factor 
a/eIF5B/IF2 and elongation factors a/eEF1α/EF-Tu and a/eEF2/EF-G, are ubiquitous in the three 
kingdoms of life and are therefore likely to represent the minimal set of trGTPases necessary for 
mRNA translation that evolved before the emergence of the three primary lineages bacteria, 
archaea and eukarya [22]. Elongation factor SelB constitutes a special case, as it is represented 
with homologs in all three domains of life, but not ubiquitously distributed among all species. 
Additional trGTPases that are not found in all three domains apparently evolved later from the 
lineages of either a/eEF1α/EF-Tu or a/eEF2/EF-G [22, 26]. These include the initiation factor a/eIF2, 
which is only found in archaea and eukarya and the release factors RF3 and eRF3 in bacteria and 
eukarya, respectively. Despite their different functions during translation, all trGTPases share a 
common evolutionarily conserved structural core, composed of the G domain and domain II, which 
is supplemented with additional factor specific domains (Fig. 1.5). The G domain, which is related 
 
Figure 1.5: The universally conserved structural core in translational GTPases. A, B) Crystal structures of GDPNP-
bound EF-Tu (A) and GDP-bound EF-G (B) from Thermus thermophilus (PDBs: 1EXM; 1FNM). Both bacterial elongation 
factors contain a G domain (G; coloring as in Fig. 1.4A) homologous to Ras-like G proteins and a β-barrel domain with 
greek-key topology (DII; dark blue), which are shared with all other trGTPases. G domain and domain II are 
supplemented with additional domains (shown in grey), which are required for factor specific functions and not 
evolutionarily universally conserved across the trGTPase lineages. 




to the G domains of other Ras-related GTPases, forms the functional center in trGTPases that 
couples GTP binding and its hydrolysis to the specific biological function of the factor during 
translation. The ribosomal complexes on which the different trGTPases fulfill their role hereby act 
as the GTPase activating element, which stimulates the usually low intrinsic GTPase activity of 
trGTPases [27]. 
 








eIF2γ aIF2γ  Forms the central subunit of the heterotrimeric eIF2 
complex; recognizes Met-tRNAi to form the 
eIF2·GTP·Met-tRNAi TC to recruit the initiator tRNAi to 
the 40S subunit; hydrolyzes GTP upon start codon 
recognition. 
eIF5B aIF5B IF2 Catalyzes ribosomal subunit joining; the bacterial 
ortholog also promotes binding of the fMet-tRNAfMet to 
the 30S subunit. 
eEF1A aEF1A EF-Tu        Delivers aa-tRNAs to the ribosome during elongation. 
eEF2       aEF2 EF-G Translocation of the mRNA/tRNA complex on the 
ribosomeduring elongation.  
eSelB aSelB bSelB Delivers Sec-tRNAsec to the ribosome during elongation. 
eRF3                    Class-2 release factor; binds class 1 release factors and 
promotes termination of the translation process. 
  RF3 Class-2 release factor; binds class 1 release factors and 
promotes termination of the translation process. 




Two trGTPases that exemplify this split between structural adaptation to new biological 
constellations and the simultaneous preservation of the underlying principles of function are the 
eukaryal initiation factors eIF2 and eIF5B. On the one hand, eIF2 constitutes an example for a 




tightly regulated trGTPase, in which the G protein forms a constitutive complex with two accessory 
subunits, and which requires various additional effector proteins to perform its role during 
translation initiation. eIF5B, on the other hand, is an example for a monomeric, universally 
conserved trGTPase that fulfills its role during subunit joining without the absolute requirement for 
additional effector molecules apart from the ribosome itself. Notwithstanding these differences, 
both proteins follow the basic paradigms of G protein function as molecular switches. 
 
1.3.1 The eukaryal translation initiation factor 2 (eIF2) 
eIF2 is responsible for the delivery of the Met-tRNAi to the 40S ribosomal subunit and plays a key 
role during the identification of the correct start site for translation (Fig. 1.3). Like other G proteins, 
eIF2 thereby oscillates between an ‘active’ GTP-bound form, in which it is able to specifically 
recognize and bind the Met-tRNAi and an ‘inactive’ GDP-bound form, in which eIF2 dissociates 
from the scanning arrested 43S pre-IC. During this nucleotide cycle, eIF2 function is dependent on 
two accessory protein factors, namely eIF5 and eIF2B. While eIF5 is essential for eIF2 TC binding to 
the 40S subunit and required to trigger the hydrolysis of eIF2-bound GTP, eIF2B functions as 
guanine nucleotide exchange factor (GEF) that recycles eIF2⋅GDP back into its GTP-bound form. 
 
1.3.1.1 eIF2 and the recognition of the Met-tRNAi 
eIF2 is a heterotrimeric G protein, comprising the subunits eIF2α, -β, and -γ. All three eIF2 subunits 
have orthologs in archaea, namely aIF2α, -β, and -γ, whereas no counterparts are known from 
bacteria [28]. With the exception of eIF2α, structural information about eIF2 is limited to its 
archaeal orthologs (Fig. 1.6). The a/eIF2 α-subunit is composed of two domains: an N-terminal 
domain that is subdivided into an S1-like OB-fold that forms a rigid body with the following small α-
helical subdomain, and a C-terminal α/β domain which contains an additional acidic extension only 
in the eukaryal orthologs (Fig. 1.6A) [29, 30]. The C-terminal domain of eIF2α is responsible for 
direct interactions with the γ-subunit of eIF2 [31-33]. The body of a/eIF2β is composed of two 
conserved sub-domains, an N-terminal α/β sub-domain and a zinc binding sub-domain (ZBD), that 
are preceded by a single N-terminal α-helix (α1) which is responsible for stable binding to the eIF2γ 
(Fig. 1.6B) [31, 32, 34]. Only the eukaryal eIF2β ortholog contains an additional long N-terminal 




extension, which harbors three conserved lysine-rich patches (K-boxes) that are involved in 
interactions with aromatic/acidic boxes (AA-boxes) in the C-terminal domains of the eIF2 effectors 
eIF5 and eIF2Bε (see next sections) which are likewise not found in archaeal cells [35, 36]. Within 
the a/eIF2 complex, the α- and β-subunits do not interact directly with each other, but both bind 
independently to the central γ-subunit [31, 32]. a/eIF2γ is the G protein within the complex, 
homologous to the elongation factors EF-Tu, eEF1A and SelB, and accordingly adopts a three-
domain architecture composed of a G domain (domain I) and two β-barrel domains (domains II and 
III) with greek key topology (Fig. 1.6C). Crystal structures of aIF2γ, obtained either in its apo state, 
in complex with GDP or with the nonhydrolyzable GTP analog GDPNP revealed that the three 
domains invariably adopt a ‘closed’ conformation similar to that of the active GDPNP-bound EF-Tu 
and in stark contrast to the ‘open’ conformation in GDP-bound EF-Tu [33, 37-39]. A number of 
eukaryal orthologs contain an additional non-conserved N-terminal extension, which was, 
however, shown to be dispensable for eIF2 function in vivo[40]. Like in other G proteins, the G 
domain of a/eIF2γ harbors the guanine-nucleotide binding site with the highly conserved 
nucleotide binding motifs [24]. This includes the two mobile switch 1 and switch 2 elements that 
are thought to change their conformation upon the transition from the GDP-bound form to the 
GTP-bound state of the G domain, thereby promoting the binding of Met-tRNAi by eIF2. GTP-
bound a/eIF2γ alone is able to bind the Met-tRNAi directly [32]. However, the affinity of the 
eIF2⋅GTP complex for the Met-tRNAi is significantly increased (∼100-fold) by each of the accessory 
subunits eIF2α and eIF2β [32, 41]. Structural analyses suggest that binding of the C-terminal 
domain of aIF2α to domain II of GTP-bound aIF2γ allosterically opens a channel between switch 1 
of the G domain and domain II, thereby allowing the accommodation of the ACC acceptor stem 
with the attached methionyl group [42, 43]. Further aIF2α- or GTP-induced domain 
rearrangements are limited and significantly smaller than those observed for the transition 
between GDP- and GTP-bound forms of EF-Tu. Consistently, it was found that the affinity of Met-
tRNAi is only ∼10-fold greater for eIF2⋅GTP than for the GDP-bound form, and that the affinities of 
eIF2⋅GTP and eIF2⋅GDP to deacylated tRNAi is about equal to that of eIF2⋅GDP for Met-tRNAi[44, 
45]. This indicates that the thermodynamic coupling between the binding of GTP and Met-tRNAi 
mainly depends on the methionyl moiety, whereas the rest of the binding interface is virtually 




unperturbed [44]. However, the first base pair of the tRNAi acceptor stem (A1:U72), together with 
the G31:C39 pair in the anticondon stem loop (ASL) and bases within the T loop form additional 
signature elements in the initiator tRNA that enhance Met-tRNAi binding to eIF2⋅GTP and allow its 
discrimination against elongator tRNAs[46, 47].  
 
 
Figure 1.6: Structure of a/eIF2. A-C) NMR solution structure of human eIF2α (A) and crystal structures of aIF2β (B) and 
GDP-bound aIF2γ (C) as found in the heterotrimeric aIF2 complex from S. solfataricus (PDBs: 1Q8K; 2QMU). A 
comparison of the domain architectures in the eukaryal (sc: S. cerevisiae) and archaeal (ss: S. solfataricus) orthologs is 
schematically shown below the structures with corresponding color codes; regions idiosyncratic to the eukaryal 
lineages are indicated in yellow. The zinc ion in aIF2β is shown as yellow sphere; the GDP molecule bound to aIF2γ is 
shown as yellow balls and sticks; G domain and domain II of aIF2γ are colored as their homologous domains in EF-Tu 
and EF-G in Fig. 1.5. D) Cartoon representation of the ternary complex of S. solfataricus aIF2 with GDPNP and Met-
tRNA
fMet
. The C-terminal domain of aIF2β is not visible in the crystal structure (PDB: 3V11) and was therefore modeled 
into aIF2 according to its position in 2QMU. The color code for the individual subunits corresponds to that in A-C; the 
Met-tRNAi is colored in magenta. 




The crystal structure of the TC formed between aIF2⋅GDPNP and E. coli Met-tRNAfMet 
revealed that aIF2 most likely binds the tRNAi in a manner significantly different from that 
observed for elongator tRNA binding by EF-Tu (Fig.1.6D) [42, 48]. The ACC end with the methionyl 
group is bound in a pocket between switch 1 of the G domain and domain II of aIF2γ in the same 
way as in TCs of EF-Tu. However, a kink in the acceptor stem reorients the rest of the tRNAi 
dramatically relative to aIF2γ, thereby preventing the direct interaction between domain III of 
aIF2γ and the T stem minor groove of the tRNA as observed in EF-Tu TCs. Instead, the acceptor arm 
and the T-loop of the tRNA form direct contacts with the C-terminal and N-terminal domains of 
aIF2α, respectively. Although similar interactions to eIF2α were not found for the eIF2⋅GTP⋅Met-
tRNAi complex in directed hydroxyl radical footprinting experiments [49], mutational analyses for 
eIF2γ, as well as the cryo-electron microscopy (cryo-EM) model of the mammalian 43S pre-IC 
suggest a similar mode of Met-tRNAi binding in the eIF2 TC, with the difference that the N-terminal 
S1-like OB-fold domain of eIF2α seems to form no direct contact to tRNAi but instead contacts the 
40S subunit [45, 50]. How the β-subunit is positioned in the TC and how it might contribute to Met-
tRNAi binding by a/eIF2 is still not known. 
 
1.3.1.2 eIF5 regulates the activity of eIF2 
eIF5 consists of two distinct structural domains (Fig. 1.7). The N-terminal domain (eIF5-NTD) shares 
sequence and structural homology with the C-terminal portion of a/eIF2β and can be further 
subdivided into an N-terminal α/β sub-domain (NSD) and a zinc binding subdomain (ZBD) [51]. 
Unique features of the eIF5-NTD that are not found in a/eIF2β are a short sequence insertion in the 
NSD which bears some resemblance with a Walker A box motif (P-loop) of nucleotide-binding 
proteins, and a flexible N-terminal tail of ∼20 residues that contains a highly conserved arginine 
residue (Arg15), which was proposed to act as catalytic arginine-finger to trigger the GTPase 
activity in eIF2 on the 43S pre-IC (see below) [52, 53]. The C-terminal domain of eIF5 (eIF5-CTD) 
adopts a globular atypical HEAT repeat fold [1, 54], which is connected to the eIF5-NTD through a 
long mainly negatively charged linker region (eIF5-LR). The overall sequence conservation within 
the eIF5-CTD is low with the exception of two regions (AA-boxes) that are rich in aromatic and 




acidic side chains and together form a large negatively charged surface area (area I) that is required 
for interactions with the three lysine-rich K-boxes in the N-terminal domain of eIF2β [35, 55]. 
 
 
Figure 1.7: Domain architecture of eIF5. A) Schematic presentation of the domain architecture in eIF5. eIF5 is thought 
to fold into an N-terminal domain (NTD; colored wine-red) that contains the putative arginine-finger (R15) in the N-
terminal extension, and a HEAT-repeat like C-terminal domain (CTD; colored in dark red). Both domains are connected 
via a flexible linker region (LR). B) NMR solution structure of the human eIF5-NTD (left; PDB: 2G2K) and the yeast eIF5-
CTD (right; PDB: 2FUL), connected by the flexible linker region (dashed line). The putative arginine-finger (R15) is 
shown as sticks. N-terminal subdomain (NSD) and zinc binding domain (ZBD) of the eIF5-NTD are homologous to those 
in the C-terminal domain of e/aIF2β (see Fig. 1.6B). The color code is the same as in (A). 
 
 
As mentioned above, eIF5 supports the recruitment of eIF2 TCs to the 40S ribosomal subunit 
during 43S pre-IC formation [56-58]. Binding of the isolated TC to the 40S subunit is slow and its 
efficient recruitment thus depends on the assistance by other factors, namely eIFs 1, 1A, 5 and the 
eIF3 complex [56, 57, 59]. With the exception of eIF1A, these factors together with the TC 
preassemble into a multifactor complex (MFC) in yeast, plants and mammals [59-61] through a 
network of physical interactions with each other, thereby mutually promoting their binding and 
the recruitment of the TC to the 40S subunit for 43S pre-IC formation. Hereby, the eIF5-CTD plays a 
key role as nucleation point for the other factors by forming a platform for direct and partially 
cooperative interactions with the N-terminal domains of eIF2β (through the K-boxes) and subunit c 
of the eIF3 complex, as well as with eIF1 [56, 57, 59]. Consistently, mutations that disrupt any of 




these interactions result in impaired 43S pre-IC formation and reduced growth rates in a manner 
that can be suppressed through the overexpression of the TC, highlighting their importance for TC 
recruitment [58, 62]. 
After 43S pre-IC formation and its recruitment to the 5’ end of the mRNA, the interaction 
between eIF2 and eIF5-CTD continues to play a role in scanning and start codon recognition by 
antagonizing eIF1 binding to the 43S pre-IC, thereby promoting the ‘closed’ scanning arrested 
conformation of the pre-IC [21, 63]. However, the main role of eIF5 during scanning and start site 
recognition is to trigger the intrinsic GTPase activity of eIF2⋅GTP in its capacity as GTPase activating 
protein (GAP). Several studies suggested that the eIF5-NTD acts as classical GAP that provides an 
arginine-finger (Arg15) in trans which is introduced into the active site of eIF2 in the context of the 
scanning 43S pre-IC and stabilizes the transition state of the GTP hydrolysis reaction [52, 53]. This 
was supported by the finding that substitutions of the invariant Arg15 in the unstructured N-
terminal tail of eIF5 are lethal and abolish the eIF5-dependent GTPase activation without reducing 
the ability of eIF5 to bind eIF2 [51-53, 64]. However, this activating effect of eIF5-NTD strongly 
depends on the structural context of the pre-IC, suggesting that eIF5 may also contribute 
allosterically to GTPase activation in eIF2γ in the scanning pre-IC [64]. Finally, it was reported that 
the eIF5-NTD is able to bind isolated eIF2γ only in the absence of eIF2β [65], which in turn is known 
to suppress the intrinsic GTPase activity of eIF2γ through its ZBD [21, 66, 67]. Based on these 
observations it was proposed that the eIF5-ZBD may displace the structurally homologous eIF2β-
ZBD from eIF2γ, thereby simultaneously removing the inhibitory effect of eIF2β and providing the 
catalytic Arg15 with access to the nucleotide binding site [21]. AUG recognition would then have to 
trigger the removal of the eIF5-NTD to allow the gated release of the orthophosphate from 
eIF2⋅GDP/Pi, which would thus be connected to the release of eIF1 from the P-site and 
accommodation of the Met-tRNAi, promoted by the interaction between eIF5-CTD and eIF2β-NTT. 
After Pi release, eIF2⋅GDP is thought to dissociate from the 43S pre-IC in a tight complex with 
eIF5 [68]. Recent studies suggested that within this eIF5⋅eIF2⋅GDP complex the flexible eIF5-LR 
between N- and C-terminal domains forms a direct contact to eIF2 in addition to that between 
eIF5-CTD and eIF2β-NTT [69]. This interaction was shown to mediate the stabilization of GDP on 
eIF2. Based on this finding and the observation that a large fraction of cytosolic eIF2 is present in a 




complex with eIF5, it was proposed that eIF5 might serve an additional role as guanine-nucleotide 
dissociation inhibitor (GDI) that antagonizes the GEF function of eIF2B by physically competing with 
the catalytic eIF2Bε-CTD (see below) and by suppressing spontaneous GDP release, thereby 
preventing eIF2⋅GDP recycling and reducing the levels of eIF2 TCs in the cell [68, 69].  
 
1.3.1.3 Recycling of eIF2·GDP by eIF2B 
After its release from the 43S pre-IC, eIF2⋅GDP has to be recycled back to eIF2⋅GTP to allow a new 
round of Met-tRNAi binding and translation initiation. Like various other Ras-related G proteins, 
eIF2 binds GDP tightly with an affinity in the low nanomolar range, and the rates of spontaneous 
GDP release are too slow to allow efficient TC formation and translation initiation [44]. Guanine-
nucleotide exchange on eIF2 is therefore catalyzed by the GEF eIF2B, which promotes GDP release 
from eIF2⋅GDP and thereby facilitates its replacement by GTP [70, 71]. eIF2B is composed of five 
non-identical subunits (α, β, γ, δ, and ε) and was recently proposed to form a functional decamer 
of ∼600 kDa in solution containing two copies of each subunit [72, 73]. The minimal catalytically 
active region of the eIF2B complex was mapped to the ∼20 kDa C-terminal domain of eIF2Bε, 
which adopts an atypical HEAT repeat fold homologous to that of the eIF5-CTD (Fig. 1.8) [1, 74]. 
Like eIF5-CTD, the eIF2Bε-CTD contains two conserved AA-boxes at its C-terminus that are required 
for strong interactions with the K-boxes of the eIF2β-NTT and are thus implicated in the 
recruitment of the substrate eIF2 to its GEF [35]. Moreover, eIF2Bε-CTD was found to interact 
directly with eIF2γ through its N-terminal portion, which was shown to contribute directly to 
nucleotide exchange on eIF2 and is thus considered to form the catalytic center [70, 71, 75, 76]. 
Together with eIF2Bγ, eIF2Bε forms the ‘catalytic’ subcomplex of eIF2B, in which the γ subunit 
serves an accessory role by promoting the nucleotide exchange activity of the ε subunit. A 
regulatory subcomplex is formed by the homologous α, β, and δ subunits, which contribute to 
eIF2⋅GDP binding through interactions with eIF2α [77].  
Due to its central position in the guanine-nucleotide cycle of eIF2, eIF2B is one of the major 
targets for the regulation of translation initiation. One of the best studied pathways of eIF2B 
inhibition is the phosphorylation of eIF2α at Ser51 (eIF2α-P) by eIF2α kinases, which in turn 








Figure 1.8: Structure of the catalytic domain in eIF2Bε. A) Crystal structure of the human eIF2Bε-CTD (PDB: 3JUI), 
comprising the minimal catalytically active domain within the heteropentameric eIF2B complex. B) Structural 
comparison of the eIF2Bε-CTD (cyan) with the eIF5-CTD (red). Both proteins adopt a structurally homologous atypical 
HEAT-repeat fold that provides surfaces for interactions with eIF2. 
 
 
1.3.2 The eukaryal translation initiation factor 5B (eIF5B) 
eIF5B is the second trGTPase involved in translation and, unlike eIF2, universally conserved among 
the three domains of life with the orthologous aIF5B and IF2 in archaea and bacteria, respectively 
[81]. Crystal structures of aIF5B and IF2 revealed a four domain architecture for both proteins with 
an N-terminal G domain followed by domains II to IV (Fig. 1.9) [82-84]. The G domain and domain II 
form the structural core, which in sequence and structure is homologous to the corresponding 
domains in other trGTPases such as EF-Tu, EF-G and eIF2γ, whereas the α/β domain III is 
idiosyncratic to a/eIF5B/IF2. The C-terminal domain IV is connected to the preceding domains 
through a ∼40 Å long α-helix and is structurally homologous to domain II; only the aerchaeal and 
eukaryal ortholgs contain two additional α-helices at their very C-terminal end, which are packed 
against the β-barrel fold of domain IV. IF2 and eIF5B contain an additional N-domain of up to 600 
residues, which displays little conservation in sequence and length and, although implicated in 





Figure 1.9: Structure of the trGTPase aIF5B. Crystal structure 
of GDPNP-bound aIF5B from M. thermoautotrophicum (PDB: 
1G7T). The color code for G domain and domain II are the 
same as for the homologous domains in EF-Tu, EF-G and 
aIF2γ in Fig. 1.6 and 1.7, with P-loop, switch 1 and switch 2 
colored light red, magenta and dark red, respectively. GDPNP 
is shown as yellow balls and sticks. Domains III and IV are 
colored in dark blue and purple, respectively. 
 
mediating interactions with the small ribosomal subunit, was shown to be dispensable for eIF5B 
function in yeast [85]. 
 
The principle role of eIF5B is to 
promote subunit joining to form the 
elongation competent 80S initiation 
complex. Following the dissociation of 
eIF2⋅GDP and most other initiation factors, 
eIF5B in its GTP-bound form binds to the 
pre-IC in a manner accelerated by 
interactions between the C-terminal tail of A 
site-bound eIF1A and the two a/eIF5B-
specific α-helices in domain IV [86-89]. 
Biochemical studies as well as the recent 
cryo-EM model of the yeast 80S pre-IC 
containing a GDPNP-bound eIF5B mutant 
(T439A) suggest that eIF5B⋅GTP binds to the 
43S pre-IC similar to IF2 on bacterial 30S 
pre-ICs with domain II interacting with the 
40S subunit, while domain IV forms a direct 
contact to the acceptor stem of the Met-
tRNAi in the P-site [85, 90, 91]. Following its 
binding to the 43S pre-IC, eIF5B⋅GTP 
promotes the association of the 60S ribosomal subunit, which in turn triggers the intrinsic GTPase 
activity of eIF5B. GTP hydrolysis and the subsequent transition to the GDP-bound state reduce 
eIF5B affinity for the 80S ribosome and trigger the concerted release of eIF5B⋅GDP and eIF1A from 
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Translation initiation results in the accurate assembly of the elongation-competent ribosome with 
the unique initiator tRNA positioned in its P site, base paired to the AUG start codon of an mRNA. 
In eukarya, recruitment of the initiator tRNA (Met-tRNAi) to the ribosome is mediated by the 
heterotrimeric initiation factor 2 (eIF2), a translational GTPase that requires the multifunctional 
effector protein eIF5 to carry out its function. Here, we present a structural and biochemical 
analysis of the interaction network between eIF2 and eIF5. A high-resolution crystal structure of 
the complex between the eIF5-CTD and the eIF2β N-terminal tail in combination with Trp 
quenching experiments shows that recruitment of eIF5 to eIF2 occurs via a flexible peptide-domain 
interaction that provides a possible explanation for the dynamic interplay between eIF2 and eIF5 
and other eIFs that occurs during start site selection on the ribosome. A second direct interaction 
was mapped between the eIF5-NTD, which is responsible for the stimulation of GTP hydrolysis by 
eIF2 on the ribosome, and the GTP-binding eIF2γ subunit. Finally, the third interaction occurs 
between the eIF5-CTD and eIF2γ in the direct vicinity to the nucleotide binding pocket, which is 
likely to be responsible for the previously reported role of eIF5 in stabilizing GDP on eIF2. Together, 
the presented findings provide a more complete and refined picture of the intricate interactions 




In eukarya, translation is initiated by the formation of an elongation-competent 80S ribosome, 
assembled with the methionlyated initiator tRNA (Met-tRNAi) in its P-site base-paired to the AUG 
start codon of an mRNA. This process depends on the concerted action of at least 12 different 
auxiliary protein factors (eIFs) that mediate the specific binding of mRNA and initiator tRNA, as well 
as the joining of the two ribosomal subunits by an intricate series of formation, rearrangement, 
and breaking of interactions and GTP hydrolysis [9, 12].  
In the first step of translation initiation, GTP-bound eIF2 binds the Met-tRNAi to form a 
ternary complex (TC). Together with eIFs 1, 1A, 5 and the eIF3 complex, the TC is then recruited to 





initiation complex (pre-IC). Assisted by eIF3 and the eIF4F complex, the 43S pre-IC subsequently 
binds to the 5’-proximal region of an mRNA, whereby it enters the scanning phase of the initiation 
process, in which the 5’-untranslated region of the mRNA is searched for the AUG start codon. 
Upon encounter of the correct initiation site, the scanning process is arrested by the formation of 
codon-anticodon interactions between the mRNA and initiator tRNA, which triggers a 
rearrangement of eIF1A, dissociation of eIF1 and finally the irreversible hydrolysis of the eIF2-
bound GTP, stimulated by eIF5. GDP-bound eIF2 then dissociates from the scanning-arrested 40S 
subunit together with eIF5, and is subsequently recycled back to eIF2⋅GTP by the guanine-
nucleotide exchange factor (GEF) eIF2B. Instead of eIF2, GTP-bound eIF5B now binds to the 
40S⋅Met-tRNAicomplex to promote the joining of the large 60S ribosomal subunit, thus forming the 
80S pre-IC. Subunit joining finally triggers GTP hydrolysis in eIF5B, resulting in the dissociation of 
eIF1A together with eIF5B⋅GDP and the transition of the 80S IC into the elongation phase of 
translation [9, 12, 16]. 
The focus of this work lies on the elucidation of the molecular details of the intricate 
interaction network between the two central initiation factors eIF2 and eIF5. eIF2 is composed of 
three subunits (eIF2α, -β, and -γ), each of which has orthologs in archaea (aIF2) but not in bacteria 
[28]. The eIF2γ subunit, a paralog of EF-Tu, belongs to the family of Ras-related G proteins and is 
responsible for the GTP-dependent binding of Met-tRNAi to form the TC, assisted by the α- and β-
subunits [32, 41, 42]. The TC does not bind to the 40S subunit on its own, but instead depends on 
the concerted action of additional factors, namely eIFs 1, 1A, 3 and 5 [12, 58, 59]. Hereby, the 
direct interaction between three lysine-rich segments (K-boxes 1-3) in the eukarya-specific N-
terminal tail (NTT) of eIF2β and the negatively charged AA-boxes 1 & 2 in the C-terminal domain 
(CTD) of eIF5 plays a central role to allow the efficient recruitment of the TC [35]. The eIF5-CTD 
thereby acts as nucleation core that mediates cooperative interactions between eIF2β-NTT, eIF1 
and the eIF3c-NTD for the formation of an intermediate multi-factor complex (MFC; composed of 
eIFs 1, 3, 5 and the TC) and finally the proper incorporation of the TC into the 43S pre-IC [56, 57, 
59]. Consequently, the loss or weakening of the eIF5-CTD⋅eIF2β-NTT interaction results in a 





Recent studies suggest an additional role for the eIF5-CTD⋅eIF2β-NTT interaction during 
scanning and start site recognition by destabilzing eIF1 binding to the pre-IC that seems to involve 
the loss of interactions between eIF1 and eIF2β-NTT and instead the formation of a stronger 
interaction of the latter to eIF5 in response to start-site recognition [21, 63]. Together with the 
displacement of the eIF1A C-terminal tail (CTT) from the P-site by the Met-tRNAi, the resulting 
release of eIF1 triggers conformational rearrangements of the 40S subunit from an ‘open’ scanning 
competent conformation to its ‘closed’ scanning arrested state, ultimately causing the irreversible 
hydrolysis of the eIF2-bound GTP by the gated release of Pi[64]. Here, eIF5 again plays a critical role 
with its N-terminal domain acting as GTPase activating protein (GAP) to trigger the GTPase activity 
in eIF2, most likely by introducing an arginine-residue (Arg15 in yeast eIF5) as catalytic residue into 
the GTPase center [52, 53, 64].  
After their release from the pre-IC, eIF2⋅GDP and eIF5 were found to remain tightly 
associated, giving rise to a large cytosolic pool of eIF2⋅eIF5 complexes that significantly exceeds the 
levels of TC in the cell [68]. This observation suggested that eIF5 might serve an additional role in 
the recycling pathway of eIF2⋅GDP by antagonizing the guanine-nucleotide exchange (GEF) activity 
of eIF2B [68, 69]. In line with this assumption an evolutionarily conserved region within eIF5, called 
DWEAR-motif, was found to be responsible for a reduced rate of GDP dissociation from eIF2. This 
suggested that eIF5 indeed contains a guanine-nucleotide dissociation inhibitor (GDI) activity, in 
addition to its ability to compete physically with eIF2B for their common substrate eIF2. Based on 
these and genetic observations, it was proposed that eIF5 provides a regulatory function under 
stress conditions by antagonizing spontaneous or GEF-catalyzed recycling of eIF2⋅GTP and TC 
formation in addition to the mechanism of eIF2B inhibition by eIF2α phosphorylation [69]. 
Over the last years, considerable progress has been achieved in the elucidation of the intricate 
series of molecular events that govern the involvement of eIF2 and eIF5 in pre-IC formation, start 
codon recognition and recycling of eIF2 [12]. However, a detailed understanding of these processes 
is still limited, in part due to the highly dynamic and transient nature of most of the involved 
interactions that, as a result, escape most biochemical techniques and resist high-resolution 
structural investigations. By combining different high- and low-resolution structural approaches 





network between eIF2 and its multifunctional effector protein eIF5, as well as its influence on the 
association of eIF1 and eIF3c with the eIF5-CTD. We find that eIF5 forms three major contact sites 
with the eIF2 complex. One is formed by the N-terminal portion of the eIF5-NTD, which harbors 
the putative catalytic arginine-finger and specifically contacts the eIF2γ subunit in the presence and 
absence of Met-tRNAi. A second interaction is formed by the eIF5-CTD, which directly contacts the 
γ-subunit close to the nucleotide binding site of the G domain. Interestingly, we could show that 
this interface involves the DWEAR-motif, which seems to form an element of the CTD itself and 
not, as previously assumed, of the flexible linker region between the N- and C-terminal domains. 
Using fluorescence-labeled nucleotide analogs, we show that this interaction, which is formed 
irrespective of the nucleotide-state of eIF2 or the presence of Met-tRNAi, is responsible for the 
stabilization of eIF2-bound guanine-nucleotides. Finally, the third interaction, which is responsible 
for the high affinity binding of the two factors, is formed between the AA-boxes in eIF5-CTD and 
the K-boxes in the eIF2β-NTT. The first high-resolution crystal structure of an eIF5-CTD⋅eIF2β-NTT 
complex, in combination with fluorescence-based tryptophan quenching and mass-spectrometry-
coupled crosslinking experiments, indicates that the two factors interact via a peptide-domain 
interaction, which allows a dynamic interplay with the simultaneously bound eIF1 and eIF3c. 
Together, the presented data provide a more complete and refined picture of interactions 
occurring between eIF2 and its effector protein eIF5, with implications for the chain of molecular 
events that accompany pre-IC formation, start codon recognition and eIF2 recycling. 
 
2.2 Results 
Contributions of the lysine-rich patches K1, K2 and K3 of the eIF2β-NTT to the interactions with 
eIF5-CTD 
In order to gain insight into the roles of the individual K-boxes for the interactions between eIF2β-
NTT and eIF5-CTD, complex formation between both proteins was monitored by means of 
tryptophan quenching. For this purpose an eIF5-CTD construct was used comprising residues 241-
405 which contains two tryptophan residues, Trp245 and Trp391. According to the previously 
determined crystal structure of eIF5(241-405)(PDB: 2FUL) [1]., the universally conserved Trp391 in 






Figure 1. A)Schematic presentation of the proposed domain architecture in eIF5 and eIF2β.B) Crystal structure of the 
C-terminal HEAT-like domain of eIF5 (residues 241-396) from S. cerevisiae(PDB: 2FUL) [1]. The left panel shows the 
eIF5-CTD in cartoon presentation; the four HEAT-like repeats (RI-RIV) are indicated, with the conserved Trp245 in RI and 
Trp391 in RIV. Next to Trp391, conserved residues of the AA-boxes are shown as balls and sticks. The right panel shows 
the surface charge distribution of eIF5-CTD (negative, red; positive, blue), revealing the highly negatively charged area 
I, formed by residues of the two AA-boxes, next to Trp391. C) Trp-quenching by eIF2β on the eIF5-CTD. The 
chromatogram shows the emission spectrum of eIF5(241-405) upon the excitation of the Trp fluorescence at 280 nm in 
the absence (blue) and presence (red) of the eIF2β-NTT. 
 
charged area I, implicated in binding of the K-boxes of eIF2β (Fig. 1 and S1). We therefore reasoned 





fluorescence signal of Trp391, either indirectly by its conformational rearrangement or directly 
through proton transfer from a nearby positioned ε-amino group.  
 
 
Figure 2. Trp-quenching experiments between eIF5-CTD and eIF2β-NTT. A) Equilibrium titrations of 0.5 µM eIF5(241-
405) with increasing amounts of wild-type eIF2β(1-106) or the three single K-box mutants K1∆, K2∆, and K3∆. The Trp 
quenching signal (in % of the original fluorescence signal of eIF5(241-405)) was plotted against the concentration of 
the respective eIF2β-NTT constructs. The black lines show the fit to the data, using a quadratic one-side binding model. 
B) Equilibrium titration of 0.5 µM eIF5(241-405) with wild-type eIF2β(1-106) or the three double K-box mutants K12∆, 
K13∆, and K23∆. C) Comparison of the Trp quenching signals for the seven eIF2β(1-106) constructs. Standard 
deviations are given as error bars. 
 
In line with this assumption, the addition of eIF2β (which contains no Trp) to eIF5(241-405) 
results in a significant decrease in the fluorescence signal at 360 nm (excitation at 290 nm), 
accompanied by a blueshift of the emission maximum from 350 to 340 nm (Fig. 1C). Both effects 
are lost in the eIF5(241-405)W391F mutant (Fig. S2). Titration of eIF5(241-405) with increasing 





the initial fluorescence signal at saturating eIF2β concentrations. Similar values are obtained with 
N-terminal fragments of eIF2β, containing either residues 1-148 (Kd = 95 nM and ~24% quenching) 
or 1-106 (Kd = 70 nM and ~24% quenching) (Fig. 2A and Table 1). These values are consistent with 
the assumption that the NTT provides the entire binding region for interactions of eIF2β to eIF5-
CTD and are in good agreement with the reported affinity (Kd = 40 nM) between eIF5-CTD and the 
heterotrimeric eIF2 complex [21, 35, 36]. We therefore used the shortest fragment containing all 
three K-boxes (eIF2β(1-106)) for the subsequent mutational analysis.  
 
Table 1. Trp quenching experiments between eIF5(241-405) and eIF2β. 
eIF2β construct Kd (nM) Reduction of affinity 
relative to wt  
Quenching signal 
(%) 
eIF2β(FL)wt 100 ± 44 -- 25 
eIF2β(1-148)wt 95 ± 24  -- 24 
eIF2β(1-106)wt 70 ± 20  -- 24 
eIF2β(1-106)K1Δ 825 ± 55 12-fold 19 
eIF2β(1-106)K2Δ 550 ± 45 8-fold 13 
eIF2β(1-106)K3Δ 200 ± 19 3-fold 24 
eIF2β(1-106)K12Δ N.D.  No signal 
eIF2β(1-106)K13Δ N.D.  No signal 
eIF2β(1-106)K23Δ 2200 ± 400 30-fold 8 
Kd is the equilibrium dissociation constant. 
N.D., not determined due to the absence of a detectable quenching signal. 
 
 
Either one or two of the K-boxes in the eIF2β-NTT (Fig. 1A) were deleted by mutation to 
alternating Ala and Ser residues. Among the single K-box mutants, the most severe effect was 
observed for K1Δ exhibiting a ~12-fold increase in the dissociation constant (Kd = 825 nM) and a 
simultaneous loss of nearly 20% of the quenching signal (Fig. 2A/C and Table 1). K2Δ resulted in an 
~8-fold loss of binding affinity (Kd = 550 nM), accompanied by a loss of nearly 50% of the quenching 
signal. Finally, K3Δ exhibited the smallest effect with an only 3-fold reduction in binding affinity (Kd 





Among the double K-box mutants only K23∆ exhibited a quenching signal (~30% of the signal 
observed for wild-type eIF2β), allowing an estimate of 2.2 µM for the Kd, corresponding to a ~30-
fold reduction in binding affinity (Fig. 2B/C and Table 2). By contrast, neither K12Δ nor K13Δ 
exhibited any quenching signal upon addition to eIF5(241-405). For K23Δ and K12Δ these 
observations are compatible with the effects of the single K-box deletions. However, it is 
interesting to note that both, the loss of binding affinity and the quenching signal for the K23Δ 
double mutant are slightly larger than an entirely additive contribution by K2 and K3 would 
suggest. Moreover, the sole presence of K2 (in K13Δ), which according to the single mutations 
contributes significantly to the binding affinity and ~50% of the total quenching signal, results in no 
signal at all. Thus, K3 actually does seem to provide contributions in K1∆ and K2∆, which, however, 
do not become apparent from its single-deletion. 
These results demonstrate that K1 and K2 provide the principal contact surface for eIF5-CTD, 
both with immediate effects on the surrounding of Trp391. This central role of Trp391 in the 
interactions with the eIF2β-NTT is further supported by the complete loss of the quenching signal 
and a severe negative impact on the interactions in GST-pull-down assays with eIF5(241-
405)W391A, -W391F (Fig. S2). At the same time, K3 seems to provide only a small contribution – at 
least in the presence of K1 and K2 –, which, moreover, does not involve a direct effect on Trp391. 
Although in this kind of experiments no quenching signal is not necessarily indicative of no binding, 
our results suggest that K2 binding is partially assisted by either K1 or K3 for its full binding affinity, 
and that K3 is able to partially substitute for the loss of K2 in the K2Δ mutant, possibly by binding 
to similar surface residues on eIF5-CTD in the absence of K2. 
 
Crystal structure of eIF2β(39-106) bound to eIF5(201-405) 
Despite the critical role which the eIF5-CTD plays as nucleation point for other eIFs during MFC and 
pre-IC assembly, scanning and start codon recognition, no structural information that would allow 
direct insight into the molecular details of any of these interactions was so far available. We 
therefore intended to determine the structure of the eIF5-CTD in complex with the eIF2β-NTT by 
means of X-ray crystallography. Based on the results from the Trp-quenching experiments we were 





Table 2. Data collection and refinement 
statistics for the structure of the eIF5(201-
405)·eIF2β(39-106) complex from  S. cerevisiae 
Crystallization 
Condition 0.8 M (NH4)SO4, 
0.3 M LiSO4 
Temperature (°C) 20 
Data Collection 
Space Group P3212 
Unit Cell 
 
a = 74.3 Å 
b = 74.3 Å 
c = 124.8 Å  
 
α = 90° 
β = 90° 
γ = 120° 
Resolution (Å) 2.0 (2.1-2.0) 
Observed reflections 359597 (87743) 
Unique reflections 48223 (11831) 
Completeness (%) 99.9 (99.8) 
<I>/𝜎 22.3 (3.9) 
Rsym (%) 8.9 (42.8) 
Refinement 
Rwork/Rfree (%) 17.4/20.1 
Rmsd from Strd. Stereochemistry 
Bond length (Å) 0.007 
Bond angles (°) 0.98 
Ramachandran Plot Statistics 
Most favored (%) 98.5 
Allowed regions (%) 1.5 
Disallowed regions (%) 0 
Values in parentheses refer to the highest resolution shell. 
Rwork and Rfree factors are calculated using the formula R = Σhkl‖F(obs)hkl| 
− |F(calc)hkl‖/Σhkl |F(obs)hkl|, where F(obs)hkl and F(calc)hkl are observed 
and measured structure factors, respectively. Rwork and Rfree differ in the 
set of reflections they are calculated from: Rfree is calculated for the test 
set, whereas Rwork is calculated for the working set. 
 
seemed to be contingent on the overall 
binding situation, apparently at odds with 
its universal conservation among eIF2β 
orthologs across the eukaryal lineages. We 
therefore purified N-terminal fragments of 
S. cerevisiae eIF2β containing either all 
three K-boxes (residues 1-106) or only K2 
and K3 (residues 39-106) in complex with 
the C-terminal domain of S. cerevisiae eIF5 
(containing either residues 241-405 or 201-
405) from E. coli cells. The longer construct 
of eIF5 including residues 201-240 was 
chosen in order to gain additional insight 
into the structural arrangement of the 
highly conserved ‘DWEAR-motif’ (residues 
220-238), previously assigned to the flexible 
linker region between eIF5-NTD and -CTD 
and proposed to stabilize GDP binding by 
eIF2 in eIF2⋅eIF5 complexes[69] (Fig. S1).  
Among the four purified 
combinations, only the eIF5(201-
405)·eIF2β(39-106) complex yielded crystals 
of sufficient quality to allow structure 
determination. The final model, refined at a 
resolution of 2.0 Å, contains two eIF5-CTD 
copies per asymmetric unit including 
residues 201 to 399 (with the additional 
vector-encoded residues PGLGS at the N-






Figure 3. Crystal structure of an eIF2β-NTT fragment bound to 
the eIF5-CTD. The eIF5(201-399)⋅eIF2β(66-106) complex is shown 
in cartoon presentation with eIF2β colored pink and the eIF5-CTD 
shown in rainbow coloring (N-terminus, blue; C-terminus, red). 
The body of the eIF5-CTD is formed by ten α-helices (α3-α12), 
folding into four atypical HEAT repeats RI-RIV (compare Fig. 1B). 
The N-terminal helices α1 and α2 protrude from the HEAT-like 
domain and form crystal contacts to symmetry related molecules. 





) connected by a loop region containing K-box 3 (K3). The 
eIF2β-NTT thereby adopts an extended conformation in which it 
wraps around the eIF5 HEAT-like domain, placing its N-terminus 
(residue 66) at repeat RIV, while the C-terminus (residue 106) is 
placed atop of RI. 
 
refinements statistics are summarized in 
Table 2). Residues 241-399 of both eIF5 
molecules adopt a fold composed of 
four antiparallel helical repeats (RI-RVI) 
(Fig. 3) that is virtually identical to that 
of the previously reported yeast eIF5-
CTD structure (rmsd of 0.8 Å over 133 Cα 
atoms) [1]. The remaining N-terminal 
residues (201-240) fold into two 
additional α-helices (α1 and α2) that 
protrude from the globular part of the 
eIF5B-CTD and form extensive contacts 
to symmetry related molecules in the 
crystal packing. Only one of the two 
eIF5-CTD molecules binds a fragment of 
eIF2β which includes only residues 66-
106 and folds into two amphipathic α-
helices (hereafter termed αNβ and αCβ), 
connected by a loop formed by K-box 3 
(Fig. 4). Residues 39 to 65, including K2, 







Figure 4. Peptide-domain interaction between the eIF2β-NTT and eIF5-CTD. A) The eIF5(201-399)⋅eIF2β(66-106) 
complex from different orientations. The eIF5-CTD is shown with surface charge presentation (negative, red; positive, 
blue), demonstrating how the eIF2β-NTT (yellow cartoon) adopts an extended conformation to associate with the 




, thereby placing K-box 3 (K3) in 
direct vicinity to the negatively charged area I. The middle and right panel reveal the existence of a hydrophobic cleft 
adjacent to area III (asterisk). B) Details of the interactions between K-box 3 of eIF2β (yellow) and the AA-boxes of eIF5 
(grey, with conserved AA-box residues and residues involved in direct contacts with eIF2β shown as balls and sticks in 
cyan). Among the seven lysine residues of K-box 3, only Lys83 and Lys89 form stable polar interactions with AA-box 1 
(indicated by black dashed lines). C) The surface charge distribution of eIF5-CTD reveals that Lys83 and Lys89 are 
inserted into negatively charged pockets from the periphery of area I, while the major part of the negative surface area 
remains available for interactions with K-boxes 1 and 2 (not present in the crystal structure).  
 
Helix αNβ (residues 69-79) lies between helices α9 and α12 of eIF5, on one side contacting 
Lys345 of eIF5 through Asp88 and Glu91 and on the other side forming a hydrophobic interface 
with Pro344, Ile348, Pro387, Phe388 and Trp391. Following helix αNβ, K3 comes to lie at the very C-





surface formed by the two conserved AA-boxes in eIF5 (area I) (Fig. 4). However, only two of the 
seven lysine residues, Lys83 and Lys89, form a direct contact to AA-box 1, with Lys83 lying in a 
pocket formed by Tyr351, Asp354 and Glu358, and Lys89 lying between Thr312 and Asp354 (Fig. 
4B/C). The remaining lysine residues of K-box 3 are poorly resolved in the electron density, 
indicating that they either do not participate in the interactions with eIF5 or that the formation of 
stable interactions is prevented by the relatively high salt concentrations at which the crystals were 
obtained (400 mM (NH4)2SO4); this may as well be responsible for the inability of K-box 2 to form a 
stable interaction under these conditions. In agreement with the absence of a strong contribution 
to the quenching signal in the fluorescence experiments, no lysine residue in K-box 3 is stably 
positioned in the direct vicinity to Trp391. Finally, helix αCβ of eIF2β-NTT (Lys89-Ala103) is packed 
on top of and orthogonal to helices α7 and α4 of eIF5, with Phe96 and Leu100 positioned in a 
hydrophobic pocket on the eIF5-CTD surface formed by Val270, Tyr273, Ala309 and the aliphatic 
part of the Lys313 side chain, whose ε-amino group additionally forms a salt bridge to Glu97 of 
eIF2β (Fig. 4B/C).  
Thus, the co-crystallized portion of the eIF2β-NTT adopts an elongated conformation 
containing secondary structure elements but no tertiary structure, thereby allowing an extended 
interaction interface that reaches half around the eIF5-CTD (Fig 4A). Interestingly, the eIF2β-NTT 
thereby only peripherally contacts the negatively charged area I of eIF5 through K-box 3 and mainly 
occupies those regions lying between the negatively charged areas I and III and the positively 
charged area II, which is thought to provide the main interface for interactions with eIF3c and eIF1 
[57]. K-box 3 thereby leaves most of area I available for interactions with K1 and K2, including the 
highly negatively charged C-terminal end (Glu393-Glu405),as well as Glu358 and Glu359 in AA-box 
1, both of which are critical for high affinity binding of the eIF2β-NTT [57, 93]. This proposed 
binding interface for the eIF2β-NTT is in good agreement with the previously reported contact sites 
for a human eIF2β-NTT fragment containing K-boxes 2 and 3 on hseIF5-CTD, determined by NMR 








The DWEAR-motif as transient element of the eIF5-CTD. 
An interesting and yet unrecognized characteristic of charge distribution and morphology on the 
surface of eIF5-CTD is a broad, mainly hydrophobic cleft lying parallel to helix α3 and ending on 
one side in the acidic area III (Fig. 4A and S3A). The comparison of the available eIF5-CTD structures 
shows that this cleft is conserved between fungi and mammals and may thus play a functional role. 
In the human ortholog the lower half of the cleft (next to the N-terminus of helix α3) is occupied by 
an α-helix formed by 11 residues of the extended C-terminal end (Fig. S4A). However, this 
extension is idiosyncratic to the human ortholog and not found in fungal eIF5, where the C-
terminal end is physically incapable of reaching this far, suggesting an alternative role for the 
hydrophobic cleft. Our structure of yeast eIF5(201-405) suggests that this role may in fact be the – 
at least transient – accommodation of helix α2 (residues 229-241) in a manner antiparallel to helix 
α3 (Fig. 5).  
To test this possibility, we took advantage of the technique of genetic code expansion which 
allows the incorporation of unnatural amino-acids such as the UV-inducible crosslinker p-benzoyl-
L-phynylalanine (Bpa) into specific positions of a protein[94]. The idea was that the 
accommodation of helix α2 into the hydrophobic cleft of the eIF5-CTD should be reflected in a 
specific crosslinking pattern, where the internal crosslink would be manifested in a faster migration 
speed during SDS-PAGE due to the formation of the more compact internal lariat topology of the 
primary structure. For this purpose Bpa was individually introduced in a number of positions of 
eIF5 along the DWEAR-motif (Asp220, Asp221, Trp223, Ala234, Glu238), and in area III (Glu261) 
(Fig. 5B). The purified eIF5(201-405)Bpa constructs were exposed to UV-radiation and the 
crosslinking products were analyzed by SDS-PAGE. In line with our assumption, UV-exposure 
resulted in the emergence of additional bands migrating faster than the original eIF5(201-405)Bpa 
constructs (Fig. 5C). No additional bands appeared at higher molecular weight, indicating the 
absence of dimer or oligomer formation. While no crosslinking was observed for the position 
Asp220, the strongest crosslink bands were obtained in the cases of E238-, A234-, E261Bpa and to 
a lesser extend, although still significant, for D221- and W223Bpa. Importantly, MS analysis 
confirmed that these bands are the product of internal crosslinks in eIF5(201-405), and the search 





(330RF331) and the loop preceding helix α11 (372FVPK375), while E221Bpa in area III was found to 




Figure 5. The DWEAR-motif as transient element of the eIF5-CTD. A)Proposed model of the DWEAR-motif (green) as 
part of the C-terminal HEAT-like domain of eIF5. According to this model, the amphipathic helix α2 is accommodated 
into the hydrophobic cleft between helices α3, α5 and α8, thereby allowing the conserved Arg233, Arg235 and Glu238 
of the DWEAR-motif to form ionic interactions with Glu253, Glu335 and Arg330, respectively. At the same time, 
Met227, Ile232, Ala236, and Leu239 of helix α1 point toward helix α3 thus forming a continuous hydrophobic interface 
within the cleft. This places the N-terminus of the DWEAR-motif with Asp220, Asp221, Trp223, Asp226, and Glu230 
next to Glu261, resulting in an extended negatively charged area III. Arg330, Glu335 and His336 indicate positions 
within helix α8 that were identified as target peptides for Bpa-crosslinks from Asp221 and Glu238 (see B). Compare 
also Fig. S4C. B)Positions in eIF5-CTD where the UV-inducible crosslinker p-benzoyl-L-phenylalanine (Bpa) was 
introduced (substituted residues are shown as sticks). The DWEAR-motif is colored green. Peptides that were identified 
as targets for internal crosslinks from Ala234/Glu238 and Asp221 are colored pink and cyan, respectively (see also 
Table 3). C) SDS-gels showing the UV- and time-dependent formation of internal crosslink bands (IntXL) for the 
eIF5(201-405)Bpa constructs (5 µM of the protein were exposed to UV light for the indicated time on ice); crosslinks 








Table 3. Internal crosslinks in eIF5(201-405)Bpa constructs. 
 Crosslinked peptides 
Construct Bpa peptide Target peptide Site Mass (Da) Error (ppm) m/z 
D221Bpa VKDbEWAVDMSE QIK 205-207 1962.9116 -1.9 555.7913 
 bEWAVD FLGLEHK 336-337 1712.8161 -1.0 571.6102 
A234Bpa bRAKELE FVPKEVSK 372-373 1929.0430 -2.0 483.0162 
 bRAKELE RFLGLEHK 330-331 1747.0014 2.0 583.0053 
 bR FVPKEVSK 375-379 1358.7377 0.1 453.5840 
 EAIRbR FGTK 367 1346.7144 0.0 449.5763  
 EAIRbR FGTK 367 1346.7144 0.3 673.8601 
 bR KFVPK 374-375 1043.5966 0.1 348.5370 
 bR FVPK 374-375 915.5028 -0.3 458.2550 
E238Bpa bLEVNSE KFVPK 374-375 1558.8025 -0.4 779.9049 
 bLE FVPKEVSK 372-374 1444.7627 -0.6 482.2590 
 bLEVNSE FVPK 374-375 1430.7201 -0.2 715.8637 
 AKbLE FVPK 374 1200.6663 0.0 600.8367 
The likely target positions in the target peptides are underlined. 
 
In theresulting structural model, Ile232, Ala236, and Leu239 point toward helix α5, thus 
forming a continuous hydrophobic interface, while the outward pointing charged residues of the 
amphipathic helix α2 would allow the formation of polar interactions to the adjacent regions in 
helices α3 and α8 and the loop preceding α11. Interestingly, as helix α2 is formed by the C-terminal 
half of the DWEAR-motif (231AIRARAKEL239) [69], this structural role would provide an explanation 
for the high degree of conservation of residues such as Arg233, Arg235 and Glu238. At the same 
time, the N-terminal mainly negatively charged half of the motif (220DDEWAVDMSEE230) would 
come to lie between the C-terminal ends of helices α3 and α8, respectively, thereby 
complementing the acidic area III. Importantly, independent support for the manually generated 
model presented in Figure 5 is provided by the modeling server CluPro[95, 96], which predicts two 






Taken together, these observations indicate that, in contrast to previous assumptions [68, 
69], helix α2 and the DWEAR-motif form an at least transient element of the eIF5-CTD rather than 
of the preceding flexible linker region (Fig. 1A and 5A). This would in part provide an explanation 
for its high degree of conservation among eIF5 orthologs via a structural role for some of its 
residues (Fig. S1). At the same time this suggests that the C-terminal domain itself, not the linker 
region, is involved in the stabilization of the guanine nucleotide bound to the γ-subunit of eIF2. In 
order to assess this possibility the effect of different eIF5 constructs on the nucleotide binding 
properties of eIF2 were studied using fluorescent derivatives of GDP and GTP (see below). 
 
Mant-GDP and -GTP as fluorescence-labeled GDP/GTP analogs to study nucleotide binding by 
eIF2 
Derivatives of guanine nucleotides, in which the fluorescent mant group is attached to the 2’ or 3’ 
positions of the ribose ring, have been widely used to study the nucleotide binding properties of a 
variety of GTP-binding proteins. The binding reaction of a mant-nucleotide to a protein can be 
monitored either by direct excitation of the mant group itself (at 355 nm), in which case the 
binding event is manifested in a change in the quantum yield of the fluorophore at its emission 
wavelength (440 nm) due to an environmental change, or indirectly by Foerster Resonance Energy 
Transfer (FRET) from a nearby tryptophan residue (excited at 280 nm) to the mant-nucleotide.    
Despite their widespread use, no study exists so far in which mant-nucleotides were used to 
monitor guanine nucleotide binding to eIF2. To test the feasibility of such experiments, both 
options for the excitation of the mant group were tested for mant-GDP and mant-GTP in the 
presence of eIF2 (Fig. 6). For both nucleotide derivatives, their binding to eIF2 resulted in a 
significant fluorescence change upon direct excitation. Likewise, a substantial energy transfer 
between tryptophan residues and the mant group was observed, which was accompanied by a 
simultaneous decrease in tryptophan fluorescence at ∼350 nm. Importantly, both fluorescence 
signals obtained either by direct or by indirect excitation were lost upon the addition of excess 
unlabeled GDP or GTP but not with ADP or ATP. Thus, mant-nucleotides seem to bind specifically 







Figure 6. Fluorescence experiments 
for the interaction between eIF2 and 
mant-labeled guanine-nucleotides. A) 
Emission spectra for 50 nM eIF2 
(black), mant-GDP (green) and eIF2 in 
the presence of mant-GDP (red) upon 
excitation at 280 nm. B) Emission 
spectra for mant-GDP (black) and 50 
nM of eIF2 in the presence of mant-
GDP (red) upon direct excitation of 
the mant-group at a wavelength of 
355 nm. C-D) Equilibrium titrations of 
100 nM eIF2 with mant-GDP either 
alone (C) or in the presence of 5 mM 
eIF5(201-405) (D). The binding 
reaction was monitored by FRET 
between eIF2 (excited at 280 nm) and 
the mant-group of the nucleotide 
(emission monitored at 440 nm). The 
black line shows the fit to the data, 
using a quadratic one-side binding 
model. E-F) Equilibrium titrations of 
100 nM eIF2 with mant-GTP alone (E) 
or in the presence of 5 mM eIF5(201-




Equilibrium titrations of eIF2 with the mant-nucleotides give equilibrium dissociation 
constants (Kd) of ∼20 and ∼30 nM for mant-GDP and mant-GTP, respectively (Fig. 6C/E and Table 
4). For mant-GDP this value is very close to that previously measured for GDP by nitrocellulose 
filtration (20 ± 5 nM)[97]. However, the value obtained for mant-GTP is significantly (57-fold) lower 
than that reported for GTP (1700 ±1000 nM) [97]. Previous studies have shown that nucleotide 
binding by GTP-binding proteins, including the eIF2γ paralog EF-Tu, is not perturbed by the mant-
group [98-100]. It is therefore possible that the high value previously reported for GTP might be 
due to the used method of nitrocellulose filtration in combination with the relatively fast 







Figure 7. Influence of eIF5 on the dissociation of mant-nucleotides from eIF2. A) Time courses for the dissociation of 
mant-GDP from eIF2 (100 nM eIF2 with 125 nM mant-GDP, followed by the addition of 5 µM unlabeled GDP) in the 
absence (black) or in the presence of different eIF5 constructs (5 µM): Full-length eIF5 (green), eIF5(201-405) (yellow), 
eIF5(241-405) (red) and the point mutant eIF5(1-262) (cyan). The grey lines represent single-exponential fits which 
yielded the respective apparent rate constants kapp. B) Time courses for the dissociation of mant-GDP from eIF2 (100 
nM eIF2 with 125 nM mant-GDP, followed by the addition of 5 µM unlabeled GDP) in the absence (black) or in the 
presence of 5 µM eIF5(201-405) (yellow), eIF5(241-405)D220A (green), eIF5(241-405)D221A (red), eIF5(241-
405)W223A (blue), eIF5(241-405)R235S (pink) and eIF5(241-405)Q293R (cyan). C) Time courses for the dissociation of 
mant-GTP from eIF2 (100 nM eIF2 with 125 nM mant-GTP, followed by the addition of 5 µM unlabeled GDP) in the 
absence (red) or in the presence (black) of eIF5(201-405) (5 µM). D) Structure of the eIF5-CTD (with the DWEAR-motif 
in green modeled as part of the CTD as shown in Fig. 5A.Positions of point mutations used in the mant-GDP 
dissociation experiments are shown as sticks. 
 
Dissociation rate constants for mant-GDP and mant-GTP were determined by chase 
experiments with excess of unlabeled GDP (Fig. 7). Under these conditions, every mant-nucleotide 










kapp   (min





K1/2 (eIF5)      
(nM)d 
eIF2       
 mGDP 0.14 ± 0.05  7 x 106 20 ± 5  
 mGTP 2.32 ± 0.11  7.7 x 107 30 ± 3  
+ eIF5(FL)       
wt mGDP 0.068 ± 0.004     
+ eIF5(201-405)       
wt mGDP 0.06 ± 0.005 0.061 ± 0.002 4.6 x 106 13 ± 4 123 ± 28 
wt mGTP  2.0 ± 0.1 5.7 x 107 35 ± 6  
A309E mGDP 0.064 ± 0.004    209 ± 66 
K313E mGDP 0.066 ± 0.006    640 ± 125 
D220A mGDP  0.088 ± 0.002    
D221A mGDP  0.08 ± 0.002    
W223A mGDP  0.112 ± 0.004    
E230A mGDP  0.066 ± 0.002    
R235S mGDP  0.088 ± 0.001    
E261A mGDP  0.068 ± 0.002    
E271A mGDP  0.073 ± 0.004    
Q293R mGDP  0.105 ± 0.003    
E298A mGDP  0.07 ± 0.002    
+ eIF5(216-405)       
wt mGDP  0.06 ± 0.005    
+ eIF5(241-405)       
wt mGDP  0.108 ± 0.006    
+ eIF5(1-262)       
wt mGDP  0.142 ± 0.01    
a
 Obtained from three independent experiments with 100 nM eIF2 in the presence of 5 µM of the respective eIF5 construct. 
b
 The bimolecular association constant was calculated according to the relation kon = koff/Kd 
c
Kd is the equilibrium dissociation constant between eIF2 and mant-GDP or mant-GTP. 
d
K1/2 is the apparent equilibrium dissociation constant between eIF2 and the eIF5 construct, obtained from the dependency of  
the kapp of mant-GDP dissociation from eIF2 on the eIF5 concentration. 
 
association is negligible. Thus, the rate by which the fluorescence signal decreases corresponds to 
the dissociation rate constant of the mant-labeled nucleotide. Single-exponential fitting of the 
resulting time courses gives values of 0.14 min-1 and 2.3 min-1 for mant-GDP and mant-GTP, 
respectively (Table 4); both values are similar to those reported previously [44, 69]. In combination 
with the Kd values obtained in equilibrium titration experiments, the obtained koff values give 
estimates for the bimolecular association constants (kon) of 7 x 10
6 M-1 min-1 and 7.7 x107 M-1 min-1 
for mant-GDP and mant-GTP, respectively. Taken together, these results show that mant-GDP and 
mant-GTP are suitable fluorescent guanine nucleotide derivatives to study the nucleotide binding 






The eIF5-CTD interacts directly with the γ-subunit of eIF2 to stabilize the bound nucleotide. 
To test the hypothesis that eIF5-CTD is directly involved in the stabilization of eIF2-bound 
nucleotides, we used fluorescence-based chase experiments with mant-GDP. For this purpose, 
eIF2⋅mant-GDP was mixed with excess of unlabeled GDP either in absence or presence of eIF5, and 
the resulting decrease of fluorescence due to mant-GDP dissociation and replacement by GDP was 
monitored over time (Fig. 7). In the absence of eIF5, mant-GDP dissociates from eIF2 with an off 
rate (koff) of 0.14 min
-1, which is decreased more than 2-fold to 0.068 and 0.06 min-1 in the 
presence of full-length eIF5 and eIF5(201-405), respectively. At the same time, the Kd for the 
eIF2⋅mant-GDP interaction decreased nearly 2-fold to 13 nM, giving a bimolecular association 
constant (kon) of ∼4.6 x 10
6 M-1 s-1. For the construct eIF5(216-405), which lacks most of helix α1 
but contains the DWEAR-motif and should thus retain the structural integrity of helix α2 in the 
context of the CTD, koff was identical to that of the longer fragment (0.06 min
-1). By contrast, the 
construct lacking the DWEAR-motif (eIF5(241-405)) showed a significantly reduced but not 
completely abolished ability to stabilize mant-GDP on eIF2 (koff = 0.11 min
-1). Finally, the construct 
eIF5(1-262), which contains the entire N-terminal domain, linker region, DWEAR-motif, and helix 
α3 of the CTD, showed no stabilizing effect at all (koff = 0.142 min
-1). These results indicate that, 
although the DWEAR-motif provides a major contribution to the GDP stabilizing function of eIF5, its 
effect is dependent on the structural context of the CTD and, moreover, complemented by regions 
of the CTD that lie C-terminal to Val241 in the primary structure. 
Similarly, but to a lesser degree, dissociation of mant-GTP from eIF2 is as well affected by the 
presence of eIF5 (Fig. 7C). The dissociation rate decreases from 2.32 min-1 in the absence of eIF5 to 
2.0 min-1 in its presence. However, this is not accompanied by an increase in the overall binding 
affinity (Kd = 35 nM), indicating that together with the decreased dissociation rate also the 
association rate is slightly reduced to ∼5.7 x 107 M-1 min-1. 
Next, we tested a number of single point mutations of residues lying within the DWEAR-motif 
(D220A, D221A, W223A, E230A, and R235S) as well as area III and adjacent regions (E261A, E271A, 
E298A and Q293R), introduced into eIF5(201-405). Among the DWEAR-motif mutants only D220A, 





0.8, 0.112 and 0.088 min-1, respectively). E261A and E298A in area III showed very slight effects 
(koff = 0.068 and 0.071 min
-1, respectively). Q293R exhibited a strong negative effect on the ability 
of the eIF5-CTD construct to stabilize mant-GDP on eIF2 (koff = 0.105 min
-1), comparable to W223A. 
The importance of this observation lies in the fact that Gln293 lies within the hydrophobic pocket 
that is proposed to accommodate helix α2 (Fig. 5A and 7D). An arginine in this position would 
necessarily prevent the association of the DWEAR-motif and its placement next to area III due to 
sterical repulsion, resulting in the loss of the contribution by the DWEAR-motif. Consistently, 
Q293R shows only a residual activity corresponding to that of the eIF5(241-405) construct without 
the DWEAR-motif. Trp-quenching and pull-down experiments with the Q293R mutant and the 
eIF2β-NTT show that it retains its ability to bind eIF2β-NTT and therefore seems to be correctly 
folded in the region C-terminal to Val241 (Fig. S5). It should be noted however that the dissociation 
rates for all eIF5-CTD point mutants represent only apparent rate constants, obtained at only one 
eIF5 concentration (5 mM) at which eIF2 is saturated with eIF5(201-405). Thus, the observed 
effects for some mutants possibly reflect only a reduction in the affinity of eIF5 to eIF2 and not 
necessarily a direct involvement of the respective residues in the stabilization of the nucleotide. 
The next question was whether the eIF5-CTD, including the associated DWEAR-motif, 
mediates the stabilization of eIF2-bound nucleotides indirectly or through a direct contact to the γ-
subunit.For RhoGDIs it is known that the stabilization of the nucleotide is achieved through the 
formation of direct contacts to the area surrounding the nucleotide binding pocket of the G 
domain [101]. For eIF5-CTD or the DWEAR-motif, however, no such direct interaction to the eIF2γ-
subunit has so far been demonstrated, most likely due to the transient character of the contacts 
mediating GDP stabilization. To assess the spatial arrangement of eIF5-CTD relative to eIF2 in the 
eIF2⋅eIF5 complex, we performed UV-crosslinking experiments usingvarious eIF5(201-405)Bpa 
constructs (see above). Among the DWEAR-motif constructs particularly D221Bpa, W223Bpa and 
A234Bpa were found to form distinct crosslink bands migrating above the 100 kDa marker, which, 
according to MS analysis, represent specific crosslinks to the γ-subunit of eIF2 (Fig. 8A). Finally, 
D220Bpa and E238Bpa as well form crosslinks to eIF2γ, but with significantly reduced efficiency. 
Importantly, E261Bpa in area III as well produces a strong and distinct crosslink band with the γ-





that the DWEAR-motif and area III form a combined surface area (in the following called area IIIext 
for extended area III; see Fig. S4B) for their interaction with eIF2γ. A number of additional weak 
bands migrating at an apparent molecular weight of 130 kDa suggest conformational 
heterogeneity for this position in the eIF2⋅eIF5-CTD complex (it should be noted here that all the 
crosslink-products elute from an analytical size exclusion column at the same volume as the 
uncrosslinked eIF2⋅eIF5-CTD complex, thus indicating that the change in migration speed on the 
SDS-PAGE is most likely due to differences in the topology of the denatured crosslinked peptides 
(e.g. the crosslink occurred either at the end or the center of the target-chain) rather than an 
actual higher molecular weight). The only position that was found to form specific crosslinks to 
eIF2β and not to the γ-subunit was V270Bpa, which produced bands migrating only slightly above 
that of uncrosslinked eIF2γ (Fig. 8D, lanes 7-9). This is in good agreement with the crystal structure 
of the eIF5-CTD⋅eIF2β-NTT complex (Fig. 8E) and is further validated by UV-crosslink experiments 
with eIF2β(1-106) alone, which show a strong crosslink only from position V270Bpa (Fig. 10B/D).  
Using ESI-MS/MS2analysis in an Orbitrapmass spectrometer, followed by an analysis of the 
obtained data with the StavroX software [102], we were able to identify potential target peptides 
for the crosslinks from positions W223Bpa, A234Bpa, E238Bpa and E261Bpa (Table 5). Several of 
the linkage sites were identified more than once (e.g. 508HWR510 from position Trp223 or 
409ADRLV413 from positions Ala234 and Glu238), which increases the probability that the 
assignment of the crosslinked peptides is correct. According to a homology model of eIF2γ, based 
on the structure of aIF2γ from the archaeon S. solfataricus, all the identified linkage sites lie in the 
frontal face of eIF2γ in domains II and III and in the vicinity of switch 1 and switch 2 of the G 
domain (Fig. 13A). In line with their spatial proximity in helix α1 of eIF5(201-405), positions 
A234Bpa and E238Bpa were found to crosslink predominantly to the same target peptide 
(409ADRLV413), which lies at the bottom of the domain II β-barrel in the eIF2γ homology model, 
directly below switch 1. The immediately preceding peptide 404PTLCR408, with Arg408 as likely 
linkage site, was identified as additional target only for E238Bpa. For W223Bpa and E261Bpa on 
the other hand, the target sites were found to lie in domain III and in direct vicinity to the switch 2 
region, with 508HWR510, the main target for W223Bpa, in the last β-hairpin loop, and 444KTD446, the 






Figure 8. Mapping of the direct interactions between the eIF5-CTD and eIF2γ. A) Coomassie stained SDS-gels showing 
the UV- and time-dependent formation of crosslinks between eIF2γ and the indicated eIF5(201-405)Bpa constructs 
(crosslink bands are indicated by red brackets). For each experiment, 2 µM eIF2 was mixed with 3 µM GDP and 5 µM 
eIF5(201-405)Bpa. B-C) High-resolution MS2 fragmentation spectra for the crosslinks of A234Bpa (B) and E238Bpa (C) 
to their target peptide in eIF2γ. A series of b and y product ions were detectable for the peptides involved in the 
crosslinks; the relative intensity of the observed peaks is plotted against their mass-to-charge ratio (m/z). The inset 
shows the observed product ions mapped to the sequences of the crosslinked peptides; b stands for Bpa. D) SDS-gels 
showing formation of crosslinks between eIF2 (2 µM) and the indicated eIF5(201-405)Bpa constructs (5 µM) in the 
presence of 3 µM GDP, 3 µM GTP or 3 µM GTP and 3 µM Met-tRNAi (crosslink bands are indicated by brackets). E) 
Structure of the eIF5-CTD (with the DWEAR-motif in green modeled as part of the CTD as shown in Fig. 5A) in complex 
with the eIF2β-NTT (yellow), indicating the positions where Bpa was introduced (residues shown as sticks). The dashed 







Taken together, these results provide evidence for a direct interaction between the eIF5-CTD 
and the γ-subunit close to the nucleotide binding pocket in the free eIF2⋅eIF5 complex. Within 
eIF5-CTD, this interaction seems to be mediated by a continuous binding interface composed of 
area III and the associated DWEAR-motif (forming area IIIext) that is required for the full nucleotide 
stabilizing effect on eIF2.  
 
Table 5. Crosslinks between eIF5(201-405)Bpa and eIF2γ. 
 Crosslinked peptides 
Construct Bpa peptide Target peptide Site Mass (Da) Error 
(ppm) 
m/z 
W223Bpa DEbAVDMSE VRKLEPNE 453-454 2111.9518 -2.9 704.65527 
 bAVD KHWRLIGWATIKK 509-510 2063.1183 -2.0 688.37726 
 VKDDEbAVD IEKHWR 507-510 2008.9739 -1.1 670.33099 
 bAVD KHWRLIGWATIK 509-512 1935.0238 -2.0 645.67914 
A234Bpa bR ADRLVGQVVGAK 411, 413 1637.9127 0.3 410.23355 
 bR ADRLVGQVVGAK 411-413 1637.9132 0.6 546.276 
 bR ADRLVGQVVGAK 411 1619.9042 1.6 540.63959 
E238Bpa AKbLE ADRLVGQVVGAK 411-413 1923.0703 0.2 641.69495 
 AKbLEVSNE ADRLVGQVVGAK 409-412 2352.2558 0.0 588.82007 
 AKbLEVSNE ADRLVGQVVGAK 411-412 2352.2569 0.5 784.75824 
 bLEVSNE ADRLVGQVVGAK 411-413 2153.1235 -0.1 539.03632 
 bLEVSNE ADRLVGQVVGAK 409-411 2153.1275 1.8 718.38037 
 bLE PTLCR 408 1139.5551 -0.3 570.28119 
 bLE VDPTLCR 408 1296.6265 -2.2 432.88034 
E261Bpa QAGbDKENLPSD RLLGVKTDGQK 447 2638.3460 -0.4 880.12018 
 WILEQAGbDKE LLGVKTD 444-446 2184.1241 0.8 728.71289 
The likely target positions in the target peptides are underlined.  
 
 
Potential involvement of helix αCβ in the eIF2β-NTT in the pre-organization of the eIF5-CTD 
relative to eIF2γ 
According to the above results, eIF5-CTD provides two distinct contact surfaces for the 
heterotrimeric eIF2 complex in solution: On the one hand, the acidic area IIIext provides the 
interface for direct interactions with the γ-subunit. On the other hand, the acidic area I is 
responsible for high affinity interactions with the eIF2β-NTT and thus for the efficient recruitment 






Figure 9.Role of helix αC
β
 in eIF2β-NTT in the pre-organization of the eIF5-CTD relative to eIF2γ. A) Structure of the 
eIF5-CTD (the DWEAR-motif (green) is modeled as in Fig. 5A in complex with the eIF2β-NTT (yellow). The black circle 
indicates area I of the eIF5-CTD, which forms the contact site for K-boxes 1-3 of eIF2β. Helix αC
β
 points away from area 
I, ending atop of repeat RI and next to area III
ext
, which contains residues involved in the interactions with eIF2γ (see 
Fig. 8). eIF2γ and the associated eIF2β-CTD are shown schematically; the linker between eIF2β-CTD and eIF2β-NTT is 
shown as yellow dashed line. The double arrow indicates the direct interaction between eIF5 and eIF2γ, which might 
be promoted by the directionality provided by helix αC
β
. Ala309 and Lys313 in eIF5 are indicated in pink. B) 
Dependency of kapp for dissociation of mant-GDP from eIF2 on the concentration of eIF5(201-405) (closed circles), 
eIF5(201-405)A309E (closed triangles) and eIF5(201-405)K313E (open circles). Standard deviations, obtained from two 
independent experiments, are given as error bars. C) Equilibrium titrations of 0.5 µM eIF5(241-405) with increasing 
amounts of wild-type eIF2β(1-106) (closed circles) or the K-box mutant K3∆ (closed triangles) and of 0.5 µM eIF5(201-
405)K313E with wild-type eIF2β(1-106) (open circles). The Trp quenching signal was plotted against the concentration 
of the eIF2β-NTT constructs. The Kd of the eIF5(201-405)K313E⋅eIF2β(1-106) complex is 212 ± 30 nM and thus similar 
to that of the eIF5(241-405)⋅eIF2β(1-106)K3∆ complex (200 nM) and ∼3-fold reduced compared to the eIF5(201-
405)K313E⋅eIF2β(1-106) complex (70 nM). It should be noted that the quenching signal for the eIF5(201-
405)K313E⋅eIF2β(1-106) complex is reduced compared to the complexes with eIF5(241-405) due to the presence of 
one additional Trp residue (Trp223) in eIF5(201-405).  
 
eIF2γ we asked whether the eIF2β-NTT might indirectly promote these interactions by pre-





point for eIF2. As indicated by the crystal structure of the eIF5-CTD⋅eIF2β-NTT complex, this could 
involve helix αCβ, which in full-length eIF2β is followed by the eIF2γ-bound eIF2β-CTD and could 
thus induce an orientation of eIF5-CTD relative to the γ-subunit that is favorable for their direct 
contact (Fig. 9A). For this purpose we purified two eIF5(201-405) constructs in which either A309 
or K313 were exchanged against glutamate, thereby disrupting the interface for αCβ either by 
sterical or electrostatic repulsion (K313 forms a salt bridge to D114 in αCβ; Fig. 9A and 4). These 
mutants were then tested for their ability to stabilize mant-GDP on eIF2. Neither of the mutants 
had a severe negative impact on the GDP-stabilizing effect of the eIF5-CTD, with off rates of 0.065 
min-1 and 0.068 min-1 for A309E and K313E, respectively, compared to 0.06 min-1 for the wild-type 
(Fig. 9B and Table 4). However, the concentration of the respective construct that was necessary to 
achieve the half maximal stabilizing effect increased relative to the wild-type construct (K1/2 = 123 
nM) by ∼2- and 5-fold for A309E (K1/2 = 209 nM) and K313E (K1/2 = 640 nM), respectively, indicative 
of a reduced affinity to eIF2γ. Trp-quenching experiments showed nearly wild-type affinities of the 
K313E mutant for eIF2β(1-106) (Fig. 9C and Table 1), in line with its relative distance from the main 
interface for K-box binding in surface area I in the crystal structure. Thus, under the assumption 
that eIF5 interacts with the isolated eIF2β-NTT in the same way as in the heterotrimeric eIF2 
complex, which was supported by the Bpa crosslinking experiments from position Val270, these 
results indicate that these mutants increase the koff/kon ratio in the direct interface between eIF5-
CTD and eIF2γ, which could be explained by a reduced ability of helix αCβ in eIF2β to pre-arrange 
eIF5-CTD relative to the γ-subunit. 
 
Interactions between eIF5-CTD, eIF2β-NTT, eIF1 and eIF3c-NTD 
Previous biochemical and genetic studies have identified the C-terminal domain of eIF5 as one of 
the key components in eukayal translation initiation as versatile interaction partner for other 
initiation factors. In recent years particularly the dynamic interplay of the eIF5-CTD with eIF1 and 
eIF2 came into focus as it was proposed to be pivotal for the fidelity of start codon selection and P i 
release from eIF2 [21, 57, 63, 103]. However, the exact nature of the structural rearrangements 
that are thought to occur between these factors upon the encounter of the AUG start codon have 





relative arrangement on the surface of eIF5-CTD. In light of our data on the interactions of eIF5-
CTD with eIF2β and eIF2γ, we therefore tried to gain further insight into its interactions with eIF1 
and the N-terminal domain of eIF3c. For this purpose we used Bpa incorporated into specific 
positions of eIF1 or eIF5 by genetic code expansion, to detect spatial proximity by UV-induced 
crosslinking and subsequent MS analysis. 
First, we tested different eIF5(201-405)Bpa constructs for their ability to form crosslinks to 
eIF1, eIF2β(1-106) or eIF3c(1-136), respectively (Fig. 10). Bpa incorporated into positions Asp220, 
Asp221 and Trp223 of the DWEAR-motif showed nearly no crosslinking at all (Fig. 10A-C, lanes 1-4). 
By contrast, the other Bpa-constructs (Glu238, Glu261, Ser268 and Val270) showed clear UV- and 
time-dependent crosslink bands for eIF1, eIF2β-NTT as well as eIF3c-NTD, however, with significant 
differences in the efficiency (Fig. 10A-C, lanes 5-8). For eIF1 the strongest bands were obtained 
from positions Glu238 and Val270 (Fig. 10A, lanes 5 and 8, respectively), while slightly weaker 
bands were observed for Glu261 and Ser268 (Fig. 10A, lanes 6 and 7, respectively). In line with the 
crystal structure, the eIF2β-NTT crosslinked efficiently to S268- and V270Bpa (Fig. 10B, lanes 7 and 
8, respectively), whereas E238- and E261Bpa showed significantly weaker bands in comparison 
(Fig. 10B, lanes 5 and 6, respectively). The opposite tendency was observed for eIF3c-NTD, with the 
strongest crosslink occurring from position Glu238, followed by Glu261 and Val270 and virtually no 
crosslink from S268 (Fig. 10C, lanes 5, 6, 8, and 7, respectively). These data result in the following 
main conclusions:  
i) E238Bpa lies close to a common binding site for eIF1 and eIF3c-NTD. The internal crosslinks 
(see above) suggest a position for E238Bpa close to the C-terminus of helix α8 and the loop 
preceding helix α11. This would suggest the conserved basic surface area II as most likely candidate 
for the interactions with eIF1 and eIF3c-NTD, in line with previous reports that identified this 
region as primary interface for both factors [57, 104] (e.g. the H336Q-K337Q double mutant in eIF5 
was found to reduce binding to eIF3c and eIF1 [57] and the same dipeptide is found in one of the 
identified target peptides (331FLGLEHK337) for E238Bpa (Table 3)).  
ii) eIF1 not only binds to area II close to Glu238 but is also able to interact with a second 
interface in direct vicinity to Val270 on the opposite side of eIF5-CTD. This would suggest 





Figure 10.Mapping of the 
interactions between eIF5-
CTD, eIF2β-NTT, eIF1 and 
eIF3c-NTD by crosslinking. 
A-C) SDS-gels showing the 
UV-dependent formation of 
crosslinks for the complexes 
between different eIF5(201-
405)Bpa constructs (Bpa 
positions indicated above 
each lane) and eIF1 (A), 
eIF2β(1-106) (B) and 
eIF3c(1-136) (C). In all cases 
(except the -UV samples), 
samples were exposed to 
UV light for 30 min on ice. 
D) Dependency of the 
crosslink patterns from 
positions Glu238 and 
Val270 in eIF5(201-405) on 
the composition of the 
formed complexes.  
E) UV- and time dependent 
formation of crosslinks 
between eIF1Bpa (with Bpa 
in positions Phe9 and 
Phe13) and eIF5(201-405) in 
the absence (lanes 1-6) or 
presence of the eIF2β-NTT 
(lanes 7-13).  
F) Influence of K-box 
mutations on the ability of 
the eIF2β-NTT to reduce 
crosslinking between eIF1-
F13Bpa and eIF5(201-405). 
The relative intensities of 
the crosslink bands were 
determined using ImageJ. 
G) Structures of eIF1 (cyan; 
PDB: 2OGH) and the eIF5-CTD (the DWEAR-motif (green)is modeled as in Fig. 5A) in complex with the eIF2β-NTT 
(yellow), indicating the positions where Bpa was introduced (as sticks). In eIF5, Asp220, Asp221, Trp223 and Ser268 are 
shown in black; Glu238, Glu261 and Val270 are shown in red, blue and green, respectively. Dashed lines indicate the 
crosslinks between the components of the minimal MFC formed from the respective positions; the thickness of the 
dashed lines roughly corresponds to the relative intensity of the crosslink bands shown in A-D. Black circles indicate 
known interaction surfaces on eIF5 and eIF1: area II on eIF5 was proposed to interact with eIF1 and eIF3c; the KR area 
on eIF1 interacts with eIF3c and the ribosome; the KH area of eIF1 was shown to interact with the eIF5-CTD and/or 
with the eIF2β-NTT [55, 57, 104]. The asterisk marks a crosslink that is not formed in the presence of the eIF2β-NTT. 
 
iii) Although all three factors seem to have preferred regions for their interactions with eIF5-





binary complexes. This necessarily raises the question whether the interactions in these regions 
can occur simultaneously or are mutually exclusive.  
In order to address this question, we repeated the UV-crosslinking experiments, this time 
forming the respective ternary and quaternary complexes of eIF5(201-405)E238Bpa or -V270Bpa 
with eIF1, eIF2β-NTT and/or eIF3c-NTD. Interestingly, diametrically opposite effects were observed 
for the two tested positions: In case of E238Bpa the simultaneous addition of eIF1 and eIF2β-NTT, 
each in 2-fold molar excess over eIF5(201-405)Bpa, increased the crosslinking efficiency to both 
proteins ∼2-fold relative to their respective binary complexes (Fig. 10D, compare lanes 1, 2 and 4). 
The addition of eIF3c-NTD (equimolar to eIF1) resulted in a significant loss in band intensity for 
eIF1 as well as eIF2β; this negative effect could be slightly but reproducibly compensated in the 
complexes containing all four components (Fig. 10D, compare lanes 5-7). In stark contrast to these 
observations, the addition of eIF2β-NTT to the V270Bpa construct completely abolished any 
crosslinks to eIF1 or eIF3c-NTD (Fig. 10D, compare lanes 8, 10 and 14), while eIF1 in turn was able 
to partially suppress the crosslinks to eIF3c-NTD in the eIF5(201-405)Bpa⋅eIF1⋅eIF3c-NTD complex 
(Fig. 10D, compare lanes 8, 10 and 12). 
To further test these results, we then introduced Bpa into eIF1 in positions Phe9 and Phe12 
of the flexible N-terminal tail (NTT) (Fig. 10G). Both constructs allowed specific crosslinks to 
eIF5(201-405), with two bands emerging in a UV- and time-dependent manner, migrating close 
together at ∼50 kDa (Fig. 10E, lanes 1-6). The addition of eIF2β-NTT in 2-fold molar excess over 
eIF1 caused a significant reduction of both eIF5-CTD⋅eIF1Bpa crosslinks (Fig. 10E, compare lanes 3 
and 6 with lanes 9 and 13). Interestingly, this negative effect of the eIF2β-NTT on the crosslink 
efficiency was particularly severe on the upper band which completely disappeared in the ternary 
complexes. The same experiments in the presence of the single and double K-box mutants of the 
eIF2β-NTT showed a clear correlation between their respective affinity to eIF5-CTD and their ability 
to reduce the crosslink efficiency between eIF1Bpa and eIF5 (Fig. 10F and 2). These observations 
indicate that the two bands originate from two alternative positions or orientations of eIF1 on the 
surface of eIF5-CTD with the upper band formed in an interaction that is incompatible with the 
presence of eIF2β, while the lower band is formed in an interaction which is not completely 





eIF5-CTD are the same as those that result in the crosslinks from V270Bpa and E238Bpa to eIF1, 
respectively.  
In combination with the tryptophan quenching and structural data, these observations 
support a model in which the respective interfaces for the interactions of eIF5-CTD with other 
initiation factors change significantly depending on the composition of the complex. Particularly 
interesting is the case of eIF1, for which the crosslink data indicate two distant binding sites on 
eIF5-CTD. The first binding site (interface I) lies close to Val270 and is completely abrogated by the 
binding of eIF2β-NTT, presumably due to an overlap between both binding sites (Fig. 10G). 
According to Luna et al.[63] this interaction is independent of the eIF1-NTT. Thus, eIF1 seems to 
interact with interface I through its globular core domain, most likely involving residues within the 
so-called KH area and surrounding Gly97 [63, 104]. The second binding site (interface II) lies close 
to Glu238 and thus most likely involves the positively charged area II. This binding site is shared 
with eIF3c-NTD and in stark contrast to interface I this contact is not only compatible with but even 
slightly strengthened by the presence of the eIF2β-NTT (Fig. 10D, lane 4). The eIF1-NTT, which is 
dispensable for the interaction with interface I [63], was shown to be required for the cooperative 
binding of eIF1 and eIF2β to eIF5-CTD and assembly of the MFC [55, 104]. This would suggest that 
the eIF1-NTT, rich in acidic and aromatic side chains, is responsible for the interaction with eIF5-
CTD in the positively charged area II (interface II), where it binds simultaneous and in close 
proximity (or even in direct contact) to eIF3c-NTD. This placement of eIF1-NTT and eIF3c-NTD is, 
moreover, in good agreement with the crystal structure of eIF2β(66-106) bound to eIF5-CTD, in 
which the N-terminus of the former lies directly above area II and thereby in a suitable position to 
contact both factors through the linker-region between K2 and K3 (Fig. 4A and 10G). Thus, within 
the eIF5-CTD⋅eIF2β-NTT⋅eIF1⋅eIF3c-NTD complex, the minimal MFC core, eIF1 would remain 
directly associated with eIF5-CTD area II only through its NTT. At the same time, the C-terminal 
domain of eIF1 could remain associated with eIF3c-NTD through the ‘KR area’ in the N-terminal α-
helix, and the KH area of eIF1, after its displacement from eIF5-CTD by the eIF2β-NTT, would 
become available for direct interactions with the eIF2β-NTT itself [104]. Considering the 





that the above described interaction network represents the state in which the four initiation 





Figure 11. Mapping of the interactions between eIF5-NTD and eIF2 by Bpa crosslinking. A) SDS-gels showing the UV-
dependent formation of crosslink bands between 5 µM of the different eIF5(FL)Bpa constructs and 2 µM eIF2. 
Crosslinks to eIF2γ are indicated by red brackets; the strong crosslink bands for positions Asn9, Phe13 and Tyr16 
directly below the 130 kDa marker (marked with *) also occur in the absence of eIF2 and are thus likely to originate 
from a crosslink between two eIF5 molecules. B)SDS-gel showing the UV- and time-dependent formation of crosslink 
bands between eIF2 and eIF5(FL)F13Bpa in the presence of 3 µM GDP, 3 µM GTP or 3 µM GTP/Met-tRNAi (crosslink 
bands are indicated by red brackets). C) Solution structure of the eIF5-NTD from H. sapiens (PDB: 2G2K) indicating the 
positions where Bpa was introduced in the yeast homolog (residues shown as pink sticks). Arg15 (cyan) in the flexible 
N-terminal tail corresponds to the putative catalytic arginine-finger [52, 53]. Dashed lines indicate crosslinks to eIF2γ. 






eIF5-NTD and eIF5-CTD interact with eIF2γ in the eIF2⋅GTP⋅Met-tRNAi ternary complex 
Up to this point all interaction studies were carried out in the absence of Met-tRNAi. It is therefore 
unclear, whether the direct contact between eIF5-CTD and eIF2γ would persist in the presence of 
the charged initiator tRNA and in the context of the eIF2⋅GTP⋅Met-tRNAi ternary complex. The UV-
crosslinking experiments with Bpa constructs of the eIF5-CTD were therefore repeated, this time in 
the presence of a 2-fold molar excess of Met-tRNAi over eIF2, equimolar to the Bpa construct. As 
shown in Figure 8D, the crosslink efficiency for the tested constructs with Bpa in positions Trp223, 
Glu261 or Val270 remained virtually unchanged upon the addition of the initiator tRNA. This 
suggests that the underlying direct interactionsof eIF5-CTD to the eIF2γ-subunit andto eIF2β exist 
in the complex with free eIF2, as well as with the ternary complex of eIF2⋅GTP with the Met-tRNAi. 
Next, we studied whether it would also be possible to detect direct interactions between the 
eIF5-NTD and eIF2 in solution using UV-inducible crosslinking. For this purpose, Bpa was 
introduced into various positions of the NTD in full-length eIF5. In the flexible N-terminal 
extension, the Bpa moiety was introduced in positions Asn9, Phe13 and Tyr16 and thus in direct 
vicinity to Arg15, the potential arginine-finger of eIF5 (Fig. 11C). Moreover, Bpa was introduced in 
lieu of Arg28 in the first hairpin loop of the N-terminal β-sheet, and Arg127 next to the zink-finger 
motif. Among the three N-terminal positions N9Bpa and Y15Bpa resulted only in faint crosslink 
bands (Fig. 11A), the strongest of which (at ∼120 kDa) occurred even in the absence of eIF2 and 
thus most likely represents a crosslink between two eIF5 molecules. Although the same band also 
occurred with F13Bpa, here two additional strong crosslink bands emerged at ∼100 and ∼140 kDa 
in a UV- and time-dependent manner only in the presence of eIF2 (Fig. 11A). A similar crosslink 
pattern was observed for R28Bpa, while no clear eIF2-dependent crosslinks could be obtained for 
position R127Bpa. MS-analysis of the crosslink bands from F13Bpa and R28Bpa revealed that both 
positions crosslink specifically to eIF2γ within the eIF2 complex. However, it was so far not possible 
to identify any target peptides of the crosslink. As the weaker crosslink bands were not analyzed by 
mass spectrometry, it cannot be ruled out at present that some of them are due to crosslinks to 
either the α- or β-subunit. Moreover, it should be noted that none of the eIF5-NTD-Bpa constructs 
were so far tested for their ability to stimulate GTP hydrolysis on eIF2 on the ribosome; it is 





between eIF5 and eIF2. Nonetheless, the presented results indicate that the eIF5-NTD within the 
eIF2⋅eIF5 complex is positioned relative to eIF2 in a way that favors specific crosslinks to the γ-
subunit particularly from the N-terminal subdomain (Fig. 11C).  
Interestingly, the addition of Met-tRNAiapparently causes slightly reduced crosslinking 
efficiency from F13Bpa, which, however, seems to be accompanied by an increase in specificity for 
the two main crosslinks to eIF2γ (Fig. 11B). Thus, it seems that the spatial proximity between eIF5-
NTD and eIF2γ persists in the ternary complex. This proximity however wasnot found to depend 
strongly on the nucleotide state of eIF2 (except in the case of the increased specificity with the TC), 
with only slight increases in crosslinking efficiency for F13Bpa and R28Bpa when GTP was present. 
Moreover, the crosslinks were not affected by the presence of GDP and fluoroaluminates (Fig. S6). 
This observation is in line with the absence of any additional fluorescence signal due to the 
addition of AlFx to the eIF2⋅mant-GDP⋅eIF5 complex, and in line with the assumption that the Arg15 
of eIF5 requires the structural context of the scanning 43S pre-IC to perform its role. 
 
The eIF5-CTD competes with eIF2Bε-CTD for the interaction interface on eIF2γ. 
Previous studies revealed a high degree of structural homology between eIF5-CTD and the C-
terminal domain of eIF2Bε(residues 524-712), which forms the minimal catalytically active domain 
of the guanine nucleotide exchange factor eIF2B[1, 54, 74]. Mutational and biochemical studies 
demonstrated that this GEF activity is mediated by residues within the first two α-helices (repeat 
RI) of the eIF2Bε-CTD, whose mutagenesis directly affects its interactions to eIF2γ. In light of our 
own data, this indicates that eIF2Bε-CTD and eIF5-CTD contact eIF2γ through structurally 
corresponding regions in RI and RI/area III, respectively. It is therefore conceivable that both 
domains interact with a common interface on the eIF2γ-subunit (between G domain, domain II and 
domain III, close to the nucleotide binding pocket) to mediate either the stabilization (eIF5) or the 
destabilization (eIF2Bε) of the bound nucleotide. It has recently been proposed that eIF2Bγ, the 
second catalytically relevant subunit within the eIF2B complex, acts as a GDI displacement factor 
(GDF) that promotes the release of eIF5. This role of eIF2Bγ was proposed to be necessary to allow 
productive binding of eIF2Bε, which on its own was unable to compete efficiently with eIF5 for 





direct contact to eIF2γ is required for the efficient competition with eIF2Bε for their common 
substrate, which in turn would indicate that the role of eIF2Bγ as GDF is to force the eIF5-CTD out 




Figure 12. The DWEAR motif in the eIF5-CTD is 
required for efficient competition with eIF2Bε-CTD 
for their common substrate eIF2. The plot shows the 
dependency of kapp values for the dissociation of the 
eIF2⋅mant-GDP complex (100 nM eIF2 with 125 nM 
mant-GDP) on the concentration of the catalytic 
eIF2Bε-CTD either in the absence of eIF5 (closed 
circles), in the presence of 100 nM eIF5(241-405) 
(closed square) or in the presence of 100 nM 
eIF5(201-405) (open triangle). eIF2Bε-CTD and 
unlabeled GDP (5 µM) were added simultaneously to 
the mixtures of eIF2⋅mant-GDP and eIF5-CTD. 
Standard deviations from two independent 
experiments are given as error bars.  
 
 
In order to assess this question, the ability of full-length eIF2Bε or eIF2Bε(524-712) to 
compete either with eIF5(201-405) or eIF5(241-405) for the interaction with eIF2 was studied 
under steady-state conditions by monitoring the dissociation of mant-GDP from preformed 
eIF2·eIF5complex (eIF5 was added equimolar to eIF2) and increasing amounts of GEF. Both eIF5 
constructs interact identically with the eIF2β-NTT and should therefore be able to compete equally 
well with eIF2Bε for this interaction. However, only eIF5(201-405) contains the DWEAR-motif and 
therefore the entire interface required to interact with eIF2γ. Thus, if the above made assumption 
is correct, eIF5(201-405) should be more efficient than eIF5(241-405) in preventing eIF2Bε to 
promote mant-GDP release. As shown in Figure 12, this is indeed the case. While eIF5(201-405) 
efficiently prevents the binding of eIF2Bε and reduces the apparent Kd (K1/2) between eIF2Bε and 
eIF2⋅mant-GDP nearly 5-fold to 1920 ± 350 nM, eIF5(241-405) is significantly less efficient with an 
only 2-fold reduction (K1/2 of 700 ± 180 nM). However, in contrast to previous reports [105], we 
observed that the presence of either eIF5 construct had no negative effect on the koff of mant-GDP 
from the eIF2 complex at saturating eIF2Bε concentrations (Fig. 12). This indicates that the GEF at 





with eIF2 efficiently, an ability that at low (physiological) GEF concentrations is limited by the direct 
contact between eIF5 and eIF2γ.  
 
2.3 Discussion 
Using a combination of mutational, biochemical and structural approaches, this work provides new 
insights into intricate interaction network between eIF2, its multifunctional effector protein eIF5, 
eIF1 and eIF3c, with a particular focus on the eIF2⋅eIF5 complex. Due to the central role of these 
factors during the process of eukaryotic translation initiation, the presented observations have 
implications for nearly all steps of the initiation pathway from MFC and pre-IC assembly to 
scanning, start codon recognition and the general regulation of protein biosynthesis. 
 
The eIF5-CTD interacts directly with eIF2γ in the eIF2⋅eIF5 complex. Previous studies established 
that eIF5 folds into two structurally independent domains, the C-terminal and N-terminal domain, 
connected via a ‘linker region’ (LR) (Fig. 1A). The eIF5-NTD (in yeast) was defined as the first 152 
amino acids and contains the putative arginine-finger (Arg15) that is thought to stimulate GTP 
hydrolysis by eIF2 in the scanning pre-IC [51-53]. The eIF5-CTD was defined as comprising residues 
241-405, which fold into the atypical HEAT motif shown in Figure 1B, and provides interfaces for 
interactions with other eIFs to promote MFC and pre-IC assembly [1] (see below). The intervening 
residues 153-240 were proposed to form the flexible and unstructured LR, in which the conserved 
residues of the DWEAR-motif (residues 220-238) mediate the stabilization of the eIF2-bound GDP 
molecule [69]. Our own data support this role of the DWEAR-motif. However, they also strongly 
suggest that the DWEAR-motif does not belong to the LR but in fact forms an at least transient part 
of the eIF5-CTD. In the resulting structural model, helix α2 is accommodated in the hydrophobic 
cleft formed by the N-terminal helices of repeats RI to RIII, while residues D220-E230 augment area 
III (Fig. 5 and S3C). Together, the DWEAR-motif and area III form an extended, mainly negatively 
charged surface (area IIIext) of the eIF5-CTD (Fig. S4B) that directly contacts eIF2γ and stabilizes the 
bound guanine-nucleotide (Fig. 7, 8 and 13). This assumption is in line with the observation that 





recruitment of eIF5 by the eIF2β-NTT) only in the structural context of the CTD [65, 69], while this 
ability is lost in a construct comprising residues 1-262 (Table 4). 
 
Figure 13. Model of the interactions between eIF5 and eIF2. A) Interaction map between eIF2 and eIF5 obtained by 
fluorescence and Bpa crosslinking experiments. eIF5-NTD and -CTD are shown in dark and light grey, respectively, with 
Bpa positions indicated (pink sticks). The eIF2β-NTT bound to eIF5-CTD and the eIF2β-CTD bound to eIF2γ (blue, with 
GDP in green) are shown in light and dark yellow, respectively. eIF2α is colored in beige. Red dashed lines indicate 
identified crosslinks between eIF5-CTD and eIF2γ, while black dashed lines indicate crosslinks were the target protein 
but no specific peptide could be identified. The heterotrimeric eIF2 complex was modeled using the structures of the 
archaeal ortholog (aIF2) and human eIF2α (PDBs: 3CW2, 1Q8K). B) Model of the eIF5-CTD in the context of the 43S pre-
IC, based on the cryo-EM map of the mammalian 43S pre-IC (EMDB accession code: 5658), the crystal structures of 
eIF1 and eIF1A bound to the 40S subunit [19, 50] and the interactions depicted in (A). The eIF5-CTD (blue cartoon) 
thereby comes to lie in the gap between eIF2γ (purple) and the platform of the 40S subunit (grey), placing the eIF2β-
NTT and area I in direct vicinity to the binding site for eIF1 (cyan cartoon; the circle indicates the KH area) and close to 





Central mechanistic questions that arise from the presented data are how eIF5-CTD contacts 
eIF2γ and how this interaction stabilizes the bound guanine nucleotide. The mass-spectrometry 
analysis of the crosslink data shows that particularly the N-terminal residues of the DWEAR-motif, 
as well as Glu261 from area III lie in direct vicinity to the frontal face of eIF2γ between G domain, 
domain II and domain III and thus close to the nucleotide binding pocket (Fig. 8 and 13). It is thus 
possible that eIF5-CTD stabilizes the nucleotide through direct contacts with the switch regions 
and/or the P-loop in a manner similar to the N-terminal α-helix bundle of RhoGDIs in complex with 
Rho proteins [106, 107] or the C-terminal α-helical ‘GoLoco’ motif in regulators of G protein 
signaling (RGS) of Gα proteins [108-110]. However, although the mutational analysis indicates that 
the conserved Asp220, Asp221, Trp223 and/or Arg235 in the DWEAR-motif could play a role in 
nucleotide-stabilization similar to the conserved Asp45 in the RhoGDI Cdc42 [110] or the arginine 
residues of the GoLoco motif [109], the absence of any effect of eIF5 on the fluorescence signal of 
eIF2-bound mant-GDP/GTP (excited directly or indirectly by FRET) rather speaks against the 
introduction of residues directly into the nucleotide binding pocket itself. Moreover, according to 
our structural model of the DWEAR motif as part of the eIF5-CTD (Fig. 5), the effect of Arg235 
mutations on nucleotide stabilization could also be explained by the putative structural role for the 
formation of the interaction interface within eIF5-CTD. A similar structural role for Asp220, Asp221 
and/or Trp223 can also not be excluded. Instead, we assume that the eIF5-CTD acts allosterically by 
stabilizing the overall eIF2γ in its nucleotide-bound conformation necessarily forming direct 
interactions with the P-loop or the switch regions. This would be in agreement with the 
observation that Bpa-constructs of eIF5-CTD crosslink to eIF2 in its GDP-, GTP- and Met-tRNAi-
bound form with virtually identical efficiency, and that the effect of eIF5-CTD on nucleotide binding 
is not limited to GDP-bound eIF2 (Fig. 7 and 8D). Both observations indicate that the contact 
between eIF5-CTD and eIF2γ does not depend on the conformation of the two switch regions. 
Moreover, they are in line with the structural studies on the archaeal eIF2 ortholg (aIF2), which 
indicate that the overall domain arrangement of aIF2γ remains essentially unchanged between 
apo, GDP- and GTP-bound states with domains I-III adopting a ‘closed’ conformation. This 





idiosyncratic to the eIF2⋅GDP⋅eIF5 complex but may in fact exist during various stages of the 
initiation process, including assembly of pre-ICs, as well as the scanning process (see next section).  
 
Role of the direct interaction between eIF5-CTD and eIF2γ: Although the DWEAR-motif is highly 
conserved among eukaryotes from yeast to human (Fig. S1), suggesting an important role in eIF5 
function, this role is still elusive. Hence, a critical question that arises from our own and previous 
data concerns the physiological relevance of the direct interaction between the eIF5-CTD and 
eIF2γ.  
Originally, the DWEAR-motif was identified as a region within eIF5 that stabilizes eIF2-bound 
GDP [69]. Based on this observation it was proposed that eIF5 on the one hand physically 
antagonizes the GEF function of eIF2B by competing for their common substrate eIF2. On the other 
hand, it has been suggested that eIF5 might acts as guanine-nucleotide dissociation inhibitor (GDI) 
for eIF2 that antagonizes spontaneous GDP dissociation and may be necessary for tight 
translational control [69]. With the central difference that we assume the DWEAR-motif to belong 
to the eIF5-CTD itself, our own results support both effects in vitro, showing that eIF5 reduces the 
dissociation rate of eIF2-bound GDP by more than 2-fold (Fig. 7 and Table 4) and antagonizes 
eIF2Bε-catalyzed GDP-dissociation at low GEF concentrations in a manner dependent on the 
presence of the DWEAR-motif (Fig. 12). This could indeed support a role for the eIF5-CTD⋅eIF2γ 
contact as physical antagonist of eIF2B association and nucleotide exchange. 
However, the claim of physiological relevance for these effects is problematic: The role of 
eIF5 as physical antagonist for eIF2B was recently questioned by the finding thateIF2Bγ provides a 
second activity within the eIF2B catalytic subcomplex as ‘GDI displacement factor’ (GDF) that 
effectively displaces eIF5 from eIF2 under physiological conditions [105]. The data presented in 
Figure 12 suggest that eIF2Bγ may destabilize the direct contact of the eIF5-CTD to eIF2γ and 
thereby supports the entry of the eIF2Bε catalytic domain even at low (physiological) GEF 
concentrations. For the role of the DWEAR-motif, this poses the question for the cause-and-effect 
relation between the eIF5-CTD and eIF2Bγ. The fact that eIF2B can effectively displace eIF5 under 
normal as well as starvation conditions (with phosphorylated eIF2α) argues against a functionally 





eIF2B evolved to antagonize the direct eIF5-CTD⋅eIF2γ contact, which would thus have to serve a 
different function at an earlier stage in the nucleotide cycle of eIF2. One of these possible functions 
is the inhibition of spontaneous GDP release from free eIF2, thereby allowing a tighter control of 
translation initiation under stress conditions [73]where an efficient stress response is dependent 
on the reduction of eIF2-TC levels [80]. Originally, this assumption was based on the observation 
that the W391F mutation in eIF5, which reduces the GDI activity, confers a Gcn- phenotype due to 
its inability to induce GCN4 translation under starvation conditions [69] (see introduction of 
chapter 4 for an explanation of the Gcn- phenotype). However, our own as well as previous data 
show that Trp391 is directly involved in the interactions with the eIF2β-NTT (Fig. 2)[35], indicating 
that its mutation reduces the presumed GDI function indirectly by destabilizing the entire eIF2⋅eIF5 
complex. It is thus problematic to assign the observed Gcn- phenotype to the GDI function alone, 
as the W391F mutation is likely to affect MFC- and pre-IC formation, as well as start codon 
recognition. As a consequence, W391F might confer a Gcn- phenotype due to leaky-scanning on 
uORF1 on the GCN4 mRNA leader, similar to other eIF5 mutations that destabilize its contacts to 
the eIF2β-NTT [58]. Moreover, the same study found that the eIF5LR7A mutation, in which seven of 
the conserved DWEAR-motif residues were mutated to Ala, had an even stronger negative effect 
on the in vitro GDI activity of eIF5, however, without conferring a Gcn- phenotype; this supports 
the idea that the loss of GDI function is not the primary origin underlying the reported W391F 
phenotype. Another indication for the relevance of the GDI activity is, according to Jennings and 
Pavitt [69], provided by the observation that the W391F and LR7A mutations in eIF5 suppress the 
lethality of the N249K mutation in eIF2Bε [105]. This was explained by the bypass of the GEF 
deficiency in eIF2B by an increase in spontaneous GDP dissociation from eIF2 due to a reduced GDI 
activity in eIF5. The central problem with this interpretation is that it is not known how the N249K 
mutation affects the GEF function by eIF2B in vivo. The isolated eIF2Bε-N249K mutant catalyzes 
nucleotide exchange as efficiently as the wild-type protein [71], arguing against a direct effect on 
the GEF activity. Instead, the deletion of the corresponding N-terminal region within eIF2Bε 
(residues 93-358) has a severe negative impact on the interactions with other eIF2B subunits, in 
line with its implication in interactions with eIF2Bγ and the formation of the γ2ε2 tetrameric core of 





negatively affecting eIF2Bγε complex formation, which is essential for productive interactions with 
eIF2 and the GDF function of eIF2Bγ [105]. The W391F and LR7A mutations in eIF5 would thus 
suppress the phenotype of eIF2Bε-N249K by allowing the partially inactive eIF2B complex to 
compete more efficiently for their common substrate eIF2 and not due to increased spontaneous 
GDP dissociation. In line with this interpretation, W391F and LR7A are unable to rescue growth of 
the eIF2Bε-E569D mutant, in which complete GEF-inactivity is caused by the loss of a key catalytic 
residue. Thus, the increased spontaneous GDP release is not sufficient to allow efficient translation 
in the absence of GEF activity. Finally, it should be noted that eIF5 reduces the rate of GDP 
dissociation only ∼2-fold at saturating eIF5 concentration (Fig. 9B and Table 4). As eIF5 and eIF2 
are thought to exist in a 1:1 ratio in the cell, this effect on free eIF2 would be additionally reduced 
to ∼1.5-fold. Thus, although the eIF2⋅eIF5 complex may play a role as stable cytosolic pool for eIF2 
similar to the Rho⋅RhoGDI complex [68, 101] or may be relevant fora channeling process, where 
the potentially unstable eIF2 is passed on from eIF5 to eIF2B, it is in our opinion unclear to what 
extent the stabilization of the eIF2-bound guanine nucleotide is actually relevant for translation 
regulation.  
An alternative option is that the moderate nucleotide-stabilizing effect is not a functionally 
relevant feature of eIF5 but merely the consequence and therefore rather a side effect of the 
direct interaction between the eIF5-CTD and eIF2γ, causing an increased internal rigidity of the 
latter. In this case, the actual mechanistic significance of the interaction may not lie in the delayed 
GDP release but in the proper arrangement of the eIF5-CTD relative to the G domain of eIF2. This 
assumption is supported by the observation that GDP-, GTP-, and GTP/Met-tRNAi-bound eIF2 seem 
to interact equally well with the eIF5-CTD (Fig. 8D).This suggests that the direct eIF5-CTD·eIF2γ 
contact exists not only in solution with the GDP-bound form, but my as well be formed at other 
stages of the initiation process in which eIF2 exists in its active GTP-bound form. Hereby, a central 
aspect is the observation that the DWEAR-motif does not belong to the flexible linker region as 
previously assumed, but instead forms an element of the CTD itself – possibly stabilized in the 
eIF5⋅eIF2 complex. Thus, the eIF5-CTD⋅eIF2γ interaction might play a functional role in the context 
of the interactions between eIF5-CTD, the eIF2β-NTT, eIF1, eIF1A and eIF3c and their involvement 





would be compatible with the recently reported cryo-EM model of the 43S pre-IC, in which the 
eIF5-CTD can be accommodated between eIF2γ of the TC and the 40S subunit (Fig. 13B). In 
agreement with previous suggestions [21, 63] this would position the eIF5-CTD within contact 
distance of the 40S subunit and with areas I and II in direct vicinity to the binding sites of eIF1 and 
eIF1A. It is thus possible that the conserved eIF5-CTD⋅eIF2γ interaction may play a subordinate role 
in the communication between the ribosome, ribosome-associated initiation factors eIF1 and 
eIF1A, and the γ-subunit of eIF2. This suggestion is clearly tentative and will have to be tested 
experimentally in the context of the initiation machinery; however, it would be in line with the 
newly identified key role for the eIF5-CTD in scanning and start-codon recognition and the 
requirement for a factor that mediates between the rearrangements occurring on the ribosome 
and the detached G domain of eIF2γ, where Pi release occurs in response to the formation of the 
codon-anticodon interaction between mRNA and initiator tRNA, reorganization of eIF1A and the 
dissociation of eIF1 from the P-site[21, 63, 64].  
 
The eIF5-NTD interacts directly with eIF2γ in the eIF2⋅eIF5 complex. Another central aspect of the 
processes of scanning and start-site selection is the role of the eIF5-NTD, the GAP domain of eIF5. 
A previous study proposed direct interactions between the eIF5-NTD and eIF2γ [65]. However, the 
designated eIF5-NTD of this study included residues 1-279, containing the NTD, the linker region as 
well as the DWEAR-motif and RI of the CTD. Although the eIF5(1-262) construct is unable to 
stabilize the guanine nucleotide (Table 4) and is therefore most likely unable to stably contact the 
γ-subunit, it is unclear what effect the presence of the complete RI repeat would have. Hence, it 
cannot be ruled out that the observed direct contact between eIF5(1-279) and eIF2γ was at least 
partially mediated by its C-terminal portion and not through the actual NTD. We reassessed this 
question and found that the eIF5-NTD in the complex with eIF2 is indeed positioned in direct 
proximity to the γ-subunit in a way that allows specific crosslinks from positions Phe13 next to the 
putative arginine-finger (Arg15) in the N-terminal tail, and from Arg28 in the first β-hairpin loop of 
the N-terminal subdomain, but not from Arg127 in the zinc binding domain (ZBD) (Fig. 11 and 13A). 
As for eIF5-CTD, the crosslinks occur with free eIF2 as well as the eIF2-TC, indicating that the 





Met-tRNAi (Fig. 11B). However, a dependency of the interactions on the presence of GTP or the 
transition state mimic GDP+AlFx could not be observed (Fig. S6), which stands in contrast to 
previous reports for the mammalian factors [53] but is consistent with the dependency of GTPase 
activation by eIF5 on the structural context of the 43S pre-IC [21]. It is thus likely that the direct 
interactions between eIF5 and eIF2γ that result in the observed crosslinks are of a transient nature 
and require additional initiation factors or the 40S subunit itself to be stabilized for productive 
interactions with the eIF2γ G domain to carry out its GAP activity. 
 
The interaction network between eIF5-CTD, eIF2β-NTT, eIF1 and eIF3c-NTD. The crystal structure of 
the eIF5(201-405)⋅eIF2β(66-106) complex in combination with tryptophan quenching studies 
suggest a highly dynamic mode of interactions between eIF5 and eIF2β with distinct roles for each 
of the three conserved K-boxes. K1 and K2 seem to be mainly responsible for the high affinity 
interactions with a Kd of ∼100 nM that center on the negatively charged area I close to Trp391 of 
eIF5-CTD and involve residues of both AA-boxes (Fig. 2, 4 and SC). By contrast, K3 is positioned in 
the periphery of area I and contributes only marginally to the overall affinity (Fig. 2 and Table 1), 
but might, together with the adjacent helix αCβ, serve a role by pre-arranging the eIF5-CTD relative 
to eIF2 in order to promote the weak direct interaction between area IIIext and eIF2γ (Fig. 9).  
As indicated by the mutational studies, the contributions of individual K-boxes to the 
interactions with eIF5-CTD are mainly additive; this indicates that the eIF2β-NTT, which is 
presumably unfolded in the unbound state [111], does not adopt a distinct tertiary domain fold 
upon binding to eIF5. Instead, it seems to form a peptide-domain interaction with eIF5-CTD, in 
which only some parts adopt a secondary structure such as αNβ and αCβ flanking K-box 3 (Fig. 3 and 
4). This mode of segmented peptide-domain contact provides a number of context-dependent 
advantages over the rigid domain-domain interaction. On the one hand, it allows rapid evolution 
and adaptation to interactions with varying partners, as the peptide sequence is constrained only 
by the need to conserve residues directly involved in these interactions and can be easily extended 
in length to provide new interfaces. On the other hand, it introduces the means for a high degree 
of internal variability in the interactions, as each interacting segment (i.e. the K-boxes) can be 





contacts and retain reasonable affinity. This is conceivable particularly in the case of the lysine-rich 
K-boxes in the eIF2β-NTT, for which the disorder-to-order transition upon binding to eIF5-CTD is 
most likely accompanied by a particularly large loss of internal conformational entropy, which is 
paid individually by the K-boxes and not collectively by the entire interface. This unfavorable 
entropic contribution results in an uncoupling of binding strength from specificity, giving rise to 
specific interactions that are at the same time relatively weak and thus reversible.  
Functional relevance for this mode of interaction most likely lies in the complex series of 
rearrangements between eIF5-CTD, eIF2β-NTT and other initiation factors such as eIF1, eIF1A, and 
eIF3c, which underlie the formation of the scanning-competent pre-IC and start codon recognition. 
In yeast cells, formation of the MFC is thought to provide a major intermediate step for the 
efficient recruitment of the eIF2-TC to the 40S subunit and pre-IC assembly. The stability of the 
MFC and consequently its ability to promote TC recruitment was shown to depend on an intricate 
interaction network between eIF5-CTD, eIF2β-NTT, eIF1 and eIF3c-NTD, in which the loss of one of 
these factors negatively affects the incorporation of the others into the 43S pre-IC. In this context, 
the eIF2β-NTT appears to play a central role for the nucleation of MFC assembly through its tight 
interactions with the eIF5-CTD and the promotion of eIF1 and eIF3c binding to eIF5-CTD. In line 
with this scenario, our structural and biochemical studies show how the eIF2β-NTT can interact 
with area I of eIF5-CTD (Fig. 2 and 4), while at the same time supporting the binding of the eIF1-
NTT and eIF3c-NTD in area II (Fig. 10). By contrast, the second binding site on the eIF5-CTD for eIF1, 
which lies in the vicinity of Val270, is incompatible with the simultaneous binding of the eIF2β-NTT 
(Fig. 10). A possible mechanistic significance of this latter observation is unclear, as the loss of this 
eIF1-binding interface due to the mutagenesis of eIF5 causes the retention of eIF1 within the pre-IC 
and a suppressor of sui- (Ssu-) phenotype (due to an increased stringency of AUG selection) rather 
than increased dissociation rates, most likely due to the simultaneous disruption of the binding 
interface between eIF5 and eIF2β-NTT (see below)[21]. 
Apart from its involvement in cooperative MFC formation, the eIF2β-NTT is as well involved 
in the stabilization of eIF1 on the 40S subunit in its open, scanning competent conformation. 
However, this interaction is thought to be destabilized upon the encounter of the AUG start codon 





Thus, in light of the proposed mode of peptide-domain interaction, this could indicate that one 
segment of the eIF2β-NTT interacts with eIF5-CTD throughout the process of pre-IC formation, 
scanning and start-site selection, whereas a second region switches between eIF5-CTD and eIF1 in 
a context-dependent manner, with eIF1 as the preferred interaction partner in the open, scanning 
competent pre-IC, while this preference switches to eIF5-CTD upon the encounter of the AUG start 
codon and initiator tRNA-induced displacement of eIF1 from the P-site [21]. In this context, the 
critical aspect of the nature of the peptide-domain interaction between eIF2β-NTT and eIF5-CTD 
would be the independency of TC stabilization in the pre-IC from these rearrangements, while they 
at the same time provide a high degree of flexibility and the means for a tightly balanced dynamic 
interplay with other factors in a changing structural context. Interestingly, the placement of the 
eIF5-CTD in the cryo-EM structure of the mammalian 43S pre-IC based on the crosslinking data, 
would be compatible with such rearrangements, as it would position the eIF2β-NTT directly 
between the eIF5-CTD and eIF1 bound adjacent to the ribosomal P-site (Fig. 13B). 
 
2.4 Materials and Methods 
Cloning 
DNA fragments corresponding to the open reading frames of eIF1 (encoded by the TIF1 gene in S. 
cerevisiae), eIF2β (SUI2), eIF5 (TIF5) and eIF2Bε (GCD6) or truncations thereof were amplified by 
PCR using yeast genomic DNA as template and a corresponding pair of primers. These fragments 
were digested using restriction enzymes for which the restriction sites had been incorporated into 
the amplification primers. The digested DNA fragments were then ligated into the desired vectors 
cut with the same restriction enzymes. The ligation mixture was subsequently transformed into 
XL1-Blue E. coli cells (Stratagene) and plated out on LB agar plates containing the appropriate 
antibiotics. Several colonies of each plate were picked and subjected to a test PCR to identify 
positive clones, which were then individually grown over night in LB medium supplemented with 
antibiotics to purify the plasmid bythe Qiaprep Spin Miniprep Kit (Qiagen) according to the 






Single or multiple point mutants of the different constructs were generated by the 
QickChange technique (Stratagene) using appropriate mutagenesis primers. For the incorporation 
of the genetically encoded unnatural amino-acid p-benzoyl-L-phenylalanine (Bpa) into a protein 
chain, the amber stop codon TGA was introduced into the desired position along the coding 
sequence. In the case of the eIF5 constructs, this was preceded by the replacement of the 
endogenous TGA stop codon by TAA. Plasmid preparation and verification of the correct sequence 
were performed as described above. 
 
Protein expression and purification 
All constructs except those for the incorporation of Bpa (see below) were expressed in E. 
coliBL21(DE3) Rosetta II cells (Novagene). Cells containing the respective plasmid were grown in 
2xYT (supplemented with antibiotics) at 37 °C with shaking at 220 rpm until they reached an OD600 
of ∼0.8 and were subsequently transferred to 16 °C. After 20 min the expression was induced by 
the addition of isopropyl-β-D-thiogalactopyranosid (IPTG) to a final concentration of 0.5-1 mM. The 
cells were harvested after 16 hours at 16 °C. 
For the expression of proteins containing the genetically encoded unnatural amino-acid Bpa, 
the mutant constructs were transformed into the expression strain BL21(DE3)+pSupBpa (provided 
by Heinz Neumann)[94]. The cells were grown in 300 ml cultures of LB medium, supplemented 
with antibiotics and 1 mM Bpa(provided by Heinz Neumann), and grown at 37 °C until an OD600 of 
∼0.6 was reached. The cultures were then transferred to 25 °C and the expression induced by the 
addition of 1 mM IPTG. The cells were harvested 15 hours after induction. 
Purification of eIF1: eIF1 (wild-type and Bpa constructs) were expressed without affinity tag. 
The cells were resuspended in L-150 buffer (150 mM NaCl, 20 mM HEPES (pH 7.5), 5% glycerol, 1 
mM EDTA, 4 mM β-mercaptoethanol) supplied with a mixture of protease inhibitors including 
aprotinin, leupeptin, pepstatin (ALP), and PMSF. The cells were lysed in a microfluidizer 
(Microfluidics, USA) and cell debris was removed by centrifugation for 30 min at 30,000 xg. The 
supernatant was applied to an SP Sepharose column (GE Healthcare) equilibrated in L-150 buffer. 
After loading the sample and washing the column with four column volumes of L-150 buffer, the 





7.5), 5% glycerol, 4 mM β-mercaptoethanol). Fractions containing eIF1 (a single peak at ∼300 mM 
NaCl) were pooled and the salt concentration reduced to ∼150 mM NaCl by dilution with L-150 
buffer containing no NaCl. The diluted protein was applied to a HiLoad Heparin Sepharose column 
(GE Healthcare) equilibrated in L-150 buffer. Elution was started with a linear gradient into high 
salt buffer. Fractions containing eIF1 were pooled and applied to a Superdex S-75 size exclusion 
column (GE Healthcare) equilibrated in GF-150 buffer (150 mM KCl, 10 mM HEPES (pH 7.5), 5% 
glycerol, 2 mM DTT). Fractions containing the pure protein were pooled, concentrated and flash-
frozen. The identity of eIF1 was verified my mass spectrometry analysis. 
Purification of eIF2β and eIF3c-NTD: Full-length eIF2β was expressed as GST-fusion protein. 
Cell lysis was carried out as described above with the difference that L-500 buffer (500 mM NaCl, 
20 mM HEPES (pH 7.5), 5% glycerol, 0.1 mM EDTA, 4 mM β-mercaptoethanol) was used instead of 
L-150 buffer. After centrifugation, the supernatant was loaded onto a GSTrap column (GE 
Healthcare) equilibrated in L-500 buffer. After loading of the sample the column was washed with 
2 column volumes of L-500 buffer and the bound fusion protein was eluted by washing the column 
with elution buffer (L-500 buffer with 30 mM reduced glutathione). Fractions containing the target 
protein were pooled and incubated over night at 4 °C with PreScission protease (GE Healthcare) in 
a 1:100 weight ratio of protease to fusion protein to remove the GST tag. After a desalting step in 
200 mM NaCl, 20 mM HEPES (pH 7.5), 5% glycerol, 4 mM β-mercaptoethanol, the cleaved GST, 
PreScission protease and uncleaved protein were removed by a second GSH Sepharose step. The 
flow-through containing the cleaved eIF2β was pooled, concentrated and applied to a Superdex S-
200 column (GE Healthcare) equilibrated in GF-150 buffer. Fractions containing the pure protein 
were pooled, concentrated and flash-frozen. All eIF2β truncations and eIF3c(1-136) (eIF3c-NTD) 
were purified according to the same protocol described for full-length eIF2β (the plasmid used for 
the expression of eIF3c(1-136) was obtained from S. Khoshnevis). 
Purification of eIF5-CTD and eIF2Bε-CTD constructs: All C-terminal eIF5 constructs and 
eIF2Bε(524-712) were expressed as GST-fusion protein and purified similar to eIF2β with some 
differences: After loading the supernatant onto the first GSTrap column and washing with L-500 
buffer, the column was equilibrated in low salt buffer (100 mM NaCl, 10 mM HEPES (pH 8), 5% 





buffer plus 30 mM reduced glutathione. After PreScission protease treatment, the cleaved protein 
was loaded onto a Source 30Q column (GE Healthcare) equilibrated in low salt buffer. While GST 
and the protease eluted in the flow-through, the target proteins bound to the column and were 
eluted with a linear gradient into high salt buffer (1 M NaCl, 10 mM HEPES (pH 7.5), 5% glycerol, 4 
mM β-mercaptoethanol). Fractions containing the target protein were pooled and loaded onto a 
Superdex S-75 column equilibrated in GF-150 buffer. Fractions containing the pure protein were 
pooled, concentrated and flash-frozenfor storage at -80 °C. 
Purification of full-length eIF5 and eIF5(1-262): Full-length eIF5 and eIF5(1-262) were 
expressed as N-terminally polyhistidine-tagged proteins. Cell resuspension and lysis were carried 
out essentially as described above for eIF2β with the difference that L-500-His buffer additionally 
contained 20 mM imidazole and no EDTA. After centrifugation the supernatant was loaded onto a 
HisTrap column (GE Healthcare) equilibrated in L-500-His buffer. The column was then washed 
with 2 column volumes of L-500-His buffer and bound protein was eluted with a linear gradient 
into elution buffer (L-500-His buffer with 300 mM imidazole). Fractions containing the target 
protein were pooled and incubated over night at 4 °C with TEV protease in a 1:100 weight ratio of 
protease to target protein to remove the His-tag. After a desalting step in 250 mM NaCl, 20 mM 
HEPES (pH 7.5), 5% glycerol, 2 mM β-mercaptoethanol and 15 mM imidazole, the cleaved His-tag, 
TEV protease and uncleaved protein were removed by a second Ni-NTA step. The flow-through 
containing the cleaved eIF5 was pooled, concentrated and applied to a Superdex S-200 column 
equilibrated in GF-150 buffer. Fractions containing the pure protein were pooled, concentrated 
and flash-frozen for storage at -80 °C. 
Purification of eIF2: Polyhistidine-tagged eIF2 was overexpressed in S. cerevisiae strain 
GP3511 (a gift from G. Pavitt) containing a high-copy plasmid for the expression of all three 
subunits of eIF2 (SUI2 (eIF2α), SUI3 (β), and His-tagged GCD11 (γ)] [112]. For expression, 15 1-L 
cultures of YPD media were each inoculated with 1 ml of an overnight culture and grown for ~16 
hours at 30 °C with shaking at 220 rpm. The cells were harvested, resuspended in lysis buffer (500 
mM KCl, 50 mM HEPES (pH 7.5), 5% glycerol, 20 mM imidazole, 1 mM MgCl2, 4 mM β-
mercaptoethanol) containing protease inhibitors ALP and PMSF, flash-frozen in liquid nitrogen and 





powder, the lysate was clarified by centrifugation at 45,000 xg for 45 minutes. The supernatant 
was filtered and applied to a HisTrap column equilibrated in lysis buffer. After washing the column 
with 4 column volumes of lysis buffer, bound protein was eluted with lysis buffer containing 300 
mM imidazole. Fractions containing eIF2 were pooled and the salt concentration reduced to ~250 
mM KCl by dilution with buffer containing 20 mM HEPES (pH 7.5), 5% glycerol and 4 mM β-
mercaptoethanol. The diluted sample was then loaded onto a HiLoad Heparin Sepharose column 
equilibrated in 300 mM KCl, 20 mM HEPES (pH 7.5), 10% glycerol and 4 mM β-mercaptoethanol. 
The column was washed with low salt buffer and bound protein was eluted with a linear gradient 
of high salt buffer (1 M KCl, 20 mM HEPES (pH 7.5), 10% glycerol, 4 mM β-mercaptoethanol). 
Fractions containing eIF2 were pooled, concentrated and loaded onto a Superdex S-200 column 
equilibrated in GF-150 buffer. The absence of residual guanine nucleotides in the eIF2 preparations 
was verified by HPLC on a NUCLEOSIL 4000-7 PEI column (Macherey-Nagel). Nucleotide-free eIF2 
complex was concentrated, flash-frozen and finally stored at -80 °C.  
Purification of the yeast Methionyl-tRNA Synthetase: Yeast Methionyl-tRNA Synthetase was 
expressed in S. cerevisiae as GST-fusion protein from a plasmid containing a TRP auxotrophic 
marker (a gift from J. Lorsch). 15 1-L cultures of synthetic complete medium lacking tryptophan 
(SC-Trp medium) were inoculated from an overnight culture of yeast cells containing the plasmid 
for expression of GST-MetRS and were grown at 30 °C for 12 hours. Harvesting and lysis of the cells 
was carried out as described for eIF2 (see above), except for a different lysis buffer (500 mM NaCl, 
50 mM HEPES (pH 7.5), 5% glycerol, 2 mM β-mercaptoethanol). The cleared lysate was loaded onto 
a GSTrap column equilibrated in lysis buffer. After washing the column with 4 column volumes of 
lysis buffer, the bound protein was eluted with 20 mM reduced glutathione. The fractions 
containing the GST-MetRS were pooled, concentrated and loaded onto a Superdex S-200 column 
equilibrated in 100 mM KCl, 40 mM Tris/HCl (pH 7.4), 10 mM MgCl2, 5% glycerol, 2 mM DTT. The 






Purification, crystallization and structure determination of the eIF5(201-405)·eIF2β(39-106) 
complex 
The individual proteins, eIF2β(39-106) and eIF5(201-405), were purified as described above. The 
complex was formed by mixing eIF5(201-405) with a 1.5-fold molar excess of eIF2β(39-106). After 
incubation for 30 min at 20 °C the complex was separated from excess eIF2β(39-106) by size 
exclusion chromatography on a Superdex S-75 equilibrated in GF-150 buffer and finally 
concentrated to ~20 mg/ml. Other complexes that did not yield any crystals suitable for structure 
determination were purified by the same protocol. 
Initial crystals of the eIF5(201-405)·eIF2β(39-106) complex grew at 20 °C within one day 
under a condition containing 0.4 M (NH4)2SO4 and 0.05 M Li2SO4. After optimization, the best 
diffracting crystals were finally obtained with 12 mg/ml protein in 0.4 M (NH4)2SO4 and 0.08 M 
Li2SO4 at 10 °C. 
X-ray diffraction data were collected at BL 14.1 (HZB, BESSY, Berlin) [113]. The obtained data 
set was processed in space group P3212 using XDS [114] and scaled to a final resolution of 2.0 Å. 
The phase problem was solved by molecular replacement using the program PHASER [115] with 
the atomic coordinates of yeast eIF5(241-396) (PDB: 2FUL) as search model. The initial structural 
model comprised two eIF5(241-396) molecules per asymmetric unit. Missing regions of the eIF5 
construct (residues 201-240) and eIF2β were built manually in Coot [116]. The final model was 
obtained gradually by iterative rounds of refinement in PHENIX [117], followed by manual model 
building.  
 
Synthesis and purification of Met-tRNAi 
Yeast initiator tRNA was synthesized by in vitro transcription. As template, a 142 nucleotides long 
DNA was used that contained the T7 promoter (underlined) and a hammer-head (HH) ribozyme 
(italic), followed by the sequence for the tRNA itself (bold) (purchased from Sigma Aldrich), as 








The use of the HH-ribozyme in front of the target RNA allows the transcription to begin with 
GGG instead of AGC, which results in a higher efficiency of the T7-RNA polymerase (T7-RNAP) 
[118]. After synthesis of the HH-tRNA fusion, the HH-ribozyme cleaves itself off in a Mg2+-
dependent reaction, leaving the native tRNA sequence.  
The DNA template was amplified by PCR using 5’GGAGCCTAATACGACTCACTATAG3’ as 
forward primer and 5’TmGmGTAGCGCCGCTCGGTTTC3’ as reverse primer. Tm and Gm are 2’-O 
methylated nucleotides to reduce the occurrence of 3’ heterogeneities due to addition of 
nontemplated nucleotides by the T7 polymerase [119]. The amplified template was purified by 
ethanol precipitation and dissolved in water.  
The optimal conditions for the transcription reaction were determined in analytical scale by 
varying the Mg2+ concentration or the ratio of T7-RNAP to the DNA template. Preparative 
transcription reactions (7 ml final volume) contained 1 x Tris buffer, 5 mM DTT, 30 mM MgCl2, 75 
µg/ml T7-RNAP, 0.54 µM DNA template, and 2.5 mM of each NTP. The reaction was allowed to 
continue for 4 hours at 37 °C. The mixture was then filtered and applied to a 1-ml Mono Q column 
(GE Healthcare). After washing the column with buffer A (400 mM Na-acetate, 0.2 mM EDTA, 100 
mM Tris/HCl (pH 6.9)), the elution was started by applying a 50-ml gradient from 0-100% buffer B 
(1.5 M Na-acetate, 0.2 mM EDTA, 100 mM Tris/HCl (pH 7.3)). The run was analyzed on a urea gel, 
showing that the cleaved tRNAi eluted in a single peak containing small contaminations of HH-
ribozyme. Uncleaved HH-tRNA and the DNA template eluted in a peak at higher salt 
concentrations, while the T7-RNAP eluted in the flow-through (according to SDS-PAGE analysis). 
Fractions containing the tRNAiwere pooled, concentrated to ∼2 ml volume and applied to a 
Superdex S200 (16/60) column equilibrated in 25 mM Tris/HCl (pH 7.5), 30 mM KCl and 1 mM DTT. 
The tRNAi eluted in a single peak, free of HH-ribozyme. The pure tRNAi was stored at -80 °C.  
In an alternative procedure, tRNAi was in vitro transcribed and purified without HH-ribozyme 
as a potential origin for a partial missfolding of the tRNA. A critical drawback of this strategy is that 
the T7-RNAP has to start at AGC instead of the optimal GGG in the HH-ribozyme, which results in 
lower initial yields. However, this is partially compensated by the fact that the Mg2+ concentration 
has to be optimized for the transcription efficiency alone and does not have to take the activity of 





of the HH-tRNAi fusion. For this purpose, the above reverse primer and 
5’AGCCTAATACGACTCACTATAAGCGCCGTGGCGCAGTGG3’ as forward primer were used to 
generate the new DNA template:  
5’AGCCTAATACGACTCACTATAAGCGCCGTGGCGCAGTGGAAGCGCGCAGGGCTCATAACCCTGATGTCC
TCGGATCGAAACCGAGCGGCGCTACCA3’ 
The optimal condition for the transcription reaction was found to be 16 mM MgCl2, 50 µg/ml 
T7-RNAP and 0.68 µM DNA template. The preparative reaction and subsequent purification was 
carried out as described above for the purification with HH-ribozyme. From the same volume of 
preparative reaction mixture, the final yield of pure tRNAi was usually about 25% lower than for 
the reaction with HH-ribozyme. 
Preparative charging of the tRNAi with methionine was carried out essentially as described 
previously [97]. The stoichiometric charging reaction mixture contained 25 mM Tris/HCl (pH 7.6), 
10 mM Mg(OAc)2, 1 mM DTT, 2 mM ATP, 200 µM methionine, 5 µM tRNAi and 3 µM MetRS in a 
total volume of 4 ml. For ‘hot’ control reactions that were carried out parallel to the stoichiometric 
charging reaction, radiolabeled L-[35S]methionine (Hartmann Analytic) was used to assess the 
amount of produced [35S]methionyl-tRNAi and thus the charging efficiency [97]. The reaction 
mixture was incubated at 30 °C for 20 min, the time point at which the maximal charging 
efficiency, usually 34-36%, had been reached according to the control reaction. The charged Met-
tRNAi was then once extracted with buffered phenol and once with chloroform, followed by the 
addition of 0.3 M NaOAc (pH 5) and an ethanol precipitation for 2 hours at -20 °C. The dried pellet 
was finally resuspended in H2O to a final concentration of 30 µM Met-tRNAi. As the remaining 
uncharged tRNAi was reported not to interfere significantly with the initiation process in an in vitro 
reconstituted system [97], a further purification of the charged initiator tRNA was not performed.  
 
UV Crosslinking Experiments with Bpa 
Crosslinking was performed by exposing Bpa-containing proteins either alone or in the presence of 
potential interaction partners to 365 nm UV light at a distance of ~5 cm for 10-30 min on ice (Vilber 
Lourmat lamp, 2 X 8W, 365 nm tubes, 32 W, 230 V #VL-208.BL). All reactions were performed in 





Following UV light irradiation, the crosslink products were separated by SDS-PAGE and 
stained with Coomassie blue. Crosslinking occurred in a UV- and time-dependent manner only in 
the presence of proteins containing Bpa. Protein bands of interest were excised and in-gel digested 
with trypsin or a mixture of trypsin and GluC as described [120] for subsequent analysis by ESI-
MS/MS2 (see below). 
 
Mass spectrometry analysis with nano LC-nano ESI-MS/MS2 
Nano LC - RSLCnano Ultimate 3000 system (Thermo Scientific): Peptides of 1 µl sample solution 
were loaded and washed on an Acclaim PepMap 100 column (75 µm x 2 cm, C18, 3 µm, 100  , 
Thermo Scientific) at a flow rate of 25 µl/min for 6 min in 100% solvent A (98% water, 2% 
acetonitrile, 0.07% TFA). Analytical peptide separation by reverse phase chromatography was 
performed on an Acclaim PepMap RSLC column (75 µm x 25 cm, C18, 3 µm, 100  , Thermo 
Scientific) typically running a gradient from 98% solvent A (water, 0.1% formic acid) and 2% solvent 
B (80% acetonitrile, 20% water, 0.1% formic acid) to 42% solvent B within 95 min and to 65% 
solvent B within the next 26 min at a flow rate of 300 nl/min (solvents and acids from Fisher 
Chemicals). 
Nano ESI mass spectrometry -OrbitrapVelos Pro (Thermo Scientific): Chromatographically eluting 
peptides were on-line ionized by nano-electrospray (nESI) using the Nanospray Flex Ion Source 
(Thermo Scientific) at 2.4 kV and continuously transferred into the mass spectrometer. Full scans 
within the mass range of 300-1850 m/z were taken from the Orbitrap-FT analyzer at a resolution of 
60.000 with parallel data-dependent top 10 MS2-fragmentation with the LTQ Veleo Pro linear ion 
trap (CID). LCMS method programming and data acquisition was performed with the software 
XCalibur 2.2 (Thermo Fisher). 
MS-data analysis - Protein identification with Proteome Discoverer 1.4: MS/MS2 data processing 
for peptides was done with the Proteome Discoverer 1.4 software (Thermo Scientific) and the 
Discoverer Daemon 1.4 software (Thermo Scientific) using the SequestHT and Mascot search 
engines (Thermo Scientific and Matrix Science, respectively) and a S. cerevisiae-specific protein 
databases (Saccharomyces Genome Database, SGD, Stanford University) extended by the most 





methionine, carbamidomethylation (+ 57.02146 Da) as static modification of cysteine. False 
discovery rates of peptide identifications were obtained by decoy database analyses of the MS 
datasets. FDR was set 0.01 at maximum. 
Identification of crosslinked peptides with StavroX: The search for target peptides for UV-induced 
crosslinks was performed using the program StavroX [102] with the following settings: Precision for 
precursor comparison, 10 ppm; precision of fragment comparison 0.8 Da; mass limits, 200-800 Da; 
used enzymes, trypsin and GluC, allowing 2 missed cleavages at Arg, Lys and Glu, and 3 missed 
cleavages at Asp; static modification on cystein (carbamidomethylation) and variable modification 
on methionine (oxidation); peaks were considered only with signal-to-noise ratio (S/N) above 2. 
The quality of the searches was assessed by a parallel decoy search using the reversed protein 
sequence to determine the occurrence of false positives, as well as by the calculation of a score, 
which is calculated from the number of signals above the specified S/N value according to the 
algorithm given in [102].   
 
Steady-State Fluorescence Measurements 
All experiments were carried out on a Fluoromax-3 spectrophotometer (Jobin Yvon Inc., USA) using 
a quartz cuvette (Hellma Analytics, Germany). All reactions were done at 20 ± 1 °C in the standard 
reaction buffer (100 mM KCl, 20 mM Tris/HCl (pH 7.5), 3 mM MgCl2 and 2 mM DTT).  
The binding of eIF2β to eIF5-CTD was monitored by tryptophan quenching experiments. 
Tryptophan fluorescence in eIF5-CTD was excited at 280 nm, resulting in an emission at 350 nm, 
which was quenched upon the addition of eIF2β (full-length and N-terminal domain fragments). 
Equilibrium dissociation constants (Kd) for the complexes were determined by titrating eIF5-CTD 
with increasing amounts of eIF2β, until saturation was reached. The residual fluorescence signal 
produced by eIF2β (which contains no tryptophan) alone was determined by blank-titrations into 
buffer and subsequently subtracted from the binding data. 
The binding of mant-labeled guanine nucleotides to eIF2 was monitored either by direct 
excitation at a wavelength of 355 nm or by Foerster Resonance Energy Transfer (FRET) from 
tryptophan residues excited at 280 nm and an emission wavelength of 440 nm. Fluorescence 





20 °C. To estimate the Kd for eIF2⋅mant-nucleotide complexes in presence or absence of eIF5, the 
fluorescence of increasing amounts of mant-nucleotides was measured either in buffer alone or in 
the presence of 200 nM of eIF2 complex. The dilution was less than 1%. To form the eIF2⋅eIF5 
complex, 20-fold molar excess of eIF5 was added to eIF2 and incubated for 10 min at 20 °C prior to 
the experiment. 
Assuming a one-site binding model for the studied binding reactions, the data obtained from 
the equilibrium titrations were fitted to a quadratic equation: 
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whereF is the fluorescence signal of the mant-nucleotide in the absence or presence of eIF2, F0is 
the initial fluorescence signal, ΔFmax is the maximum fluorescence signal, X is the total 
concentration of eIF2, Y is the total concentration of the added mant-nucleotide and Kd is the 
equilibrium dissociation constant.  
For the determination of the apparent equilibrium dissociation constants of eIF2·mant-GDP 
to eIF5 from the pre-steady-state experiments (see below), the above equation was modified as 
follows:   
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Here, kapp is the characteristic apparent rate constant for the dissociation of the mant-nucleotide 
from eIF2 in the presence of a specific concentration of eIF5, Z is the concentration of eIF5, ka is the 
dissociation rate constant of mant-GDP from eIF2 alone, kb is the dissociation rate constant of 
mant-GDP from eIF2 in the presence of saturating concentrations of eIF5 and K1/2 is the 
concentration of eIF5 at which the half maximal effect on the dissociation rate of mant-GDP from 
eIF2 is reached (the apparent equilibrium dissociation constant). Data evaluation was done with 
the SigmaPlot software. 
 
Pre-Steady-State fluorescence measurements 
Pre-steady-state experiments were carried out on a Fluoromax-3 spectrophotometer using a 





were done at 20 ± 1 °C in standard reaction buffer. The fluorescence of mant-nucleotides was 
excited either directly at 355 nm or via FRET from tryptophan residues excited at 280 nm and 
monitored at an emission wavelength of 440 nm.  
To study the dissociation of nucleotides, 100 nM eIF2·mant-GDP or eIF2·mant-GTP complex 
was formed by adding 125 nM of the respective mant-nucleotide to 100 nM nucleotide-free eIF2, 
followed by an incubation for 3 min at 20 °C. To start the reaction, unlabeled GDP was added in 
excess and the decrease in mant-fluorescence was monitored over time. The data were evaluated 
by fitting to a single exponential function with the equation: 
 ( )       
       
whereF(t) is the fluorescence at time t, Fo is the final fluorescence signal, kapp is a characteristic 












Figure S1. Multiple sequence alignment of eIF5 orthologs.Highly conserved residues are highlighted in dark blue, 
conserved residues in light blue and variable residues in grey; the putative arginine-finger (Arg15) and Trp391 in AA-
box 2 are highlighted in red and yellow, respectively. The numbering above the alignment corresponds to the yeast 
ortholog (Sc-eIF5); the DWEAR motif and AA-boxes 1 & 2 are indicated below the alignment. Dm, Drosophila 
melanogaster; Xl, Xenopous laevis; Gg, Gallus gallus; Mm, Mus musculus; Rn, Rattus norvegicus; Hs, Homo sapiens; Sc, 









Figure S2. Effect of Trp391 mutations in eIF5 on the interaction with the eIF2β-NTT. A) GST-pull down experiments 
between GST-eIF2β(1-106) and eIF5(241-405) wild-type (wt), eIF5(241-405)W391F and eIF5(241-405)W391A. For each 
experiment, 50 µg of GST-eIF2β(1-106) were first immobilized on GSH-Sepharose beads and subsequently incubated 
for 10 min at 20 °C with 100 µg eIF5(241-405). The beads were then washed three times with washing buffer (100 mM 
NaCl, 20 mM Hepes (pH 7.5), 5% glycerol, 2 mM DTT) and the bound proteins were finally eluted from the beads with 
washing buffer containing 20 mM reduced glutathione. S, supernatant after incubation and before washing; W, 
supernatant after the third washing step; E, supernatant after elution; P, pellet after elution.B) Tryptophan quenching 
experiment between eIF5(241-405)W391F and eIF2β(1-106). The chromatogram shows the emission spectrum of 









Figure S3. Binding ofthe eIF2β-NTT by eIF5-CTD. A) The fragment of the eIF2β-NTT (yellow) binds eIF5-CTD in a 
comparatively conserved area, with the highest degree of conservation occurring in the vicinity of Trp391 (arrow). 
B)eIF5-CTD is shown as grey surface, with residues directly involved in contacts with the eIF2β-NTT (yellow) colored 
pink. C) Model of eIF2β-NTT (yellow) bound to the human eIF5-CTD (PDB: 2IU1) according to the structure of the yeast 
complex (B). The hseIF5-CTD is shown as grey surface; in the left panel, residues affected by eIF2β(K2K3) binding in 
NMR chemical shift assays are colored orange; in the right panel, residues affected only by eIF2β(K2K3) or eIF1 are 






























Figure S4. Model of the DWEAR-motif as element of the eIF5-CTD. A) Overview of the eIF5-CTD⋅eIF2β-NTT complex 
with residues 241-399 of eIF5 shown in surface charge presentation; helices α1 and α2 are shown as grey cartoon with 
DWEAR-motif residues as green sticks (circle) and the eIF2β-NTT as yellow cartoon. In the crystal structure of human 
eIF5-CTD (PDB: 2IU1), the hydrophobic cleft below area III is partially occupied by an α-helix formed by the C-terminal 
residues 399-409 (purple), which have no counterpart in yeast (see also Fig. S1). B) Surface charge presentation of the 
eIF5-CTD model presented in Figure 5A, with helix α1 and the DWEAR-motif accommodated in the hydrophobic cleft. 
As a consequence, the negatively charged N-terminal portion of the DWEAR-motif comes to lie next to area III of the 
CTD, thereby forming the extended area III
ext
. C) Two models of helix α1 (grey and green, respectively) accommodated 









Figure S5. Effect of eIF5-CTD single mutations on the interaction with the eIF2β-NTT. A)GST-pull down experiments 
between GST-eIF2β(1-106) and eIF5(201-405) D220A, D221A, W223A, E230A, R235S, E261A, E271A, Q293R, E298A, 
and the wild-type protein (wt). For each experiment, 50 µg of GST-eIF2β(1-106) were first immobilized on GSH-
Sepharose beads and subsequently incubated for 10 min at 20 °C with 100 µg eIF5(201-405). The beads were then 
washed three times with washing buffer (100 mM NaCl, 20 mM Hepes (pH 7.5), 5% glycerol, 2 mM DTT) and the bound 
proteins were finally eluted from the beads with washing buffer containing 20 mM reduced glutathione. S, supernatant 
after incubation and before washing; E, supernatant after elution.B-C)Tryptophan quenching by eIF2β(1-106) upon 
binding to eIF5(201-405)W223A (B) and eIF5(201-405)Q293R (C). The chromatograms show the emission spectra of 
the respective eIF5(241-405) construct(1 µM) upon the excitation of the Trp fluorescence at 280 nm in the absence 
(blue) and presence (cyan) of the eIF2β-NTT (2 µM). It should be noted that the quenching signal for the eIF5(201-
405)Q293R is weaker than the one observed for eIF5(241-405) (Fig. 1C) or eIF5(201-405)W223A as it contains one 









Figure S6. Dependency of the Bpa-crosslinks between the eIF5-NTD and eIF2 on the presence of nucleotides and 
fluoroaluminates. A) SDS-gel showing the UV-dependent formation of crosslink bands between 5 µM eIF5(FL)F13Bpa 
and 2 µM eIF2 in the absence or presence of GDP (3 µM), GTP (3 µM) and/or AlFx (2 mM AlCl3/20 mM NaF). Lane 1 
contains the molecular weight marker; lane 2 contains only eIF2; lanes 3 and 11 contain only eIF5 without (3) and with 
(11) UV-irradiation; lanes 4-10 contain eIF2 and eIF5; lane 10 contains the same mixture as lane 9 with the difference 
that it contains 200 mM KCl instead of 100 mM.  B) SDS-gel showing the UV-dependent formation of crosslinks 
between 5 µMeIF5(FL)Y16Bpa (left) or eIF5(FL)R28Bpa (right) and 2 µM eIF2in the absence or presence of GDP (3 µM), 
GTP (3 µM) and/or AlFx (2 mM AlCl3/20 mM NaF). Lane 8 contains the molecular weight marker; lanes 2-7 and 9-14 
contain eIF2 and eIF5; lanes 1 and 15 contain only eIF5(FL)Y16Bpa (1) or eIF5(FL)R28Bpa after UV-irradiation. For all 
experiments, crosslinking was performed on ice for 30 min. Crosslinks to eIF2γ are indicated by red brackets; the 
strong crosslink bands for positions directly below the 130 kDa marker (marked with *) also occur in the absence of 
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The eukaryal initiation factor 2 (eIF2) is a heterotrimeric translational GTPase, responsible for the 
GTP-dependent delivery of the methionylated initiator tRNA to the ribosome. The guanine 
nucleotide cycle performed by eIF2 during translation initiation is tightly regulated by the opposing 
effects of the GTPase activating protein (GAP) eIF5 and the guanine-nucleotide exchange factor 
(GEF) eIF2B. Here, we present a structural and biochemical analysis of the interaction network 
between eIF2 and eIF2Bε, the catalytic subunit of the heteropentameric eIF2B complex, with the 
aim to gain insight into the mechanism of nucleotide exchange. On the one hand, we show that the 
main interaction, which is responsible for the recruitment of eIF2Bε to eIF2, is mediated by a 
dynamic peptide-domain interaction between the catalytic eIF2Bε-CTD and the eIF2β N-terminal 
tail. On the other hand, a second interaction was mapped directly between eIF2Bε-CTD and the 
immediate vicinity of the nucleotide binding pocket on eIF2γ, an interaction that is most likely 
responsible for the destabilization of the eIF2-bound nucleotide. Together, the presented findings 
provide a refined model for the interactions between eIF2Bε and its substrate eIF2, which has 
implications for the mechanism of nucleotide exchange and possibly provides insight into the 




The eukaryal translation initiation factor 2 (eIF2) is a G protein that plays an essential role during 
the initiation phase of translation in eukarya. In its GTP-bound form, eIF2 specifically recognizes 
and binds methionylated initiator tRNA (Met-tRNAi) and delivers it to the 43S pre-initiation 
complex (43S pre-IC) [12, 16]. Upon the recognition of the correct start site for translation, the 
GTPase activating protein (GAP) eIF5 triggers the GTPase activity in eIF2, resulting in the 
irreversible hydrolysis of eIF2-bound GTP. After the release of Met-tRNAi, the inactive eIF2⋅GDP 
dissociates from the ribosome and has to be recycled back to eIF2⋅GTP for a next round of 
initiation. Like other Ras-related G proteins, eIF2 binds GDP tightly with an affinity in the lower 
nanomolar range, and the rate of spontaneous GDP dissociation is too slow to support efficient 





factor (GEF) eIF2B, which promotes the dissociation of GDP, followed by binding of GTP due to its 
∼10-fold higher cellular concentration. 
eIF2 is an unusually complex translational GTPase, formed by the three highly conserved 
non-identical subunits eIF2α, -β, and -γ [121, 122]. According to biochemical studies and crystal 
structure analyses of the archaeal ortholog (aIF2), eIF2α and -β form no direct contact to each 
other and bind the central eIF2γ subunit independently [31]. The γ-subunit adopts a three-domain 
architecture homologous to that of elongation factors EF-Tu and eEF1A, with the nucleotide 
binding pocket located in the G domain (domain I) [37]. Similar to other G proteins, it is thought 
that a/eIF2γ undergoes structural rearrangements when switching from the inactive GDP-bound to 
the active GTP-bound state, initiated by conformational changes in two conserved dynamic 
elements of the G domain, termed switch 1 and switch 2, that are responsible for the recognition 
and binding of the GTP γ-phosphate [31, 33]. The α-subunit was identified as a major factor in 
protein synthesis control as target for phosphorylation at a universally conserved serine (Ser51) by 
eIF2α kinases in response to stress conditions [78, 112]. Phosphorylation of eIF2α is thought to 
convert eIF2⋅GDP from a substrate to a competitive inhibitor of its GEF eIF2B, thereby reducing the 
rate of translation initiation and thus protein synthesis in general [112, 123, 124]. 
eIF2B is a large protein complex of five non-identical subunits that was reported to exist as a 
functional decamer of ∼600 kDa in solution [72, 73]. The homologous eIF2Bα, -β, and -δ subunits 
form a regulatory subcomplex that contributes to eIF2 binding through interactions with eIF2α 
[77]. These interactions are enhanced by eIF2α-phosphorylation, thereby abrogating GEF activity 
by rendering phosphorylated eIF2 a competitive inhibitor of eIF2B [112]. The eIF2Bγ and -ε 
subunits form the catalytic subcomplex that mediates the GEF function of eIF2B [112]. Within this 
catalytic subcomplex, eIF2Bε is the actual catalytic subunit, whose activity is stimulated by eIF2Bγ.  
The minimal catalytically active region within eIF2B was mapped to the C-terminal domain of 
eIF2Bε (residues 524-712 in yeast), which was shown to adopt a HEAT repeat-like domain fold 
homologous to that of the eIF5-CTD [1, 54, 74]. Like eIF5-CTD, the eIF2Bε-CTD contains two 
conserved aromatic/acidic motifs (AA-boxes) that interact with the lysine-rich K-boxes in the eIF2β-
NTT [35] (Fig. 1 and S1). Moreover, it was found that mutagenesis of Trp699 in AA-box 2 





eIF2Bε and its substrate eIF2 [75]. A second interaction was mapped between the two N-terminal 
α-helices of eIF2Bε-CTD and eIF2γ itself, which was proposed to be directly involved in the catalysis 
of nucleotide exchange [70, 75, 76]. This assumption was based on the observation that 
mutagenesis of conserved surface residues in the N-terminal α-helices, namely Thr552, Leu568, 
Glu569 and Ser576, caused growth defects or lethality in vivo, accompanied by a reduced or 
abolished catalytic activity of the eIF2Bε mutant in vitro. Hereby, particularly Glu569 was identified 
as key catalytical residue, whose mutagenesis to alanine abolishes GEF activity without affecting 
the affinity of the construct to eIF2γ. However, up to now it is unknown how and in which 
orientation the eIF2Bε-CTD enters the eIF2 complex and where the interface on the eIF2γ subunit 
lies. Consequently, the actual mechanism of eIF2Bε-catalyzed nucleotide exchange and the order 
of molecular events that accompany GEF-binding, GDP release and GTP rebinding are still 
enigmatic. 
Here we used a combination of structural and biochemical methods to gain insight into the 
interactions between eIF2Bε and its substrate eIF2 to provide a better understanding of the 
molecular events that result in nucleotide exchange. On the one hand, we studied the interactions 
between eIF2Bε and the N-terminal tail of eIF2β using tryptophan quenching experiments. These 
indicate that the eIF2β-NTT forms a high affinity peptide-domain interaction with the AA-boxes of 
eIF2Bε-CTD very similar to that observed between eIF2β and the eIF5-CTD (see chapter 2). On the 
other hand, mass-spectrometry-coupled UV-crosslinking reveals that the N-terminal end of eIF2Bε-
CTD, containing the catalytic center, contacts the eIF2γ subunit directly and in the immediate 
vicinity to the nucleotide binding pocket through an interface that overlaps with that observed for 
the DWEAR-motif and area III of eIF5-CTD. Finally, the effect of eIF2Bε on nucleotide binding and 
dissociation was studied using fluorescent derivatives of GDP/GTP. Together, the presented 
findings suggest that the eIF2Bε-catalyzed exchange reaction follows a successive series of 
reversible steps involving the formation of an intermediate unstable eIF2⋅GDP·eIF2Bε ternary 
complex, in which the GEF promotes nucleotide release by inducing conformational 






Figure 1. Structure of the eIF2Bε-CTD A) Schematic presentation of the proposed domain architecture in eIF2Bε with 
an N-terminal pyrophosphorylase-like (PL) domain, a central left-handed β-helix (LβH) domain and the C-terminal 
HEAT-like domain, which constitutes the minimal catalytic domain within the eIF2B complex. B) The left panel shows 
the superposition of the crystal structures of the eIF2Bε-CTD (residues 524-712, colored in cyan; PDB: 3JUI) and eIF5-
CTD (red) bound to a fragment of the eIF2β-NTT (yellow) (see chapter 2). Selected conserved residues of AA-boxes 1 
and 2 are shown as balls and sticks, including the homologous Trp699 and Trp391 in eIF2Bε and eIF5, respectively. As  
shown in the right panel, this positions K-box 3 (K3) of the eIF2β-NTT in direct vicinity to the negatively charged area I 
of eIF2Bε and allows an overall interaction between eIF2Bε-CTD and the eIF2β-NTT very similar to that observed for 
the eIF5-CTD (compare Figure 4 in chapter 2). 
 
3.2 Results 
Model of the eIF2β-NTT bound to the catalytic C-terminal domain of eIF2Bε 
The minimal catalytically active domain of eIF2Bε (residues 544-712 in the S. cerevisiae ortholog) 
and the C-terminal domain of eIF5 (residues 241-405) share structural homology over the entire 
HEAT repeat-like fold (Fig. 1). Despite differences in the structural details [1], this homology is 
complemented by the presence of the two conserved AA-boxes (1 & 2) close to the C-terminal end, 
which form the negatively charged area I in the tertiary structure of both proteins. In both cases, 





of eIF2β [35]. However, structural information for this interaction is so far not available for eIF2Bε 
and it is not known whether both interactions follow similar or distinct patterns.  
Attempts to solve the structure of eIF2Bε-CTD in complex with fragments of eIF2β-NTT 
analogous to those for the eIF5-CTD⋅eIF2β-NTT complex (see chapter 2) were unsuccessful. 
Instead, part of the eIF2β-NTT (residues 66-106; including K-box 3) was modeled onto eIF2Bε-CTD 
according to the eIF5-CTD⋅eIF2β-NTT complex structure (Fig. 1B). In this model, K-box 3 comes to 
lie in the periphery of area I, which allows the direct contact of its lysines 83 and 89 with Tyr663, 
Asp666 and Glu670 in eIF2Bε (corresponding to Tyr351, Asp354 and Glu358 in eIF5, respectively). 
Moreover, the adjacent regions on eIF2Bε-CTD would provide mainly hydrophobic surface areas 
for the binding of helices αNβ and αCβ flanking K-box 3, complemented by salt bridges of Lys608 
and Arg624 in eIF2Bε to acidic side chains in αNβ and αCβ, similar to those observed in the complex 
with eIF5. Thus, it is conceivable from this model that the structural homology between eIF2Bε- 
and eIF5-CTD is as well reflected in their respective interaction with the fragment eIF2β(66-106).  
 
Contributions of the lysine-rich K-boxes 1-3 of the eIF2β-NTT to the interactions with eIF2Bε. 
As in the case of eIF5-CTD, eIF2Bε-CTD contains a universally conserved solvent exposed 
tryptophan residue within AA-box 2 (Trp699; Trp391 in eIF5) that was previously shown to be 
important for interactions with eIF2β [74, 75]. We therefore assumed that it is possible to 
determine the relative contributions of K-boxes 1, 2, and 3 in eIF2β-NTT to its interactions with 
eIF2Bε-CTD by monitoring Trp-quenching upon complex formation. Unlike eIF5(241-405) with its 
two tryptophan residues, the corresponding eIF2Bε(524-712) fragment contains five tryptophan 
residues. Among these, Trp618, Trp676 and Trp677 are buried within the hydrophobic core, 
whereas Trp696 and Trp699 lie in direct vicinity to area I on the protein surface. Surprisingly, this 
larger number of Trp residues did not result in a smaller quenching signal due to an increased 
background fluorescence by unaffected residues; instead, the addition of full-length eIF2β or 
eIF2β(1-106) to eIF2Bε-CTD resulted in a substantial reduction of the emission at 360 nm by ∼43% 
(compared to ∼24% for eIF5-CTD), accompanied by a slight blueshift of the emission maximum 
(Fig. 2). A possible explanation for this rather unexpectedly strong signal is that not only Trp699, 





of eIF2β. As the mutagenesis of Trp699 to alanine completely abolishes any quenching signal, most 
likely due to its inability to bind eIF2β at all, and due to the potential structural role of the other 
residues, we were not able to determine the relative contributions of the individual Trp residues to 
the quenching signal. However, the fact that four of the five tryptophan residues are located in 
helices α7 and α8 in the vicinity of the negatively charged area I and Trp699, whereas the fifth 
tryptophan in helix α4 is buried in the hydrophobic core suggests that area I provides the main 
interface for the binding of the three K-boxes. 
As observed for eIF5-CTD, eIF2Bε-CTD binds eIF2β(1-106) and full-length eIF2β with similar 
affinities (Kd of 100 and 120 nM, respectively) and results in the same quenching signal (Table 1). 
The following experiments were therefore carried out with the isolated eIF2β-NTT (residues 1-
106), containing either single or double K-box mutations. The single K-box mutations exhibit only a 
slightly different pattern of contributions in comparison to their interactions to eIF5 (see chapter 
2), with 5-, 8- and 1.8-fold reductions in binding affinity for K1∆, K2∆ and K3∆, respectively (Fig. 
2B/D and Table 1). Thus, again K-boxes 1 and 2 seem to provide the primary interface for eIF2Bε 
binding with only minor contributions by K-box 3. It is, however, interesting to note thatthe 
contribution by K-box 1 seems to be less prominent than in the eIF2β⋅eIF5 interaction, which is also 
reflected by the maintenance of the full quenching signal in K1∆. By contrast, K2∆ results in the 
loss of nearly 30% of the quenching signal, while K3∆ shows no effect – in analogy to the 
observations with eIF5-CTD (see chapter 2). Interestingly, the double mutants show some 
variations in their pattern of interactions with eIF2Bε-CTD compared to those observed for eIF5-
CTD (Fig. 2C/D and Table 1). K12∆ completely abolishes the quenching signal, in line with their 
strong respective contributions suggested by the single mutants and identical to the observation 
for eIF5-CTD. K23∆ shows an entirely additive effect of the K2∆ and K3∆ single mutations on the 
binding affinity (Kd = 1.4 µM; 14-fold reduction) and quenching signal (loss of ∼30%), suggesting 
that K-box 3 in the interaction with eIF2Bε is not able to partially compensate the loss of K-box 2 as 
proposed for the eIF2β⋅eIF5 interaction. The largest difference is exhibited by the K13∆ mutation, 
which still conferred the full quenching signal at a ∼12-fold reduced binding affinity (Kd = 1.2 µM), 







Figure 2. Trp-quenching experiments between eIF2Bε-CTD and eIF2β-NTT. A) Trp quenching on the eIF2Bε-CTD by the 
eIF2β-NTT. The chromatogram shows the emission spectrum of 1 µM eIF2Bε(524-712) upon the excitation of the Trp 
fluorescence at 290 nm in the absence of eIF2β-NTT (blue line) or in the presence of 2 (red) or 3 µM (green) eIF2β(1-
106). B) Equilibrium titrations of 0.5 µM eIF2Bε(524-712) with increasing amounts of wild-type eIF2β(1-106) or the 
three K-box mutants K1∆, K2∆, and K3∆. The Trp quenching signal (in % of the original fluorescence signal of 
eIF2Bε(524-712)) was plotted against the concentration of the respective eIF2β-NTT constructs. The black lines 
represent the fit to the data using a quadratic one-side binding model. C) Equilibrium titration of 0.5 µM eIF2Bε(524-
712) with wild-type eIF2β(1-106) or the double K-box mutants K12∆, K13∆, and K23∆. C) Comparison of the Trp 
quenching signals for the seven eIF2β(1-106) constructs. Standard deviations, obtained from three independent 
experiments, are given as error bars. 
 
 
Taken together, these data suggest an interaction between the eIF2β-NTT and eIF2Bε-CTD 
similar to that with the eIF5-CTD, which is centered on the area surrounding Trp699 and area I and 





contributions for the interactions are provided by K-boxes 1 and 2, while K-box 3 plays only a 
subordinate role.  
 
Table 1. Trp quenching experiments between eIF2Bε(524-712) and eIF2β. 
eIF2β construct Kd (nM) Reduction of affinity 
relative to wt  
Quenching signal 
(%) 
eIF2β(FL)wt 90 ± 41 -- 41 
eIF2β(1-106)wt 100 ± 30 -- 43 
eIF2β(1-106)K1Δ 510 ± 65  5-fold 44 
eIF2β(1-106)K2Δ 830 ± 35  8-fold 32 
eIF2β(1-106)K3Δ 180 ± 22  1.8-fold 42 
eIF2β(1-106)K12Δ N.D.  1 
eIF2β(1-106)K13Δ 1230 ± 430 12-fold 41 
eIF2β(1-106)K23Δ 1400 ± 380 14-fold 29 
Kd is the equilibrium dissociation constant. 
N.D., not determined due to missing quenching signal. 
 
 
eIF2Bε-CTD contacts the γ-subunit of eIF2 directly next to the nucleotide binding pocket. 
Within the eIF2Bε-CTD, the catalytic center was mapped to the N-terminal helices α1 and α2 
opposite to Trp699, with Thr552, Leu568, Ser576 and particularly Glu569 as critical catalytic center 
residues that interact directly with the eIF2γ-subunit [74, 75]. In order to identify the binding site 
for the catalytic center of eIF2Bε-CTD on eIF2, the photo-inducible crosslinker Bpa was introduced 
in various positions of eIF2Bε(524-712) (Asp544, Gln559, Thr572 and Met575) in the periphery of 
the proposed catalytic center (Fig. 3C). All four eIF2Bε-CTD-Bpa constructs still stimulated GDP 
dissociation from eIF2, however, with reduced activity when compared to the wild-type protein 
(Fig. S2). For the first crosslinking experiments, the heterotrimeric eIF2 complex in the presence of 
GDP was mixed with a 2-fold molar excess of purified eIF2Bε(524-712)Bpa and exposed to UV light. 
UV- and time-dependent crosslink bands emerged for all constructs, however, with significantly 
different efficiencies depending on the position of the crosslinker (Fig. 3A). According to MS-







Figure 3. Mapping of the interactions between the eIF2Bε-CTD and eIF2 by UV-crosslinking. A) SDS-gels showing the 
UV- and time-dependent formation of crosslinks between eIF2γ and the indicated eIF2Bε(524-712)Bpa constructs 
(crosslink bands are indicated by brackets). For T572Bpa, the band migrating at ∼70 kDa above eIF2γ as well occurs in 
a UV-dependent manner and is most likely a crosslink between eIF2Bε(524-712)T572Bpa and eIF2β; an unambiguous 
identification of the target molecule was so far not possible. For each experiment, 2 µM eIF2 was mixed with 4 µM 
eIF2Bε(524-712)Bpa. B) Nucleotide-dependency of the crosslinks between eIF2Bε(524-712)Bpa and eIF2. Crosslinking 
experiments were carried out with 2 µM eIF2 and 4 µM eIF2Bε(524-712)Bpa either in the absence of guanine-
nucleotides or in the presence of 4 µM GDP or GTP. C) Structure of the eIF2Bε(524-712) (with the eIF2β-NTT in yellow 
modeled as shown in Fig. 1B), indicating the positions where Bpa was introduced (pink sticks). The dashed lines 
indicate the crosslinks to eIF2 formed from the respective positions. D) High-resolution MS2 fragmentation spectra for 
the crosslink of N559Bpa to a target peptide in eIF2γ. A series of b and y product ions were detectable for the peptides 
involved in the crosslinks; the relative intensity of the observed peaks is plotted against their mass-to-charge ratio 





By far the most efficient crosslink was obtained for the (nearly fully active) N559Bpa construct (Fig. 
S2) with Bpa at the very C-terminus of helix α1, which migrated at ∼130 and ∼100 kDa, 
respectively (both elute from the analytical size exclusion column at the same volume as the 
uncrosslinked eIF2⋅eIF2Bε(524-712) complex). Less efficient but still significant crosslinks to eIF2γ 
were observed for T572Bpa and M575Bpa, both of which produced a stronger upper band (∼120 
kDa) and a weaker lower band (∼105 kDa). The least efficient position was D544Bpa, which instead 
formed a strong internal crosslink. 
Table 2. Crosslinks between eIF2Bε(524-712) and eIF2γ. 
 Crosslinked peptides 





N559Bpa XL1a AMEbNHDLDTALLE ADMAR 484 2285.0215 -0.1 762.3448 
 XL1b AMEbNHDLDTALLE ADmAR 484 2301.0157 -0.2 767.6765 
 XL1c RAMEbNHDLDTALLE PNE 458 2237.0176 -0.1 746.3440 
 XL2a GIATVERAMEbNHD IEIR 361 2223.0868 0.2 556.5271 
 XL2a AmEbNHD IEIRPGIVTKD 362-367 2223.0881 5.9 556.5274 
 XL2b bNHD PTLCRAD 408-411 1410.6128 1.5 705.8107 
 XL2c AmEbNHD PTLCRAD 408-410 1757.7259 0.0 586.5801 
T572Bpa XL3a LNbLR LLGVK 441-443 1276.7775 -0.1 432.2674 
 XL3b LNbLR LLGVKTDGQK 442-443 1806.0260 -0.7 452.2619 
 XL3c LNbLR LLGVKTDGQK 440 1806.0279 0.3 456.7647 
 XL3d LNbLR LLGVK 444 1276.7774 -0.2 324.4524 
 XL3e LNbLR RLLGVKTDGQK 443 1980.1385 -0.2 495.7900 
 XL3f LNbLR RLLGVK 444 1450.8894 0.1 363.4778 
M575Bpa XL4a LNTLRbSMNVTYHE LLGVK 442 1741.8528 -5.2 785.7448 
 XL4b bSMNVTYHEVRIATITALLR HWR 509-510 2918.5253 0.2 730.3867 
Target positions in the target peptides are underlined.  
 
 
Using ESI-MS/MS2analysis in an Orbitrapmass spectrometer, followed by an analysis of the 
obtained data with the StavroX software [102], we were able to identify potential target peptides 
for the crosslinks from positions N559Bpa, T572Bpa and M575Bpa (Table 2). For the upper band 
produced by N559Bpa (crosslink XL1), 480ADMAR484and 458PNE460were identified as potential target 
peptides for the crosslink (target positions are underlined). In a homology model of yeast eIF2γ 
(based on crystal structures of the archaeal aIF2γ) both peptides lie at the lower side of domain III 
adjacent to the cleft to domain II (Fig. 7). The crosslink-peptides for the stronger lower crosslink 





barrel as target sites. For the upper band of T572Bpa (XL3) 441LGVK444 was identified as main target, 
which lies in the long flexible loop following the first β-strand of domain III, positioned directly next 
to the switch 2 region of the G domain (Fig. 7). The same peptide, as well as the adjacent 508HWR510 
in domain III could also be identified as targets for M575Bpa (Table 2). For D544Bpa, no target 
peptides could be clearly identified so far. 
 
eIF2Bε-CTD interacts with eIF2γ in a nucleotide-dependent manner. 
An important further question was whether the crosslink pattern would change depending on the 
nucleotide status of eIF2. For this purpose, the experiments were repeated either in the absence or 
presence of excess GDP or GTP. Interestingly, N559-, T572- and M575Bpa but not D544Bpa 
exhibited a strong but non-uniform dependency of their crosslinks on the nucleotide status of eIF2 
(Fig. 3B). For T572Bpa and M575Bpa in helix α2, the most efficient crosslinking was observed with 
apo eIF2, which significantly decreased in the complex with GDP- or GTP-bound eIF2 (including 
XL3). The opposite tendency was observed for N559Bpa, where both crosslinks to eIF2γ (XL1 and 
XL2) significantly improved in the presence of either nucleotide;only with apo eIF2 an additional 
crosslink from N559Bpa occurred at ∼50 kDa at the expense of the upper eIF2γ-containing bands, 
which according to MS analysis was a specific crosslink to the α-subunit of eIF2.  
These results indicate that the eIF2⋅eIF2Bε-CTD complex undergoes a conformational 
rearrangement upon the transition of eIF2 from the nucleotide-bound to the apo state, in which 
the C-terminus of helix α2 moves into a position that allows more efficient crosslinking to eIF2γ, 
while the C-terminus of helix α1 (with Gln559) moves into a position that allows less efficient 
crosslinking to eIF2γ but instead provides access to the α-subunit. These rearrangements, however, 
are insensitive to the species of the bound nucleotide and occur with GDP and GTP alike. 
 
Influence of eIF2Bε on the kinetics of guanine nucleotide binding by eIF2 
To study the interactions of eIF2 with eIF2Bε and GDP or GTP, we used the fluorescent derivatives 
of GDP/GTP, mant-GDP and mant-GTP, to monitor binding and dissociation of guanine nucleotides 
(see chapter 2). The affinities of mant-GDP and -GTP to eIF2 in the presence of eIF2Bε were 





in chase experiments with excess unlabeled GDP (Fig. 5). Finally, the bimolecular association 
constants (kon) were estimated from Kd and koff according to the relation Kd = koff/kon. Previous 
reports suggested that full-length eIF2Bε and the C-terminal fragment eIF2Bε(524-712) show the 
same level of GEF activity [70]; we therefore used the fragment eIF2Bε(524-712) in most 
experiments unless stated otherwise.  
 
 
Figure 4. Influence of the eIF2Bε-CTD and 
Mg
2+
 ions on the binding of mant-GDP 
and mant-GTP by eIF2. A-B) Equilibrium 
titrations of 100 nM eIF2 with mant-GDP 
(A) and mant-GTP (B) in the presence of 5 
µM eIF2Bε(524-712). C-D) Equilibrium 
titrations of 100 nM eIF2 with mant-GDP 
without (C) or with (D) 5 µM eIF2Bε(524-
712) and in the absence of Mg
2+
. The 
binding reaction was monitored by FRET 
between eIF2 (excited at 280 nm) and the 
mant-group of the nucleotide (emission 
monitored at 440 nm). The black lines 
show the fit to the data, using a quadratic 
one-side binding model; the resulting 
values are summarized in Table 3. 
 
 
Mant-GDP bound to the eIF2⋅eIF2Bε-CTD complex with a Kd of 53 nM and thus nearly 3-fold 
weaker than to the eIF2 complex alone (Kd = 20 nM) (Fig. 4 and Table 3). The dissociation rate 
constant (koff) was determined to be 3.42 min
-1, giving an estimate for the kon of 6.5 x 10
7 M-1 min-1. 
Thus, the eIF2Bε-CTD promotes the dissociation of GDP by ∼25-fold relative to the non-catalyzed 
reaction (0.14 min-1) under the used conditions, while simultaneously allowing a ∼10-fold faster 
association (Table 3). Likewise, the affinity of eIF2 for mant-GTP was reduced ∼6-fold from a Kd of 
30 nM in the absence to a Kd of 176 nM in the presence of eIF2Bε-CTD. As for GDP, this reduction 
in affinity is accompanied by a significant increase of the dissociation rate (koff = 2.32 min
-1 for eIF2 








Figure 5. Effect of eIF2Bε(524-712) and Mg
2+
 on the dissociation of mant-GDP from eIF2. A) Representative time 
courses for the dissociation of mant-GDP from eIF2 (50 nM eIF2 with 100 nM mant-GDP and 3 µM unlabeled GDP) in 
the presence of 0 (black), 100 (red) and 500 nM (blue) eIF2Bε(524-712). The smooth black lines represent single-
exponential fits which yielded the respective apparent rate constants kapp. B) Time courses for the dissociation of mant-
GDP from eIF2 (50nM eIF2 with 100 nM mant-GDP and 3 µM unlabeled GDP) in the presence of 200 nM eIF2Bε(524-
712) either in the presence (black) or in the absence of 2.5 mM Mg
2+
 (red). C) Dependency of the dissociation of 
eIF2⋅mant-GDP (50 nM) on the concentration of eIF2Bε(524-712) either in the presence (closed circles) or absence of 
2.5 mM Mg
2+
 ions (open circles). 
 
To determine the approximate affinity between eIF2Bε-CTD and GDP-bound eIF2, the 
apparent off rates (kapp) for the dissociation of mant-GDP from eIF2 at increasing concentrations of 
the GEF were fitted to a quadratic equation, giving an estimate for the K1/2 of 423 ± 53 nM (Fig. 4C), 





For other GEF-catalyzed nucleotide exchange reactions it is known that the GEF contributes 
to the destabilization of the guanine nucleotide by destabilizing the coordination of the Mg2+ ion. 
To study the contribution of Mg2+ coordination to GDP binding, the affinity and dissociation rate of 
mant-GDP was determined in the absence of Mg2+ and the presence of 1 mM EDTA. Although 
having only a minor effect on the affinity of mant-GDP to eIF2 determined under steady-state 
condition (Kd = 25 nM), the absence of Mg
2+ resulted in a ∼20-fold increased dissociation rate (koff 
= 2.7 min-1). Consequently, this implies that the association rate constant (kon) as well increases to 
1.1 x 108 M-1 min-1. Addition of eIF2Bε-CTD further increased the dissociation rate by a factor of 9.4 
to 25.2 min-1 (7.4-fold faster than the catalyzed reaction in the presence of Mg2+), accompanied by 
a decreased affinity (Kd = 109 nM) and an increased association rate constant of 3.9 x 10
6 M-1 s-1.  
 
Table 3. Influence of eIF2Bε(524-712) on the binding of mant-GDP and mant-GTP by eIF2 
 Nucl. 
 
MgCl         
(mM) 
koff(min




K1/2 (2Bε)      
(nM)c 
eIF2 mGDP 2.5 0.14 ± 0.05 7 x 106 20 ± 5 N.D. 
eIF2 mGDP 0 2.7 ± 0.15 1.1 x 108 25 ± 6 N.D. 
eIF2 mGTP 2.5 2.32 ± 0.11 7.7 x 107 30 ± 3 N.D. 
eIF2 +       
eIF2Bε-CTD mGDP 2.5 3.42 ± 0.21 6.5 x 107 53 ± 6 432 ± 53 
eIF2Bε-CTD mGDP 0 25.2 ± 0. 2.3 x 108 109 ± 9 195 ± 40 
eIF2Bε-CTD mGTP 2.5 N.D.  176 ± 11 N.D. 
a
 The bimolecular association constant was estimated according to the relation kon = koff/Kd 
b
Kd is the equilibrium dissociation constant between eIF2 and mant-GDP or mant-GTP. Values for eIF2 binding to mGDP or 
mGTP in the presence of MgCl2 are adapted from Table 4 in chapter 2. 
c
K1/2 is the apparent equilibrium dissociation constant between eIF2 and eIF2Bε(524-712), estimated from the dependency of 
kapp of mant-GDP dissociation from eIF2 on the concentration of eIF2Bε-CTD. 
N.D., not determined 
 
 
An intermediate ternary complex of GEF, eIF2 and the nucleotide is formed during the exchange 
reaction catalyzed by the eIF2Bε-CTD. 
As indicated by the crosslink data, the eIF2-bound nucleotide has the ability to influence the way in 
which eIF2Bε is arranged relative to eIF2, without abolishing its binding. This suggests that 
nucleotide and exchange factor can bind simultaneously to eIF2 to form an intermediate ternary 





eIF2⋅mant-GDP with increasing amounts of the exchange factor (either full-length or the CTD 
alone). If the binding of GDP and GEF were mutually exclusive, the latter should be able to 
compete with the bound mant-nucleotide, resulting in the loss of the fluorescence signal at 
saturating amounts of eIF2Bε.  
 
 
Figure 6. eIF2, guanine-nucleotide and eIF2Bε form a 
ternary complex. A) Titration of eIF2⋅mant-GDP (100 nM 
eIF2 with 125 nM mant-GDP) with increasing amounts of 
eIF2Bε. Each of the black arrows indicates the addition of 
5 µM eIF2Bε, until 25 µM (250-fold excess) was reached. 
‘+GTP’ indicates the time point at which 10 µM unlabeled 
GTP was added to the mixture. The mant-fluorescence 
was excited directly at 355 nm and monitored at 440 nm. 
B) Analytical size exclusion chromatography for eIF2 in 
complex with guanine-nucleotides and eIF2Bε. The upper 
panel shows the runs of eIF2 either with GDP (red and 
pink) or with mant-GDP (blue and cyan) with the 
absorption monitored at 280 and 355 nm. Only for the 
eIF2⋅mant-GDP complex, absorption at 280 nm (blue) and 
at 355 nm (cyan) is observed. The lower panel shows the 
complex run (blue, 280 nm; cyan, 355 nm) between 
eIF2⋅mant-GDP and eIF2Bε (the green curve corresponds 
to eIF2Bε alone), in which the main peak is shifted ∼0.6 
ml relative to the eIF2⋅mant-GDP peak (grey dashed line). 
In order to highlight the observed absorption by mant-
GDP (arrow) in the eIF2⋅eIF2Bε containing peak, the scale 
for the absorption at 355 nm in the lower panel was 







As shown in Figure 6A, eIF2Bε causes a slight decrease of the fluorescent signal, indicating 
either a direct effect on the fluorescence by the mant group or a reduction of the amount of mant-
GDP bound to eIF2. After adding a 250-fold excess of eIF2Bε over eIF2, which should be sufficient 
to saturate the latter with the GEF, unlabeled GTP was added in excess to determine the ground-
fluorescence of the unbound mant-GDP. According to this final signal, the addition of excess eIF2Bε 
resulted in the loss of only ∼20% of the initial fluorescence. Consistent with the crosslinking 
studies, this indicates that the remaining ∼80% originate from mant-GDP still bound to the binary 
complex of eIF2⋅eIF2Bε. 
To further test the existence of an eIF2⋅mant-GDP⋅eIF2Bε ternary complex we tried to 
monitor it by analytical size exclusion chromatography. The binary eIF2⋅mant-GDP complex eluted 
at ∼11.4 ml and exhibited a clear peak for the absorption at 355 nm, the excitation wavelength for 
the mant moiety (Fig. 6B). A corresponding absorption at 355 nm was not observed for the apo 
eIF2 complex or for eIF2⋅GDP. We then added excess eIF2Bε to the preformed eIF2⋅mant-GDP 
binary complex, which should yield the eIF2⋅mGDP⋅eIF2Bε ternary complex, and loaded it onto the 
column. As expected, eIF2 and eIF2Bε formed a complex which eluted at ∼10.7 ml (monitored by 
absorption at 280 nm), corresponding to a 0.7 ml shift relative to eIF2⋅mant-GDP alone. 
Importantly, a correspondingly shifted peak was observed for the absorption at 355 nm, indicating 
that the eIF2⋅eIF2Bε complex still contained mant-GDP and demonstrating the existence of a 




Implications for the mechanism of eIF2Bε-catalyzed nucleotide exchange on eIF2. 
Like eIF2, a large number of Ras-related G proteins bind GDP with high affinity and have very low 
rates of spontaneous GDP release. In order to allow nucleotide exchange and thus efficient 
activation of the G protein for its function in biological time scales, GEFs are used to accelerate 
GDP release by several orders of magnitude [23, 25]. Although GEFs of different G protein families 
are structurally unrelated and bind to their substrates in different ways, it was found that they use 





considerable differences in the molecular details how the underlying problem is solved. Initially, 
GEFs bind to the GTPase⋅GDP complex forming an unstable ternary complex in which both, the 
nucleotide as well as the GEF are bound with low affinity by the G protein. In the majority of cases, 
GDP-destabilization is primarily achieved by deformation of the nucleotide-binding site in the two 
switch regions and the P-loop that are responsible for Mg2+ coordination and phosphate binding. 
Usually, the flexible switch 1 becomes displaced by the GEF through steric hindrance, while 
extensive contacts are formed with switch 2. As a result, switch 2 is usually remodeled in a way 
that allows the formation of a salt bridge between the aspartate of its conserved DXXG motif and 
the invariant P-loop lysine, causing the loss of critical contacts for the Mg2+ ion and the GDP-β-
phosphate. Alternative or additional features are the introduction of side chains in cis by the G 
protein or in trans by the GEF that obstruct the binding sites for the Mg2+ ion and/or the phosphate 
moiety. Moreover, some GEFs distort the P-loop backbone, thereby breaking hydrogen bonds that 
stabilize the β-phosphate. As a consequence of these rearrangements, the GDP molecule is 
released more rapidly from the unstable ternary complex, followed by the formation of a stable 
GTPase⋅GEF complex. Subsequently, a GTP molecule binds, again to form an unstable ternary 
complex from which the GEF is finally released to yield the GTP-bound G protein [23, 25, 101].For 
the exchange reaction on eIF2 it was so far unclear to what extent these basic principles of GEF 
activity also apply to the guanine-nucleotide exchange reaction catalyzed by eIF2Bε.  
 
A structural model for the interactions between the catalytic subdomain of eIF2Bε and eIF2 
Interactions between eIF2Bε and eIF2β. Using tryptophan quenching experiments, we sought to 
provide a better understanding of the interaction between eIF2β and the eIF2Bε-CTD, which was 
proposed to involve interactions between the three K-boxes in eIF2β and the two conserved AA-
boxes in the C-terminal region of eIF2Bε [35, 74].  
Our experiments show that the eIF2β-NTT provides a high-affinity binding site for the eIF2Bε-
CTD within the eIF2 complex with a Kd of ∼100 nM (Fig. 2, Table 1), in line with the proposed role 
as docking site for the GEF on its substrate eIF2 [35, 74]. This affinity is dependent on the presence 
of the three lysine-rich K-boxes, in particular K-boxes 1 and 2, consistent with the idea that ionic 





indicated by the location of the solvent-exposed tryptophan residues that are likely to contribute 
most to the quenching signal induced by K-box 2 (Trp677, 696, and 699), area I and the acidic C-
terminal tail are the most likely candidates for these interactions, in line with the high degree of 
conservation of their acidic residues (Fig. 1B and S1). The contributions of the three K-boxes to the 
overall binding affinity are entirely additive suggesting that they interact with eIF2Bε 
independently from each other via a peptide-domain interaction similar to that proposed for the 
eIF5-CTD (see chapter 2), in which the eIF2β-NTT does not adopt a tertiary structure upon binding, 
but instead adopts an extended conformation to wrap around the eIF2Bε-CTD. Consistently, the 
topology and surface charge properties of the eIF2Bε-CTD would be compatible with a mode of 
binding for K-box 3 and the adjacent α-helices αNβ and αCβ similar to that seen in the eIF5-
CTD⋅eIF2β-NTT complex structure (Fig. 1B). If so, it can be envisaged that α-helix αNβ serves a 
similar role in the eIF2⋅eIF2Bε complex as proposed for the complex with eIF5 by prearranging the 
eIF2Bε-CTD relative to eIF2γ in a way that promotes the direct interactions between the two 
proteins to mediate nucleotide exchange. This would provide an explanation why K-box 3 is highly 
conserved among eIF2β orthologs, despite its relative marginal contribution to the overall affinity 
and despite the apparent absence of an evolutionary constraint imposed by the necessity to 
stabilize a tertiary structure fold. 
Interactions between eIF2Bε and eIF2γ. In previous studies the interface for direct 
eIF2Bε⋅eIF2γ interactions was mapped to the first two α-helices of the eIF2Bε-CTD; however, the 
binding site on eIF2γ was unknown. We could show that the short-range UV-inducible crosslinker 
Bpa, introduced in various positions in the periphery of the proposed interface, crosslinks 
specifically to the γ-subunit of eIF2 (Fig. 3). Moreover, we were able to identify specific target 
peptides within eIF2γ for the crosslinks from positions Asn559, Thr572 and Met575 in eIF2Bε (Fig. 
7, Table 2). These suggest that the eIF2Bε-CTD, like eIF5, contacts the frontal face of eIF2γ, with 
Thr572 and Met575 in helix α2 positioned close to residues 440-444 in domain III of eIF2γ (green 
surface in Fig. 7), while Asn559 at the C-terminus of α1 points toward residues 362-367 in domain 
II and the probable binding site for eIF2α on eIF2γ (golden surfaces in Fig. 7). Hence, this 
orientation would explain why Bpa in lieu of Asn559, but not Thr572 or Met575, is able to crosslink 





the catalytic center residues would come to lie atop of the G3 (194DCPG197) motif and the switch 2-
helix (helix B in EF-Tu [38]), and in the direct vicinity to the binding sites for the β- and γ-




Figure 7. Model for the eIF2·eIF2Bε-
CTD complex. The eIF2Bε-CTD is 
shown as cyan cartoon, between the 
eIF2β-NTT (dark grey surface) and 
eIF2γ (blue surface, with the GDP 
molecule shown as yellow sticks and 
P-loop, switch 1 and switch 2 in light 
red, wine red and dark red, 
respectively). Target peptides for 
crosslinks (black dashed lines) from 
positions T572/M575 and N559 are 
highlighted as green and dark yellow 
surfaces on eIF2γ, respectively. N559 
is oriented toward eIF2α (light grey), 
as suggested by the direct crosslink 
observed in the absence of a bound 
guanine-nucleotide. The linker 
peptide between the eIF2β-NTT and -
CTD is indicated by a thick grey 
dashed line next to eIF2γ. The orange 
dashed line between Lys67 in eIF2α 
(orange surface) and Lys691 on eIF2Bε 
(orange sticks) indicates a crosslink 
identified in[73]. According to this 
model, the eIF2Bε-CTD is clamped 
between the eIF2β-NTT, which 
provides the K-boxes for high affinity 
interactions in the area surrounding 
Trp699 (pointing away from eIF2γ), 
and the frontal face of eIF2γ. The 
putative catalytic center residues of 
eIF2Bε (located between T572/M575 
and N559) in repeat RI are thereby 
positioned next to the nucleotide 




Under the assumption that the eIF2Bε-CTD retains its structural integrity upon binding to 





structural model predicts that the C-terminal end of eIF2Bε with Trp699 and area I points away 
from eIF2γ, which would allow the eIF2β-NTT to clamp the eIF2Bε-CTD between both eIF2-subunits 
(Fig. 7). As a consequence, the C-terminal end of helix αNβ (residues 91-103) points toward domain 
III of eIF2γ, supporting the idea that helix αNβ might promote the direct eIF2Bε⋅eIF2γ interaction by 
prearranging the eIF2Bε-CTD relative to the G protein (see above). The remaining distance of 40-50 
Å to helix α1 (residues 127-140) of the eIF2β-CTD, which anchors eIF2β to the eIF2γ G domain, 
could be readily spanned by a flexible linker formed by the missing 23 residues. Interestingly, it was 
reported that within the eIF2⋅eIF2B complex Lys691 of eIF2Bε can be crosslinked to Lys67 in the N-
terminal domain of eIF2α using the chemical crosslinker BS3 (spacer length 11.4 Å) [73]. 
Considering the flexibility of the eIF2α-NTD relative to the eIF2γ-bound C-terminal domain, this 
finding is in excellent agreement with the proposed structural model for the eIF2⋅eIF2Bε-CTD 
complex, in which Lys691 points away from eIF2γ and is thus freely accessible for the eIF2α-NTD 
(Fig. 7). It should, however, be mentioned that this model is incompatible with the proposal that 
Trp699 is directly involved in interactions with eIF2γ and in the catalysis of nucleotide exchange 
[75, 76]. Instead, our model would favor a scenario in which Trp699 is limited to a critical role in 
the interactions with the eIF2β-NTT, where its loss due to mutagenesis weakens the high affinity 
binding to eIF2 through eIF2β similar to the W391A/F mutation in eIF5, and thus affects the 
exchange activity of eIF2Bε merely indirectly by abolishing the efficient recruitment of the GEF. 
 
Implications for nucleotide-exchange by eIF2Bε  
Does the eIF2⋅eIF2Bε interaction follow the common basic principles that underlie most GEF-
catalyzed exchange reactions? Positioning of the eIF2Bε-CTD relative to eIF2 on the basis of the 
crosslink data suggests that helices α1 and α2 bind eIF2γ in the direct vicinity to helix B (switch 2) 
(Fig. 8). This would indeed indicate that eIF2Bε approaches the nucleotide binding pocket from the 
phosphate-binding side to form contacts to the switch 2 region, similar to those found in 
complexes of other G proteins with their GEFs [25]. Moreover, eIF2 forms intermediary ternary 
complexes with guanine-nucleotide and eIF2Bε (Fig. 6), however, with a reduced affinity and 
increased rates of dissociation for the nucleotide (Fig. 4, 5). Although the affinity between eIF2Bε 





proteins was found to depend strongly on the nucleotide state of eIF2, without making a difference 
between GDP and GTP (Fig. 3B). These observations indicate that the eIF2⋅eIF2Bε complex 
undergoes a series of reversible conformational rearrangements from the GDP-bound state to the 
nucleotide-free state and finally to the GTP-bound state, in which the first and the last state adopt 
similar arrangements. It is therefore conceivable that the eIF2Bε-catalyzed exchange reaction 
follows a multi-step process analogous to that on other G proteins, involving two low-affinity 
ternary complexes, in which the GEF destabilizes the bound nucleotide and vice versa, as well as 
three high-affinity binary complexes with eIF2 bound to GDP, eIF2Bε or GTP, respectively. 
 
 
Figure 8. Detail of the modeled interactions between the eIF2Bε-CTD and eIF2γ. A) Front view of repeat RI of eIF2Bε 
(cyan cartoon) on the surface of eIF2γ (blue surface with the GDP molecule shown as yellow sticks; P-loop, switch 1 
and switch 2 are colored light red, wine red and dark red, respectively). N559, T572 and M575 are shown as green balls 
and sticks. Residues that are either universally conserved and/or were reported to contribute to the exchange activity 
of eIF2Bε are shown as balls and sticks in cyan. B) Top view of eIF2Bε on the surface of eIF2γ (colored as in A). 
 
 
One of the salient features of nucleotide destabilization by GEFs is the distortion of the Mg2+-
binding site [25, 101]. In line with previous reports [125], we found that Mg2+ ions stabilize the 
binding of GDP to eIF2, resulting in a ∼20-fold acceleration of GDP release in its absence (Fig. 4, 5, 





corresponds to a 7.4-fold faster GDP release relative to the GEF-catalyzed reaction in the presence 
of Mg2+ ions. This indicates that the removal of Mg2+ plays a role in eIF2Bε-catalyzed nucleotide 
release, consistent with the position of helices α1 and α2 in the direct vicinity of switch 2 (Fig. 8). A 
possible scenario for this effect is that eIF2Bε stabilizes the formation of a salt bridge between 
aspartate 193 of the 193DCPG196(G3) motif in switch 2 and the invariant P-loop lysine (Lys114),an 
interaction that is observed in the apo states and some GDP-bound forms of trGTPases which do 
not require specialized GEFs, as well as in structures of the eIF2γ-orthologs eEF1A and EF-Tu in 
complexes with their respective GEFs eEF1Bα and EF-Ts [126, 127].  
As indicated by the acceleration of GDP release by eIF2Bε in the absence of Mg2+ ions, 
further contributions seem to arise from the deformation of the nucleotide-binding site itself. An 
interesting observation in this context is that GTP as well as GDP stabilize switch 1 in a way that 
protects it from proteolytic cleavage (Fig. S3). Thus, efficient GDP destabilization by eIF2Bε might 
requirethe displacement of switch 1 from the nucleotide binding site. According to the structural 
model presented in Figure 8, helix α1 could function as a wedge that intercalates between switch 1 
and switch 2 and thereby displaces the former, similar to helix α14 of SOS1 in its complex with Ras 
(PDB: 1BKD). Notably, this positions the highly conserved Glu548 and the catalytically relevant 
Glu569 close to switch 2 and the Mg2+ and phosphate-binding sites, similar to Glu942 in SOS1. At 
the same time, the invariant Arg555 comes to lie close to the N-terminus of the switch 2-helix, 
which would allow a stabilizing contact to the invariant Asp198 in switch 2 following the 193DCPG196 
(G3) motif. This might be relevant, as one reoccurring feature of complexes between G proteins 
and their GEFs is the stabilization of switch 2 by a conserved acidic residue following the G3 (DXXG) 
motif through ionic interactions with the GEF [128, 129].  
Taken together, the proposed placement of eIF2Bε-CTD relative to the nucleotide binding 
site on eIF2γ places the highly conserved catalytic center residues of the GEF within contact 
distance to the switch regions and the P-loop and is thus compatible with their direct involvement 
in GDP release. It should be noted that single mutations of most of the conserved residues within 
helices α1 and α2, including Glu458 and Arg555, were not found to have a detectable negative 
impact on yeast cell growth [74, 75]. However, is it in our opinion likely that similar to the 





between eIF2 and eIF2Bε contribute only marginally to the overall nucleotide release efficiency, 
but instead contribute synergistically to bring about the GDP destabilization required for its 
efficient release. 
Due to the low resolution of our structural model for the eIF2⋅eIF2Bε complex based on the 
crosslink data, the assumptions about the contributions by eIF2Bε to nucleotide exchange and the 
involvement of specific residues are necessarily tentative and remain speculative. However, our 
data clearly favor a mechanism of eIF2Bε-induced nucleotide exchange that proceeds via a 
successive series of reversible steps and the distortion of the Mg2+ and phosphate binding sites by 
the remodeling of the switch regions and/or the P-loop. Hence, our data support the idea that the 
eIF2Bε-CTD-catalyzed exchange reaction follows the common basic principles of nucleotide 
exchange known from other GEFs.   
 
Implications for the evolution of the C-terminal domains of eIF2Bε and eIF5 and their 
interactions with eIF2 
Within the family of trGTPases, only four factors, namely eIF2 and the homologous EF-Tu, eEF1A, 
and aEF1A, are known to have dedicated protein-GEFs that catalyze nucleotide exchange. For all 
other trGTPases no GEFs are known, which is consistent with their usually low affinities for GDP 
and its fast dissociation rates (with the possible exception of RF3, for which the ribosome itself was 
proposed to act as GEF [131]). In this context, it is interesting to note that all four GEF-dependent 
trGTPases belong to the same monophyletic clade, with eIF2γ most likely derived from the EF-Tu 
lineage [22]. An obvious conclusion would be to expect a common evolutionary history for the 
respective GEF functions as well. However, this is not the case. All three GEFs, namely EF-Ts, 
a/eEF1B and eIF2Bε, share no mutual sequence or structural homology, and at least for EF-Ts and 
eEF1B it is known that their structural differences are reflected in very different ways by which 
they approach and bind their respective substrate trGTPases [126, 127]. Moreover, no GEF is 
known for the archaeal eIF2 ortholog aIF2. Thus, it seems evident that the catalytic activity of 
eIF2Bε-CTD evolved after the divergence of the archaeal and eukaryal lineages and independently 
from EF-Ts or a/eEF1B. Similarly, no structural or functional counterpart for the eIF5-CTD is known 





From the data presented here, it becomes evident that eIF2Bε-CTD and eIF5-CTD share two 
critical interactions with eIF2: On the one hand the high affinity interaction between the conserved 
AA-boxes and the K-boxes in the eIF2β-NTT. On the other hand the direct interaction to 
overlapping interfaces on the frontal face of eIF2γ, which in both cases involve the regions 
surrounding repeat RI of the HEAT repeat-like fold and which have direct, though opposing, effects 
on the nucleotide binding properties of their common substrate eIF2γ. In light of the similarity of 
these interactions, combined with the structural and partial sequence homology between both 
proteins (Fig. S1), it is conceivable that eIF2Bε-CTD and eIF5-CTD share a common evolutionary 
origin in an AA-box-containing protein, which already bound eIF2 in a manner similar to the extant 
proteins and modulated its nucleotide binding properties – although this does not necessarily 
imply physiological relevance of this effect, similar to the suggestion for eIF5 (see chapter 2). 
Unfortunately, due to the low degree of sequence conservation between eIF2Bε-CTD and eIF5-
CTD, their apparently ubiquitous distribution among eukarya, and the absence of homologs in 
archaea or bacteria which could be used as outgroups for a phylogenetic analysis, it is currently not 
possible to determine whether the ancestral protein was more eIF5- or eIF2Bε-CTD-like, which 
would provide valuable insight into the process of evolution of the complex eukaryal initiation 
apparatus. 
It has previously been noted that with the exception of the two AA-boxes, eIF5-CTD and eIF2Bε-
CTD share very little sequence similarity (Fig. S1), which further extends to the details of the overall 
charge distribution and structural characteristics of the surfaces of both proteins, even in the area 
surrounding the two AA-boxes [1]. This divergence of sequence and structure in regions that are 
directly involved in an apparently highly conserved interaction with the eIF2β-NTT might be 
surprising at first sight. However, an explanation is provided by the proposed mode of peptide-
domain interaction between eIF2β-NTT and eIF2Bε-CTD or eIF5-CTD, respectively. For the eIF2β-
NTT it was proposed that the absence of any obvious sequence conservation outside the K-boxes is 
due to the absence of any evolutionary constraint that would be imposed by the necessity to adopt 
a stable tertiary structure fold for interactions with eIF5 or eIF2Bε (chapter 2). Similarly, the 
peptide-domain interaction would also release the peptide-binding sites on both proteins from the 





interaction partner for both C-terminal domains. The intrinsically flexible eIF2β-NTT would not 
require an in sequence and structure highly conserved interface on both proteins, but instead 
allows relatively rapid divergence of its two interaction partners. Consistent with this proposal of 
rapid evolution for eIF2Bε-CTD and eIF5-CTD, both proteins show a low degree of sequence 
similarity not only between each other, but also within each of the two lineages themselves. 
 
3.4 Materials and Methods 
Cloning 
The DNA fragment corresponding to the open reading frame of eIF2Bε (encoded by the GCD6 gene 
in S. cerevisiae) or truncations thereof were amplified by PCR using yeast genomic DNA as template 
and a corresponding pair of primers. Cloning, mutagenesis and verification of the different 
plasmids used in this study were performed as described in chapter 2(page 69). 
 
Protein expression and purification 
Expression of the various constructs and the purification of eIF2β and eIF2 was performed as 
described in chapter 2(pages 70-73). 
Purification of eIF2Bε-CTD constructs: All C-terminal eIF2Bε constructs (residues 524-712), 
including those containing Bpa, were expressed as GST-fusion protein and purified according to the 
protocol for the eIF5-CTD constructs described in chapter 2 (page 71). 
Purification of full-length eIF2Bε: Full-length eIF2Bε was expressed without affinity tag. Cell 
lysis was carried out as described (chapter 2, page 70) in L-150 buffer (150 mM NaCl, 20 mM HEPES 
(pH 7.5), 5% glycerol, 1 mM EDTA, 4 mM β-mercaptoethanol) supplied with a mixture of protease 
inhibitors including aprotinin, leupeptin, pepstatin (ALP), and PMSF. The cleared lysate was applied 
to a Q Sepharose (GE Healthcare) and bound nucleic acids and proteins, including eIF2Bε, were 
eluted with a linear gradient into high salt buffer (1 M NaCl, 20 mM HEPES (pH 7.5), 5% glycerol, 4 
mM β-mercaptoethanol). Fractions containing the target protein were pooled and ammonium 
sulfate added to a final concentration of 1 M. The sample was then loaded onto a phenyl-
sepharose column (GE Healthcare) equilibrated in 200 mM NaCl, 1 M (NH4)2SO4, 20 mM HEPES (pH 





eIF2Bε remained bound to the column and could be eluted with a linear gradient in low salt buffer 
containing 50 mM HEPES (pH 7.5), 5% glycerol and 4 mM β-mercaptoethanol. Peak fractions 
containing eIF2Bε were pooled and applied to a Superdex S-200 equilibrated in GF-150 buffer. The 
concentrated protein was flash-frozen in liquid nitrogen and stored at -80 °C.  
 
UV Crosslinking Experiments with Bpa and analysis by mass spectrometry 
Crosslinking experiments and the subsequent analysis of the formed crosslinks by mass-
spectrometry were performed as described inchapter 2 (pages 76-78). 
 
Steady-State Fluorescence Measurements 
All experiments were carried out on a Fluoromax-3 spectrophotometer (Jobin Yvon Inc., USA) using 
a quartz cuvette (Hellma Analytics, Germany). All reactions were done at 20 ± 1 °C in the standard 
reaction buffer (100 mM KCl, 20 mM Tris/HCl (pH 7.5), 3 mM MgCl2 and 2 mM DTT).  
The binding of eIF2β to eIF2Bε-CTD was monitored by tryptophan quenching experiments. 
Tryptophan fluorescence in eIF2Bε-CTD was excited at 280 nm, resulting in an emission at 350 nm, 
which was quenched upon the addition of eIF2β (full-length and N-terminal domain fragments). 
Equilibrium dissociation constants (Kd) for the complexes were determined by titrating eIF2Bε-CTD 
with increasing amounts of eIF2β, until saturation was reached. The residual fluorescence signal 
produced by eIF2β (which contains no tryptophan) alone was determined by blank-titrations into 
buffer and subsequently subtracted from the binding data. 
The binding of mant-labeled guanine nucleotides to eIF2 was monitored either by direct 
excitation at a wavelength of 355 nm or by Foerster Resonance Energy Transfer (FRET) from 
tryptophan residues excited at 280 nm and an emission wavelength of 440 nm. Fluorescence 
emission spectra were recorded after incubating the eIF2⋅mant-nucleotide complexes for 5 min at 
20 °C. To estimate the equilibrium dissociation constants (Kd) for eIF2⋅mant-nucleotide complexes 
in presence or absence of eIF2Bε, the fluorescence of increasing amounts of mant-nucleotides was 
measured either in buffer alone or in the presence of 200 nM of eIF2 complex. The dilution was 
less than 1%. To form eIF2⋅eIF2Bε complexes, eIF2Bε was added to eIF2 in a 20-fold molar excess 





Titrations of eIF2⋅mant-GDP with eIF2Bε were carried out by adding increasing amounts of 
the GEF to 1 ml of 100 nM eIF2⋅mant-GDP. The solution was carefully mixed and the fluorescence 
signal at 440 nm (after excitation at 355 nm) measured until a stable value was obtained. At the 
end of the titration a 200-fold excess of unlabeled GDP was added to determine the contribution of 
the unbound mant-GDP to the observed fluorescence signal.  
Assuming a one-site binding model for all studies reactions, the data obtained from 
equilibrium titrations were analyzed according to a quadratic binding model: 
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whereF is the fluorescence signal of the mant-nucleotide in the absence or presence of eIF2, F0is 
the initial fluorescence signal, ΔFmax is the maximum fluorescence signal, X is the total 
concentration of eIF2, Y is the total concentration of the added mant-nucleotide and Kd is the 
equilibrium dissociation constant. For the determination of the apparent equilibrium dissociation 
constants of eIF2·mant-GDP to eIF2Bε, the above equation was modified as follows:   
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Here, kapp is the characteristic apparent rate constant of the mant-nucleotide from eIF2 in the 
presence of a specific concentration of eIF2Bε (see below), Z is the concentration of eIF2Bε, ka is 
the dissociation rate constant of mant-GDP from eIF2 alone, kb is the dissociation rate constant of 
mant-GDP from eIF2 in the presence of saturating concentrations of eIF2Bε and K1/2 is the 
concentration of eIF2Bε at which their respective half maximal effect on the dissociation rate of 
mant-GDP from eIF2 is reached (the apparent equilibrium dissociation constant). Data evaluation 
was done with the SigmaPlot software. 
 
Pre-Steady-State Fluorescence Measurements 
Pre-Steady-State experiments were carried out on a Fluoromax-3 spectrophotometer using a 
quartz cuvette with stirring magnet to allow fast mixing of the reacting components. All reactions 





excited either directly at 355 nm or via FRET from tryptophan residues excited at 280 nm and 
monitored at an emission wavelength of 440 nm.  
To study the dissociation of nucleotides, 50 nM eIF2·mant-GDP or eIF2·mant-GTP complex 
was formed by adding 100 nM of the respective mant-nucleotide to 50 nM nucleotide-free eIF2, 
followed by an incubation for 10 min at 20 °C. To start the reaction, unlabeled GDP was added in 
excess and the decrease in mant-fluorescence was monitored over time. The data were evaluated 
by fitting to a single exponential function with the equation: 
 ( )       
       
whereF(t) is the fluorescence at time t, Fo is the final fluorescence signal, kapp is a characteristic 
apparent time constant and A is the amplitude. The data evaluation was done with the SigmaPlot 
software. 
 
Interaction studies using analytical size exclusion chromatography 
Complex formation between nucleotide-bound eIF2 and eIF2Bε was studied by size exclusion 
chromatography on an analytical Superdex S-200 (10/300) column (GE Healthcare). For runs 
without eIF2Bε, 50 µg eIF2 complex was incubated for 5 min at 20 °C with 1 mM guanine 
nucleotide (GDP or mant-GDP) in a total volume of 300 µl reaction buffer (100 mM KCl, 20 mM 
Tris/HCl (pH 7.5), 3 mM MgCl2 and 2 mM DTT). To study complex formation between nucleotide-
bound eIF2 and eIF2Bε, 50 µg of preincubated eIF2⋅nucleotide complexes were incubated for an 
additional 5 min at 20 °C in the presence of 60 µg of full-length eIF2Bε resulting in a ∼2-fold molar 
excess of the GEF over eIF2. The samples were then loaded onto the column, equilibrated in 







3.5 Supplementary information 
 
Figure S1. Multiple sequence alignment of the eIF5-CTD with eIF2Bε-CTD.Residues conserved between both proteins 
are highlighted in dark blue, conserved residues in light blue and variable residues in grey; the universally conserved 
Trp391 (eIF5) and Trp699 (eIF2Bε) in AA-box 2 is highlighted in yellow. The numbering above the alignment 
corresponds to the yeast ortholog of eIF2Bε (Sc-eIF2Bε), the numbering below the alignment corresponds to the yeast 
ortholog of eIF5 (Sc-eIF5). The DWEAR motif and AA-boxes 1 & 2 are indicated below the alignment. Sc, Saccharomyces 
cerevisiae; Hs, Homo sapiens; Dm, Drosophila melanogaster; Xl, Xenopous laevis; Gg, Gallus gallus; Mm, Mus musculus; 
Rn, Rattus norvegicus; Sp, Schizzosaccharomyces pombe. The alignment was initially generated using the clustal omega 
algorithm and subsequently corrected manually according to the structural alignment between the yeast orthologs of 






Figure S2. Influence of Bpa mutations on the guanine-nucleotide exchange activity of eIF2Bε-CTD. Time courses for 
the dissociation of mant-GDP from eIF2 (50 nM eIF2 with 100 nM mant-GDP and 3 µM unlabeled GDP) in the absence 
of eIF2Bε (black) and in the presence of 500 nMeIF2Bε(524-712)T572Bpa (green), eIF2Bε(524-712)N559Bpa or 
eIF2Bε(524-712). The smooth black lines represent single-exponential fits which yielded the apparent rate constants 
(kapp)of 0.135 min
-1




, and 2.3 min
-1
 for eIF2 with eIF2Bε(524-712) T572Bpa, 


















Figure S3. Influence of GDP and GTP on the limited proteolysis of eIF2 by thermolysine. Depending on the presence 
or absence of GDP and GTP (20-fold excess over eIF2), full-length eIF2γ (lane 1; running at ~65 kDa) is cleaved either 
into a fragment running at ~55 kDa (fragment 1) or a fragment running at ~46 kDa (fragment 2). According to MS-
analysis, these fragments originate from a cleavage either in front of the G domain (fragment 1) or within switch 1 
(fragment 2). While ATP, like in apo eIF2, is unable to protect switch 1 from proteolytic cleavage, GDP and GTP both 
stabilize switch 1 in a conformation that is not accessible to thermolysine. The cleavage reaction was performed for the 
indicated time (in hours) in 100 mM KCl, 20 mM Tris (pH 7.5), 5% glycerol, 2.5 mM MgCl2, 1 mM DTT at 20 °C and in the 
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The eukaryal translation initiation factor 2B (eIF2B) acts as guanine nucleotide exchange factor (GEF) for 
eIF2 and forms a central target for pathways regulating translation initiation. eIF2B consists of five non-
identical subunits (α-ε), which assemble into a catalytic subcomplex (γ and ε) that catalyzes nucleotide 
exchange on eIF2 and a regulatory subcomplex (α, β and δ) that regulates eIF2B function under stress 
conditions by tight binding of eIF2. Here, we provide new structural insight into the regulatory subcomplex 
of eIF2B from the fungus Chaetomium thermophilum, obtained by its in vitro reconstitution from the 
individually purified subunits and by solving the first high-resolution crystal structures of eIF2Bβ and eIF2Bδ. 
These structures confirm the proposed structural homology between the three regulatory subunits, but at 
the same time reveal critical differences that may be relevant for the assembly of the eIF2Bαβδ complex. 
Based on the presented findings, we propose a structural model for the eIF2B regulatory subcomplex, which 




The initiation of ribosomal protein synthesis in eukarya is a highly regulated process, which 
requires the concerted action of at least twelve different auxiliary protein factors, called eukaryal 
translation initiation factors (eIFs) [12]. One of the central hubs for translational regulation during 
the initiation phase is the eukaryal translation initiation factor 2B (eIF2B), which functions as 
guanine nucleotide exchange factor (GEF) for eIF2 to regenerate the latter in its GTP-bound form 
[80, 112]. 
The translation initiation cycle in eukarya starts when GTP-bound eIF2 specifically forms a 
ternary complex (TC) with methionylated initiator tRNA (Met-tRNAi) and, supported by other eIFs, 
delivers it to the P-site of the 40S ribosomal subunit to form the 43S pre-initiation complex (pre-
IC). The 43S pre-IC is subsequently recruited to the 5’-end of an mRNA to be translated and enters 
the scanning phase of translation initiation, during which it searches the 5’-untranslated region (5’-
UTR) of the mRNA for the start site of translation. Upon recognition of the correct AUG start 
codon, eIF2 hydrolyzes the bound GTP and dissociates from the pre-IC in its GDP-bound form. For a 





Due to the high affinity of the eIF2⋅GDP complex and the low rate of spontaneous GDP release, the 
exchange of GDP for GTP on eIF2 depends on the catalytic activity of the GEF eIF2B  [12, 112]. 
Consistent with this central position in the guanine-nucleotide cycle of eIF2, eIF2B is one of 
the main targets for global regulation of translation in eukarya [132]. The best characterized 
mechanism to control eIF2B activity is the phosphorylation of serine 51 (S51-P) in the α-subunit of 
eIF2 (eIF2α) by kinases in response to stress or starvation conditions [78-80]. eIF2α 
phosphorylation results in a significantly increased affinity of eIF2(α-P) for eIF2B, thereby 
converting eIF2 from a substrate into a competitive inhibitor of its GEF, and giving rise to the 
formation of non-productive eIF2(α-P)⋅eIF2B complexes [78, 112, 123, 124]. As a consequence, 
inhibition of eIF2B function reduces the cellular levels of TCs that are available for translation 
initiation, thus causing the down-regulation of overall protein synthesis. However, at the same 
time, eIF2α phosphorylation causes the up-regulation of certain mRNAs via a mechanism called 
translation re-initiation through upstream open reading frames (uORFs) in the 5’-leader region. 
One well studied example for such an mRNA is that for the transcription factor GCN4 in the yeast 
Saccharomyces cerevisiae, whose expression is up-regulated due to eIF2α phosphorylation by the 
kinase GCN2 in response to amino-acid starvation, and which in turn stimulates the expression of 
enzymes involved in amino-acid synthesis [79, 80].  
Compared to the GEFs of most other Ras-related G proteins, eIF2B is an unusually large and 
complex exchange factor, comprising five non-identical subunits (α, β, γ, δ, and ε) which form two 
subcomplexes that bind eIF2 independently from each other [112].eIF2Bγ and eIF2Bε together 
form the catalytic subcomplex, in which the C-terminal domain (CTD) of the ε-subunit constitutes 
the minimal catalytically active fragment [65, 74, 112]. The N-terminal regions of eIF2Bε exhibit 
sequence similarity to eIF2Bγ and are most likely involved in their mutual interaction [133, 134]. 
eIF2Bα, -β, and -δ form the regulatory subcomplex of eIF2B [112, 135], in which all three subunits 
share mutual sequence similarity over the entire length of eIF2Bα [136]. While the disruption of 
the genes for eIF2Bβ-ε is lethal in mammals and yeast, eIF2Bα is not essential [137]. However, 
eIF2Bα was found to be critical for the sensitivity of the eIF2B regulatory subcomplex to eIF2α 
phosphorylation and thus de-repression of GCN4 expression in yeast. The essential roles for eIF2Bβ 





roles in complex assembly, eIF2Bβ was found to promote eIF2 binding and to contribute to the 
efficiency in nucleotide exchange, while eIF2Bδ was proposed to play a role in Met-tRNAi 
recruitment to eIF2⋅GTP [77].  
For all five eIF2B subunits, a number of mutations have been identified that affect the activity 
of the eIF2B complex. Here, two main phenotypes can be distinguished in S. cerevisiae. On the one 
hand, mutations that decrease the GEF activity of eIF2B and thereby lower the cellular TC 
concentration, resulting in GCN4 derepression independently of eIF2α phosphorylation and amino-
acid starvation. This phenotype is called general control de-repression (Gcd-) and has been found 
for mutations in all five eIF2B subunits. On the other hand, mutations that prevent the expression 
of GCN4 even under stress conditions by rendering eIF2B insensitive to eIF2α phosphorylation are 
called general control non-derepressible (Gcn-). Such a phenotype was found for mutations in the 
three subunits of the regulatory subcomplex, which is thought to be indicative of a large interface 
for eIF2α binding on the eIF2Bαβδ complex [80, 135]. 
Despite considerable efforts over the last decades to understand eIF2B function, the 
architecture of the eIF2B complex remains elusive, thereby hampering the interpretation of 
available biochemical and genetic observations at the molecular level. This is exemplified by the 
lack of high-resolution structural insight into the eIF2B complex, which is limited to the isolated 
structures of the C-terminal catalytic domain of eIF2Bε from yeast and human and the human 
eIF2Bα subunit. Moreover, until recently it was thought that eIF2B forms a hetero-pentamer 
containing one copy of each of the five subunits. However, recent studies indicate that eIF2B in 
yeast and mammals in fact forms a functional decamer in solution that is composed of two 
eIF2Bαβδγε hetero-pentamers. The way in which the contact between the two pentamers is 
mediated is still not clear, as the available data contradict each other in this respect, suggesting 
that decamerization is either mediated by an eIF2Bα2 dimer [72, 138] or an eIF2B(γε)2 tetramer 
[73]. Similarly, the proposed arrangement of the individual subunits differs considerably between 
the studies, illustrating the problem to provide a clear picture of the eIF2B complex and its putative 
interactions with the substrate eIF2 on the basis of the available data. 
The aim of this study was to provide structural insight into the molecular architecture of the eIF2B 





from the thermophilic fungus Chaetomium thermophilum, which allowed us to reconstitute the 
eIF2B regulatory subcomplex in vitro. Analytical size exclusion chromatography experiments 
suggest that this subcomplex exists as an eIF2Bα2(βδ)2 hexamer in solution, in which an eIF2Bα2 
dimer most likely mediates the dimerization of two eIF2Bαβδ heterotrimers. Moreover, we solved 
the first high-resolution crystal structures of eIF2Bβ and eIF2Bδ, which demonstrate their 
structural homology to each other and to eIF2Bα. Using the presented results in combination with 
previous biochemical and genetic data, we generate a structural model for the eIF2B regulatory 
subcomplex. The possibility to in vitro reconstitute the eIF2B regulatory subcomplex in a pure form 
and in large amounts, as well as the availability of structural models for eIF2Bα, -β, and -δ provides 
a promising basis for future structural and functional studies on the eIF2B complex. 
 
4.2 Results 
Overall structure of eIF2Bβ(∆123-148) 
Initial trials to crystallize wild-type eIF2Bβ from C. thermophilum were unsuccessful. We therefore 
designed a construct lacking residues 123-148 (eIF2Bβ(∆123-148)), which, according to secondary 
structure predictions and sequence comparison with orthologs from other species, form a non-
conserved unstructured loop region between two conserved α-helical regions. Unlike the wild-type 
protein, eIF2Bβ(∆123-148) readily crystallized in a condition containing 100 mM HEPES (pH 6.8) 
and 1.33 M tri-sodium citrate. The structure of C. thermophilumeIF2Bβ(∆123-148) was solved by 
molecular replacement and refined at a resolution of 2.54 Å (Table 1). The final model contains two 
eIF2Bβ(∆123-148) molecules (molecules A and B) per asymmetric unit, consisting of an N-terminal 
α-helical domain (residues 10-202) and a C-terminal Rossmann-fold-like domain (residues 203-419) 
(throughout the manuscript we will follow the residue-count for wild-type eIF2Bβ, ignoring the 
internal deletion) (Fig. 1). The N-terminal domain folds into six α-helices, with helices α1, 2, 4, 5, 
and 6 assembled around helix α3 through hydrophobic interactions. Residues 1-9 are not resolved 
in the electron density and are therefore considered to be disordered. Likewise, residues 106-180 
are not resolved in molecule B of the asymmetric unit. In molecule A residues 106-112 and 160-174  
are not resolved, whereas the region comprising residues 113-122 and 149-159 (in which residues 





that form contacts to symmetry related molecules in the crystal packing. The C-terminal 
Rossmann-fold-like domain is composed of a seven-stranded β-sheet with the first six β-strands 
parallel and the seventh oriented antiparallel to the rest. The β-sheet is sandwiched between six α-
helices, three on each side. A second three-bladed antiparallel β-sheet (strands β5, β6, and β8) is 
Table 1. Crystallization, X-ray data collection and refinement statistics for structures of 
Chaetomium thermophilum eIF2B subunits β and δ 




100 mM HEPES (pH 6.8), 
1.33 M tri-sodium citrate 
100 mM MES (pH 6.2), 0.8 M 
(NH4)2SO4 
Temperature (°C) 20 20 
Data Collection 
Space Group R3 P212121 
Unit Cell 
 
a = 138 Å 
b = 138 Å 
c = 146.6 Å  
α =  β = 90° 
γ = 120° 
a = 74.8 Å 
b = 94.5 Å 
c = 107.8 Å  
α =  β =  γ = 90° 
 
Molecules/asym. unit 2 2 
Resolution (Å) 2.54 (2.63-2.54) 2.55 (2.65-2.55) 
Observed reflections 134799 (14846) 93747 (10009) 
Unique reflections 34537 (3801) 25018 (2697) 
Completeness (%) 99.9 (99.9) 97.7 (98.3) 
<I>/𝜎 23.7 (2.6) 16.4 (3.0) 
Rsym (%) 5.0 (58.4) 5.6 (48.1) 
CC(1/2) (%) 99.9 (76.4) 99.7 (73.4) 
Refinement 
Rwork (%) 17.0 18.8 
Rfree (%) 20.3 22.7 
Rmsd from Standard  
Stereochemistry 
Bond length (Å) 0.008 0.004 
Bond angles (°) 1.14 0.85 
Ramachandran Plot  
Statistics 
Most favored (%) 98.2 98.7 
Allowed regions (%) 1.8 1.3 
Disallowed regions (%) 0 0 
Values in parentheses refer to the highest resolution shell. 
Rwork and Rfree factors are calculated using the formula R = Σhkl‖F(obs)hkl| − |F(calc)hkl‖/Σhkl |F(obs)hkl|, where F(obs)hkl and F(calc)hkl are observed 
and measured structure factors, respectively. Rwork and Rfree differ in the set of reflections they are calculated from: Rfree is calculated for the test 






packed against strands β4, β7, and β9 of the first β-sheet, with the strands of the two sheets lying 
orthogonal to each other. An additional α-helix (α13) forms the C-terminal end of eIF2Bβ. Two loop 
regions comprising residues 253-258 and 347-373 (denoted the ‘arm-region’), respectively, are 




Figure 1. Overall crystal structure of C. thermophilumeIF2Bβ(∆123-148).eIF2Bβ is shown in cartoon presentation with 
the N-terminal α-helical domain (residues 10-202) colored blue, and the helices and β-sheets of the C-terminal 
Rossmann-fold-like domain (residues 203-419) are colored red and yellow, respectively. The arm region is only partially 
resolved in the electron density. In the left panel, the grey colored molecule represents the second copy of eIF2Bβ in 
the asymmetric unit, which is omitted in the right panel. Helix α5’, which is stabilized through contacts to symmetry 
related molecules in the crystal packing, contains the fusion between residues 122 and 149. 
 
The two monomers of the asymmetric unit are arranged back-to-back to each other (Fig. 1), 
with the mainly hydrophobic dimer-interface formed solely by the backside of the C-terminal 
domains, involving helices α7 and α12 and strand β9 of the large β-sheet of each monomer. The 
individual N- and C-terminal domains of the two molecules can be superimposed well with rmsd 





terminal domain. The overall proteins differ more significantly (rmsd of 0.59 Å over 270 Cα atoms) 
due to different angles between N- and C-terminal domains, as indicated by a slight increase in the 
angle between the connecting helices α6 and α7 from ∼40° in molecule A to ∼45° in molecule B 
(Fig. 3B). In both molecules, this conformation is stabilized through hydrophobic, as well as ionic 
interactions between helices α5 and α6 in the NTD and helix α13 in the CTD. As a consequence, the 
N- and C-terminal domains together form a deep cleft at the front of the molecule, with a mainly 
negatively charged platform formed by the connecting α2-α3 and α4-α5 loops in the NTD and a 
mainly positively charged lid formed by the CTD (Fig 3E). 
 
Overall structure of eIF2Bδ(148-443) 
During purification, eIF2Bδ usually degraded into two fragments of ∼35 kDa and ∼20 kDa 
according to SDS-PAGE analysis (see Materials and Methods for details). Crystallization trials were 
performed for the full-length protein, as well as for the 35 kDa fragment. Only the latter yielded 
high quality crystals that could be used for data collection and allowed the determination of the 
crystal structure of C. thermophilumeIF2Bδ(148-443) by molecular replacement (Table 1). The final 
model, refined at 2.55 Å resolution, contains two eIF2Bδ(148-443) molecules (molecules A and B) 
per asymmetric unit, which superimpose well with each other with an rmsd of 0.2 Å over 239 Cα 
atoms (Fig. 2). Each monomer is formed by an N-terminal α-helical domain (residues 148-266) and 
a C-terminal Rossmann-fold-like domain (residues 267-443). The N-terminal domain folds into five 
α-helices that lie nearly parallel to each other, assembled around a hydrophobic core. The N-
terminal 147 residues are not resolved in the electron density. As the theoretical masses of this 
fragment and that of the crystallized protein correspond well to the two degradation fragments 
observed during purification, we assume that the N-terminal residues were lost during purification 
due to a proteolytic event, which would also be consistent with the low R-factors of 18.8 and 
22.7% (Table 1). The C-terminal Rossmann-fold-like domain is composed of a six-stranded parallel 
β-sheet (β1-β4, β7 and β9), sandwiched between three α-helices on each side. A second three-
bladed antiparallel β-sheet (strands β5, β6, and β8) is packed against strands β4, β7, and β9 of the 
first β-sheet, with the strands of the two sheets lying orthogonal to each other. The long loop 





asymmetric unit. Likewise, the C-terminal 23 residues are not resolved in the electron density, 
indicating that they are either flexible or were lost during purification.  
Together with helix α2, helices α5 and α6 form the ∼3800 Å2 large interface for homodimer 
formation between the two molecules of the asymmetric unit, with the helices of one monomer 
oriented nearly orthogonal to those of the other (Fig. 2, 5A). The most intimate contact is thereby 






Figure 2. Overall crystal structure of C. thermophilumeIF2Bδ(148-443).eIF2Bδ is shown in cartoon presentation with 
the N-terminal α-helical domain (residues 148-266) colored blue, and the helices and β-sheets of the C-terminal 
Rossmann-fold-like domain (residues 267-443) colored red and yellow, respectively. The arm region is mainly 
disordered and therefore not resolved in the electron density. In the right panel, the grey colored molecule represents 









Figure 3. Comparison of the structures of human eIF2Bα with C. thermophilum eIF2Bβ and eIF2Bδ. A-C) Compared to 
cteIF2Bδ (C), hseIF2Bα (PDB: 3ECS) (A) and cteIF2Bβ (B) exhibit significantly increased angles between the two long 
connecting helices between N- and C-terminal domains (colored blue and red, respectively), which might be 
dependent on the presence of the additional C-terminal α-helix (green) that forms direct contacts to the NTD and 
which is absent in the cteIF2Bδ structure. cteIF2Bβ (B) exhibits an additional N-terminal α-helix (α1; purple), which is 
not found in hseIF2Bα or cteIF2Bδ. Homodimer formation by hseIF2Bα through helices α9 and α10 of the C-terminal 
domain is indicated by the second hseIF2Bα molecule of the asymmetric unit as golden surface. D-E) Surface charge 
presentation (negative, red; positive, blue) of the cleft between N- and C-terminal domains in hseIF2Bα (D), cteIF2Bβ 
(E) and cteIF2Bδ (F). The crystal structure of hseIF2Bα accommodates a sulfate ion at the bottom of the cleft, 
surrounded by positively charged residues. Although some of these residues are conserved also in cteIF2Bβ and 





Structural comparison between the subunits of the eIF2B regulatory subcomplex 
Earlier analyses revealed mutual sequence similarities between the three eIF2Bα, β, and δ subunits 
[136]. Consistently, our structural analysis for eIF2Bβ and eIF2Bδ from C. thermophilum 
demonstrate that both subunits share a common overall fold, comprising an N-terminal helix 
bundle and a C-terminal α/β Rossmann-like fold, which is, moreover, homologous to the previously 
reported structure of eIF2Bα from Homo sapiens[139]. 
Notwithstanding their overall structural similarity, each of the three structures reveals 
features that are either idiosyncratic among the three proteins, or shared with only one of the 
other subunits (Fig. 3). One prominent example is the first of the six α-helices of the N-terminal 
domain in subunit β (α1), which replaces the four-stranded antiparallel β-sheet that usually 
occupies this position in 5-methylthioribulose 1-phosphate isomerases (5M1PIs), ribose-1,5-
bisphosphate isomerases (RBPIs) or archaeal eIF2B-like proteins (e.g. PDBs 1T5O, 1W2W), proteins 
which were found to be in sequence and structure homologous to eIF2Bα, -β and -δ [28, 139, 140]. 
Neither the additional α-helix nor the β-sheet is observed in the eIF2Bα- or δ-subunit. It should be 
noted, however, that the sequence conservation between eIF2Bβ orthologs is low in this region 
[136], suggesting that helix α1 might not be universally conserved.  
Another distinctive feature is the relative orientation of the five conserved helices of the N-
terminal helix bundle (Fig. 3A-C). In eIF2Bβ and -δ all five α-helices lie nearly parallel to each other. 
A similar arrangement is found in 5M1PIs, RBPIs and eIF2B-like proteins. By contrast, helices α1-α5 
in eIF2Bα are significantly less parallel to each other, particularly with helix α1 reoriented relative 
to the following helices by nearly 50°, thereby allowing a direct contact between the α1-α2 loop to 
helix α7 in the C-terminal domain that is not observed in the structurally related homologues [139].  
In agreement with the relative high degree of sequence similarity, the C-terminal Rossmann-
like domain of the eIF2B subunits exhibits a higher degree of structural homology and only minor 
differences in the arrangement of helices α8 and α9 (α9 and α10 in cteIF2Bβ). One of the most 
prominent distinctive features within the C-terminal domain is the C-terminal α-helix found in the 
structures of eIF2Bα (helix α12) and eIF2Bβ (helix α13) (Fig. 3A/B). This α-helix is not present in 
eIF2Bδ (Fig. 3C), despite the fact that it contains conserved residues at its C-terminus that would 





packing would allow its formation in the same position. In eIF2Bα and -β, this helix forms mainly 
hydrophobic contacts to the N-terminal domain, thereby stabilizing one of the most salient 
features of both proteins: the strong kink in the transition of helix α5 of the NTD to helix α6 of the 
CTD (helices α6 and α7 in eIF2Bβ). The angle between the axes through both helices is ∼30° in 
eIF2Bα and 40-45° in eIF2Bβ. By contrast, these helices are nearly coaxially fused in eIF2Bδ with an 
angle of close to 20°, suggesting that the contact to the C-terminal α-helix observed in the other 
two subunits is a requirement for the conformational rearrangement to the kinked state (Fig. 3A-
C). This is supported by the structures of 5M1PI/eIF2B-like structures, which usually lack a 
structural element corresponding to the C-terminal helix in eIF2Bα and -β, resulting in nearly 
straight connecting helices. An exception from this rule is the RBPI from Thermococcus 
kodakarensis, which contains a homologous C-terminal α-helix that forms contacts to the N-
terminal domain as observed in eIF2Bα and -β and thereby stabilizes an angle of ∼50° between 
helices α5 and α6 (PDB: 3A11)[141].  
As a consequence of the increased angle, the cleft formed by the N- and C-terminal domains 
is considerably larger in eIF2Bα and eIF2Bβ than in the δ-subunit, which in the case of eIF2Bα 
allows the coordination of a sulfate ion in a pocket of the cleft ∼16 Å from its entrance [139] (Fig. 
3D). Sulfate ions have also been observed in the narrower clefts of several 5M1PI/eIF2B-like 
proteins. However, in these cases the sulfate ion is positioned significantly closer to the entrance 
and coordinated by a different set of residues [139]. Although some of the residues responsible for 
sulfate ion binding in eIF2Bα are conserved in subunits β and δ [139], and despite the presence of 
0.8 M sulfate ions in the crystallization condition for eIF2Bδ (Table 1), neither of the two structures 
exhibited an electron density in the corresponding position that could be explained by a sulfate ion 
(Fig. 3E/F). This apparent inability of subunits β and δ to coordinate the sulfate ion can be 
explained by the fact that eIF2Bβ and eIF2Bδ contain residues (Asp43 and His292, respectively) 
that would overlap with the putative sulfate ion binding site, causing electrostatic and/or steric 
repulsion (Fig. 3D-F). 
Another important aspect of the newly determined structures is their implication for the 
oligomeric state of eIF2Bβ and eIF2Bδ. So far studied eIF2B-like proteins, 5M1PIs, as well as RBPIs 





have so far been determined revealed a structurally nearly identical dimer interface, in which two 
adjacent α-helices of the C-terminal domain in one monomer pack against the same helices of the 
other [138]. Additionally, a structurally conserved loop (the ‘arm-region’) protrudes from one CTD 
and packs against the other, thereby extending the large central β-sheet of the Rossmann-like fold. 
The same dimer interface was found in the crystal structure of H. sapiens eIF2Bα (Fig. 4A), and 
recent biochemical studies suggest that eIF2Bα uses this interface to form a physiological 
homodimer in solution [72, 138]. It is therefore noteworthy that the structures of eIF2Bβ and 
eIF2Bδ presented here constitute an exception among their homologues (eIF2Bα/eIF2B-
like/5M1PIs/RBPIs) as they apparently do not form stable homodimers along this interface. For 
eIF2Bβ, the crystal structure does not suggest an alternative interaction that might allow stable 
dimerization, in line with our observation that cteIF2Bβ exists as a monomer in solution (see 
below). By contrast, cteIF2Bδ seems to exist as a mixture of monomers and homodimers in 
solution (see below), which could indicate that the monomeric form crystallized under the used 
condition, and that an unstable homodimer could still be formed through the same interface as in 
eIF2Bα. However, unlike eIF2Bβ, the two monomers in the asymmetric unit of the eIF2Bδ structure 
do interactvia a large interface formed by helices α2, α5, and α6, which could thus provide an 
alternative means to form a homodimer in solution (Fig. 5A).  
 
Protein interaction studies by analytical size exclusion chromatography 
To study the solution state and interactions between the individual eIF2B subunits α, β, and δ from 
Chaetomium thermophilum, we used analytical size exclusion chromatography (SEC) (Fig. 6).  
CteIF2Bα exists as a homo-dimer in solution. We found that cteIF2Bα (∼41 kDa) alone elutes from 
the analytical SEC column in two peaks. The smaller peak elutes at 10.8 ml, while the main peak 
elutes at 12.5 ml, corresponding to apparent molecular weights of ∼250 and 95 kDa, respectively. 
No peak was observed at an elution volume that would correspond to a monomer (∼14 ml). This 
suggests that cteIF2Bα most likely forms mainly dimers (∼82 kDa) in solution, while a small fraction 
forms higher oligomeric states, possibly homo-tetramers. 
CteIF2Bβ exists as a monomer in solution. In contrast to cteIF2Bα, cteIF2Bβ (∼45 kDa) alone 





molecular weight of ∼40 kDa, as expected for a monomer. An additional small shoulder elutes at 




CteIF2Bδ exists as a mixture of monomers and homo-dimers in solution. Finally, full-length 
cteIF2Bδ (∼49 kDa) alone elutes in two main peaks, the first at 12.1 ml and the second at 14.1 ml, 
corresponding to apparent molecular weights of ∼120 and ∼40 kDa, respectively. This suggests 
that cteIF2Bδ exists as a mixture in solution of nearly equal amounts of monomers and dimers (~98 
kDa), with the equilibrium slightly shifted in favor of dimer-formation. 
 
 
Figure 4.Model for the heterodimer between 
eIF2Bβ and eIF2Bδ. A) The hseIF2Bα 
homodimer (PDB: 3ECS). Like in the 
homologous 5M1PIs and RBPIs, the dimer 
interface is mainly formed by helices α9 and 
α10 of the CTD in one monomer, which pack 
against the same helices of the second 
molecule. The interface is complemented by the 
‘arm-region’, which protrudes from one CTD to 
extend the large central β-sheet of the 
Rossmann-like fold in the CTD of the second 
monomer. B) Model for the eIF2Bβ⋅eIF2Bδ 
heterodimer along the same interface as seen 
for eIF2Bα. In the structures of the individual 
subunits, the helices corresponding to α9 and 
α10 in eIF2Bα are not occupied by homodimer 
formation and are thus available for 
heterodimer formation. C) The left panel shows 
the view directly onto the hypothetical 
eIF2Bβ⋅eIF2Bδ heterodimer interfaces of eIF2Bβ 
(blue) and eIF2Bδ (dark red), respectively. The 
right panel shows the same view on both 
proteins in surface charge presentation (red, 
negative; blue, positive). The horizon indicated 
by the dashed line corresponds to that shown in 
(B), demonstrating that the surface charge 
distribution on the two proteins would be 






Figure 5. Model for the heterodimer between eIF2Bα and eIF2Bδ. A) The cteIF2Bδ homodimer observed in the 
asymmetric unit of the crystal structure (see also Fig. 2). In both molecules, the interface is mainly formed by helices 
α2, α5 and α6, which are oriented nearly orthogonal between the two protomers. The most intimate contacts are 
formed in the area of the kink-region between helices α5 and α6, where the green residues indicate positions of Gcn
-
 
mutations. The contact between the two cteIF2Bδ molecules is mediated mainly by polar interactions between 
complementary charged surfaces (charged residues are shown as sticks). B) Model for the eIF2Bα⋅eFI2Bδ heterodimer, 
in which the grey copy of eIF2Bδ from A) is exchanged for a homology model of cteIF2Bα (golden; based on the 
hseIF2Bα structure, generated by the Phyre2 modeling server). The lower panel shows the direct view onto the 
potential binding interfaces of eIF2Bα (left) and eIF2Bδ (right) in surface charge presentation, with dashed arrows 
indicating the areas that contact each other in the model shown in the upper panel (red, negative; blue, positive).   
 
Formation of the cteIF2Bαβδ complex depends on the presence of all three subunits. Mixing 
cteIF2Bα with either cteIF2Bβ (full-length or ∆123-148) or with cteIF2Bδ alone did not result in 
complex formation between the respective proteins, as indicated by the elution profiles of the SEC 
(Fig. 6A/B). In the case of the cteIF2Bα-cteIF2Bδ mixture it cannot be excluded that a hetero-dimer 
is formed that migrates at approximately the same volume as the respective homo-dimers; 





of the individual runs (blue line in Fig. 6B), and the amount of monomeric cteIF2Bδ seems to be 
unchanged between the presence or absence of cteIF2Bα. Thus, neither cteIF2Bβ nor cteIF2Bδ 
seem to interact with cteIF2Bα individually. By contrast, mixing cteIF2Bβ with cteIF2Bδ in the 
absence of cteIF2Bα results in the complete precipitation of both proteins, leaving in solution only 
the protein that had been added in excess over the other. Indirectly, this indicates that eIF2Bβ and 
δ interact with each other independently of eIF2Bα and form a 1:1 complex with low solubility.  
Finally, we tried to in vitro reconstitute the entire cteIF2Bαβδ regulatory subcomplex by first 
mixing eIF2Bβ with a ~2-fold molar excess of eIF2Bα, followed by the addition of eIF2Bδ in ~1.5-
fold excess over the β-subunit. This time, no precipitation occurred and the analytical SEC run 
clearly shows the formation of a new peak, eluting at a volume of 10.31 ml (Fig. 6C), which 
corresponds to an apparent molecular weight of ∼320 kDa. SDS-PAGE analysis of the peak 
fractions demonstrates that they contain all three subunits in approximately a 1:1:1 ratio (Fig. 6C, 
right panel). The calculated molecular mass of a hetero-trimer of the three subunits is ∼135 kDa, 
which is significantly smaller than the size of the observed complex in solution as indicated by SEC. 
Instead, the obtained results would be in better agreement with a hexamer of eIF2Bα, β, and δ in a 
2:2:2 ratio (eIF2Bα2β2δ2), which would add up to a complex of ∼270 kDa. Importantly, this putative 
eIF2Bα2β2δ2 complex also contained small amounts of the upper degradation product of eIF2Bδ 
(35 kDa), which contains the crystallized fragment eIF2Bδ(148-443) (Fig. 6C), while the second 
smaller degradation product elutes separately from the complex peak at a higher volume. 
Moreover, the construct eIF2Bβ(∆123-148), used for structure determination (see above), formed 







Figure 6. Reconstitution of the eIF2B regulatory subcomplex from C. thermophilum by analytical size exclusion 
chromatography. A)Chromatograms for cteIF2Bα (red curve), cteIF2Bβ (green curve) and the mixture of cteIF2Bα and 
cteIF2Bβ (blue curve). While cteIF2Bα elutes as an apparent dimer at ∼12.5 ml, corresponding to a size of ∼95 kDa, 
cteIF2Bβ elutes at 14.2 ml, corresponding to an apparent molecular weight of ∼40 kDa, as expected for a monomer. 
No shift in the elution volume is observed for either peak when both subunits are mixed, indicating that no complex 
formation takes place (as confirmed by the SDS-PAGE). B)Chromatograms for cteIF2Bα (red curve), cteIF2Bδ (green 
curve) and the mixture of cteIF2Bα and cteIF2Bδ (blue curve). cteIF2Bδ elutes in two peaks at 12.1 ml and 14.1 ml, 
respectively, corresponding to apparent molecular weights of ∼120 and ∼40 kDa, respectively. No shift in the elution 
volume is observed for either peak when both subunits are mixed, indicating that no complex formation takes place. C) 
When all three regulatory subunits are mixed, a new peak emerges at an elution volume of 10.31 ml (blue line), which 
corresponds to an apparent molecular weight of ∼320 kDa. SDS-PAGE analysis of the peak fractions (right panel) 






In comparison to most known GEFs of Ras-related G proteins, eIF2B, the GEF for eIF2, is an 
unusually large and complicated protein complex composed of five non-identical subunits. Despite 
considerable efforts over the last decades, little is known about the actual architecture of this large 
protein complex, the arrangement of the individual subunits relative to each other, and the way in 
which they bind their substrate eIF2. Previously available high-resolution structural information for 
the eIF2B complex was limited to the isolated ∼20 kDa C-terminal catalytic domain of eIF2Bε and 
the eIF2Bα regulatory subunit from H. sapiens [74, 139]. Thus, the lack of detailed structural 
information for the individual eIF2B subunits, as well as for their mutual interactions is one of the 
key problems that currently hamper the interpretation of available mutational and genetic data to 
obtain a detailed picture of the molecular mechanisms that underlie eIF2 binding by eIF2B, 
nucleotide exchange and its regulation under stress conditions.  
The motivation for this present work was toprovide insight into the architecture of the eIF2B 
regulatory subcomplex in its molecular details. For this purpose, the orthologs of the three 
subunits eIF2Bα, -β, and -δ from the thermophilic fungus Chaetomium thermophilum were 
recombinantly expressed and purified in their respective full-length forms that were active in in 
vitro reconstitution experiments for the regulatory subcomplex (Fig. 6). Initial trials to crystallize 
the entire regulatory subcomplex were not successful. However, it was possible to improve the 
crystallizability of the isolated cteIF2Bβ by deleting a non-conserved predicted loop region within 
the N-terminal domain, resulting in the first high-resolution crystal structure of an eIF2Bβ ortholog 
(eIF2Bβ(∆123-148)) (Fig. 1). Moreover, by using a spontaneously occurring degradation product 
containing only the conserved C-terminal part of eIF2Bδ, we solved the first crystal structure of an 
eIF2Bδ ortholog (eIF2Bδ(148-443)) (Fig. 2). Importantly, both constructs were found to be 
incorporated into the eIF2Bαβδ regulatory subcomplex with wild-type eIF2Bα, indicating that the 
missing regions are not critical for its formation.  
Together with the structure of H. sapiens eIF2Bα, the newly determined structures provide a 
vantage point for further structural studies on the architecture of the regulatory subcomplex. In 
line with predictions on the basis of sequence homology [136], both crystal structures confirmed 





terminal domain and a C-terminal Rossmann-like α/β domain. One of the most striking 
observations from the crystal structures of eIF2Bβ and eIF2Bδ is the fact that they constitute the 
first examples from this protein family that do not stably homodimerize via the usual interface in 
the C-terminal domain. Hence, the same interface used for homodimerization in eIF2Bα, archaeal 
eIF2B-like proteins, 5M1PIs and RBPIs [138] would be available in eIF2Bβ and eIF2Bδ for 
heterodimerization either with each other or with eIF2Bα. The latter option is unlikely, since 
eIF2Bα from C. thermophilum (Fig. 6) as well as from yeast forms stable homodimers in solution 
using this interface [138] and does not form stable complexes with the isolated eIF2Bβ or eIF2Bδ 
(Fig. 6A/B). By contrast, the analytical SEC experiments revealed that eIF2Bβ forms a monomer and 
eIF2Bδ is present as a mixture of monomers and homodimers in solution, which would allow the 
formation of heterodimers between both proteins. Consistently, eIF2Bβ or eIF2Bδ interact with 
each other, most likely forming a tight 1:1 complex in solution that, however, was not soluble 
under the used experimental conditions. Heterodimerization between eIF2Bβ and eIF2Bδ via the 
usual homodimerization interface has been suggested previously [138] and would be consistent 
with the complementary surface charge distribution on both C. thermophilum proteins (Fig. 4B/C). 
Moreover, phylogenetic analyses suggest a common clade for these two proteins within the family 
of eIF2B regulatory subunits [140], which indicates that they could constitute a derived homo-
dimer that originates in a duplication event of their ancestral gene and a subsequent derivatization 
of the two lines without losing their ability to interact. The specific interaction between eIF2Bβ and 
eIF2Bδ is further supported by previous studies that demonstrated co-depletion of eIF2Bδ together 
with the genetic depletion of eIF2Bβ in S. cerevisiae, indicating that the latter is required to 













Figure 7. Structural model for the eIF2B regulatory subcomplex. A)According to the model, the regulatory eIF2B 
subomplex consists of one central eIF2Bα2 homodimer (gold and grey surfaces) which mediates the interactions 
between two eIF2Bβδ heterodimers (blue and red surfaces) through direct contact to the δ-subunit (as in Fig. 5B). Pink, 
green and yellow surfaces indicate positions of Gcn
-
 mutations in eIF2Bα, eIF2Bβ and eIF2Bδ, respectively[123, 135, 
142, 143]. The complex has a two-fold symmetry axis through the dimerization interface of the eIF2Bα2 dimer 
(indicated by the black ellipsis). B) The resulting half-moon structure of the regulatory subcomplex suggest that the 
eIF2Bγ2ε2 catalytic subcomplex (presented as by Gordiyenko et al.[73]) becomes bound between the two eIF2Bβδ 
heterodimers and thus in the vicinity of the previously identified Gcn
-
 mutations. The asterisks mark positions of lysine 
residues that were found to be crosslinked to specific positions on the eIF2Bγ2ε2 complex (indicated by black arrows) 
[73]. eIF2Bγ and eIF2Bε each consist of a pyrophosphorylase-like domain (PLD) and a left-handed β-helix (LβH) domain, 







An interesting question that arises from our own and previous data is that of the 
topology/connectivity within the eIF2Bαβδ regulatory subcomplex. In line with recent biochemical 
and mass-spectrometry data [72, 138], the analytical SEC experiments shown in Fig. 6 suggest that 
the regulatory subcomplex is not a heterotrimer as previously thought but in fact a dimer of 
heterotrimers, forming an eIF2Bα2(βδ)2 complex. The necessity to allow further binding of two 
additional eIF2Bγε subcomplexes assembled as a symmetrical γ2ε2 complex [73], as well as the 
problem to avoid aggregation between eIF2B complexes favors an arrangement of the two 
eIF2Bαβδ trimers in a way that allows their superposition by a simple rotational symmetry 
operation. Within this complex, neither eIF2Bβ, nor eIF2Bδ are individually sufficient to interact 
with eIF2Bα but require the structural context of the eIF2Bβδ complex to allow the formation of 
the hexamer. This suggests that the eIF2Bβδ complex either forms a combined interaction surface 
for the α-subunit or that one subunit induces conformational changes within the other that render 
it active for interactions with eIF2Bα. In both cases, the assumption that eIF2Bα2 and eIF2Bβδ each 
dimerize via the usual interface of the C-terminal domain (Fig. 4) makes it necessary to search for 
an alternative interface to mediate the association between the two dimers.  
One interesting candidate for such an interaction is the interface between the two eIF2Bδ 
protomers within the asymmetric unit of the crystal structure (Fig. 5). This interface along helices 
α5 and α6 is sufficiently large (∼7600 Å2 of combined buried surface area) to be physiologically 
relevant. Interestingly, yeast eIF2Bα and eIF2Bδ, but not eIF2Bβ, both contain sites of Gcn- and 
Gcd- mutants in the kink-region between helices α5 and α6 that forms the area for the most 
intimate contact within the eIF2Bδ dimer interface (Fig. 5B). Thus, an appealing option would be 
that each of the two eIF2Bβδ dimers associates with one copy of eIF2Bα in the eIF2Bα2 homodimer 
through the δ-subunit and via an interface formed by helices α5 and α6 in both proteins (Fig. 7A). 
As an increased kink between helices α5 and α6 in eIF2Bδ would allow a more intimate contact to 
its interaction partner eIF2Bα, it is conceivable that eIF2Bβ-binding might stabilize the C-terminal 
helix in eIF2Bδ (which is disordered in the crystal structure of eIF2Bδ and stabilizes the large angles 
between α5 and α6 in eIF2Bα and eIF2Bβ (Fig. 3A-C)), thereby providing a possible explanation for 
the apparent cooperativity in their binding to eIF2Bα. In this scenario, the inability of the Gcn- 





destabilization or even loss of eIF2Bα, the primary sensor of eIF2α(S51-P), from the eIF2B complex 
by interrupting the contact to eIF2Bδ.  
In the resulting model, eIF2Bα would play a critical role by mediating hexamer formation in 
the regulatory subcomplex (Fig. 7), consistent with previous studies that demonstrated that eIF2Bα 
promotes decamer formation between two eIF2Bβδγε complexes [72]. It should be noted however 
that data presented by Gordiyenko et al.[73] suggest that decamer formation is mediated between 
two eIF2Bγε dimers, whereas the two regulatory subcomplexes, each comprising eIF2Bαβδ in a 
1:1:1 stoichiometry would not contact each other directly [73]. This is ostensibly at odds with the 
data by Wortham et al.[72] and our own observations and would require the dissociation of the 
conserved stable eIF2Bα2 dimer upon complex formation. Although the studies by Wortham et 
al.[72] and by Gordiyenko et al.[73] were done with proteins from different species (mammals and 
yeast, respectively), it is in our opinion unlikely that the observed differences are due to species-
specific modes of decamerization, particularly as our own data for the fungus C. thermophilum 
support the data from the mammalian system. To reconcile both data sets it is in our opinion 
conceivable that decamerization is in fact mediated by the eIF2Bα2 homodimer, as well as the 
eIF2B(γε)2 tetramer, with each γε dimer binding independently to a regulatory subcomplex formed 
by one copy of eIF2Bα and the eIF2Bβδ heterodimer (Fig. 7B). This possibility would explain why 
Wortham and coworkers [72] found that the disruption of the eIF2Bα dimer by mutagenesis does 
not abolish eIF2Bα-dependent decamerization [72], while the data by Gordiyenko et al. [73] 
indicate that the presence of eIF2Bα stabilizes eIF2B(βδ)2(γε)2 formation [73]. The resulting half-
moon shape of the eIF2Bα2(βδ)2 model would be consistent with an eIF2B(γε)2 tetramer assembled 
on the inner side (Fig. 7B). Moreover, most identified Gcn- mutations would as well map to the 
inner side of the model. Finally, Gordiyenko and coworkers [73] found that K107 in yeast eIF2Bα 
and K422 in yeast eIF2Bδ crosslink to K412 and K410 in the left-handed β-helix (LβH) domain of 
eIF2Bγ, respectively. As K107 in eIF2Bα and K422 in eIF2Bδ occupy adjacent positions within our 
structural model (∼17 Å apart) and are both orientated toward the inner side of the half-moon, 






4.4 Materials and Methods 
Cloning 
The coding sequences of eIF2B subunits α, β and δ were amplified by PCR as individual exons from 
Chaetomium thermophilum genomic DNA and introduced into the expression vector according to 
the InFusion protocol (Clontech). The coding sequence for full-length eIF2Bα was introduced into 
pET22b vector cleaved with the restriction enzymes NcoI and XhoI. The coding sequences for full-
length eIF2Bβ and δ were introduced into the pGEX-6P1 vector cleaved with BamHI and XhoI. The 
InFusion mixture was transformed into XL1-Blue E. coli cells (Stratagene) and plated out on LB agar 
plates containing appropriate antibiotics. Several colonies of each plate were picked and subjected 
to a test PCR to identify positive clones. Positive colonies were grown over night in LB medium 
supplemented with antibiotics and the plasmid was purified withthe Qiaprep Spin Miniprep Kit 
(Qiagen) according to the manufacturer’s instructions. The sequences of the selected constructs 
were verified by DNA sequencing.  
The construct encoding eIF2BβΔ123-148 was generated by deletion of the corresponding 
codons from the original plasmid (wild-type eIF2Bβ in pGEX-6P1) according to the QickChange 
technique (Stratagene) using appropriate mutagenesis primers. The plasmid was prepared and 
verified by sequencing as described above. 
 
Protein expression and purification 
Expression: All three constructs were expressed in E. coliBL21(DE3) Rosetta II cells (Novagene). 
Cells containing the respective plasmid were grown in 2xYT medium (supplemented with 
antibiotics) at 37 °C with shaking at 220 rpm until they reached an OD600 of ∼0.8. Subsequently the 
cell cultures were transferred to 16 °C, and the expression was induced after 20 min by the 
addition of isopropyl-β-D-thiogalactopyranosid (IPTG) to 0.5 mM final concentration. The cells 
were harvested after 16 hours at 16 °C. 
Purification of eIF2Bα: Cells containing C-terminally His-tagged eIF2Bα were resuspended in 
L-100-His buffer (20 mM Hepes (pH 7.5), 100 mM KCl, 10% glycerol, 15 mM imidazole, 2 mM β-
mercaptoethanol) containing a mixture of protease inhibitors including aprotinin, leupeptin, 





cell debris was removed by centrifugation for 30 min at 30,000 xg. The supernatant was loaded 
onto a HisTrap column (GE Healthcare) equilibrated in L-100-His buffer. The column was then 
washed with 2 column volumes of L-100-His buffer and bound protein was eluted with a linear 
gradient into elution buffer (L-100-His buffer with 350 mM imidazole). Fractions containing the 
target protein were pooled, concentrated to a volume of 5 ml and applied to a Superdex S-200 
gelfiltration column (GE Healthcare) equilibrated in G-100 buffer (10 mM Hepes (pH 7.5), 100 mM 
KCl, 10% glycerol and 2 mM DTT). The pure protein was concentrated to 20 mg/ml, flash-frozen in 
liquid nitrogen and stored at -80 °C. 
Purification of eIF2Bβ, eIF2Bβ(∆123-148) and eIF2Bδ: All three constructs were expressed as 
N-terminally GST-tagged fusion proteins. Cell lysis was performed as described for eIF2Bα with the 
difference that L-500 buffer (20 mM Hepes (pH 7.5), 500 mM KCl, 10% glycerol, 4 mM β-
mercaptoethanol) was used to resuspend the cells. After removal of cell debris by centrifugation, 
the supernatant was applied to a GSTrap column (GE Healthcare) equilibrated in L-500 buffer. After 
washing the column with 4 column volumes of L-500 buffer, the bound fusion protein was eluted 
with 30 mM reduced glutathione in L-500 buffer. Fractions containing the target protein were 
pooled and desalted on a HiPrep Desalting column (GE Healthcare) equilibrated in desalting buffer 
(10 mM Hepes (pH 7.5), 200 mM KCl, 10% glycerol, 4 mM β-mercaptoethanol). The pooled protein 
was incubated over night at 4 °C with Prescission protease in a 1:100 weight ratio of protease to 
target protein to remove the GST-tag. In order to remove the GST-tagged protease, cleaved GST 
and uncleaved fusion protein the sample was applied to a second GSTrap column equilibrated in 
desalting buffer. The flow-through was pooled and concentrated to 5 ml before loading onto a 
Superdex S-200 gelfiltration column equilibrated in G-100 buffer. eIF2Bβ and eIF2Bβ(∆123-148), 
which eluted as pure protein in a single peak, were concentrated to 15-20 mg/ml and stored at -80 
°C. eIF2Bδ usually suffered strong degradation resulting in the cleavage of the full-length protein 
into two fragments migrating at ∼36 kDa and ∼20 kDa, respectively, on the SDS-PAGE. As a 
consequence, eIF2Bδ eluted in two major peaks from the S-200 column containing either the full-
length protein or the 36-kDa fragment. Both fragments were pooled independently, concentrated 






Protein crystallization and structure determination 
eIF2Bβ. Initial crystallization trials for full-length eIF2Bβ were performed by sitting-drop vapor 
diffusion with commercially available standard screens. No crystals were obtained at any of the 
tested protein concentrations (between 6 and 15 mg/ml) or temperatures (4 and 20°C). In order to 
improve the crystallizability of the protein, we decided to remove residues 123 to 148 from the 
peptide-chain by deletion of the corresponding coding sequence from the expression vector. 
According to multiple sequence alignments of C. thermophilum eIF2Bβ with its homologs from 
other species, these residues are not conserved and seem to correspond to a loop region between 
two conserved α-helices that is idiosyncratic to cteIF2Bβ. Thus, we reasoned that its removal would 
have no negative impact on the overall structure of the protein, which is supported by the fact that 
it still forms a complex with eIF2B subunits α and δ (see below). In initial crystallization trials with 
the construct eIF2BβΔ123-148, crystals were obtained after 5 days at 20 °C in a condition 
containing 100 mM HEPES (pH 7.5) and 1.0 M tri-sodium citrate. After optimization, diffraction 
quality crystals were obtained with 9.5 mg/ml protein at 20 °C in 100 mM HEPES (pH 6.8) and 1.33 
M tri-sodium citrate. X-ray diffraction data were collected at BL 14.1 (HZB, BESSY, Berlin) [113]. The 
phase problem was solved by molecular replacement using the program PHASER [115] and the 
atomic coordinates of the N-terminal domain of the Bacillus subtilis 5-methylthioribose 1-
phosphate isomerase (PDB: 2YVK) and the C-terminal domain of Homo sapiens eIF2Bα (PDB: 3ECS) 
as independent search models. The structure was refined in trigonal space group R3 at a resolution 
of 2.54 Å using the program PHENIX [117]. Missing regions of the peptide chain were built 
manually in Coot [116]. The final model contains two molecules per asymmetric unit (see Table 1 
for details of data collection and refinement).     
eIF2Bδ. Initial crystallization trials for eIF2Bδ were performed by sitting-drop vapor diffusion 
with commercially available standard screens. With the truncated version of eIF2Bδ (35 kDa 
fragment) initial crystals grew with 10 and 12 mg/ml protein at 20 °C in a condition containing 100 
mM MES (pH 6.0) and 1.0 M (NH4)2SO4. After optimization, diffraction quality crystals were 
obtained in 100 mM MES (pH 6.2) and 0.8 M (NH4)2SO4. X-ray diffraction data were collected at BL 
14.1 (HZB, BESSY, Berlin) [113]. The phase problem was solved by molecular replacement using 





(residues 27-93) of the N-terminal domain of  Homo sapiens eIF2Bα (PDB: 3ECS), and residues 116-
295 of its C-terminal domain. The structure was refined in primitive orthorhombic space group 
P212121 at a resolution of 2.54 Å using the program PHENIX [117]. The final model contains two 
molecules per asymmetric unit (see Table 1 for details of data collection and refinement). 
 
Interaction studies by analytical size exclusion chromatography 
Complex formation between eIF2Bα, -β and -δ was studied by size exclusion chromatography on an 
analytical Superdex S-200 (10/300) column (GE Healthcare). For the individual standard runs for 
the subunits, 50 µg protein in a total volume of 300 µl was loaded onto the column equilibrated in 
running buffer (100 mM KCl, 20 mM Tris/HCl (pH 7.5) and 2 mM DTT). For the analysis of binary 
complex formation between two subunits, 50 µg of each protein were mixed in 300 µl running 
buffer and incubated for 5 min at 20 °C before loading onto the column. In case of the eIF2Bβ-
eIF2Bδ mixture, the simultaneous presence of both proteins resulted in their complete 
precipitation until only the subunit added in excess over the other was still in solution. To study 
complex formation between all three subunits, eIF2Bβ (50 µg) was first mixed with a ~2-fold excess 
of eIF2Bα (100 µg), followed by the addition of eIF2Bδ in ~1.5-fold excess over the β-subunit (80 
µg). The mixture was incubated for 5 min at 20 °C in 300 µl running buffer before loading onto the 

















This manuscript has originally been published in The EMBO Journal 
 
eIF5B employs a novel domain release mechanism to catalyze ribosomal 
subunit joining 
 
Bernhard Kuhle1,§ and Ralf Ficner1 
 
 
1 Abteilung für Molekulare Strukturbiologie, Institut für Mikrobiologie und Genetik, Göttinger 
Zentrum für Molekulare Biowissenschaften, Georg-August-Universität Göttingen, D-37077 
Göttingen, Germany 
$ To whom correspondence should be addressed: bkuhle@gwdg.de 
 
 




Received 6 November 2013 | Revised 6February 2014 | Accepted 20 February 2014 | Published 
online 31 March 2014 








BK: Conceived the study and designed the experiments; prepared and crystallized proteins, 
collected X-ray data andsolved the structures;performed ITC experiments; created figures; 






eIF5B is a eukaryal translational GTPase that catalyzes ribosomal subunit joining to form elongation 
competent ribosomes. Despite its central role in protein synthesis, the mechanistic details that 
govern the function of eIF5B or its archeal and bacterial (IF2) orthologs remained unclear. Here, we 
present six high resolution crystal structures of eIF5B in its apo, GDP- and GTP-bound form that, 
together with an analysis of the thermodynamics of nucleotide binding, provide a detailed picture 
of the entire nucleotide cycle performed by eIF5B. Our data show that GTP binding induces 
significant conformational changes in the two conserved switch regions of the G domain, resulting 
in the reorganization of the GTPase center. These rearrangements are accompanied by the 
rotation of domain II relative to the G domain and release of domain III from its stable contacts to 
switch 2, causing an increased intrinsic flexibility in the free GTP-bound eIF5B. Based on these data, 
we propose a novel domain release mechanism for eIF5B/IF2 activation that explains how eIF5B 




Translation is the fundamental cellular process in which the ribosome synthesizes proteins 
according to genetically encoded information. Among the individual steps, translation initiation is 
the most complex and most divergent in the three domains of life, which is highlighted by the 
different number of initiation factors (IFs) employed by eukaryal (∼12 eIFs) or bacterial cells (three 
IFs) to accomplish the same goals during ribosome assembly [9]. The major differences between 
eukaryal and bacterial translation initiation concern the formation of the 48S/30S pre-initiation 
complex (pre-IC) where the small 40S/30S ribosomal subunit is assembled at the AUG start codon 
of an mRNA with the charged initiator-tRNA (Met-tRNAi
Met/fMet-tRNAfMet) in its P site [9]. This is 
followed by the formation of the elongation competent 80S/70S ribosome, which is achieved by 
the joining of the large 60S/50S ribosomal subunit, catalyzed by the orthologous GTPases eIF5B, 
aIF5B and IF2 in eukarya, archea and bacteria, respectively [15, 144, 145].  
Together with the elongation factors EF-Tu and EF-G the initiation factors eIF5B, aIF5B and 





cellular life. This suggests that the function of eIF5B and its orthologs was fixed at an early stage of 
cellular evolution before the onset of speciation, reflecting the importance of subunit joining as the 
final control step in the initiation pathway. Up to now, however, the structural dynamics between 
the active and inactive factor that govern the process of subunit joining, and the degree of their 
conservation across the three domains of life remain unclear. 
Earlier crystal structures of aIF5B and IF2 revealed similar architectures for both proteins 
with an N-terminal GTP binding (G) domain and a β-barrel domain II as structural core, followed by 
domains III and IV [82-84]. IF2 and eIF5B contain an additional N-domain, which displays little 
conservation in sequence and length and was shown to be dispensable for the function of yeast 
eIF5B [85]. 
Like all trGTPases eIF5B and its orthologs belong to the family of guanine nucleotide-binding 
(G) proteins [24]. Consequently, their mechanism has to be viewed as a specific variation of the 
classical concept of G proteins as molecular switches that alternate between an inactive GDP- and 
a structurally distinct active GTP-bound state. The transition between the two states is defined by 
conformational changes in two dynamic elements of the G domain, termed switch 1 and switch 2, 
which specifically interact with the γ-phosphate of the GTP molecule [23]. Only in the GTP-bound 
state the G protein interacts tightly and productively with effector molecules. Accordingly, the 
functional cycle of the G protein ends when it is ‘switched off’ by GTP hydrolysis and the following 
structural transition to the inactive GDP-bound state [23, 24]. 
For eIF5B it was demonstrated that it interacts with the ribosomal subunits and catalyzes 80S 
ribosome formation in a GTP-dependent manner [145, 146]. It was further shown that subunit 
joining occurs catalytically in the presence of GTP but only stoichiometrically with the 
nonhydrolyzable GTP analog GDPNP. This indicates that GTP hydrolysis is required for the release 
of the factor from the 80S ribosome, in line with the observation that GDPNP but not GTP slows 
down the dissociation of eIF5B from 80S ribosomes and inhibits the peptidyl-transfer reaction [85, 
145]. Similarly, it was found that IF2 promotes subunit joining much more efficiently in the 
presence of GTP and GDPNP than with GDP, and that GTP hydrolysis is required for the dissociation 





suggested that eIF5B and IF2 employ a similar mechanism to promote subunit joining [147] which 
is compatible with the classical concept of G protein function. 
However, this assumption stands in sharp contrast to other structural and biochemical data. 
It was found that GDP- and GTP-bound IF2 catalyze subunit joining nearly equally well, and that 
GTP hydrolysis is not required for the release of IF2 from the ribosome [150, 151]. Based on these 
observations, it was proposed that IF2 functions differently from eIF5B and as a non-classical 
GTPase with apparently no role for GTP hydrolysis [27, 82, 150], raising the question why the 
catalytic machinery required for GTP binding and hydrolysis is universally conserved in IF2.  
So far available structure-based models for eIF5B/IF2 function do not provide explanations 
for these contradictory results. The ‘articulated lever model’ for eIF5B/IF2 function, which is based 
on crystal structures of aIF5B, assumes that a GTP-induced ∼2 Å shift in switch 2 is amplified by an 
en bloc rearrangement of domains II to IV into a ∼5 Å movement of domain IV [84]. According to 
this model, neither switch 1 nor switch 2 undergoes the conformational changes or form the direct 
contacts to the γ-phosphate that are typical for the classical molecular switch. However, low 
resolution cryo-EM reconstructions of bacterial and eukaryal 70S/80S ICs revealed conformations 
of IF2 and eIF5B that are incompatible with the articulated lever model [91, 152]. In order to 
reconcile the contradictory experimental data with the classical concept of molecular switching it 
was suggested that eIF5B and IF2 follow a mechanism of ‘conditional switching’, in which GTP 
binding alone is insufficient to activate eIF5B/IF2 but requires the ribosome as a cofactor that shifts 
the equilibrium between an inactive and an active GTP-bound form toward the latter [153, 154]. 
More recently it was proposed that IF2 does not have an ‘effecter domain’ like other trGTPases 
and therefore behaves different from eIF5B and not as a classical GTPase [82], which, however, 
leaves open the question how the nucleotide status of the G domain is communicated into 
domains III and IV. 
For aIF5B as well as IF2, crystal structures have previously been solved in the GDPNP- and 
GTP-bound state, respectively [83, 84]. However, in both cases the G domain remained in the 
apo/GDP conformation despite the presence of the γ-phosphate. Thus, the knowledge of eIF5B and 
IF2 function is limited by the fact that up to now no high resolution structural information is 





switching. Though of paramount importance to the understanding of eIF5B/IF2 function, it is 
therefore not known what distinguishes the active from the inactive state of the G domain and 
how these differences modulate the affinity of the overall eIF5B/IF2 to ribosomal effector 
complexes or influence the mechanism of ribosome induced GTP hydrolysis.   
Here we present thermodynamic data and high resolution structures of eIF5B that provide a 
detailed picture of its entire nucleotide cycle. We determined six crystal structures of eIF5B from 
Saccharomyces cerevisiae and Chaetomium thermophilum containing the G domain and domains II-
IV or substructures thereof in the apo, GDP- and GTP-bound states. These structures 
unambiguously demonstrate that the G domain of free eIF5B follows the classical switch 
mechanism involving large structural rearrangements of the two switch regions. The GTP-induced 
changes result in the formation of a catalytic GTPase center similar to that in EF-Tu suggesting a 
possible scenario for ribosome dependent GTPase activation in eIF5B. Most importantly, the 
various structures in combination with an analysis of the thermodynamics of nucleotide binding 
suggest a mechanism for eIF5B activation in which the local switch within the G domain is 
propagated into the rest of the factor through the release of domain III, resulting in an increase of 
intrinsic flexibility that is necessary for efficient subunit joining. Based on these observations, we 
propose a domain release mechanism for eIF5B activation, which represents a novel variation from 




Overall structure and domain arrangement in apo eIF5B 
Six different crystal structures of eIF5B from Chaetomium thermophilum (Ct) and Saccharomyces 
cerevisiae (Sc) were solved either in the apo form or cocrystallized with GDP or GTP. All structures 
were solved by means of molecular replacement. A summary of structures, crystallographic details 
and data statistics is presented in Table I and Fig. S1. 
The topology of the individual domains as well as the overall domain arrangement of apo 
eIF5B is similar to that of the archeal ortholog aIF5B [84] (Fig. 1). Domains I-III form the core 





Table 1. Crystallization, X-ray data collection and refinement statistics 
Organism C. thermophilum S. cerevisiae 















100 mM MES (pH 
6.8), 12% PEG 
20000, 10 mM 
Na-lactate 
100 mM MES (pH 
6.8), 12% PEG 
20000, 10 mM 
Na-lactate 
15% PEG 8000 
and 0.5 M Li2SO4 
100 mM Hepes (pH 
7),  13% PEG 4000 
and 100 mM NaOAc 
20% ethylene 
glycol, 5% PEG 3350 
and 20 mM MgCl2 
8% PEG 8000 and 
0.37 M Li2SO4 
Temperature (°C) 4 4 20 20 4 10 
Data Collection 
Space Group P3221 P3121 P212121 P21 P41 P212121 
Unit Cell 
 
a = b = 111.5 Å   
c = 115.2 Å 
 
 
α = β = 90°  
γ = 120° 
a = b = 98.2 Å  
c = 97.4 Å          
 
 
α = β = 90° 
γ = 120° 
a = 66.9 Å  
b = 72.9 Å  
c = 199.2 Å  
 
α = β = γ = 90° 
a = 55.4 Å 
b = 114.8 Å 
c = 65.9 Å  
 
α = 90° 
β = 102.3° 
γ = 90° 
a = b = 118.0 Å 
c = 77.5 Å  
 
 
α = β = γ = 90° 
a = 73.6 Å  
b = 119.5 Å  
c = 120.7 Å;  
 
α = β = γ = 90° 
Molecules/asym. 
unit 
1 1 2 2 2 2 
Resolution (Å) 2.75 (2.85-2.75) 3.2 (3.3-3.2) 2.12 (2.21-2.12) 1.87 (1.97-1.87) 1.83 (1.93-1.83) 3.02 (3.12-3.02) 
Observed reflections 168769 (15898) 59836 (5506) 288203 (38832) 251805 (36887) 426259 (62736) 108724 (10591) 
Unique reflections 22063 (2217) 9288 (800) 56555 (7213) 66297 (9605) 93360 (13677) 21521 (1972) 
Completeness (%) 99.9 (100) 99.8 (100) 99.7 (99.9) 99.8 (99.8) 99.8 (99.9) 99.2 (99.5) 
<I>/𝜎 32.66 (3.29) 32.12 (4.31) 17.79 (2.97) 20.53 (2.38) 21.05 (3.11) 23.3 (3.52) 
Rsym (%) 3.7 (58.9) 3.4 (57.4) 5.6 (63.1) 4.4 (62.0) 3.9 (52.5) 5.3 (60.6) 
Refinement 
Rwork (%) 19.3 19.0 21.9 16.7 16.8 24.9 
Rfree (%) 23.8 22.0 25.2 20.6 19.4 28.7 
Rmsd from  
Standard  
Stereochemistry 
Bond length (Å) 0.005 0.003 0.005 0.019 0.008 0.004 
Bond angles (°) 0.82 0.66 0.95 1.75 1.17 0.99 
Ramachandran Plot  
Statistics 
Most favored (%) 98.0 98.0 98.8 98.3 98.5 97.0 
Allowed regions (%) 2.0 2.0 1.2 1.7 1.5 3.0 
Disallowed regions 
(%) 
0 0 0 0 0 0 
Values in parentheses refer to the highest resolution shell. 
Rwork and Rfree factors are calculated using the formula R = Σhkl‖F(obs)hkl| − |F(calc)hkl‖/Σhkl |F(obs)hkl|, where F(obs)hkl and F(calc)hkl are observed and measured 
structure factors, respectively. Rwork and Rfree differ in the set of reflections they are calculated from: Rfree is calculated for the test set, whereas Rwork is calculated for 
the working set. 
 
are tightly associated through hydrophobic contact areas composed of β2 (part of switch 1), β3 and 
β4 in the G domain as well as β9, β10 and β16 in domain II (Fig. 1). The orientation of domain II 
relative to the G domain is nearly identical in Ct-eIF5B and Sc-eIF5B and similar to that found in IF2, 








Figure 1.Front view of the overall structure of C. 
thermophilumeIF5B(517C) in the apo form. The Cα 
trace is shown in rainbow coloring from the N- 
(blue) to the C-terminus (red). The functional core 
of eIF5B is composed of the G domain (I) with the 
nucleotide binding site (arrow), domain II, domain 
III and domain IV. 
 
Stable interactions of domain III with other 
domains are restricted to the area surrounding 
the N-terminal half of helix α9 (Fig. 1 and 3A/B). 
Van der Waals contacts are formed with domain 
II and the linker-helix α8 with a buried surface 
area of ~700 Å2. Helix α9 also interacts with 
switch 2 as the only stable contact partner for 
domain III within the G domain. Further contacts 
are formed between the N-terminus of helix α12 
and α4; however, these do not seem to be 
functionally relevant, as they differ between the 
various apo structures. Consequently, the 
orientation of domain III relative to the G 
domain differs considerably in Sc-eIF5B, Ct-eIF5B 
and aIF5B, which amounts to a displacement of 
the C-terminus of α12 by 12-22 Å between the 
three apo structures (Fig. S2A). In a direct 
superposition of domain III from aIF5B, Ct-
eIF5B(517C) and Ct-eIF5B(870C) the C-terminal 
ends of α12 lie only 3-3.5 Å apart. However, 
domain IV adopts significantly different 
orientations relative to α12 and domain III, 
indicating a high degree of flexibility (Fig. S2B). 
 
Conformational changes in the G domain of eIF5B upon GTP binding 
GTP is bound by eIF5B in the way common for G proteins involving five conserved sequence motifs 
termed G1-G5 [24] (Fig. 2 and S3). The base is in contact with the 530NKID533 (G4) and 598SAx600 (G5) 





the phosphates of the nucleotide are stabilized by main- and side-chain interactions with the P 
loop (G1).  
 
 
Figure 2.The nucleotide-dependent conformational switch in the G domain of eIF5B. A-C) Structural 
transition of the G domain from its apo form (A) to the GTP- (B) and the GDP-bound (C) states. P-loop, 
switch 1 and switch 2 are colored pink in the apo state, yellow in the GTP-bound state and cyan in the GDP-
bound state. Thr439, Asp476, Gly479 and His480 (S. cerevisiae numbering) are shown as sticks; the Mg2+ 
ion, Na+ ion and water molecules are shown as spheres in magenta, blue and grey, respectively; nucleotides 
are shown as balls and sticks. D, E) Network of interactions in the nucleotide binding pocket of the GTP- (D) 
and GDP-bound (E) factor. Direct interactions are indicated by dashed lines. 
 
The most severe conformational changes are observed for the two switch regions which 
contain the 437GIT439 (G2) and 476DTPG479 (G3) motifs that function as sensors for the presence of 
the γ-phosphate (Fig. 2). In the apo state most of switch 1 (residues 427-443) forms an 





the inactive switch 1 forms a short β strand (β2) oriented antiparallel to β3 as part of the interface 
with domain II. Upon GTP binding, switch 1 flips over by ∼180° using Gln427 and Gly443 as hinges 
(Fig. 2A/B and S4A). As a result its N-terminal part is oriented antiparallel to helix α1 toward the 
nucleotide binding pocket where it forms a one-turn α-helix (α1’) above the α-phosphate, followed 
by a turn toward the β- and γ-phosphates that continues into β3. The critical Thr439 is displaced 
from its position in β2 of the apo state by nearly 20 Å to form direct contacts to the Mg2+ ion and 
the γ-phosphate. In this new position switch 1 has almost no contacts outside the nucleotide 
binding pocket with the exceptions of a salt bridge between Glu434 and Arg688 of the β13-β14 
loop and a hydrogen bond of Gln441 to the conserved Glu636 in domain II (Fig. 2D).   
Switch 2 (476-492) undergoes a substantial rearrangement as well. In the apo state the G3 
motif in switch 2 runs parallel to β4 as far as Gly479, where the peptide backbone makes a sharp 
turn of >90° and continues through the inter-domain cleft formed by domains I-III toward the back 
of the protein (Fig. 2A and 3B). Here switch 2 turns a second time toward the dorsal side of the G 
domain forming the two-turn helix α3. In this conformation switch 2 makes van der Waals contacts 
to domain II but mainly interacts with domain III: The backbone CO of Ser484 accepts a hydrogen 
bond from Gly763, Arg487 forms a hydrogen bond and salt bridges to Glu766 and Asp770, and 
Arg489 forms a strong salt bridge to Asp740 (Fig. 3A/B).  
Upon GTP binding Asp476 moves 3.1 Å toward the γ-phosphate and forms a hydrogen bond 
to one of the water molecules coordinating the Mg2+ ion (Fig. 2B/D and S4B). The universally 
conserved Gly479 of switch 2 moves ∼8 Å toward the γ-phosphate; concomitantly, the peptide 
bond between Pro478 and Gly479 flips by ∼160°. In its new position Gly479 interacts directly with 
the γ-phosphate and the putative catalytic water molecule (Wcat). The movement of the G3 motif 
has a profound impact on the rest of switch 2: His480 moves by 12 Å and forms part of a loop at 
the front of the G domain that is stabilized by Arg487 (Fig. S4B). In its new position His480 lies next 
to Val414 (P loop) with the imidazole moiety pointing outward, away from Wcat (Fig. 2D). The rest 
of switch 2 (484-493) forms the extended helix α3 next to α4, with some residues up to 15 Å 
relocated from their original position in apo eIF5B; the axis through α3 is thereby rotated by more 
than 90° (Fig. S4A). In order to achieve this conformational change in switch 2 all its interactions to 






Figure 3.Nucleotide-dependent conformational changes in eIF5B. A) G domain-based superposition of 
domains I (G), II and III from Ct-eIF5B in the apo and GTP-bound state. Both G domains are shown in grey; 
otherwise the same color code as in Fig. 2. The GTP-induced rearrangements result in the loss of 
interactions between switch 2 and helices α8 and α9 (circle) and ultimately in the release of domain III from 
the G domain. Domain II rotates by ∼30° relative to the G domain and is stabilized in its new orientation by 
the newly formed contact between β13-β14 loop and domain I. B) In apo eIF5B the inactive switch 2 (pink) 
forms stable contacts to helices α8 and α9 of domain III which are broken upon the GTP-induced transition 
of switch 2 to its active state (yellow). C) Comparison of the molecular switch mechanisms in EF-Tu (left) and 
eIF5B (right). Both trGTPases are shown in their inactive apo or GDP-bound (top) and GTP-bound (bottom) 
states, respectively. Functionally relevant interactions between the switch regions (yellow) of the G domain 
and downstream functional domains (blue) are indicated by dashed circles. D) The contact surface (pink) 
found between domain III (blue) and domains I and II in apo eIF5B (top) is entirely lost in ribosome-bound 
eIF5B·GDPCP (bottom; PDB: 4BVX [91]), where domains III and IV become stabilized between SRL and Met-
tRNAi





Switch 1 and switch 2 are stabilized in their active GTP-bound conformations through a 
network of interactions surrounding the Mg2+ ion and γ-phosphate (Fig. 2D). The Mg2+ ion is 
coordinated by six oxygen ligands with octahedral coordination geometry; two of the ligands are 
water molecules, two come from the β- and γ-phosphates and two are provided by the side chains 
of Thr419 and Thr439. The γ-phosphate is further stabilized by Lys418 (P loop), Thr439 and Gly479. 
Wcatlies 2.8 Å from the outward pointing γ-phosphate oxygen in position for an in-line attack on the 
γ-phosphate, stabilized by the backbone amides of Gly479 and His480 and the backbone CO of 
Thr439. Next to the γ-phosphate an additional strong electron density was observed, which was 
assigned to a Na+ ion. Its pentagonal coordination shell with the typical bond lengths of 2.3-2.5 Å 
[156] is constituted by two oxygens from the α- and γ-phosphates, the β-γ-bridging oxygen, the 
caboxylate of Asp415 (P loop) and the CO from Gly437 in switch 1. Together, P loop, switch 1 and 
switch 2 form a closed ∼10 Å deep pocket that accommodates the Mg2+ and Na+ ions as well as all 
three phosphates with the γ-phosphate and Wcat at its bottom. His480 and bulk solvent are 
excluded from this pocket by a gate formed by Val414 and Ile438. 
A comparison with the structure of EF-Tu⋅GDPNP [157] shows a strikingly high degree of 
similarity between the catalytic centers in GTP/GDPNP-bound EF-Tu and eIF5B with nearly identical 
positions for all conserved residues with a pair-wise Cα rmsd of 1.1 Å over 99 residues as well as for 
Wcat and the Mg2+ ion (Fig. 4A and S5A). However, the position occupied by the Na+ ion in eIF5B is 
vacant in the EF-Tu⋅GDPNP structure and a perfect agreement between eIF5B and EF-Tu is 
restricted to residues that are directly involved in nucleotide binding or implicated in GTPase 
activity. Switch 1 in eIF5B lacks the second helix (A’’) that serves factor specific functions in EF-Tu 
[48].   
 
Domain rearrangements in eIF5B upon GTP binding 
Upon GTP binding domain II performs two main movements that result from the activation of the 
G domain (Fig. 3A): on the one hand the dorsal portion of domain II tilts inward, following the 
movement of β3 and β4 that was induced by the 3.1 Å shift of Asp476 toward the Mg2+ ion (Fig. 
S4); on the other hand domain II rotates by ∼30° causing the front portion to move upward and 





is stabilized by a newly formed interaction of the β13-β14 loop (residues 684-689) with the G 
domain, which takes over the position next to β3 that was originally occupied by β2 and left vacant 
after the GTP-induced rearrangement of switch 1 (Fig. 2 and 3A). 
As described above, all residues of switch 2 that are involved in contacts with domains II and 
III in the apo structure are rearranged and move by an average of ~14 Å upon GTP binding (Fig. 3B 
and S4). Since switch 2 is the main contact area for domain III in the G domain either a completely 
new set of interactions has to be formed or the interaction of domain III to the G domain is entirely 
lost. As domain III is not present in the structure of Ct-eIF5B⋅GTP, direct information about its 
position in free eIF5B⋅GTP is not available. However, our ITC experiments described below point 
toward a scenario in which domain III is released from the G domain without forming stable new 
contacts with the reorganized G domain in the free form of eIF5B⋅GTP (see below). 
 
Conformational changes in eIF5B during the transition from the GTP- to the GDP-bound state 
Subsequent to GTP hydrolysis and release of Pi most conformational rearrangements that followed 
GTP binding are reversed in eIF5B⋅GDP (Fig. 2). Switch 1 flips back to its original position, thereby 
displacing the β13-β14 loop. Switch 2 loses part of its α-helical structure and retracts toward the 
back of the protein to adopt a conformation nearly identical to that found in the apo form (Fig. S4). 
However, Asp476 in the G3 motif of Ct-eIF5B·GDP remains in its activated position in contact with 
the Mg2+ ion. Likewise, Thr477 and Pro478 retain their activated positions, whereas Gly479 is 
rotated back. As a consequence, the entire switch 2 is still shifted ~3 Å relative to its apo position 
but already forms the interactions to domains II and III found in apo eIF5B (Fig. S4). Accordingly, α9 
and therewith domain III are shifted 3-4 Å relative to their apo state position. Finally, also the 
ventral side of domain II is still shifted forward, however, no upward movement of its frontal face 
occurs, indicating that the loss of interactions between domains I and III is a prerequisite for this 
domain rearrangement (Fig. S4C).  
In summary, the transition from the GTP to the GDP state allows domain III to reassociate 
with the core domains of eIF5B and reverses the rotation of domain II. Interestingly, binding of 
GDP and Mg2+ seems to be able to partially activate switch 2 (including the peptide flip of Gly479), 






Figure 4. Structural model of eIF5B·GTP on the ribosome.A) Superposition of the catalytic centers of 
eIF5B⋅GTP (yellow) and free EF-Tu⋅GDPNP (cyan; PDB: 1EXM). Conserved residues are shown as sticks; 
GDPNP is omitted for clarity. B) Superposition of the catalytic centers of eIF5B⋅GTP (yellow) and ribosome-
bound EF-Tu⋅GDPCP (PDB: 2XQD, 2XQE) with the sarcin-ricin loop (SRL) in pink. Structural alterations 
relative to free eIF5B⋅GTP and EF-Tu⋅GDPNP are limited to Hiscat of EF-Tu, which is reoriented (arrow) into its 
active position between A2662 and Wcat. C) Model of domains I and II of eIF5B (orange) on the ribosome, 
based on the superposition with EF-Tu⋅GDPCP. Similar to eIF5B·GDPCP in the cryo-EM model of the 80S IC 
(see Fig. S5B) the G domain is associated with the SRL of the large subunit (LSU; green), while domain II 
interacts with the body of the small subunit (SSU; light pink). D) Putative interactions between the G domain 
and the SRL/H95 (green). Direct interactions are indicated by black dashed lines; red dashed lines indicate 
the positions in H95 that are cleaved by Fe(II)-BABE introduced in the position of Lys540 [90]. His505 lies 
only 3.5 Å from H95, explaining why the H505Y mutation results in a reduced affinity for the ribosome and 
GTPase deficiency in eIF5B [85] (see also Table S1). The conserved Arg534 likely contributes to the 








Thermodynamics of the interactions between eIF5B and guanine nucleotides 
In order to gain further insight into the domain rearrangements during the nucleotide cycle of 
eIF5B we performed ITC experiments to determine the thermodynamic parameters of eIF5B 
binding to GTP and GDP in the temperature interval of 5-30 °C (a summary of the data is given in 
Tables II and III; Fig. 5 and S6).  
To probe the conformational changes in eIF5B upon GTP binding and to test the particular 
influence of domain III we performed ITC experiments with two different constructs, one 
comprising domains I-IV (Ct-eIF5B(517C)), the other comprising only domains I and II (Ct-
eIF5B(517-858)). In both cases, GTP binding was driven by favorable negative changes in binding 
enthalpy (∆H = -9.34 kcal/mol for domains I-IV and -18.8 kcal⋅mol-1 for domains I-II at 30 °C) and 
opposed by unfavorable entropic contributions (Table II).  
For both constructs, ∆H plotted against the temperature results in a straight line with 
negative slope (Fig. 5A) representing the change in heat capacity (∆Cp) which can be used as 
estimate for the change in solvent accessible surface area (∆ASA) upon complex formation (see 
Materials and Methods). For Ct-eIF5B(517C) a ∆Cp of -155 cal·mol
-1·K-1 is calculated, corresponding 
to 344 to 646 Å2 of surface area that become buried upon GTP binding (Table III). In contrast, GTP 
binding to Ct-eIF5B(517-858), the construct lacking domains III and IV, gives a ∆Cp of -553 cal·mol
-
1·K-1, corresponding to a GTP-dependent surface burial of 1229 to 2304 Å2, in agreement with the 
∼1800 Å2 that become buried by switch 1 and the β13-β14 loop in domains I and II according to 
the crystal structures (Table III). Thus, the presence of domains III and IV contributes to the overall 
∆Cp of -155 cal·mol
-1·K-1 in Ct-eIF5B(517C)⋅GTP with +398 cal⋅mol-1⋅K-1 to compensate the 
contribution of -553 cal·mol-1·K-1 by domains I and II alone. This corresponds to a ∆ASA of 884 to 
1658 Å2 that are exposed upon GTP binding simultaneously to the burial of ∼1800 Å2 (or 1229 to 
2304 Å2) in domains I and II. The only reasonable candidates that can account for this 
compensatory effect are the surface areas buried between domain III and the G domain (∼1150 
Å2) and domain II (∼700 Å2), respectively, in apo eIF5B (Fig. 5B). Thus, these data indicate that 
domain III is released from most or all its contacts with the G domain and domain II in response to 






Table 2.Thermodynamic parameters of eIF5B binding to GDP and GTP at different 
temperatures and in presence or absence of Mg2+ ions. 












Ct-eIF5B(517C)       
 GDP 2.5 5 2.09 -6286 -7.23 1.0 
 GDP 2.5 10 1.92 -5057 -7.4 2.3 
 GDP 2.5 15 2.61 -5240 -7.36 2.0 
 GDP 2.5 20 2.9 -5520 -7.43 1.9 
 GDP 2.5 25 3.3 -6058 -7.48 1.4 
 GDP 2.5 30 3.45 -6650 -7.58 0.9 
 GDP 0 5 0.8 -1855 -7.76 5.9 
 GDP 0 10 1.0 -2385 -7.77 5.4 
 GDP 0 15 1.14 -2805 -7.84 5.0 
 GDP 0 25 1.96 -3912 -7.79 3.9 
 GTP 2.5 5 4.21 -5346 -6.84 1.5 
 GTP 2.5 10 4.83 -6192 -6.89 0.7 
 GTP 2.5 15 5.68 -7033 -6.92 0.12 
 GTP 2.5 20 6.02 -7423 -7.0 -0.6 
 GTP 2.5 25 6.20 -8426 -7.1 -1.3 
 GTP 2.5 30 7.04 -9344 -7.03 -2.2 
Ct-eIF5B(517-858)      
 GTP 2.5 5 1.34 -4860 -7.47 2.6 
 GTP 2.5 10 1.58 -7822 -7.52 -0.3 
 GTP 2.5 20 2.12 -12985 -7.61 -5.4 
 GTP 2.5 30 4.07 -18810 -7.48 -11.3 
All measurements were performed two to four times; for GTP binding to both constructs and for GDP binding in the presence of 
Mg
2+
 the experiments were done with two independent purifications of the respective construct; for GDP binding in the absence 
of Mg
2+
 the experiments were done with protein from one purification. 
Kd, dissociation equilibrium constant; calculated as 1/Ka. 
Ka, association equilibrium constant; standard deviation did not exceed ±15%. 
ΔH, standard enthalpy change; standard deviation did not exceed ±10%. 
ΔG, Gibbs energy; calculated from equation ΔG = −RTlnKa. 
TΔS, standard entropy change; calculated from equation ΔG = ΔH − TΔS. 
 
GDP binding to Ct-eIF5B(517C) was driven by favorable contributions of both, binding 
enthalpy and entropy (∆H = -6.65 kcal/mol and T∆S = 0.9 kcal/mol at 30 °C) (Table II). In contrast to 
GTP binding, the temperature dependency of ∆H was not linear for GDP binding; instead the data 
between 10 and 30 °C fit better to a second order polynomial function, indicating a strong 
temperature dependency of ∆Cp (Fig. 5A). This suggests that the amount of contact surface within 




















Ct-eIF5B(517C)      
 
GDP+Mg -140 ± 23
a -311 -583 -400c 
 
GDP-Mg -102 ± 5
b -227 -425  
 
GTP+Mg -155 ± 8
b -344 -646  
Ct-eIF5B(517-858)      
 
GTP+Mg -553 ± 11
b -1229 -2304 -1800c 
∆Cp, heat capacity change; obtained from ΔH/dT 
∆ASAmin and ∆ASAmax, changes in solvent accessible surface areas assuming that all changes were conferred by either apolar or 70% apolar and 30% 
polar surfaces, respectively 
a Calculated for 30 °C from the first derivative of the second order polynomial fit to ΔH measured at five different temperatures between 10 and 30 
°C. 
b Obtained from the slope of the linear fit to ΔH measured at different temperatures between 5 and 30 °C. 
cCalculated from the crystal structures of GDP- and GTP-bound eIF5B relative to the apo state. 
 
GDP binding results in a ∆Cp of -140 cal·mol
-1·K-1, corresponding to a surface burial of 311 to 583 Å2 
(Table III), which agrees well with a ∆ASA of ~400 Å2 for GDP binding according to the crystal 
structures. However, the negative value for ∆Cp decreases with lower temperatures. Below 10 °C 
the second order polynomial behavior of ∆H breaks down and ∆Cp changes sign, indicating a net 
exposure of ASA upon GDP binding. Here, three observations based on the eIF5B⋅GDP structures 
are of particular interest: i) GDP/Mg2+ is able to partially activate switch 2 and to induce 
conformational strain on its interactions to domains II and III (Fig. S4), ii) domain III contacts switch 
2 primarily through ionic interactions (Fig. 3B) which are destabilized at low temperatures [158, 
159], and iii) domain III is released from the G domain in molecule B of Sc-eIF5B⋅GDP for which 
crystals were obtained at 10 °C (Table I; Fig. S1E and S7A). Since switch 1 and the β13-β14 loop 
remain flexible in this structure, the release of domain III upon GDP binding results in a positive 
∆ASA corresponding to a positive contribution to ∆Cp as observed in the ITC experiments. The non-
linear behavior of ∆Cp above 10 °C would thus indicate that domain III always has the propensity to 
be released in eIF5B·GDP due to the partial activation of switch 2 in the presence of Mg2+, 
however, with a reduced tendency to do so with increasing temperatures at which the ionic 





we found that the temperature dependency of ∆H does not break down at low temperatures when 
the ITC experiments are repeated with GDP in the absence of Mg2+ (Fig. 5A). Instead, ∆H plotted 
against the temperature results in a straight line with a slope (∆Cp) of -102 cal⋅mol
-1⋅K-1, which is 
comparable to that for the eIF5B⋅GDP complex in the presence of Mg2+ at higher temperatures 
(Table III).  
 
 
Figure 5.eIF5B interactions with guanine nucleotides measured by ITC.A) Heat capacity changes upon 
eIF5B interaction with GDP or GTP. Temperature dependency of binding enthalpy changes (ΔH) upon Ct-
eIF5B(517C) interactions with GDP in the presence (●) or absence (○) of MgCl2 and of Ct-eIF5B(517C) (▼) 
and Ct-eIF5B(517-852) (Δ) with GTP in the presence of MgCl2. Standard deviations are given by error bars (in 
some cases not visible because they are smaller than the symbol size). B) Domains I-III of apo Ct-eIF5B. 
Indicated are the contact areas of domain III to domains I and II, respectively. 
 
 
Taken together, these data support the idea that the conserved Asp476 in the G3 motif plays 
a critical role in the reorganization of switch 2 in response to nucleotide binding and indicate a 
direct connection between the Mg2+ ion and the temperature dependency of ∆Cp in the eIF5B⋅GDP 
complex. The fact that GTP binding in contrast to GDP binding shows no temperature dependency 
of ∆Cp indicates that the interactions of domain III to domains I and II in apo eIF5B are broken upon 





positive contribution to ∆Cp is compensated by the large negative contribution due to the burial of 
ASA in the GTP-bound G domain. 
 
5.3 Discussion 
The molecular switch between the GDP- and GTP-bound states of eIF5B: the domain release 
mechanism 
The structural and thermodynamic data presented here provide the first detailed picture of the 
entire nucleotide cycle of eIF5B. The structures of eIF5B in its apo, GTP- and GDP-bound states 
reveal that its G domain follows the classical molecular switch mechanism, oscillating between an 
inactive (apo and GDP-bound) and a structurally distinct active GTP-bound form (Fig. 2). The GTP-
induced transition from the inactive to the active conformation of the G domain is characterized by 
marked rearrangements in the two switch regions, which allow the conserved Thr439 of switch 1 
and Gly479 of switch 2 to directly contact the γ-phosphate and Wcat, resulting in the formation of 
the catalytic GTPase center (Fig. 2B/D). This observation is in line with previous findings that the 
mutagenesis of Thr439 or Gly479 to Ala results in severe functional defects in eIF5B, including 
GTPase deficiency [85, 160] (see also Table S1). In switch 2 the initial signal of GTP binding 
experiences a considerable amplification along its way through the inter-domain cleft toward the 
back of the protein with a movement of 3 Å at Asp476, 8 Å in Gly479, 12 Å in His480 and finally 
∼14 Å in Arg487 and Arg489, which form the primary contact surface for domain III in apo eIF5B 
(Fig. 3A/B and S4A/B). As a result, domain III is released from the activated G domain, accompanied 
by the counter-clockwise rotation of domain II with respect to the G domain (Fig. 3A). As indicated 
by the ITC data, domain III remains released in free eIF5B⋅GTP and does not form stable new 
contacts to the reorganized switch regions. Thus, the signal of GTP binding is amplified from a 
relatively small conformational change in the nucleotide binding pocket into the release of domain 
III and thereby ultimately translated into a gain of conformational freedom and higher structural 
flexibility of domains III and IV relative to domains I and II. 
This mechanism for the activation of eIF5B in solution contradicts earlier assumptions that 
GTP alone is insufficient to induce the conformational switch in free eIF5B in the absence of the 





mechanism of conditional switching [153]. Moreover, the domain release mechanism is in stark 
contrast to the previously proposed non-classical articulated lever model for eIF5B/IF2 function, in 
which the GTP-induced conformational changes in the G domain are limited to a ∼2 Å shift in 
switch 2. This causes a rigid body movement of domains III and IV and a displacement of the latter 
by ∼5 Å as ultimate result of eIF5B activation [84, 144]. In contrast to the release mechanism, this 
involves neither a conformational change in switch 1 or switch 2 to form the canonical catalytic 
GTPase center nor does it require the loss or the formation of contacts between G domain and 
domains II and III at any stage of the activation process (Fig. S8). The articulated lever model 
therefore does not explain why switch 1 and switch 2 are universally conserved among eIF5B 
orthologs and why the mutagenesis of conserved residues in both motifs results in severe 
functional defects in eIF5B [85, 161, 162]. 
 
eIF5B combines the classical GTP operated switch mechanism in the G domain with a novel 
mechanism of activation for a trGTPase 
TrGTPases such as eIF5B and EF-Tu are multidomain proteins which consist of a universally 
conserved structural core composed of the G domain and domain II that is supplemented with 
additional functional domains related to the respective role of the GTPase during translation. The 
activation of trGTPases by GTP is therefore not merely restricted to the G domain but involves a 
reorganization of the overall domain arrangement, induced by a modulation of the interactions 
between G domain and the downstream functional domains. 
This principle was first established for the elongation factor EF-Tu. Here, the GTP-induced 
transition from the inactive apo form to the GTP-bound state depends on the rearrangement of 
the switch regions in the G domain that follows the canonical switch mechanism of Ras-like 
GTPases [163]. As a consequence, domain II, which is separated from the G domain in inactive EF-
Tu, stably associates with the reorganized G domain involving the newly formed surface of the 
activated switch 2 [163] (Fig. 3C). Only in this more compact GTP-conformation EF-Tu is able to 
form a stable ternary complex with aminoacyl-tRNA – involving also the reorganized switch 1 – for 





activeconformation of switch 1 and 2 functions as the critical signal and thereby is a necessity for 
the overall activation of EF-Tu (Fig. 3C). 
The same basic principle of activation also applies to eIF5B. The G domain follows the 
classical molecular switch mechanism (Fig. 2) and the signal of G domain activation is propagated 
into domains II-IV through the reorganization of the switch regions. However, the mechanism by 
which this signal transduction is achieved appears to be different from that in EF-Tu and so far 
unprecedented in trGTPases: in eIF5B the GTP-induced absence of the inactive conformation of 
switch 2 and the resulting release of domain III seems to be the decisive signal that renders 
eIF5B⋅GTP activated for productive interactions with the ribosome (Fig. 3). This does not imply that 
the GTP-bound conformation of the G domain is irrelevant for eIF5B function but is most likely 
required for tight interactions of the G domain with the large ribosomal subunit and GTPase 
activity (Fig. 4) as well as to prevent the reassociation of domain III before GTP hydrolysis. Instead, 
this means that the defined GTP-conformation is not as critical for productive interactions between 
eIF5B and its effector molecules as it is for EF-Tu.  
This scenario is in line with earlier biochemical studies that identified mutations in the G 
domain and domain III that are able to partially activate eIF5B by destabilizing the interactions 
between domain III and switch 2 in inactive eIF5B. The mutation of Gly479 in switch 2 to Ala was 
found to reduce GTP binding and to impair subunit joining and ribosome dependent GTP hydrolysis 
[160]. Our structural analysis shows that this Gly residue undergoes a peptide flip of ∼160° during 
the transition of switch 2 from its inactive to the active state (Fig. 4B), a conformational change 
that is energetically not allowed for any other residue. G479A would thus stabilize the inactive 
switch 2 preventing the formation of the GTPase center and the release of domain III, ultimately 
causing the inability of the mutant to promote subunit joining and to hydrolyze GTP. A444V and 
D740R were identified as two independent intragenic suppressor mutants for G479A that restore 
nucleotide binding, GTP hydrolysis and subunit joining activities in eIF5B [160]. Interestingly, 
Asp740 is located in domain III ∼30 Å apart from the nucleotide binding pocket and forms a direct 
salt bridge to the conserved Arg489 of the inactive switch 2 which moves ∼15 Å upon GTP binding 
(Fig. 3B and S7B/C). Consequently, D740R would result in a steric and electrostatic repulsion of the 





A444V is located at the N-terminus of strand β3 close to Asp476 in the G3 motif and most likely 
causes the constitutive reduction of the energy barrier that has to be overcome by GDP and GTP to 
move Asp476 into a GTP-like position thereby facilitating the distortion of the interactions 
between switch 2 and domain III [160] (Fig. S7C). Particularly interesting is that A444V does not 
only restore GTP dependency in eIF5B but even allows GDP to activate eIF5B for stable interactions 
with the ribosome [160]. This demonstrates that the full GTP-conformation in the G domain is not 
an absolute requirement for stable interactions between eIF5B and the ribosome. Instead, it seems 
to be critical that the suppressor mutations overcome the increased energy barrier introduced by 
G479A by destabilizing the inactive conformation and thereby the contact between switch 2 and 
domain III either directly in the case of D740R or indirectly in the case of A444V (see also Table S1).  
 
 
Figure 6.Schematic model of the of nucleotide cycle of eIF5B during subunit joining.eIF5B with domains I 
(G) to IV is shown in blue. (1) GTP binding activates eIF5B by release of domain III and rotation of domain II 
relative to the G domain. (2) Binding of eIF5B·GTP to the small subunit (SSU) in the absence of Met-tRNAi
Met 
results in a nonproductive complex in which eIF5B is not able to stimulate subunit joining. (3) In the 
correctly preassembled 48S pre-IC the subunit joining competent conformation of eIF5B·GTP is stabilized by 
the P site-bound initiator-tRNA, (4) resulting in the recruitment of the large ribosomal subunit (LSU). (5) 
Formation of the 80S pre-IC triggers GTP hydrolysis in eIF5B, which reverts back into its inactive 






Implications of the domain release mechanism for ribosomal subunit joining 
eIF5B interacts with the ribosomal subunits and catalyzes subunit joining in a GTP-dependent 
manner [145, 146]. This indicates that eIF5B undergoes a structural transition from the inactive 
apo-conformation to a GTP-bound state that allows productive interactions with its ribosomal 
effector complexes. However, it was shown in kinetic experiments that even in its GTP-bound 
state, eIF5B is unable to catalyze subunit joining unless the Met-tRNAi
Met has been positioned in 
the P site of the 40S subunit [146]. This seemingly paradoxical situation is compatible with the 
domain release mechanism of eIF5B activation. On the one hand the GTP-induced release of 
domain III allows domain II to stably interact with the 18S rRNA (without steric hindrance by 
domain III as discussed below; see also Fig. S5C). On the other hand the conformational freedom of 
domains III and IV relative to each other (Fig. S2B), relative to domains I and II, as well as to the 40S 
subunit, prevent eIF5B from self-supporting a conformation that allows efficient subunit docking 
on the 40S⋅eIF1A complex without Met-tRNAi
Met (Fig. 6). Consequently, for the domain release 
model a distinction has to be drawn between the activated state of eIF5B⋅GTP in solution and its 
subunit joining competent conformation on the 48S pre-IC, which is only one of the many possible 
conformations accessible to the free eIF5B⋅GTP, and which requires the reduction of 
conformational freedom of domains III and IV and their stabilization in the correct orientation. This 
proposed dependency of eIF5B⋅GTP on the ribosomal effector complex resembles the hypothesis 
of conditional switching for eIF5B [153]. However, the critical conceptual difference is that eIF5B 
does not require the ribosome as cofactor to induce the GTP-dependent conformational switch, 
but instead depends on the ribosomal effector complex to stabilize the sole conformation of GTP-
bound eIF5B (among the many possible) capable to promote the association of the 60S subunit. 
The recent cryo-EM structures of eIF5B on the 80S ribosome demonstrate that this stability is 
primarily provided by the methionylated 3’-CCA end of Met-tRNAi
Met [91]. In agreement with the 
domain release mechanism, the cryo-EM structures show that the activation of the G domain by 
GDPCP is sufficient to induce the release of domain III from switch 2 and domain II, but insufficient 
to stabilize domains III and IV in a defined conformation, as they remain disordered in the absence 
of amino-acylated tRNA. Only through the interactions between domain IV and the amino-acylated 





which domain III is released from all its contacts to the G domain and domain II that are also found 
in the apo state of eIF5B and is reoriented relative to domain I and II by ∼65° (Fig. 3D and S5C) 
[91].  
Taken together, according to the presented domain release mechanism the preparation of 
eIF5B for the catalysis of subunit joining involves a two-step process: i) activation of the G domain 
by GTP binding, resulting in the release of domain III and an increased intrinsic flexibility that 
allows productive binding to the effector complexes and ii) stabilization of eIF5B⋅GTP in the subunit 
joining competent conformation by the 48S pre-IC through a reduction of conformational entropy 
within the factor (Fig. 6). According to this scenario, eIF5B requires GTP as well as the correctly 
assembled 40S⋅Met-tRNAi
Met effector complex for its function. Thus, the domain release 
mechanism seems evolved to ensure the formation of productive 80S ICs by discriminating against 
pre-ICs that do not contain Met-tRNAi
Met. 
 
Ribosome induced GTP hydrolysis by eIF5B 
Crystal structures of EF-G⋅GDPCP and EF-Tu⋅GDPCP on the ribosome suggest a common 
mechanism of GTPase activation for both elongation factors [168, 169]. According to the current 
model, the G domain of the translation factor binds to the sarcin-ricin loop (SRL) of the 50S 
ribosomal subunit and the GTPase activity is triggered as Hiscat (His84 in EF-Tu) rotates inward, 
where it is stabilized by hydrogen bond interactions with the phosphate of A2662 (SRL) and Wcat 
which becomes subsequently activated for the in-line attack on the γ-phosphate [168]. 
Our own structural investigations show that the catalytic centers in eIF5B⋅GTP and free EF-
Tu⋅GDPNP exhibit nearly identical positions for residues implicated in ribosome binding and GTP 
hydrolysis (Fig. 4). In line with the recent cryo-EM model of ribosome bound eIF5B [91], this 
suggests that domains I and II of eIF5B bind the 80S ribosome in the same way as the bacterial 
elongation factor (Fig. 4 and S5A/B). As for His84 in free EF-Tu⋅GDPNP, the imidazole moiety of 
His480 (Hiscat) in eIF5B points outward and therefore requires rearrangement in order to contact 
Wcat (Fig. 4B). In combination with earlier studies that highlight the importance of His480 for GTP 





activation of initiation factor eIF5B follows the same basic mechanism as employed for the 
elongation factors EF-Tu and EF-G. 
 
Dissociation of eIF5B⋅GDP from the 80S ribosome 
In accordance with the function of G proteins as molecular switches, the formation of the 
elongation competent 80S ribosome by eIF5B⋅GTP results in GTP hydrolysis and Pi release, followed 
by the dissociation of eIF5B⋅GDP [145, 161]. Thus, the reduced affinity for the ribosome and 
dissociation of eIF5B depends on its structural transition from the GTP-bound state to the inactive 
GDP-bound conformation. 
Our data show that upon transition from the GTP- to the GDP-bound state the G domain of 
eIF5B switches back into its inactive conformation (Fig. 2 and S4A). As a result, domain III is 
retrieved to interact with switch 2 and domain II, causing the latter to rotate clockwise relative to 
the G domain (Fig. 3A and S4C). This reorientation relative to each other necessarily disrupts the 
interactions of the G domain and domain II with the 60S and 40S subunits, respectively, which 
were formed by eIF5B⋅GTP in the rotated state (the rotation is also observable in the cryo-EM 
structure of eIF5B in the 80S IC [91]). Under the assumption that the interactions between domain 
II and the 18S rRNA are the last to be broken (as they do not directly depend on the presence of 
GTP as do those of the G domain with the SRL), domain III moves away from the SRL and domain IV 
moves away from the peptidyl-transferase center (PTC) toward the 40S subunit and helix H38 (60S) 
(Fig. S5C). This position of eIF5B⋅GDP is not stable as domains III and IV would clash with the 
ribosomal protein S23e and eIF1A, respectively, and the G domain is rotated into the SRL. As a 
result, eIF5B would have to retreat from the factor binding site toward h6 of the 40S subunit as 
seen in the cryo-EM structure of IF2⋅GDP on the 70S ribosome [170], followed by its dissociation 
(Fig. 6). 
 
IF2 might function according to the domain release mechanism  
Despite a large body of experimental data for IF2, its precise mode of function during subunit 
joining in bacteria is still unclear [27, 82, 147, 150, 151]. For the reasons discussed below it is in our 





residues involved in the contacts between switch 2 and domain III in eIF5B, particularly also those 
in the N-terminus of helix α9, are highly conserved in a/eIF5B/IF2 orthologs (Fig. S3). In structures 
of the IF2 G domain switch 2 is usually flexible with only partial helical character [82, 83, 171] and 
would thus be easily accessible for interactions with domain III. Moreover, from the high degree of 
structural and sequence homology it can be inferred that the G domain of IF2, like in eIF5B, follows 
the classical switch mechanism, resulting in the formation of the canonical active site. The 
transition of IF2 between the GDP- and GTP-bound states would therefore result in the release of 
domain III and an increase in the overall flexibility of the factor, and the reduction of flexibility and 
retraction of domain III upon GTP hydrolysis. Indeed this becomes apparent in cryo-EM structures 
of bacterial initiation complexes, where domain III is associated with domains I and II in IF2⋅GDP 
whereas the GTP/GDPNP-bound forms adopt an elongated shape to contact the P site-bound 
fMet-tRNAfMet[152, 170, 172, 173].  
The assumption that the domain release mechanism applies to IF2 seems to be contradicted 
by two recent structural studies [82, 83]. The only so far available high resolution structure of GTP-
bound IF2 appears to indicate that its G domain does not follow the classical switch mechanism as 
switch 1 remains virtually unchanged upon GTP binding and switch 2 undergoes only a small local 
rearrangement without forming a contact to the γ-phosphate [83]. However, it is important to 
note that this IF2⋅GTP structure was obtained by soaking GTP into crystals of apo IF2, in which both 
switch regions are fixed by extensive contacts to symmetry related molecules. A reorganization of 
the G domain that would allow the G2 and G3 motifs to contact the GTP molecule in the classical 
way is thus most likely prevented by crystal contacts and not due to a non-classical behavior of IF2. 
The recent crystal structure of T. thermophilus IF2(3-467) in the apo and GDP-bound state as well 
seems to argue against the domain release mechanism for IF2 as domain III has no direct contact 
to either of the switch regions [82]. The authors propose that the increased length of helix α8 (the 
linker between domains II and III) compared to α8 in aIF5B accounts for the inability of domain III 
to contact switch 2 [82]. However, the lengths of helix α8 and the following flexible linker to 
domain III are actually compatible with a direct contact between the N-terminal half of helix α9 
and switch 2 as observed in apo a/eIF5B (Fig. 3A/B). Instead, the crystal packing shows that the 





crystals. Crystallization would therefore be selective for the state in which domain III is released, 
irrespective of its fraction among the IF2 molecules in solution. As we show by means of ITC and 
observe in the Sc-eIF5B·GDP structure (Fig. S1E and S7A), domain III in eIF5B has the ability to 
dissociate from the G domain even in the absence of GTP. This, we suggest, also applies to IF2. 
As for eIF5B, the domain release model can explain why IF2 requires GTP for efficient 
interactions with ribosomal complexes and the fMet-tRNAfMet in the context of the 30S pre-IC [147, 
174], why IF2⋅GTP is unable to promote subunit docking in the absence of the initiator-tRNA [175] 
and finally, why even GDP is able to partially activate IF2 for ribosome binding and subunit joining 
in in vitro studies despite its inability to stabilize the GTP-conformation of the G domain. With the 
critical conceptual difference that in the domain release mechanism the GTP-dependent 
conformational switch in IF2 precedes and is therefore not a consequence of its interaction with 
the ribosome, this hypothesis of a common mechanism for eIF5B and IF2 is in agreement with 
previous proposals of a stepwise activation mechanism for IF2 by GTP and the 30S⋅fMet-tRNAfMet 
complex made on the basis of biochemical experiments [147, 154].  
 
5.4 Materials and Methods 
Protein preparation, crystallization and structure determination 
The N-terminally His-tagged versions of eIF5B from C. thermophilum (Ct-eIF5B(517-1116), -(517-
970) and -(517-858)) and S. cerevisiae (Sc-eIF5B(399-852)) were expressed in E. coli and purified 
using standard procedures. Crystals used for structure determination were obtained by sitting-
drop vapor diffusion using standard screens either in the presence or absence of GDP or GTP (for 
details see Table I and supplementary text). 
X-ray diffraction data were collected using synchrotron radiation. For all structures, the 
phase problem was solved by molecular replacement using the program PHASER [115]. Structures 
were refined to reasonable R-values and stereochemistry using the program PHENIX [117]. Data 






Isothermal Titration Calorimetry 
The thermodynamic parameters of Ct-eIF5B binding to GDP or GTP were measured using a 
MicroCal VP-ITC instrument (GE Healthcare). Experiments were carried out essentially as described 
previously [176]. The obtained values for enthalpy changes (∆H) at different temperatures were 
used to estimate the change in heat capacity (∆Cp) for the various protein-nucleotide complexes. 
These ∆Cp values were then used to estimate the conformational changes occurring in Ct-eIF5B 
upon GDP or GTP binding, using the empirically determined relation ∆Cp = ∆cap ⋅ ∆ASAap + ∆cp ⋅ 
∆ASAp (where ∆cap and ∆cp are the area coefficients in cal⋅K
-1⋅(mole⋅Å2)-1 for contributions of apolar 
or polar side chains to the change in solvent accessible surface area (∆ASA), respectively) [177]. For 
more details see supplementary text.   
 
Coordinates 
Coordinates have been deposited in the PDB: Apo Ct-eIF5B(517C) (4N3N); Ct-eIF5B(870C) (4N3G); 




The Supplementary Information includes extended Materials and Methods, eight figures and one 
table and is available at The EMBO Journal Online. 
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5.5 Supplementary information 
Supplementary Materials and Methods 
Protein preparation and crystallization 
The plasmid for the expression of N-terminally His-tagged C. thermophilum (Ct-)eIF5B(517C) 
(comprising residues 517-1116 that form the G domain, domain II, III and IV) was transformed into 
E. coli BL21 (DE3) cells (Stratagene) by heat shock. Transformed cells were grown in 1 l cultures of 
2YT medium at 37 °C to an OD600 of 0.6-0.8, followed by the induction of protein expression with 
0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG). Cells were grown for an additional 18 h at 16 
°C before harvesting. The harvested cells were resuspended in buffer A (40 mM Hepes (pH 7.5), 
500 mM KCl, 10% glycerol, 30 mM imidazole, 2 mM β-mercaptoethanol), lysed using a 
Microfluidizer (Microfluidics) and clarified by ultracentrifugation. The supernatant was loaded onto 
two HisTrap columns (GE Healthcare), equilibrated in buffer A. After the elution of bound proteins 
with a linear gradient of imidazole (30-300 mM), eIF5B-containing fractions were pooled and 
desalted in buffer B (20 mM Hepes (pH 7.5), 200 mM KCl, 10% glycerol, 30 mM imidazole and 2 
mM β-mercaptoethanol) for subsequent TEV-protease cleavage at 4 °C over night to remove the 
His-Tag. Uncleaved protein was removed by a second HisTrap in buffer B and the flow-through was 
pooled and concentrated for the final size exclusion chromatography step on a Superdex 200 
column (GE Healthcare), equilibrated in buffer C (10 mM Hepes (pH 7.5), 50 mM KCl, 3 mM MgCl2 
and 1 mM DTT). The purified eIF5B was finally pooled and concentrated to 15-20 mg/ml. Other 
versions of Ct-eIF5B containing residues 517-970 or 517-858 and of S. cerevisiae (Sc-) eIF5B 
containing residues 399-852 were purified according to the same protocol.  
For ITC experiments truncated versions of Ct-eIF5B were purified according to the above protocol 
with the difference that ITC buffer (see below) was used in the size exclusion chromatography step. 
The concentration of the protein was determined by absorbance at 280 nm (with extinction 
coefficients for the different Ct-eIF5B constructs: ε517C = 30370 M
-1cm-1, ε517-970 = 20400 M
-1cm-1 
and ε517-852 = 14440 M
-1cm-1). The protein was >95 % pure as judged by SDS-PAGE and free of 
nucleotides as determined by HPLC. 
Crystals of Ct-eIF5B(517C) without nucleotide were obtained after two days at 4 °C via sitting-drop 
vapor diffusion against 100 mM MES (pH 6.8), 12% PEG 20000 and 10 mM Na-lactate. The crystals 
grow in primitive hexagonal space group P3221 with one molecule per asymmetric unit (unit cell: a 





Despite extensive trials we were not able to obtain crystals of the Ct-eIF5B(517C) construct in the 
GDP- or GTP-bound forms. However in the presence of GTP another type of crystals was obtained 
after 5 days at 4 °C under the above conditions. These crystals grew in the primitive hexagonal 
space group P3121 (unit cell: a = b = 98.23 Å, c = 97.42 Å, α = β = 90°, γ = 120°; diffraction limit = 3.2 
Å) with one molecule per asymmetric unit comprising only domains III and IV of Ct-eIF5B (residues 
870-1116). 
Crystals of Ct-eIF5B(517-970) in the presence of 2 mM GDP grew within 4 days at room 
temperature against 15% PEG 8000 and 0.5 M Li2SO4 in primitive orthorhombic space group 
P212121 with two protein-GDP complexes per asymmetric unit (unit cell: a = 66.9 Å, b = 72.96 Å, c = 
199.23 Å, α = β = γ = 90°; diffraction limit = 2.1 Å).  
Crystals of Ct-eIF5B(517-970) in the presence of 2 mM GTP grew over night at room temperature 
against 100 mM Hepes (pH 7),  13% PEG 4000 and 100 mM sodium acetate in primitive monoclinic 
space group P21 with two protein-GTP complexes per asymmetric unit (unit cell: a = 55.4 Å, b = 
114.83 Å, c = 65.85 Å, α = 90°, β = 102.3°, γ = 90°; diffraction limit = 1.87 Å).  
Crystals of the nucleotide free form of Sc-eIF5B(399-852) grew after 2 days at 4 °C against 20% 
ethylene glycol, 5% PEG 3350 and 20 mM MgCl2 in primitive tetragonal space group P41 with two 
molecules per asymmetric unit (unit cell: a = b = 118.01 Å, c = 77.51 Å, α = β = γ = 90°; diffraction 
limit = 1.83 Å). The data were twinned with a twin fraction of 18% (twin law h, -k, -l).  
Finally, crystals of the GDP-bound form of Sc-eIF5B(399-852) could be obtained over night at 10 °C 
against 8% PEG 8000 and 0.37 M Li2SO4 in primitive orthorhombic space group P212121 with two 
protein-GDP complexes per asymmetric unit (unit cell: a = 73.56 Å, b = 119.46 Å, c = 120.73 Å, α = β 
= γ = 90°; diffraction limit = 3.02 Å). 
 
X-ray data collection, structure determination and refinement 
For the structure of Ct-eIF5B⋅GTP X-ray diffraction data were collected at BL 14.1 (HZB, BESSY, 
Berlin) [113]. All other structures were solved using X-ray diffraction data collected at P13 
beamline (EMBL, PETRA III, Hamburg). The structure of free Ct-eIF5B(517C) was solved by 
molecular replacement using the program PHASER [115] using the atomic coordinates of the 
archeal ortholog of eIF5B from M. thermoautotrophicum (PDB: 1G7R) with the individual domains 
as independent search models. The structure was refined using the program PHENIX [117]. The 
other structures where solved by means of molecular replacement using the individual domains of 
the newly determined structure as search model as described below (Data collection and 
refinement statistics are summarized in Table I). 
The second structure obtained from Ct-eIF5B(517C), this time in the presence of GTP, was solved 
using domains I to IV of Ct-eIF5B(517C) as independent search models. A solution was found only 
for domains III and IV and the final model after refinement comprises residues 870 to 1116 
(domains III and IV). A Coomassie Blue-stained SDS-PAGE gel of dissolved crystals confirmed that 





The structures of Ct-eIF5B(517-970) in the GDP- and GTP-bound state and of free Sc-eIF5B(399-
852) were solved using domains I to III of Ct-eIF5B(517C) as independent search models. The 
resulting models of Ct-eIF5B(517-970) in complex with either GDP or GTP contains two copies of 
Ct-eIF5B(517-970), each bound to a Mg2+ ion and GDP or GTP, respectively. In the final model of Ct-
eIF5B(517-970)⋅GTP residues 517-859 are resolved in the electron density, however the entire 
domain III (residues 860-970) is missing, probably due to a proteolytic event during crystallization 
as indicated by a Coomassie Blue-stained SDS-PAGE gel of dissolved crystals. The final model of the 
nucleotide-free form of Sc-eIF5B(399-852) contains two copies of Sc-eIF5B(399-852). 
Finally, the structure of Sc-eIF5B⋅GDP was solved using domains I to III of free Sc-eIF5B(399-852) as 
independent search models. The final model contains two Sc-eIF5B⋅GDP complexes in the 
asymmetric unit.  
 
Isothermal Titration Calorimetry 
The thermodynamic parameters of eIF5B binding to GDP or GTP were measured by means of ITC 
using a MicroCal VP-ITC instrument (GE Healthcare). Experiments were carried out in ITC buffer (30 
mM Hepes pH 7.5, 100 mM KCl, 10% glycerol, 4 mM β-mercaptoethanol, 0.01% tween20, 2.5 mM 
MgCl2) at six different temperatures (5, 10, 15, 20, 25 and 30 °C). 14-µl aliquots of 200-400 µM 
ligand were injected into the 1.42 ml cell containing 10-30 µM eIF5B. The heat of dilution was 
measured by injecting the ligand into the buffer solution without protein; the values were then 
subtracted from the heat of the individual binding reactions to obtain the effective heat of binding. 
The final titration curves were fitted using the ‘Origin’ based MicroCal software, assuming one 
binding site per protein molecule. For each isotherm the binding stoichiometry (N), enthalpy 
changes (∆H) and the association constants (Ka), were obtained by a nonlinear regression fitting 
procedure. These directly measured values were then used to estimate the Gibbs energy (∆G) from 
the relation ∆G = - R⋅T⋅lnKa and the entropy changes (∆S) through ∆G = ∆H – T⋅∆S. 
To investigate the influence of the Mg2+ ion on the binding of GDP to eIF5B, experiments were 
repeated in a modified ITC buffer, containing 0.25 mM EDTA instead of MgCl2 (Mg
2+ was omitted 
also from the buffers used during purification). 
In order to estimate the change in heat capacity (∆Cp) upon complex formation, the measured ∆H 
values were plotted against the temperature [178, 179]. Depending on whether a linear or non-
linear temperature dependency was applicable for ∆H, the data were fitted either to a linear or a 
second-order polynomial function. In the first case, the slope of the fitted line directly represents 
the ∆Cp of the binding reaction, whereas in the second case the ∆Cp for a given temperature can be 
calculated from the first derivative of the polynomial function.    
∆Cp can be used as an estimate for the change in solvent-accessible surface area (∆ASA) upon 
complex formation as it was found to be proportional to the size of the area which is either 
exposed to or excluded from the aqueous environment during the binding event [176, 177, 180-





⋅∆ASAp where ∆cap and ∆cp are the area coefficients in cal⋅K
-1⋅(mole⋅Å2)-1  for the contributions of 
apolar or polar side chains to ∆ASA, respectively [177]. Studies on the dissolution of model 
compounds and protein unfolding suggest a negative contribution due to the burial of apolar 
surfaces (∆ASAap) and a positive contribution upon burial of polar surfaces (∆ASAp) with values for 
∆cap and ∆cp of 0.45 and -0.26, respectively [177, 182, 184]. Since binding of guanine nucleotides 
can be expected to involve both, apolar and polar residues, a treatment of the obtained ∆Cp values 
solely based on nonpolar contributions according to Connelly et al. (1992) would be insufficient. At 
the same time, the differential treatment by calculating the individual contributions of apolar and 
polar groups to the total surface area often proved to be inaccurate, especially in cases where the 
interactions did not conform to a rigid-body binding model [185-188]. We therefore use two values 
for the area coefficients to estimate the total surface area upon ligand binding: ∆cmax = 0.24 (= 
0.7⋅∆cap + 0.3 ⋅ ∆cp) as the upper limit case, assuming ∼70% apolar and ∼30% polar groups 
contributing to the total ∆ASA (calculated from the crystal structures of Ct-eIF5B in its apo, GDP 
and GTP forms using the program AREAIMOL from the CCP4 Program Suite 6.3.0) and ∆cmin = 0.45 









Figure S1.Structures of eIF5B from C. thermophilum and S. cerevisiae.A) Structure of apo Ct-eIF5B(517C) 
containing residues 517-1116 comprising the G domain (domain I) and domains II, III and IV. The P-loop, 





III and IV. C) Structure of apo Sc-eIF5B(401-852) comprising the G domain, domain II and domain III. Switch 1 
and switch 2 are shown in pink. D) Structure of Ct-eIF5B(517-859) in the GTP-bound state comprising G 
domain and domain II. The switch regions and the P-loop are shown in yellow; the Mg2+ ion, Na+ ion and 
water molecules are shown as spheres in magenta, blue, and grey, respectively; GTP is shown as balls and 
sticks. E) Molecule B in the asymmetric unit of the Sc-eIF5B⋅GDP structure containing residues 401-852, 
comprising G domain and domains II and III. P-loop and the switch regions are colored cyan; the GDP 
molecule is shown as balls and sticks. F) Structure of Ct-eIF5B(520-970)⋅GDP comprising G domain, domain II 
and domain III. P-loop and switch regions are colored cyan, the GDP molecule is shown as balls and sticks. 
G) Molecule A in the asymmetric unit of the Sc-eIF5B⋅GDP structure containing residues 401-852, 




Figure S2.A)G domain based superposition of the apo structures of eIF5B from C.thermophilum (purple), 
S.cerevisiae (yellow) and aIF5B from M. thermoautotrophicum (blue; PDB:  1G7R), showing the 
conformational flexibility of domain III relative to domain I in the absence of a bound nucleotide. The C-
terminus of helix α12 in apo aIF5B lies 12 and 22 Å apart from that in Ct-eIF5B and Sc-eIF5B, respectively. 
The GDPNP-bound form of aIF5B is also shown (wheat; PDB:  1G7T), highlighting the relatively changes 
observed in the archeal ortholog upon binding of the GDPNP (see also Fig. S8). As the structure of the S. 
cerevisiae ortholog does not contain the second half of helix α12 and domain IV, domains III and IV of the 
Ct-eIF5B structure were superimposed onto domain III of the Sc-eIF5B structure. B) Superposition of 
domains III and IV of the apo Ct-eIF5B(517C) structure (purple) with the structure of Ct-eIF5B(870C) (grey), 
based on domain III. Domain III and the following helix α12 are nearly identical in both structures; in 
contrast, the orientation of domain IV relative to domain III differs significantly, indicating a high degree of 






Figure S3. Sequence alignment of the G domains (upper panel) and domains III (lower panel) from 
different aIF5B, eIF5B and IF2 homologues. Highly conserved residues are highlighted in blue; conserved 
residues that are directly involved in the stable contacts between switch 2 and domain III in inactive (apo 
and GDP-bound) eIF5B are highlighted in red. P-loop (G1 motif), switch 1 (with the G2 motif containing 
Thr439), switch 2 (with the G3 motif “DTPG”) and motifs G4 and G5 in the G domain are indicated. The 
numbering above the sequences is according to the eIF5B homologue from Saccharomyces cerevisiae. 
Residues within the G domain that are implicated in nucleotide binding and the GTP-dependent molecular 
switch in eIF5B are universally conserved among all three orthologs. Domain III is significantly less well 
conserved than the G domain; however, the N-terminal part of helix α9 (residues 763-768 in eIF5B) is highly 
conserved, particularly in those residues involved in the interactions with switch 2. Species names are 
abbreviated as follows: Hmar, Haloarculamarismortui; Mmar, Methanococcusmaripaludis; Aful, 
Archaeoglobusfulgidus; Mthe, Methanothermobacterthermoautotrophicum; Nequi, 
Nanoarchaeumequitans; Aper, Aeropyrumpernix; Ddis, Dictyosteliumdiscoideum; Scer, 
Saccharomycescerevisiae; Cter, Chaetomiumthermophilum; Cele, Caenorhabditiselegans; Mmus, 
Musmusculus; Hsap, Homosapiens; Ttherm, Thermusthermophilus; Ecoli, Escherichiacoli; Styph, 
Salmonellatyphimurium; Bdent, Bifidobacteriumdentium; Bsupt, Bacillussubtilis; mitIF2_Sce, mitochondrial 










Figure S4.Nucleotide-dependent conformational changes in switch 1 and switch 2 of eIF5B.A) Overview of 
the GTP-induced conformational changes in the G domain. P loop, switch 1 and switch 2 are colored pink for 
apo eIF5B, cyan for eIF5B·GDP and yellow for eIF5B·GTP; the Mg2+ ion is shown as sphere in magenta; GTP is 
shown in balls and sticks; GDP is omitted for clarity. In the apo state switch 1 points away from the 
nucleotide binding pocket and is partially disordered. Switch 2 adopts a loop conformation with most 





reorganized (yellow arrows) to form the catalytic center around the GTP-γ-phosphate. Switch 1 flips over by 
~180° relative to its position in the apo state and the residues forming strand β2 are repositioned to form 
part of the coordination sphere for the Mg2+ ion. Switch 2 moves up to 15 Å in some residues, resulting in an 
extended helix α3, which is reoriented relative to α3 in the apo state by more than 90°. The transition from 
the GTP- to GDP-bound state reverses these changes and results in conformations of switch 1 and 2 like for 
the apo form, however, with switch 2 shifted ~3 Å towards the nucleotide binding pocket. B) Details of the 
transition between apo and GTP-bound forms of switch 2. The color code is the same as in A); water 
molecules are shown as grey spheres; hydrogen bonds indicated as dashed lines. Upon GTP binding Asp476 
moves ~3 Å towards the GTP molecule (arrow). Gly479 moves towards the γ-phosphate (meanwhile the 
peptide bond to the preceding Pro478 flips by ∼160°) resulting in a reorganization of the rest of switch 2 
including His480 (Hiscat) and Arg487, which is involved in interactions with domain III in the apo and GDP-
bound states of the factor (see also Fig. 3A/B). C) As shown in A), switch 2 in Ct-eIF5B·GDP (blue with switch 
2 in cyan) remains ~3 Å closer to the nucleotide binding pocket than in the apo form (grey with switch 2 in 
pink) but forms the same contacts to domains II and III as found in apo eIF5B. As a consequence, also 

























Figure S5. A) Superposition of eIF5B⋅GTP (orange with P loop, switch 1 and switch 2 in yellow) and free EF-
Tu⋅GDPNP (light blue with P loop, switch 1 and switch 2 in cyan; PDB code: 1EXM), based on their respective 
catalytic centers. Domains I and II from eIF5B and EF-Tu show the same overall dimensions and exhibit very 
similar arrangements in regions involved in nucleotide binding (switch 1 and switch 2) or in interactions with 
the small ribosomal subunit (e.g. the β9-β10 loop in eIF5B and the B0 loop in EF-Tu). B) Cryo-EM model of 
domains I and II of eIF5B·GDPCP (orange) on the 80S ribosome [91].  The large ribosomal subunit (LSU) is 





the 80S IC (orange; [91]) with inactive eIF5B (blue). The structure of inactive eIF5B was modeled by 
superposition of its domain II onto domain II of eIF5B⋅GDPCP. According to this model, GTP hydrolysis and 
subsequent Pi release causes domain IV to move away from the acceptor end of the tRNA (dark red) as 
domain III associates with domains I and II. Simultaneously, the G domain rotates with respect to domain II 
by ~30° towards the SRL. These movements result in clashes (red stars) of domains I, III and IV with the SRL, 
ribosomal protein S23e and A site-bound eIF1A (yellow; modeled according to the structure of eIF1 and 
eIF1A on the 40S subunit (PDB: 4BPE)), respectively, which reduce the affinity of eIF5B·GDP to the ribosome 








Figure S6. A-D) Titration curves (upper panels) and binding isotherms (lower panels) of eIF5B interactions 
with GDP or GTP.A) Ct-eIF5B(517C) with GDP at 20 °C in the presence of MgCl2; B) Ct-eIF5B(517C) with GDP 
at 25 °C in the absence of MgCl2; C) Ct-eIF5B(517C) with GTP at 20 °C in the presence of MgCl2; D) Ct-












Figure S7. A) G domain-based superposition of eIF5B domains I-III from S. cerevisiae in its apo and GDP-
bound states. The G domain is colored grey; the switch regions are colored pink for the apo state, cyan for 
molecule A of Sc-eIF5B·GDP and dark yellow for molecule B of Sc-eIF5B·GDP. While domains II and III of 
molecule A in the Sc-eIF5B·GDP structure superimpose well with domains II and III of the apo form (grey), 
domain III in molecule B (dark yellow) is moved away from the G domain (arrows) and has no contact to the 
partially disordered switch 2. Domain II of molecule B is in its rotated state with the β9-β10 loop moved 
upwards; switch 1 and the β13-β14 loop remain in their respective inactive conformations. B) Overview of 
apo eIF5B with the locations of Ala444 and Asp740 relative to the nucleotide binding pocket and switch 2. 
Switch 2 is shown in its apo (pink), GDP- (cyan) and GTP-bound forms (yellow). C) Detail of the area 
indicated in B) (box). Switch 2 is shown in four different states: i) The inactive apo state (pink), in which 
Asp476 and Gly479 point away from the nucleotide binding pocket and Arg489 forms a salt bridge to 
Asp740 of domain III. ii) The partially activated GDP state in Ct-eIF5B·GDP (cyan), in which Asp476 interacts 
with the Mg2+ ion. Gly479 has undergone the peptide flip relative to the apo state. iii) The partially activated 
GDP state in molecule B of Sc-eIF5B·GDP (dark yellow). Asp476 interacts with the Mg2+ ion; switch 2 is 





of the activated switch 2 in Ct-eIF5B·GTP (brown; the rest of switch 2 is not shown). Gly479 has undergone 
the peptide flip relative to the apo state and contacts the γ-phosphate. Mutagenesis of Gly479 to Ala most 
likely prevents the peptide flip and thereby stabilizes the inactive conformation of switch 2. Mutagenesis of 
Asp740 to Arg would result in the steric and electrostatic repulsion of switch 2 in its inactive conformation. 
Mutagenesis of Ala444 to Val would result in a steric clash with domain II (grey surface), most likely causing 
strand β3 to move towards Asp476 (green model). To avoid a clash with the repositioned strand β3 Asp476 
would have to retreat towards the nucleotide binding pocket, thereby facilitating the partial or full 




Figure S8. The articulated lever model for eIF5B/IF2 activation [84, 144].A) Superposition of switch 1 and 
switch 2 from GDP- (cyan) and GDPNP-bound (yellow) aIF5B from M. thermoautotrophicum (PDB:  1G7S, 
1G7T). The structural transition from the GDP-bound state to the GDPNP-bound form is limited to the N-
terminal half of switch 2, which moves ~2 Å towards the nucleotide binding pocket, while switch 1 remains 
unaltered. Neither Thr39 in the G2 motif nor Gly79 in G3 form a direct contact to the γ-phosphate; the only 
potential interaction occurs between Glu81 and the γ-phosphate. The region of switch 2 forming the 
contacts to domain III (dashed circle) remains virtually unchanged. Compare also to Fig. S4. B) The GDPNP-
induced shift in switch 2 is thought to cause a concerted rearrangement of domains II and III (dashed 
arrows), resulting in a ~5 Å shift of domain IV (arrow). The interaction interface between switch 2 and 
domains II and III (dashed circle) remains nearly unchanged. The switch regions are colored as in A); 
domains II-IV are colored grey for apo aIF5B (PDB:  1G7R), cyan for aIF5B·GDP and yellow for aIF5B·GDPNP. 
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From bacteria to eukarya, the specific recognition of the amino-acylated initiator tRNA by the 
universally conserved translational GTPase eIF5B/IF2 is one of the most central interactions in the 
process of translation initiation. However, the molecular details, particularly also in the context of 
ribosomal initiation complexes, are only partially understood.    
Results 
A reinterpretation of the 6.6 Å resolution cryo-electron microscopy (cryo-EM) structure of the 
eukaryal 80S initiation complex using the recently published crystal structure of eIF5B reveals that 
domain IV of eIF5B forms extensive interaction interfaces with the Met-tRNAi, which, in contrast to 
the previous model, directly involve the methionylated 3’ CCA-end of the acceptor stem. These 
contacts are mediated by a conserved surface area, which is homologous to the surface areas 
mediating the interactions between IF2 and fMet-tRNAfMet as well as between domain II of EF-Tu 
and amino-acylated elongator tRNAs.  
Conclusions 
The reported observations provide novel direct structural insight into the specific recognition of 
the methionylated acceptor stem by eIF5B domain IV and demonstrate its universality among 
eIF5B/IF2 orthologs in the three domains of life.  
 
6.1 Background 
The process of translation initiation results in the formation of an elongation-competent ribosome 
with the start codon of an mRNA in its P site, base paired to the amino-acylated initiator tRNA. In 
bacteria and eukarya this process follows significantly different mechanisms, highlighted by 
different numbers of auxiliary protein factors (initiation factors or IFs) that are employed by 
bacterial (three IFs) or eukaryal cells (at least 12 eIFs) for correct ribosome assembly [9]. Only two 
of these factors, a/eIF1A/IF1 and the translational GTPase a/eIF5B/IF2, are universally conserved in 
the three domains of life [81]. In bacteria, IF2 plays a critical role throughout the initiation 
pathway. In the early stages, IF2 binds to the 30S subunit in a GTP-dependent manner and 
stimulates the recruitment of the N-formylmethionylated initiator tRNA (fMet-tRNAfMet) to the P 




catalyzes the joining of the 50S ribosomal subunit to form the elongation-competent ribosome [15, 
189]. Speed and accuracy of both processes depend of the specific recognition of the αNH-blocked 
methionine esterified to the 3’ CCA-end of tRNAfMet[190-193]. Biochemical studies showed that all 
determinants required for this interaction are located in domain IV of IF2, which consists of a six-
stranded β barrel [194-197]. Domain IV of IF2 exhibits a marked structural homology to domain II 
of EF-Tu that, together with the G domain, forms the universally conserved structural core among 
translational GTPases [198] and in EF-Tu constitutes part of the binding pocket for the amino-
acylated acceptor arm of elongator tRNAs [48, 163, 197]. Based on this observation it was 
suggested that IF2 domain IV and EF-Tu domain II use similar interfaces for their interactions with 
the tRNA [197]. This assumption is at least partially corroborated by mutational and NMR 
spectroscopy analyses [196]. Cryo-EM structures of bacterial 30S pre-ICs and 70S IC containing 
GTP/GDPNP-bound IF2 show how this interaction mutually stabilizes fMet-tRNAfMet and IF2 in 
conformations that allow the efficient association of the 50S subunit [152, 172]. However, none of 
these structures were determined at sufficiently high resolution to give any detailed insight into 
the interaction that would allow a correlation with the biochemical data.  
In contrast to bacterial IF2, the role of a/eIF5B in eukarya and archaea seems to be confined 
to the GTP-dependent promotion of subunit joining, the last step of the initiation process [145, 
161, 199]. The recruitment of the charged initiator tRNA (Met-tRNAi) to the small ribosomal 
subunit is carried out by the heterotrimeric a/eIF2, a specialized EF-Tu paralog that has no 
counterpart in bacteria [200]. Accordingly, a/eIF5B⋅GTP binds to the small ribosomal subunit 
already containing the P site-bound Met-tRNAi, which invokes the question whether a/eIF5B still 
has to interact with Met-tRNAi to promote joining of the large ribosomal subunit, and whether this 
interaction would involve a specific recognition of the methionylated acceptor end, similar to the 
recognition of the fMet-tRNAfMet by IF2. Genetic, biochemical and structural studies point toward 
essentially the same mechanisms for eIF5B and IF2 catalyzed subunit joining [84, 91, 145, 154, 199, 
201]. Crystal structures of aIF5B and eIF5B revealed a six-stranded β barrel fold for domain IV, 
homologous to domain IV in IF2 [84, 201]. Indirect biochemical assays showed that a/eIF5B binds 
Met-tRNAi in solution, however, with very low affinity and specificity for the methionyl moiety in 





ethyl ester (mimicking the ester bond between tRNA and the methionly moiety) and eIF5B domain 
IV in the area corresponding to the surface on IF2 that is affected by N-formylmethionine binding 
[86]. Finally, the recently determined 6.6 Å resolution cryo-EM structure of the yeast 80S IC (EM-
Databank: EMD-2422) demonstrates that, like IF2 in the corresponding bacterial 70S complex 
[152], eIF5B and the P site-bound Met-tRNAi stabilize each other in their subunit joining-competent 
conformations through the direct contact between domain IV and acceptor stem [91]. Surprisingly 
however, according to the structural model this contact does not involve the methionylated 3’ 
CCA-end of the tRNA [91]. Instead, the CCA-end points away from domain IV, placing the methionyl 
moiety ∼23 Å from the protein. Thus, this model is clearly at odds with the observations from 
biochemical studies [86, 202] and fails to explain why deacylation of the initiator tRNA results in 
the loss of its ability to stabilize eIF5B [91].  
Here, we provide an analysis and reinterpretation for the cryo-EM density of the yeast 80S IC 
[91] for domain IV and its contact to the initiator tRNA. We show that the original structural model 
for this region, based on the fit of the archaeal aIF5B ortholog, is only partially consistent with the 
available density. Fitting of the recently determined structure of eIF5B domain IV from C. 
thermophilum, which shows a significantly higher degree of sequence similarity to the S. cerevisiae 
ortholog, allows a reinterpretation of the 6.6 Å resolution density. The resulting model 
demonstrates a direct contact between the methionylated CCA-end of the tRNA and a conserved 
surface area of domain IV that directly corresponds to the binding sites for the tRNA acceptor arm 
on domain IV of IF2 or domain II of EF-Tu [48, 196, 197]. Thus, we show that the high-quality cryo-
EM density of the 80S complex not only provides the first direct structural indications for the EF-
Tu-like interactions between eIF5B/IF2 domain IV and the initiator tRNA but also for their 
universality among a/eIF5B/IF2 orthologs in the three domains of life. Finally, we use our 
observations to propose a possible scenario for the evolution of the translational β barrel fold in 









Figure 1. Model for the interactions between eIF5B domain IV and Met-tRNAi in the 80S IC. A) Crystal 
structure of cteIF5B domain IV (PDB: 4N3G). The most marked differences to domain IV of aIF5B from the 
archaeon M. thermoautotrophicum (PDB: 1G7T) (B) are found in the lengths of the β3-β4 hairpin and loop 
L5 as well as in the arrangement of the two C-terminal α helices. C) Original model for the interactions 
between domain IV (cyan) and Met-tRNAi (purple), fitted into the cryo-EM density of the 80S IC (EMD-2422) 
[91]. D) New model for the interactions between domain IV (blue) and Met-tRNAi (purple), based on the 
rigid-body fitting of the crystal structure of domain IV from cteIF5B. The 3’ CCA-end now forms a direct 






6.2 Results and Discussion 
Model of eIF5B domain IV and the acceptor end of Met-tRNAi in the 80S IC. 
Recently, we were able to solve two structures of eIF5B domain IV from the fungus 
C. thermophilum [201]. It consists of six antiparallel β strands (β1-β6) forming a closed β barrel that 
is followed by two α helices (Figure 1A). At its top and bottom, the β barrel is closed by an 
additional short β strand (βL4) and a one-turn α helix (αL5), respectively. Despite relatively low 
sequence similarity, it is structurally very similar to domain IV of aIF5B from the archaeon M. 
thermoautotrophicum (rmsd of 2.2 Å for Cα atoms with ∼20% identity and ∼30% similarity). 
However, in the cteIF5B ortholog the β hairpin formed by β strands 3 and 4 and the loop following 
strand β5 (L5) contain 9 and 5 additional amino acids, respectively (Figure 1A/B). Further 
differences can be found in the organization of the two C-terminal α helices that are rotated by 
∼25° with respect to the β barrel.  
Compared to the archaeal ortholog, domain IV from cteIF5B shows a relatively high sequence 
similarity to the yeast ortholog (19% identity and 30% similarity for mtaIF5B compared to 49% 
identity and 65% similarity for cteIF5B) including the β3-β4 hairpin, L5 and the two C-terminal α 
helices. Based on this observation, we assumed that the cteIF5B structure allows a better fit to the 
recently determined cryo-EM density of the yeast 80S IC with initiator tRNA and eIF5B⋅GDPCP than 
obtained with the mtaIF5B structure [91] (Figure 1C). Rigid-body fitting of cteIF5B domain IV (cross-
correlation coefficient (CCC) of 73%) results in an improved correlation between structural model 
and density (Figure 1D): In contrast to the original fit of mtaIF5B [91], no clashes occur between 
the ribosomal RNA and cteIF5B domain IV, as the loop between β strands 1 and 2 (L1) is moved 
away from C2284-U2286 and now lies next to the acceptor stem of the tRNA. Compared to the 
original model [91] the β barrel is rotated by ∼30°, causing the conserved helix αL5 at the bottom of 
the β barrel to displace the β3-β4 hairpin in the major groove of the initiator tRNA acceptor stem. 
In turn, the long, poorly conserved β3-β4 hairpin now occupies previously unexplained density 
close to the C-terminus of the last α helix and forms apparently no direct contacts to the tRNA 
(Figure 1D). 
An interesting consequence of this reorganization of domain IV is the emergence of a well 




α helices (Figure 1D). This density starts next to the very C-terminus of β strand 4 and the following 
loop (L4) and runs across strands β5, β2 and finally β1 where it directly leads into the continuous 
density of the phosphate backbone of the initiator tRNA at A73. Interestingly, this same position 
(A73) also marks the starting point for the distortion of the following 3’ CCA-end in the original 
model that is markedly different from its canonical conformation [91]. For the following reasons, it 
is unlikely that this original model gives the correct conformation for the tRNA acceptor arm in the 
80S pre-IC: First, C75 and A76 clash extensively with the ribosomal RNA between G2615 and C2625 
(Figure 1C). Second, the CCA-end is oriented away from eIF5B domain IV, resulting in a distance of 
∼23 Å between the ribose of A76 (which carries the methionyl moiety) and the nearest parts of 
domain IV. This is clearly inconsistent with the observation that deacylation of the tRNA results in 
the loss of its contact to eIF5B in the 80S complex [91] and is at odds with the expected direct 
contact between the methionyl moiety and domain IV [86, 199, 202]. Remodeling of the 3’ CCA-
end into the vacant density next to the β barrel of eIF5B avoids the clashes with the rRNA and, 
moreover, allows a direct recognition of the aminoacyl group by the protein by placing the 3’ end 
of the tRNA directly on top of the conserved Ala1056 of strand β5 (Figure 1D). It is important to 
note, that there is no alternative density present that could accommodate the entire CCA-end 
without causing a sterical conflict with the rRNA. Independent support for this new placement of 
the CCA-end is provided by the just recently published lower resolution (8-9 Å) cryo-EM model of 
the mammalian 80S pre-IC with eIF5B bound on HCV-IRES RNA, which suggests a direct contact 
between the acceptor end of the Met-tRNAi and domain IV of eIF5B [203]. 
As reported previously for mtaIF5B [84], the β barrel of eIF5B is structurally homologous to 
domain IV (C2 domain) of bacterial IF2 [197] and domain II of EF-Tu homologs, despite an overall 
low sequence similarity (Figure 2 and 3). Using site directed mutagenesis and NMR spectroscopy, it 
was shown that IF2 interacts with the αNH-formylmethionylated CCA-end of fMet-tRNAfMet 
through a surface of domain IV that overlaps with that used by EF-Tu domain II to interact with the 
acceptor end of elongator tRNAs [48, 163, 196, 197]. The superposition of domain IV of cteIF5B 
with domain IV of IF2 from Bacillus stearothermophilus[197] and domain II of EF-Tu from Thermus 
aquaticus in complex with Phe-tRNAPhe[48] reveals that these surface areas coincide perfectly with 





structure-based sequence alignment reveals the highest degree of sequence conservation between 
the eIF5B orthologs and EF-Tu domain II in those residues implicated in tRNA binding in IF2 and EF-
Tu (Figure 3).  
 
 
Figure 2. The interaction interface between the acceptor stem of Met-tRNAi and domain IV of eIF5B. 
Interactions between Met-tRNAi (purple) and eIF5B domain IV (A-D), Phe-tRNA
Phe and domain II of EF-Tu 
(PDB: 1TTT) (E) and fMet-tRNAfMet and IF2 domain IV (F). A) Domain IV of eIF5B in ribbon presentation 
(yellow) with residues potentially involved in interactions with the tRNA as green sticks. B) Surface 
presentation of domain IV, revealing the two well defined pockets below loop L4 that are also visible on the 
surfaces of EF-Tu domain II (E, right) and IF2 domain IV (F, right), and might accommodate A76 and the 
methionyl moiety of the 3’ CCA-end. C) Electrostatic surface potential of domain IV. D) Conservation of 
residues lying in the proposed interaction interface to the acceptor stem. E) Position of the acceptor stem of 
Phe-tRNAPhe (purple) on the surface of domain II of EF-Tu (yellow; PDB: 1TTT). F) Model of domain IV of IF2 
(PDB: 1D1N) and the initiator tRNA positioned as in A). The green surfaces indicate residues of IF2 that were 





The analysis of the surface area in cteIF5B reveals two pockets next to the modeled 3’ end of 
the tRNA (Figure 2 and 4). The first formed by Val999, Gly1037, Glu1039 and the aliphatic part of 
Lys1058, corresponding to the EF-Tu residues Val237, Gly269, Glu271 and Leu289, respectively, 
which accommodate the base of A76 in Phe-tRNAPhe[48]. A similar pocket is found on the surface 
of IF2, whose residues are directly affected by fMet-tRNAfMet binding [196, 197]. The second pocket 
is separated from the first by the methyl group of Ala1056 (corresponding to the conserved Gly287 
in EF-Tu and Gly715 in bsIF2) and is formed on the one side by the hydrophobic Val989, Ala990, 
Phe992, Gly1001 and Ala1054 and on the other by the peptide backbone of Glu1039 to His1042. 
The position of this pocket corresponds to the localization of the aminoacyl groups in ternary 
complexes of EF-Tu, and residues of this area were found to interact specifically with N-
formylmethionine in IF2 [196] and methionine-ethyl ester in eIF5B [86]. Consistently, this second 
pocket is compatible with the binding of a methionyl moiety in size as well as electrostatic surface 
properties (Figure 2 and 4). Notably, in both available crystal structures of cteIF5B domain IV, this 
pocket is occupied by a large additional electron density. Due to the absence of alternatives in the 
crystallization condition (100 mM MES, 12% PEG 20000, 10 mM Na-lactate; ethylene glycol was 
used for cryo protection), this density was originally assigned to a lactate molecule [201]. However, 
refinement with the lactate molecule still results in positive difference electron density. A 
simulated annealing omit map for this area gives a density too large for a lactate (Figure 4B). Thus, 
the density would be compatible with the size of a methionine or other similarly large amino-acids 
whose α-carboxylate and α-amino groups form hydrogen bonds to the amide proton of Asp1041 
and the main chain CO of Ala1054, respectively, corresponding to His273 and Asn285 that form 
similar contacts to the aminoacyl group in ternary complexes of EF-Tu [48, 204] (Figure 4D). 
However, the resolution of the structures (2.75 and 3.02 Å) necessarily does not allow an 
unambiguous assignment of the densities to a certain ligand, and a possible origin for a putative 
amino acid in this position remains elusive, as the weak binding between IF2 and fMet or eIF5B and 
methionine-ethyl ester [86, 196] makes a co-purification unlikely. The critical point, however, is the 
observation that the described pocket is evidently suited to accommodate organic molecules of a 
size similar to that of methionine and could thus accommodate the methionyl moiety of the Met-






Figure 3.Partial structure-based sequence alignment of the β barrel fold of domain IV (D4). The aligned 
sequences are from B. stearothermophilus IF2, M. thermoautotrophicum aIF5B, C. thermophilum eIF5B and 
S. cerevisiae eIF5B with domain II (D2) from E. coli EF-Tu and S. solfataricus aIF2γ (GenBank: CAA27987, 
AAB84765, EGS21143, AAC04996, CAA40370, AAK40740, respectively). Highly conserved residues are 
highlighted in dark blue, conserved residues in light blue and similar residues in grey. Sequence numbering 
and secondary structure elements correspond to the cteIF5B structure (PDB: 4N3G). As there is no structure 
of sceIF5B available so far, its sequence was aligned directly with that of cteIF5B. 
 
In ternary complexes of EF-Tu, the binding site for the 3’ CCA-end on domain II is 
complemented by the conserved Phe229 in strand β1 that stacks against C4 and C5 of the A76 
ribose and by Arg274 (sometimes Gln or Lys) in the flexible loop following strand β4 that interacts 
with the phosphate of A76 [48, 204] (Figure 4C). The density assigned to the CCA-end of the Met-
tRNAi suggests similar interactions for the conserved Phe992 (in few cases Tyr or Ile) and His1042 
in cteIF5B (Figure 4A). According to the model, the rest of the acceptor stem of the tRNA adopts a 
slightly different orientation relative to the β barrel than observed for aa-tRNA bound to EF-Tu. In 
good agreement with the predictions made for IF2 [196], C75 and C74 seem to be rotated ∼20° 
toward the L1 loop (Figure 2). Interestingly, the orientation of the β barrel would allow several 
positively charged residues to interact directly with the acceptor stem. Lys994 in the L1 loop could 
contact the initiator tRNA specific A1:U72 base pair. The conserved Arg1070 and His1071 in helix 
αL5, positioned in a well defined density in the cryo-EM map (Figure 1D), are within contact 
distance to the phosphate backbone at G68 and C69 in the major groove. Notably, EF-Tu domain II 
contains a corresponding short helix αL5 in which the conserved Arg295 as well forms a contact to 
the acceptor arm of the bound tRNA [48, 204] (Figure 2E). Based on the comparison with EF-Tu it 
was previously assumed that a similar contact might be formed between Lys725 and Glu726 of 
bsIF2 and fMet-tRNAfMet. However, such an interaction could not be observed by NMR 
spectroscopy in solution [196]. It is therefore conceivable that these interactions are formed only 
in the context of the ribosomal pre-IC, where the tRNA is stabilized in a specific orientation relative 





Figure 4. Recognition of the methionylated 3’ CCA-end by eIF5B domain IV. A) CCA arm, A76 and the 
methionly moiety of Met-tRNAi modeled into the two surface pockets on eIF5B domain IV according to the 
cryo-EM density. Residues implicated in the interactions with the 3’ end are indicated. B) Simulated 
annealing fo-fc omit map for the putative methionyl-binding pocket in eIF5B domain IV (blue mesh; 
contoured at 3𝜎). C) Met-tRNAi bound to aIF2γ (PDB: 3V11). D) Phe-tRNA
Phe bound to EF-Tu (PDB: 1TTT).  
 
Biological relevance of this domain IV-tRNA interaction lies in the mutual stabilization of 
initiator tRNA and eIF5B in conformations that allow efficient recruitment of the large ribosomal 
subunit and insertion of the acceptor arm into the peptidyl-transferase center (PTC). In the 80S 
complex domain IV stabilizes the tRNA in a non-canonical P/I orientation [91] that according to our 
model places the 3’ end ∼20 Å from the PTC without inducing a major distortion of the CCA-end 
from its canonical conformation (Figure 5). The following GTP hydrolysis and dissociation of eIF5B 





canonical P site conformation. Through the specificity of domain IV for the methionylated acceptor 
arm, which might be more pronounced in the context of the preassembled 40S⋅Met-tRNAi complex 
than in solution [202], this interaction would mark a final checkpoint in the initiation process that 
allows subunit joining only on correctly assembled 48S pre-ICs with a charged initiator tRNA bound 
in the P site [146, 201].  
 
 
Figure 5. Conformational rearrangement of Met-tRNAi on the initiation complex. eIF5B stabilizes the 
initiator tRNA (purple) in a non-canonical P/I conformation [91] with the 3’ CCA-end outside of the PTC. 
Upon GTP hydrolysis in eIF5B and the release of the 3’ CCA-end from its contacts to domain IV, the initiator 
tRNA rearranges into the canonical P site conformation, involving a 20 Å repositioning of the 3’ end into the 
PTC. 
 
Implications for the evolution of the translational β barrel fold 
As reported previously, domain IV of IF2 and the structurally homologous domain II of EF-Tu use 
similar surface areas to interact with amino-acylated tRNAs [196, 197] (Figure 2E/F). The structure 




aIF2γ (a paralog of EF-Tu) and the Met-tRNAi[42] (Figure 4C). Our observations provide structural 
evidence that this also applies to domain IV of eIF5B. This common binding interface for the 3’ 
CCA-end on the translational β barrel fold is centered on β strands 1, 2 and 5 and framed by the 
flexible loops L1 and L4 (Figure 2 and 4). In all cases additional interactions are made by the short 
capping α-helix that provides positively charged residues for contacts to the phosphate backbone 
of the acceptor stem, while at the same time allowing substantially different overall orientations of 
the tRNA relative to the β barrel, irrespective of an identical polarity of the bound CCA-end (Figure 
6). Despite the low average sequence identity over the various β barrel folds (Figure 3), the 
significant structural and functional parallels in their interactions with amino-acylated tRNAs 
clearly point toward a common evolutionary origin. As eIF5B/IF2 and EF-Tu are both universally 
conserved in the three domains of life, their divergence and thus the origin for their respective 
tRNA-binding domains most likely lies long before the onset of speciation; this raises the 





Figure 6.Comparison of the interactions 
between eIF5B, EF-Tu and aIF2γ with 
tRNA. Despite the same polarity and 
similar interfaces for the interactions 
between the translational β barrel fold 
and the single-stranded 3’ CCA-end, the 
tRNAs adopt significantly different overall 
orientations relative to the protein in 
ribosome-bound eIF5B (red) or the ternary 
complexes of S. solfataricus aIF2 (cyan; 
PDB: 3V11) and T. aquaticus EF-Tu (yellow; 
PDB: 1TTT). ASL is anticodon stem loop. 
 
A central question for the problem of cellular evolution is the appearance of the basic 
protein-folding types and of domains as functional building blocks for proteins. Folded proteins 





divergent evolution from a single ancestor or independently by convergent evolution from 
different lineages is unclear. In this context, it is interesting that the characteristic features of tRNA 
binding by the translational β barrel fold show significant parallels to those between OB-fold 
domains and single-stranded nucleic acids (Figure 7). The OB-fold is a five-stranded mixed β barrel, 
capped on one end by an α-helix [205]. Most known OB-fold domains are involved in interactions 
with single-stranded RNA or DNA [206]. Despite very low sequence similarity among its members, 
the OB-fold superfamily is thought to be an ancient domain structure that derived by divergent 
evolution from a common ancestral protein – an assumption that is based on the common features 
of their fold-related ligand-binding interface [206, 207]. Despite a different overall topology of the 
OB-fold (Figure 7C/D) and a different classification in the SCOP (Structural Classification of 
Proteins) database, this interface, composed of β1-L1-β2-β3-L3/αL3-β4-L4 (Figure 7B), shows an 
intriguing structural and functional correspondence to the identically arranged but differently 
connected building blocks of β1-L1-β2 and β4-L4-β5-L5/αL5-β6 in the translational β barrel fold that 
are responsible for its interactions with tRNA (Figure 7A).  
These similarities might merely be a functional analogy between both protein families that 
arose by convergent evolution from two distinct starting points. However, by the argument of a 
common descent based on a fold-related ligand-binding interface, the evident similarities might as 
well be indicative of a common evolutionary origin for the two equally ancient protein folds. For 
this hypothesis, two previously proposed theories are of particular interest: i) The emergence of 
domain folds by polyphyletic evolution from self-assembling short peptide ancestors, whose 
remnants (in sequence, structure or function) still exist in extant proteins [208]; and ii) the theory 
of a chemoautotrophic origin of life on volcanic iron-sulfur surfaces, according to which protein 
domains emerged from functional peptides that used metal ions as folding determinants or formed 
surface-bonded β-sheets that finally detached from the stabilizing surfaces (e.g. to form β-barrel 
domains) in the course of progressing cellularization  [209-211]. In both theories, the transition 
from the peptide- to the independently folding protein-domain proceeds concomitant to the 
refinement of the genetic machinery that allows the synthesis of increasingly long polypeptides 






Figure 7. Translational β barrel fold and OB-fold share the same fold related ligand-binding interface. A 
and C) The interaction interface between the 3’ CCA-end of the tRNA and the translational β barrel (here 
Phe-tRNAPhe (purple) bound to T. aquaticus EF-Tu domain II (PDB: 1TTT)) centers on β strands 1, 2 and 5 and 
is augmented by loops L1, L4 and L5, containing helix αL5. B and D) A related ligand-binding interface is 
found in single-stranded nucleic acid binding OB-folds (here the anticodon binding domain of the aspartyl-
tRNA synthetase (PDB: 1ASZ) from S. cerevisiae[212]). Similar to the interactions observed for EF-Tu and 
despite a different topology, the bases of the anticodon stem loop (purple) point toward the surface of the 
β barrel, centered on β strands 1, 2 and 3, while the flexible loops L1, L4 and L3 with αL3 form additional 
contacts to the phosphate backbone. 
 
In light of these hypotheses, we suggest a possible common polyphyletic origin of both fold-
related RNA binding interfaces discussed above. At the earliest stages of cellular evolution, when 





nucleic acid-peptide interactions most likely played an essential role, particularly for the genetic 
machinery. In this context, it would be conceivable that the common ligand-binding interface in 
the ancient lineages of OB-fold proteins and translational GTPases has arisen as an ancient 
structural entity formed by individually synthesized peptides, associating with single-stranded 
nucleic acids as folding determinants, similar to metallo-peptides as precursors for metallo-
proteins [209-211]; during the gradual replacement of peptides by their fusion into independently 
folding proteins, this would ensure the conservation of the nucleic acid-binding interface, while at 
the same time allowing a substantially different connectivity of the individual building blocks in the 
emerging protein families. 
 
Conclusions 
In this study, we used the recently reported medium resolution cryo-EM density of the yeast 80S IC 
[91] and high resolution crystal structures of eIF5B from C. thermophilum to propose a new model 
for the interactions between eIF5B domain IV and the Met-tRNAi in the context of the ribosome 
(Figure 1). According to this model, domain IV forms direct interactions with the phosphate 
backbone in the major groove of the acceptor arm, the initiator tRNA specific A1:U72 base pair and 
– most importantly – with the methionylated 3’ CCA-end. The relevance of these findings lies in the 
novel insight into the specific recognition of the amino-acylated initiator tRNA by eIF5B/IF2 in the 
context of pre-initiation complexes, which, as a final checkpoint for ribosomal subunit joining, is 
one of the central interactions in the process translation initiation. Finally, the identified binding 
interface between eIF5B and Met-tRNAi directly corresponds to that reported earlier for the 
interaction between the homologous domains in IF2, EF-Tu and aIF2γ with their respective tRNA 
ligands [48, 197] and exhibits a striking structural and functional similarity to the fold-related 
ligand-binding interface of OB-fold domains, possibly reflecting a common evolutionary origin of 








Rigid-body fitting of cteIF5B domain IV (residues 382-1116; PDB codes 4N3N and 4N3G) was 
performed using UCSF Chimera [213]. Despite entirely different sets of crystal contacts for domain 
IV in the two X-ray structures they are very similar to each other (rmsd of 0.34), indicating a high 
degree of structural rigidity. Thus, although domain IV might undergo minor conformational 
changes upon interacting with ribosome and tRNA, particularly in the loop regions, we decided not 
to include any flexible fitting procedures to avoid overfitting of the model. Manual rebuilding of 
the acceptor stem of the Met-tRNAi between bases G70 and A76 into the density next to domain IV 
was done in COOT [116]. Figures were prepared using UCSF Chimera [213] or Pymol 
(http://www.pymol.org). 
We would like to mention here that in our hands the isolated domain IV of the mtaIF5B 
crystal structure (PDB: 1G7R) is fitted to the cryo-EM density in the same way as the cteIF5B 
structure (with a CCC of 67%), supporting the newly proposed fit shown in Figure 1D. However, the 
mtaIF5B domain IV of the cryo-EM based model (PDB: 4BYX) is fitted as presented in [91] with a 
CCC of 78.7% (Figure 1C), most likely as the result of a combination of rigid-body and flexible fitting 
procedures [91], which gave rise to rmsds of 5.8 Å and 7.5 Å (over 106 Cα atoms) relative to the 
crystal structures of mteIF5B and cteIF5B, respectively, while the two crystal structures themselves 
differ only by an rmsd of 2.2 Å. Thus, the higher CCC for the cryo-EM-based model is most likely 
due to its distortion from the original rigid structure of mtaIF5B and is therefore not comparable to 
the CCC values obtained for our rigid-body fit.  
 
Sequence alignments 
Multiple sequence alignments were done using the iterative alignment program MUSCLE [214]. 
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Translational GTPases are universally conserved GTP hydrolyzing enzymes, critical for fidelity and 
speed of ribosomal protein biosynthesis. Despite their central roles, the mechanisms of GTP-
dependent conformational switching and GTP-hydrolysis that govern the function of trGTPases 
remain poorly understood. Here, we provide biochemical and high-resolution structural evidence 
that eIF5B and aEF1A/EF-Tu bound to GTP or GTPγS coordinate a monovalent cation (M+) in their 
active site. Our data reveal that M+ ions form constitutive components of the catalytic machinery 
in trGTPases acting as structural cofactor to stabilize the GTP-bound ‘on’ state. Additionally, the M+ 
ion provides a positive charge into the active site analogous to the arginine-finger in the Ras-
RasGAP system indicating a similar role as catalytic element that stabilizes the transition state of 
the hydrolysis reaction. In sequence and structure, the coordination shell for the M+ ion is, with 
exception of eIF2γ, highly conserved among trGTPases from bacteria to human. We therefore 
propose a universal mechanism of M+-dependent conformational switching and GTP-hydrolysis 
among trGTPases with important consequences for the interpretation of available biochemical and 
structural data.   
 
7.1 Introduction 
Translation – the ribosome-catalyzed synthesis of biologically functional polypeptides according to 
genetically encoded information – is one of the most fundamental and complex biochemical 
processes in extant cellular life. In all stages of protein biosynthesis the ribosome depends on a set 
of auxiliary guanine nucleotide binding (G) proteins (termed translational GTPases or trGTPases) 
that include initiation factor 2 (IF2), which catalyzes ribosomal subunit joining and formation of the 
elongation-competent ribosome, elongation factor Tu (EF-Tu), which delivers aminoacyl-tRNA (aa-
tRNA) to the ribosomal A site, as well as  elongation factor G (EF-G) that catalyzes the translocation 
of the mRNA-tRNA complex on the ribosome [8, 9]. Despite the differences in their respective 
functions, trGTPases from bacteria to eukarya share a common evolutionarily conserved structural 
core composed of the G domain and domain II, which is supplemented with additional factor 





binding and hydrolysis to the specific biological function of the translation factor [9]. This present 
work focuses on so far unresolved aspects of the universal molecular mechanisms that govern the 
functional cycle of the G domain in trGTPases and that are therefore central to the understanding 
of the process of translation as well as its evolution.   
In sequence and architecture the G domain in trGTPases is related to small Ras-like G 
proteins and thus belongs to the superfamily of P-loop GTPases [24]. According to the classical 
view, G proteins are thought to act as molecular switches that oscillate between a GDP-bound ‘off’ 
state and a structurally distinct GTP-bound ‘on’ state [23, 24]. The exchange of GDP for GTP is 
accompanied by conformational changes in two conserved dynamic elements termed switch 1 and 
switch 2 that form specific interactions with the GTP-γ-phosphate. Conversion back to the GDP-
bound state requires the hydrolysis of GTP and release of inorganic phosphate (P i), allowing switch 
1 and 2 to relax back into their inactive conformations. These structural changes ensure that only 
the GTP-bound form of a G protein is able to interact productively with effector molecules to carry 
out its biological function [23]. 
Despite its importance for the understanding of the translation process, the mechanism of 
GDP/GTP-dependent conformational switching has remained obscure for nearly all trGTPases. 
Over the years, high resolution structures have become available for various trGTPases in their apo 
states as well as in complex with GDP and the nonhydrolyzable GTP analogs GDPNP or GDPCP (β-γ-
imidoguanosine 5’-triphosphate and β-γ-methyleneguanosine 5’-triphosphate, respectively). 
Surprisingly, however, from these structures a highly heterogeneous picture emerged for the 
mechanisms of conformational switching in the G domains of trGTPases that is at odds with their 
evolutionary and structural homology: While only EF-Tu exhibited clearly distinct GDP- and GDPNP-
bound conformations in agreement with the classical concept [38, 163], EF-G, aIF5B and eRF3 
adopted virtually identical structures in their respective GDP- and GDPNP/GDPCP-bound forms, 
invoking suggestions about non classical mechanisms in these G proteins [84, 216, 217]. SelB, 
finally, seemed to constitute an intermediate case with switch 2 undergoing conformational 
changes upon GDPNP binding, while switch 1 remained mainly flexible similar to the GDP-bound 
state [218]. In order to reconcile the structural data with the classical model of GTPase function it 





‘conditional switching’ [153]. According to this concept, the GTP alone is insufficient to induce the 
GTP-conformation in the G domain but requires the ribosome as additional cofactor for the 
efficient conformational switch to the ‘on’ state. However, biochemical experiments as well as a 
recent crystal structure of eIF5B bound to GTP indicate that EF-G, SelB and eIF5B in fact do 
undergo significant structural rearrangements in the presence of true GTP instead of GDPNP or 
GDPCP, indicating that they conform to the classical model without the requirement of the 
ribosome or aa-tRNA for the conformational switch [183, 219, 220]. These observations are 
paralleled by a large body of biochemical data indicating that GDPNP is not an authentic GTP 
analog for nearly all trGTPases [153, 183, 221-224] and that the use of nonhydrolyzable analogs in 
structural experiments most likely accounts for the apparent deviation from the classical switch 
mechanism [153]. Hence, it seems evident that the stable conformational switch is dependent on 
critical contributions by the GTP molecule that are, however, not provided by the structurally 
similar GDPNP/GDPCP. It is therefore a central conceptual assumption of this present work that 
the identification of this so far unknown contribution by the GTP molecule provides a key to a 
more unified view on the GDP/GTP cycle in trGTPases, in agreement with their common 
evolutionary descent.  
Another central and yet unresolved problem in the functional cycle of trGTPases is the 
molecular mechanism of ribosome-induced GTP hydrolysis. Similar to other Ras-like G proteins, 
trGTPases possess a low intrinsic GTPase activity which is accelerated by several orders of 
magnitude upon productive binding to the ribosome [27, 225]. In analogy to the systems of the 
GTPase activating protein (RasGAP) of Ras or the regulators of G protein signaling (RGS) of Gα 
proteins, it was shown that the ribosome stimulates rapid GTP hydrolysis in trGTPases by the 
precise positioning of an invariant histidine (Hiscat) in switch 2 (corresponding to Gln61 in Ras) in its 
catalytically active conformation [168, 169]. However, the actual origin of the catalytic effect in the 
activated system has remained controversial [168, 226-229]. That is, it remained unclear how the 
nucleophilic water (Wcat) is activated for its attack on the γ-phosphate and how the subsequent 
stabilization of the transition state (TS) is achieved. In the Ras system RasGAPs further stimulate 
GTP hydrolysis by supplying an additional catalytic residue, the ‘arginine-finger’, into the active 





electrostatic stabilization of developing negative charges in the TS [106]. Analogous catalytic 
elements provided in cis or in trans have been identified in P-loop GTPases from Gα proteins to 
MnmE, dynamin and the signal recognition particle [25, 230-232]. However, up to now, trGTPases 
seemed to be an exception among Ras-related G proteins, as the search for an arginine-finger or an 
analogous catalytic element has been unsuccessful [233-236]. 
Here, we discuss the unresolved questions concerning the GTP-induced conformational 
switch and GTP hydrolysis in trGTPases in light of the novel assumption that trGTPases utilize a 
monovalent cation (M+ ion) as structural and catalytic cofactor. We show that eIF5B (eukaryal IF2 
ortholog) as well as aEF1A (archaeal EF-Tu ortholog) coordinate an M+ ion in their active sites in the 
same position as known M+-dependent GTPases, thus placing a positive charge analogous to the 
guanidino group of the arginine-finger in the Ras-RasGAP complex. The coordination shell for the 
M+ ion is, with the notable exception of eIF2γ, universally conserved among trGTPases from 
bacteria to humans and directly involves the oxygen atom of GTP that is replaced in GDPNP and 
GDPCP but not in the slowly hydrolyzable GTPγS. In combination with mutational, biochemical and 
isothermal titration calorimetry (ITC) data, these findings provide the conceptual framework and a 
significant explanatory power for the interpretation of a large body of previously unexplained 
observations for trGTPases, resulting in the conclusions that i) the M+ ion acts as structural cofactor 
that stabilizes the ‘on’ state of the G domain and thus contributes to the conformational switch in 
trGTPases; ii) GDPNP and GDPCP are unable to coordinate the M+ ion and thereby destabilize the 
GTP-conformation; iii) GTPγS is able to coordinate the M+ ion and thus a suitable GTP analog for 
trGTPases; iv) the M+ ion participates in the GTP hydrolysis reaction, most likely by stabilizing its TS; 
v) with few exceptions M+-dependency is universal among canonical trGTPases. 
 
7.2 Results 
GTP-bound eIF5B coordinates an M+ ion in its catalytic center 
Recently we reported the crystal structure of GTP-bound eIF5B from C. thermophilum, solved at 
1.9 Å resolution (protein data bank (PDB): 4NCN) [220]. This structure revealed a Na+ ion next to 
the GTP-γ-phosphate in a catalytically relevant position of the active site, which has so far never 





Na+ ion is penta-coordinated with coordination distances between 2.3 and 2.5 Å by two oxygens 
from the α- and γ-phosphates, the β-γ-bridging oxygen, the carboxylate group of Asp533 in the P-
loop (which we denote AspMC for aspartate involved in monovalent cation-binding) and the 
backbone CO from Gly555 in switch 1 (GlyMC). The latter is part of a short peptide backbone 
excursion of switch 1 (formed by Gly554 and Gly555) which approaches the Na+ ion opposite to the 
β-γ-bridging oxygen and is denoted ‘MC-loop’ (Fig. 1).  
 
GTPγS but not GDPNP supports crystallization of eIF5B in its GTP-bound conformation. 
The position of the M+ ion in eIF5B⋅GTP suggests that it provides a direct contribution to the 
stabilization of the GTP-bound switch 1 by forming a stable link to the GTP molecule (Fig. 1A). To 
test the relevance of this contribution, crystallization trials were performed with the construct 
cteIF5B(517-858) in the presence of GTP, GDPNP and GTPγS. If the M+ is relevant for the 
conformational switch in eIF5B, GTP and GTPγS but not GDPNP, in which the β-γ-bridging oxygen is 
replaced by an NH-group (Fig. 2A), should readily stabilize the GTP-conformation and allow 
crystallization of cteIF5B(517-858) in an optimization screen for the original crystallization 
condition (0.1 M HEPES/NaOH (pH 7); 13% PEG 4000; 0.1 M NaOAc) (see Expanded View for 
details).  
In line with our assumption, eIF5B(517-858)⋅GTP and  eIF5B(517-858)⋅GTPγS readily 
crystallized, while no crystals grew in the presence of GDPNP. The structure of eIF5B(517-858)⋅GTP, 
solved at 1.55 Å resolution, is very similar to that reported previously [220] (see Table 1 for details 
of data collection and refinement). The electron densities for both Na+ ions in the asymmetric unit 
are well defined with occupancies of 100%.  
The structure of eIF5B(517-858)⋅GTPγS was solved at 1.53 Å resolution, exhibiting an overall 
structure and nucleotide binding virtually identical to that of the GTP-bound form (Fig. E1B/D). The 
sulfur atom of the γ-phosphate points outward and thus replaces the non-bridging oxygen atom 
that is involved in the coordination of the M+ ion in eIF5B⋅GTP. Nonetheless, both eIF5B⋅GTPγS 
complexes in the asymmetric unit contain the Na+ ion in the pentameric coordination shell with 
coordination distances of 2.2-2.6 Å to the four oxygen ligands from the GTP molecule, AspMC and 





calculated from the van der Waals radius of sulfur (1.8 Å) and the effective ion radius of Na+ (1.0 Å 
for coordination number 5) [237, 238]).  
 
 















100 mM HEPES (pH 
7.25), 12% PEG 4000, 
100 mM NaOAc 
100 mM HEPES (pH 7), 
13% PEG 4000, 125 mM 
NaOAc 
11% PEG 8000, 6% 
glycerol, 50 mM KCl 
Temperature (°C) 20 20 20 
Data Collection 
Space Group P21 P21 P41212 
Unit Cell 
 
a = 55.6 Å 
b = 116.5 Å 
c = 66.2 Å  
α = β = 90° 
β = 101.1° 
a = 55.6 Å 
b = 115.9 Å 
c = 66.1 Å  
α = β = 90° 
β = 101.4° 
a = 116.1 Å 
b = 116.1 Å 
c = 120.3 Å  
α = β = γ = 90° 
Molecules/asym. unit 2 2 2 
Resolution (Å) 1.55 (1.64-1.55) 1.53 (1.63-1.53) 2.28 (2.42-2.28) 
Observed reflections 405616 (64352) 510862 (86738) 307464 (49685) 
Unique reflections 118431 (18849) 121606 (20942) 38004 (6021) 
Completeness (%) 98.8 (97.7) 98.5 (98.4) 99.9 (99.7) 
<I>/𝜎 15.5 (2.3) 18.8 (2.8) 19.3 (3.8) 
Rsym (%) 4.6 (50.5) 3.7 (49.6) 6.3 (54.2) 
CC(1/2) (%) 99.9 (75.1) 99.9 (82.2) 99.9 (99.1) 
Refinement 
Rwork (%) 15.7 16.3 20.0 
Rfree (%) 18.4 18.8 23.9 
Rmsd from Standard  
Stereochemistry 
Bond length (Å) 0.019 0.02 0.005 
Bond angles (°) 1.8 1.9 1.0 
Ramachandran Plot  
Statistics 
Most favored (%) 98.9 98.1 98.5 
Allowed regions (%) 1.1 1.9 1.5 
Disallowed regions (%) 0 0 0 
Values in parentheses refer to the highest resolution shell. 
Rwork and Rfree factors are calculated using the formula R = Σhkl‖F(obs)hkl| − |F(calc)hkl‖/Σhkl |F(obs)hkl|, where F(obs)hkl and F(calc)hkl are observed and measured 
structure factors, respectively. Rwork and Rfree differ in the set of reflections they are calculated from: Rfree is calculated for the test set, whereas Rwork is calculated for 
the working set. 
 
These results demonstrate that GTPγS is a suitable structural GTP analog that is able to 





unable to stabilize efficiently the same conformation (and thus to provide the same surfaces for 
crystal contacts) as GTP, resulting in the inability of the eIF5B⋅GDPNP complex to crystallize under 
the same conditions as eIF5B⋅GTP. The likely explanation for this observation is that, while GTP and 
GTPγS provide all the ligands required for the coordination of the Na+ ion and thus allow the stable 
association of switch 1, GDPNP is unable to provide the M+ ion as structural cofactor due to the 
replacement of the β-γ-bridging oxygen of GTP with a β-γ-bridging imido (NH) group (Fig. 2A).  
 
 
Figure 1. GTP-bound eIF5B coordinates an M+ ion in its GTPase center. A) Overview of G domain and 
domain II of GTP-bound eIF5B with a Na+ ion (purple sphere) in the active site. P-loop and switch regions are 
shown in cyan; GTP is shown as balls and sticks. The Na+ ion is bound by a pentameric coordination sphere 
(inset; indicated by purple lines) formed by GTP, AspMC and GlyMC. Mg2+ and water molecules are shown as 
spheres in light brown and grey, respectively; the catalytic histidine (His480) and highly conserved residues 
that interact with GTP or the cations are indicated; hydrogen bonds are shown as dashed lines. B) The active 
site of eIF5B·GTPγS with a K+ ion (yellow sphere) bound in a heptameric coordination sphere. C) 
Superposition of eIF5B·GTPγS structures with either Na+ (purple sphere) or K+ (yellow sphere) bound in the 
active site. Due to the shorter coordination distances to the Na+ ion, AspMC and GlyMC (purple sticks) are 
drawn closer to the GTP molecule than in the K+-structure (yellow sticks). D) Superposition of 








Figure 2. Biochemical characterization of nucleotide binding and GTP hydrolysis by eIF5B.A) GDPNP 
disrupts the coordination sphere for the M+ ion (blue sphere) formed by AspMC, GlyMC and three oxygens 
from GTP by replacing the β-γ-bridging oxygen (O) with an NH group. B) Temperature dependency of 
binding enthalpy changes (ΔH) upon eIF5B(517-858) interaction with GDP (●), GDPNP (○) or GTPγS (▼) 
measured by ITC. C) Intrinsic GTPase activity of eIF5B(517-858) (wild-type (wt) or the D533A mutant) 
determined at 35 °C in the presence of 200 mM of the indicated salts, 25 µM protein and 300 µM GTP and 
subsequent analysis by HPLC. The order in which the combinations are given on the right corresponds to the 
relative rates of GTP hydrolysis. D) Intrinsic GTPase activity of eIF5B(517-858) wild-type (black), D533A (red), 
D533N (green), and D533R (green) in the presence of NaCl under conditions as in C). E and F) Dependency 
of the intrinsic GTPase activity of eIF5B(517-858) wild-type (●), D533A (○), and D533R (▼) on the 
concentration of KCl (E) or NaCl (F). Experiments were repeated two to three times; standard deviations are 





GTPγS but not GDPNP is able to substitute for GTP to induce the conformational switch of eIF5B 
in solution. 
GTP binding to apo eIF5B induces a substantial rearrangement of the switch regions, involving a 
∼180° flip of switch 1 and the burial of ∼1800 Å2 of solvent accessible surface area (ASA) within G 
domain and domain II, accompanied by significant changes in heat capacity (∆Cp = -553 cal⋅mol
-1K-
1) [220]. Our structural data argue for a scenario in which the M+ ion provides a direct contribution 
as structural cofactor to stabilize the ‘on’ state of eIF5B. In order to test this assumption for free 
eIF5B we probed the conformational changes in cteIF5B(517-858) upon binding of GDP, GTPγS or 
GDPNP using ITC under conditions reported earlier for GTP binding [220] (Table E1, Fig. 2B and E2). 
The affinities of GDP, GTPγS and GDPNP to cteIF5B(517-858) were measured at different 
temperatures between 10 and 30 °C. At 30 °C GDP binds to cteIF5B(517-858) with an equilibrium 
dissociation constant (Kd) of 10.4 µM, 2.5-fold weaker than GTP (4.1 µM). GDPNP binds with a Kd of 
20.8 µM (at 30 °C), ∼5-fold weaker than GTP. GTPγS has an about 4-fold higher affinity to 
cteIF5B(517-858) (0.92 µM at 30 °C) than GTP. Comparable values were reported from 
fluorescence experiments with mammalian eIF5B and mant-nucleotides [239].  
The interactions of cteIF5B(517-858) with GTPγS, GDPNP and GDP result in significant 
exothermic heat effects (ΔH = -15.8, -9.7 and -11.5 kcal⋅mol-1, respectively, at 30 °C). As for GTP, 
their binding is driven by favorable changes in binding enthalpy and opposed by unfavorable 
entropic contributions (TΔS = -7.4, -3.2 and -4.6 kcal⋅mol-1 for GTPγS, GDPNP and GDP at 30 °C, 
respectively) (Table E1).  
In the temperature range between 10 and 30 °C ∆H is temperature dependent. When ∆H was 
plotted against the temperature, straight lines were obtained with the slopes representing the 
changes in heat capacity (∆Cp) upon complex formation (Table 2 and Fig. 2B) [179]. GTPγS causes a 
∆Cp of -539 cal⋅mol
-1⋅K-1, very similar to the value observed for GTP (-553 cal⋅mol-1⋅K-1) [220]. 
Significantly smaller changes in heat capacity were obtained for GDPNP and GDP binding (∆Cp = -
197 cal⋅mol-1⋅K-1 and -228 cal⋅mol-1⋅K-1, respectively). ∆Cp can be used as an estimate for the 
change in solvent accessible surface area (∆ASA) upon complex formation. The burial of surface 
area was shown to be associated with a negative change in heat capacity, with ∆Cp being 





According to this correlation, GTPγS binding induces major structural rearrangements in 
cteIF5B(517-858) similar to those observed for GTP binding (Table 2), suggesting nearly identical 
structures for cteIF5B(517-858)⋅GTP and cteIF5B(517-858)⋅GTPγS in solution. In contrast, GDPNP 
induces significantly smaller changes which are similar to those for GDP (Table 2), indicating a GDP-
like conformation for the cteIF5B(517-858)⋅GDPNP complex. These results are in line with the 
observations from the crystal structures of GTP-, GTPγS- and GDP-bound eIF5B and GDPNP-bound 
aIF5B [84], as well as the assumption of a specific inability of GDPNP to efficiently stabilize the 
conformational switch of the G domain by repulsion of the M+ ion (Fig. 2A). 
 
The structure of eIF5B bound to GTPγS and potassium. 
Most M+-dependent enzymes show a preference for potassium (K+) over other M+ ions as cofactor. 
A preference for K+ is known also for the translation apparatus in general and the function of 
trGTPases in particular [241-244]. We therefore assumed that K+ is able to substitute for Na+ as 
cofactor in the GTP-bound form of eIF5B. Consistently, we were able to obtain crystals of 
eIF5B(517-858)⋅GTPγS in space group P41212 that grew within two weeks at 20 °C under a 
condition containing 50 mM KCl (Table 1). The structure was solved at 2.28 Å resolution and 
contains two eIF5B⋅GTPγS complexes in the asymmetric unit. The two water molecules in the 
coordination shell of the Mg2+ ion and Wcat are weakly defined in the electron density, with the 
latter lying 3.1-3.2 Å from the outward pointing sulfur atom of GTPγS. On the other side of the 
Table 2. Changes in heat capacity and solvent accessible surface area for cteIF5B(517-858)  







 (with ∆cmin = 0.45) 
∆ASAmax [Å
2] 
(with ∆cmax = 0.24) 
 
GTP -553 ± 11a 1229 2304 
 
GTPγS -539 ± 30b 1198 2254 
 
GDPNP -197 ± 26
b 438 820 
 
GDP -228 ± 10b 507 950 
∆Cp, heat capacity change; obtained from ΔH/dT 
∆cmin and ∆cmax, area coefficients in cal⋅K
-1⋅(mol⋅Å2)-1 for calculation of ΔASA. 
∆ASAmin and ∆ASAmax, changes in solvent accessible surface areas assuming that all changes were conferred by either apolar or 70% apolar and 
30% polar surfaces, respectively. 
a Obtained from [220]. 





sulfur atom, opposite to Wcat, a strong electron density peak was observed that was assigned to a 
K+ ion with a coordination shell nearly identical to that of the Na+ ion in eIF5B⋅GTPγS (Fig. 1B and 
E1C). However, additional weak densities were observed on the solvent exposed side of the cation, 
suggesting that two water molecules contribute to a heptameric coordination shell. As expected 
for a K+ ion [156], the coordination distances to most oxygen ligands lie between 2.7 and 3.0 Å and 
are thus clearly different from those observed for the Na+ ions. The distance to the β-γ-bridging 
oxygen is slightly increased (~3.47 Å), most likely due to the large sulfur atom that coordinates the 
K+ ion at a distance of 3.2 Å (in good agreement with the theoretical distance of 3.26 Å, calculated 
from the van der Waals radius of sulfur (1.8 Å) and effective ion radius of K+ (1.46 Å for 
coordination number 7) [237, 238]).  
Despite the different crystallization conditions and a different set of crystal contacts, the 
overall structure of eIF5B⋅GTPγS bound to K+ is nearly identical to that of eIF5B⋅GTP/GTPγS bound 
to Na+ with the switch regions stabilized in their typical GTP-conformation. Significant differences 
are limited to GlyMC and the MC-loop of switch 1 which is moved ∼2 Å away from the guanine 
nucleotide, owing to the increased coordination distances to the K+ ion (Fig. 1C). This demonstrates 
that the position of the MC-loop in switch 1 is directly influenced by the species of the M+ ions 
coordinated next to the nucleotide, indicating a direct contribution of the M+ ion to the 
stabilization of the activated switch 1 conformation.  
 
eIF5B coordinates the M+ ion in the same position as known M+-dependent GTPases. 
Superposition of the eIF5B⋅GTP/GTPγS structures with MnmE and dynamin reveals that the K+ and 
Na+ ions in eIF5B are coordinated in the same position as the catalytic K+ and Na+ ions in the 
presence of GDP-AlFx in the two known M
+-dependent GTPases [231, 232] (Fig. 1D and E1E). AspMC 
replaces an identically positioned and conserved Asn or Ser, and the backbone CO of GlyMC 
replaces two backbone COs from the ‘K-loop’ in switch 1 which circles around the position of the 
MC-loop of eIF5B. The contacts formed between the K+ and Na+ ions and GTP in eIF5B are virtually 
identical to those of the K+ ion in MnmE or the Na+ ion in dynamin with the transition state mimic 
GDP-AlFx, where a β-phosphate oxygen of GDP represents the former β-γ-bridging oxygen and the 






The structural elements required for M+ coordination in eIF5B are highly conserved among 
trGTPases 
The G domains of trGTPases are highly conserved in sequence and structure. In order to investigate 
whether M+ ion binding may be a common characteristic among trGTPases we analyzed sequences 
and available structures with regard to key features involved in M+ ion binding in eIF5B. The key 
determinants for M+ ion binding are AspMC in the P-loop and GlyMC in the MC-loop of switch 1. 
Sequence analysis reveals that both residues, AspMC and GlyMC, are universally conserved among 
orthologs of eIF5B, EF-Tu, SelB, aIF2γ, eRF3, EF-G, RF3 and LepA from bacteria to human (Fig. 3A). 
The only notable exception among trGTPases is eIF2γ, where AspMC and GlyMC are replaced by Ala 
and Asn, respectively.  
Structurally, the P-loop is well conserved among trGTPases. In contrast, switch 1 shows a high 
degree of variability in sequence and structure, which is, however, limited to regions lying N-
terminally of the MC-loop. In a superposition of eIF5B⋅GTP with EF-Tu⋅GDPNP or the ribosome-
bound EF-G⋅GDPCP (Fig. 3B/C), the nucleotide binding motifs occupy virtually identical positions 
including all residues directly involved in the coordination of the nucleotide and Mg2+ ion. 
Importantly, the structural homology extends to AspMC as well as GlyMC, the latter of which 
invariably forms part of the characteristic MC-loop excursion of switch 1 at the end of helix A’’ in 
EF-Tu and EF-G, placing its carbonyl group in the correct position to coordinate the cation.  
 
GTP-bound aEF1A coordinates an M+ ion in its catalytic center 
Most known structures of trGTPases that were reported to be in the GTP-conformation do not 
contain GTP but GDPNP or GDPCP that contain either an NH or a CH2 group in lieu of the β-γ-
bridging oxygen. Both prevent the coordination of the M+ ion as observed in structures of known 
M+-dependent GTPases [245, 246] (Fig. 2A and E4). We therefore searched the PDB for structures 
of trGTPases that were cocrystallized with GTP and found two structures, both of the archaeal EF-







Figure 3. Structural elements required for M+-coordination in eIF5B are universally conserved among 
trGTPases.A) Excerpt of a multiple sequence alignment of different trGTPases (orthologs of RF3, eIF5B, 
eIF2γ, SelB, eRF3, EF-Tu, LepA, EF-G) showing P-loop and switch 1. The upper and lower numbering 
corresponds to C. thermophilum eIF5B (Cthe) and E. coli EF-Tu (Ecoli), respectively. Highly conserved 
residues are highlighted in dark blue, conserved residues in light blue. AspMC and GlyMC are highlighted in 
red, residues in eIF2γ that replace AspMC and GlyMC are highlighted in yellow. B) Superposition of 
eIF5B·GTPγS·K+ (colored as in Fig. 1) with ribosome-bound EF-G·GDPCP (brown; PDB: 4JUW). Ribosome-
bound EF-G provides all structural elements to bind the M+ ion; however, its coordination is prevented by 
the CH2 group of GDPCP in lieu of the β-γ-bridging oxygen (arrow). A water molecule (red sphere) is bound 
next to the M+-binding site instead. C) Similarly, EF-Tu·GDPNP (purple; PDB: 2C78) provides all structural 
elements to bind the M+ ion; however, its coordination is prevented by the NH group of GDPNP (arrow). A 
water molecule (red sphere) is bound next to the M+ binding site instead. 
 
Crystals of the aEF1A/pelota complex contained four aEF1A molecules (chains A, C, E, G) per 
asymmetric unit, each bound to GTP. The structure had been determined at 2.3 Å resolution[247]. 
Each of the aEF1A molecules contains a water molecule modeled in the position occupied by the 
M+ ion in eIF5B⋅GTP. Accordingly, the supposed water molecules are coordinated by five hydrogen 
bond acceptors with the sphere formed by the outward pointing α- and γ-phosphate oxygens and 





1. The MC-loop lies at the end of helix A’’ in switch 1 and adopts the same conformation found in 
eIF5B (Fig. 1A and 4A/B). The coordination distances of the supposed water molecules lie between 
2.2 and 2.7 Å with an overall average of 2.45 Å. Thus, the coordination pattern as well as the 
distances is in better agreement with those expected for a Na+ ion than for water [156]. 
Reevaluation of the experimental X-ray diffraction data (downloaded from the PDB (3AGJ)) 
revealed positive difference electron density for the supposed water molecules in aEF1A molecules 
C and E in the asymmetric unit, indicating a higher density of electrons in these positions than 
provided by H2O (Fig. E3A). Replacement of the four water molecules by Na
+ and subsequent 
refinement results in occupancies of 92 and 94% for the Na+ ions in molecules A and G, 
respectively, and 100% in molecules C and E. Since the crystals used for structure analysis were 
grown in the presence of NaCl [247], these observations indicate that the supposed water 
molecules next to Asp16 of aEF1A are most likely Na+ ions (Fig. 4A and E3C).  
The structure of the aEF1A/aRF1 complex was solved at 2.3 Å resolution and contains one 
copy of GTP-bound aEF1A per asymmetric unit [248]. This structure as well has been built with a 
water molecule in the pentameric coordination sphere described above. Its contact distances lie 
between 2.6 and 3.1 Å (2.7 to 3.0 Å after reevaluation of the experimental data, downloaded from 
the PDB (3VMF)) which are typical for the coordination of a K+ ion [156]. However, the electron 
density in this position does not correspond to K+. This observation is supported by the fact that 
the crystallization condition did not contain K+ but instead 200 mM of NH4
+ ions [248]. NH4
+ has a 
similar ion radius as K+ (1.46 Å and 1.38 Å, respectively) and was shown to substitute for the latter 
structurally and functionally in the K+-dependent GTPase MnmE [231]. Thus, the properties of the 
observed coordination point toward an NH4
+ ion lying in the same position as the K+ and Na+ ions in 
eIF5B⋅GTP and the aEF1A⋅GTP/pelota complex (Fig. 4B and E3D). 
 
The intrinsic GTPase activity of eIF5B depends on monovalent cations  
The position of the observed M+ ion in eIF5B suggests a direct involvement in the catalysis of GTP 
hydrolysis in analogy to MnmE and dynamin. To test this possibility, we monitored the intrinsic 
GTPase activity of either wild-type eIF5B(517-858) or various AspMC mutants (D533A, D533R and 






Figure 4.The GTP-bound EF-Tu ortholog aEF1A coordinates an M+ ion in its GTPase center.A) Overview of 
domains I (G) to III of GTP-bound aEF1A with a Na+ ion (purple sphere) in the active site. P-loop and switch 
regions are shown in yellow. The inset shows a detailed view on the active site with the coordination sphere 
of the Na+ ion (indicated by purple lines) formed by GTP, AspMC and GlyMC in the MC-loop. B) Superposition 
of GTP-bound aEF1A with either a Na+ (purple sphere) or NH4
+ ion (blue sphere) in the active site. Both ions 
are coordinated by the identical sphere, however, with different coordination distances. C) Superposition of 
EF-Tu⋅GDPNP (switch 1 in red; PDB: 1EXM) with EF-Tu⋅GDPNP in the ternary complex (TC) with aa-tRNA 
(blue; PDBs: 1TTT, 1OB2) and aEF1A·GTP·M+ (M+ in blue; switch 1 in yellow). The M+ ion stabilizes a 
conformation of helix A’’ that is required for stable TC formation. D) Dependency of the intrinsic GTPase 
activity of E. coli EF-Tu wild-type (●) or the D21A mutant (○) on the concentration of K+ ions, determined in 
the presence of 0-1 M KCl under single turnover conditions (20 µM GTP-bound EF-Tu) at 30 °C and 
subsequent analysis by HPLC. E) Intrinsic GTPase activity of E. coli EF-Tu determined in the presence of 200 
mM of the indicated salts under single turnover conditions. The order in which the combinations are given 
on the right corresponds to the relative rates of GTP hydrolysis. Experiments were repeated two to three 
times; standard deviations are given by error bars (in some cases not visible because they are smaller than 





First, we tested whether GTPase stimulation in eIF5B depends on the species of the available 
M+ ion (at 200 mM) (Fig. 2C). The experiments revealed that the GTPase activity is stimulated most 
in the presence of Na+ and K+, followed by Rb+, Li+ and finally Cs+ and NH4
+ with the lowest degree 
of activation. Importantly, this dependency was lost for the eIF5B mutant carrying Ala in lieu of 
AspMC. In the presence of 200 mM K+ or Na+, wild-type eIF5B catalyzed GTP hydrolysis at rates of 
0.023 and 0.027 min-1, respectively. The Ala mutant of AspMC exhibited significantly reduced rates 
of 0.0018 min-1 in K+ or Na+, corresponding to a 13- to 15-fold reduction of the intrinsic GTPase 
activity. Similar results were obtained for the substitution of AspMC by Arg (D533R) (Table 3). By 
contrast, an Asn mutant retained the ability to catalyze GTP hydrolysis nearly at wild-type rates 
(Fig. 2D), in line with the assumption that an Asn but not an Ala or Arg residue would retain the 
ability to coordinate the M+ ion. This is corroborated by crystal structures of the respective 
mutants in complex with GTP (or GTPγS), which reveal that D533N contains the M+ ion in its active 
site, whereas the cation is not present in D533R and D533A and exchanged for a water molecule in 
the latter  (Fig. E5). Moreover, fluorescence measurements with mant-labeled GTP show that all 
three mutants bind the nucleotide with a Kd comparable to that of the wild-type protein, speaking 
against the possibility that the observed effects on the GTPase activity are due to reduced affinities 
to the substrate (Fig. E5E-H). 
Next, we studied the effect of increasing Na+/K+ ion concentrations (Fig. 2E/F). In the absence 
of M+ ions (~600 µM Na+ were added with the GTP), eIF5B hydrolyzed GTP with a rate of 0.002 
min-1. This rate successively increased with increasing concentrations of K+ or Na+ ions, resulting in 
an 11- to 12-fold rate enhancement at 200 mM salt (Table 3). By contrast, the rate of GTP 
hydrolysis in the D533A mutant was found to be insensitive to the salt concentration with 
invariably low rates in the absence or presence of M+ ions, whereas D533R exhibited a slightly 
increased GTPase activity in the absence of M+ ions (0.005 min-1), which successively decreased 
with increasing salt concentrations (Fig. 2F). 
 
The intrinsic GTPase activity of EF-Tu depends on monovalent cations  
The GTPase center of bacterial EF-Tu is virtually identical to that of its archaeal ortholog and 





To test the generality of our assumption of M+-dependency in trGTPases, we studied the influence 
of M+ ions on the intrinsic GTPase activity of E. coli EF-Tu by monitoring GTP hydrolysis at different 
K+-concentrations (Fig. 4D). As observed for eIF5B, the rate of GTP hydrolysis successively 
increased with increasing concentrations of K+, corresponding to a nearly 10-fold rate 
enhancement for the intrinsic GTPase reaction at 200 mM (Table 3). This dependency is lost when 
Asp21 (AspMC) in EF-Tu is mutated to Ala (D21A), consistent with a role of AspMC as key ligand for 
the coordination of an M+ ion in EF-Tu at physiological salt concentration as observed for GTP-
bound aEF1A (see above; Fig. 4A/B).   
 









Fold reduction compared 
to wild-type at 200 mM KCl 
cteIF5Ba wt  200 0.023   ± 0.0015  
wt 0 0.0021 ± 0.001 11 
D533A 200 0.0018 ± 0.0005 13 
D533A 0 0.0016 ± 0.0008 14 
D533N 200 0.017   ± 0.002 1.4 
D533R 200 0.0028 ± 0.0007 8 
ecEF-Tub wt  200 0.026   ± 0.0005  
wt  0 0.003   ± 0.0002 9 
D21A  200 0.0035 ± 0.0008 7 
D21A 0 0.0041 ± 0.0001 6 
Measurements were performed two to three times. 
k, rate of GTP hydrolysis under the used experimental conditions. 
a
, Measured under multiple turnover conditions at 35 °C. 
b
, Measured under single turnover conditions at 30 °C. 
 
In order to identify the preferences of EF-Tu for GTPase stimulation, we analyzed the effect 
of different alkali salts (Li+, Na+, K+, Rb+, Cs+) or NH4
+ (each at 200 mM) on the intrinsic hydrolysis 
rates (Fig. 4E). The strongest stimulating effect was observed for NH4
+ and K+. Na+, Li+ and Rb+ ions 
showed only a slight activation; virtually no effect was observed for the large Cs+ ion. Importantly, 
none of the tested M+ ion species show a significant stimulating effect on the D21A mutant of EF-
Tu, which, moreover, shows no preference for NH4







M+-dependent conformational switching of eIF5B  
Elucidation of the structural dynamics – that is the conformational switch – of the G domain in 
response to GDP/GTP exchange and GTP hydrolysis is one of the central problems to understand 
the functional cycle of GTPases. Here we identified a monovalent cation (Na+/K+) as structural 
cofactor in the active site of GTP-bound eIF5B, which stabilizes the GTP-dependent reorganization 
of its G domain (Fig. 1 and 5). The M+ ion is bound in a highly conserved coordination shell formed 
by two non-bridging α- and γ-phosphate oxygens and the β-γ-bridging oxygen of the GTP molecule, 
AspMC in the P-loop and GlyMC in the MC-loop of switch 1. P-loop and GTP molecule thus form a 
stable socket for the M+ ion, which in turn constitutes an anchor point for the reorganized switch 1 
in the ‘on’ state. Structural and thermodynamic data demonstrate that GTPγS is a faithful 
replacement for GTP that coordinates the M+ ion and is thus able to stabilize the GTP-bound ‘on’ 
state of eIF5B (Fig. 1 and E4A). In contrast, replacement of GTP with GDPNP disrupts the 
coordination shell, resulting in the inability of the analog to stabilize the GTP-conformation in eIF5B 
through the M+ ion (Fig. 2A/B and 5A). As a consequence, the equilibrium between ‘on’ state and 
GDP-like ‘off’ state is shifted toward the latter in eIF5B⋅GDPNP allowing the GDPNP-bound factor 
to crystallize in the GDP-conformation, as observed for aIF5B⋅GDPNP from M. 
thermoautotrophicum [84] (Fig. 5A and E4A).  
This interpretation is supported by the parallels between our observations and previous 
reports on M+-dependent GTPases, distantly related to trGTPases. In MnmE an identically 
positioned K+ ion (Fig. 1D) is required for the rearrangement of switch 1 and subsequent 
dimerization [231]. K+-dependent dimerization in MnmE was found to be induced by GTP and 
GTPγS, while GDPNP and GDPCP failed to support the stable switching of the G domain in 
biochemical as well as structural experiments [231, 249]. Similarly, GDPCP was found to be unable 
to induce stable G domain dimerization in dynamin or the conformational switch in EngA GD2, with 
structural changes limited to a shift of switch 2 [232, 246, 250]. Moreover, FeoB was crystallized in 
the presence of GDP-AlFx with switch 1 stabilized in the ‘on’ state by a K
+ ion [245], whereas the 
GDPNP-bound structures either remained in the ‘off’ state (2WIC) or did switch to the ‘on’ state 





findings support the idea that GDPNP and GDPCP are incompatible with the coordination of an M+ 




Figure 5. The mechanism of M+-dependent conformational switching in trGTPases. A) The nucleotide-
dependent conformational switch in the G domain of a/eIF5B. In eIF5B·GDP, switch 1 and 2 are oriented 
away from the nucleotide binding pocket. Upon exchange of GDP for GTP, the switch regions undergo a 
large conformational rearrangement that results in direct contacts with the γ-phosphate. Here, the M+ ion 
(blue sphere) provides a direct contribution to the stabilization of switch 1 (inset). This contribution is 
missing in aIF5B·GDPNP (PDB: 1G7T), allowing it to crystallize in the GDP-like ‘off’ state conformation. 






Based on the presented data, we propose an M+-dependent conformational switch 
mechanism for eIF5B in solution (Fig. 5) similar to that in MnmE [231], where the M+ ion in tandem 
with Mg2+ acts as structural cofactor that supports binding of the GTP molecule and helps to 
reorganize and close the active site around the substrate. The M+ ion would thus form a 
constitutive component in the preorganized active site, required to stabilize the ‘on’ state 
conformation of the trGTPase for productive interactions with the ribosome. 
 
Universality of M+-dependent conformational switching among trGTPases  
Like for eIF5B, the mechanism of nucleotide-dependent conformational switching has remained 
obscure for most other trGTPases. Crystal structures of isolated EF-G and eRF3 reveal essentially 
identical conformations for their respective apo, GDP- and GDPNP-bound forms [216, 217] (Fig. 
E4). In SelB, the canonical GDPNP-induced structural rearrangements are limited to switch 2, while 
switch 1 is only partially reorganized and remains mainly flexible [218] (Fig. E4C). In the crystal 
structure, GDPNP is bound by SelB in the canonical way and provides the Mg2+ ion as well as its 
coordinating water molecules that usually contribute to the association of switch 1. However, 
although Thr46 (Thr557 in cteIF5B) interacts with Mg2+ in the canonical way, the preceding 
residues starting with Ile45 and Gly44 (GlyMC in cteIF5B) remain flexible together with the rest of 
switch 1 [218]. This observation cannot be explained by the loss of the hydrogen bond between 
the β-γ-bridging atom of the nucleotide and the backbone NH of the P-loop, but can be readily 
explained by the loss of the M+ ion as structural cofactor, required to stabilize Gly44 (GlyMC) and 
thereby the rest of switch 1 in the ‘on’ state. This is corroborated by ITC experiments with SelB, 
showing that GDP and GDPNP binding result in similar structures for SelB⋅GDP and SelB⋅GDPNP, 
whereas GTP and GTPγS induce substantial structural rearrangements [183]. Similarly, ITC 
experiments with EF-G indicate large differences between the GTP-bound and apo conformation 
[219]. In both cases, these results were interpreted as the GTP-induced burial of surface areas by 
switch 1 and 2 that, however, do not become apparent from the crystal structures.  
The parallels to the observations discussed above for a/eIF5B are obvious. It is moreover 
evident from sequence comparison that nearly all trGTPases, including EF-Tu, EF-G, SelB, and eRF3 





shell for the M+ ion (Fig. 3). The loss of the M+ ion as structural cofactor between nucleotide and 
switch 1 due to the use of GDPNP or GDPCP therefore provides a general explanation for the 
observations for EF-G, SelB and eRF3, as well as other previously reported discrepancies in the 
behavior of trGTPases toward GTP or its nonhydrolyzable analogs [166, 183, 221-224]. The 
common evolutionary origin of trGTPases and their functional homology during the translation 
process argue in favor of a systematic origin rather than individual reasons why GDPNP and GDPCP 
but not GTPγS are generally unable to substitute for GTP. In light of the above presented 
observations, we therefore propose that with few exceptions (eIF2γ) trGTPases utilize M+ ions as 
structural cofactor and that the mechanism of M+-dependent conformational switching as 
suggested for eIF5B (Fig. 5B) is universal among canonical trGTPases. 
This proposed commonality of M+-dependency is corroborated by the example of elongation 
factor Tu (EF-Tu). In line with our prediction on the basis of sequence and structural homology to 
eIF5B, we found that the active site of the archaeal EF-Tu ortholog aEF1A bound to GTP as well 
contains an M+ ion (Na+/NH4
+), bound by an identical coordination shell as observed for eIF5B⋅GTP 
(Fig. 4 and E3). Likewise, M+ ion binding was demonstrated for free EF-Tu by the finding that its 
intrinsic GTPase activity is accelerated by M+ ions in a manner dependent on Asp21 (AspMC), in line 
with its role as key ligand for M+ ion coordination (Fig. 4D/E). The usage of M+ ions as structural 
cofactor in EF-Tu provides a simple explanation why ternary complexes (TC) of EF-Tu with aa-tRNA 
formed in the presence of GDPNP exhibit decreased stability compared to those formed with GTP 
[166, 224] due to the loss of the M+-dependent allosteric stabilization of the GTP-conformation 
required for aa-tRNA binding. This is highlighted by the comparison of EF-Tu⋅GDPNP with the 
structures of EF-Tu⋅GDPNP⋅aa-tRNA complexes and aEF1A⋅GTP, which indicates that the M+ ion 
specifically stabilizes a conformation of switch 1 in which helix A’’ is drawn toward the GTP 
molecule, which seems necessary for stable TC formation (Fig. 4C). Hence, in the absence of the M+ 
ion, the aa-tRNA itself has to overcome the entropic penalty to arrange switch 1 in the correct 







The M+ ion as catalytic element in the GTPase reaction of trGTPases 
Apart from the GTP-induced conformational switch, the mechanism of GTP hydrolysis is another 
unresolved problem in the universal functional cycle of trGTPases. Although it has been established 
that the precise ribosome-induced positioning of the invariant Hiscat from the inactive ground state 
to the catalytically active conformation is critical for GTP hydrolysis [168], it remained obscure how 
the ribosome-bound trGTPase stabilizes the transition state (TS) of the hydrolysis reaction in the 
absence of an arginine-finger.  
As demonstrated above, trGTPases coordinate an M+ ion next to the GTP-γ-phosphate in a 
conserved coordination shell, where it forms a structurally relevant component of the catalytic 
center (Fig. 1 and 4). The M+ ion thus adds another positive charge to the preorganized active site 
of trGTPases that together with the invariant lysine of the P-loop and the Mg2+ ion forms a triangle 
of positively charged moieties around the β-γ-bridging oxygen of the GTP molecule (Fig. 6A). 
Following the ribosome-induced activation of Hiscat (which leaves the coordination shell for the M+ 
ion intact (Fig. 3B) [168]), the M+ ion would thus be in a suitable position to neutralize negative 
charges of the TS in the γ-phosphate as well as the designated leaving group (GDP) (Fig. 6A/B). This 
suggests that the M+ ion might function as the so far elusive catalytic element in trGTPases that 
acts in the second step of the ribosome-dependent GTPase reaction and contributes to rapid GTP 
hydrolysis by providing electrostatic stabilization for the TS, in analogy to the arginine-finger in the 
Ras-RasGAP system (Fig. 6) or the M+ ion in MnmE (Fig. 1D).  
Structurally, this role for the M+ ion in trGTPases is supported by the superposition of GTP-
bound eIF5B and aEF1A with MnmE, dynamin or the Ras-RasGAP complex where the catalytic M+ 
ions and the guanidino group are located in virtually identical positions (Fig. 1D, 6C and E1E) [106, 
231, 232]. For AspMC this indicates a role of vital importance in the universal functional cycle of 
trGTPases as key ligand for the M+ ion that provides an explanation for its invariant conservation 
(Fig. 3A). Consistently, we found that the loss of AspMC in the D533A mutant results in M+-
independency of the intrinsic GTPase activity in eIF5B, whereas the M+-dependency of the wild-
type protein is retained in the D533N mutant. The marked effect of AspMC mutations in eIF5B, 
which directly correlates with the ability of the substituted residue to coordinate M+ ions, clearly 






Figure 6. The M+ ion as catalytic element in the GTP hydrolysis reaction.A) Model of aEF1A·GTP·M+ on the 
ribosome (the sarcin-ricin loop (SRL) is shown as green sticks), based on a superposition with ribosome-
bound EF-Tu (grey; PDB: 2XQD). Upon productive interactions with the SRL, the imidazole moiety of Hiscat is 
reoriented from its inactive ground state (purple) to the active position (yellow) in which it forms a 
hydrogen bond to Wcat[168]. The invariant P-loop lysine, the Mg2+ ion (light brown sphere) and the M+ ion 
(blue sphere) form a triangle of positively charged moieties around the β-γ-bridging oxygen. The M+ ion is 
thus suitably positioned to stabilize negative charges that develop in the TS of the hydrolysis reaction. B) 
Schematic presentation of the active site of a ribosome-bound trGTPase with GTP in the transition state of 
the hydrolysis reaction stabilized by the M+ ion (blue). TrGTPase and ribosome are colored in purple and 
green, respectively; negative charges, the P-loop lysine and the Mg2+ ion are omitted for clarity. For 
simplicity, Hiscat is shown in its neutral form, although it might be double protonated in its activated state 
[226-229]. C and D) The M+ ion in eIF5B and aEF1A (purple) is coordinated in a position analogous to the 
arginine-finger in the complex of Ras (grey) and RasGAP (green) (Fig. B and D are modified from [25, 233]). 
 
Further evidence is provided by experiments with bacterial EF-Tu. In agreement with earlier 
observations from Parmeggiani and coworkers [244] we found the intrinsic GTPase activity of EF-Tu 
to depend on the concentration as well as the species of M+ ions, with a preference for K+ and NH4
+ 





dependency in the D21A (AspMC) mutant argues for a direct effect on GTP hydrolysis. Moreover, 
kinetic experiments indicated that mutations of Asp21 in E. coli EF-Tu result in a significant 
reduction of the GTPase activity in the EF-Tu·GTP·aa-tRNA complex in the presence of the correct 
codon on the ribosome (C. Maracci and M.V. Rodnina, personal communication). This observation 
as well is consistent with a role of AspMC as key ligand for a catalytic M+ ion in EF-Tu, involved in 
ribosome-dependent GTP hydrolysis. Moreover, the ribosome-dependent GTPase activity of EF-Tu, 
EF-G as well as IF2 was reported to depend on M+ ions [149, 243, 244]. However, in all these cases 
the GTPase activity reaches maximum values between 20 and 100 mM M+ ions, most likely 
reflecting compensating effects of the salt concentration e.g. on the stability and/or conformation 
of the ribosomal complexes and their interactions with trGTPases [251] that necessarily obscure a 
direct effect of M+ ions on the GTPase reaction. Importantly, similar observations are known from 
dynamins, where the stimulating effect of M+ ions on GTP hydrolysis is compensated at increasing 
salt concentrations due to an inhibition of oligomerization and consequently dimerization-
dependent GTPase activation [246, 252, 253]. 
The question, whether trGTPases are specific for K+ ions under physiological conditions 
cannot be unambiguously answered at present. The structural and biochemical analyses indicate 
that eIF5B and EF-Tu/aEF1A have slightly different specificities in their usage of M+ ions in vitro. 
However, given the general preference of the translation apparatus for K+ or ions with similar ionic 
radii [149, 241-244], the similarly strong stimulation of the GTPase activity in eIF5B and EF-Tu by 
K+, and the usually high cellular K+/Na+ ratio, we assume that K+ is preferred by trGTPases under 
physiological conditions. 
An interesting case that provides further indirect evidence for M+-dependency among 
trGTPases is the γ-subunit of eukaryal initiation factor 2 (eIF2γ). Notably, eIF2γ is the only trGTPase 
for which a specific GAP (eIF5) has been identified that was reported to provide an arginine-finger 
as catalytic element to promote GTP hydrolysis in eIF2 [53, 254]. The coordination sphere for the 
M+ ion would therefore not be required in eIF2γ. Consistently, eIF2γ is the only trGTPase that 
contains neither an AspMC nor GlyMC (Fig. 3A). Instead, AspMC is replaced by Ala, which might be 





M+ ion. Importantly, the archaeal ortholog, aIF2γ, contains AspMC and GlyMC and no GAP is known 
indicating that aIF2γ in contrast to eIF2γ may be M+-dependent.   
 
Implications for the evolution of trGTPases 
At the center of this work stands the conclusion that trGTPases belong to the group of M+-
dependent G proteins. This establishes trGTPases as a functionally distinct subfamily among 
GTPases in which the ribosome, as an RGS-like GAP, stabilizes the active conformation of the 
catalytic machinery of the GTPase [168] which includes an M+ ion as an additional trans-acting 
catalytic element, constitutively bound in the active site. Conceptually, this places trGTPases 
between the classical GAP- or RGS-activated GTPases and GTPases activated by homodimerization 
(GADs) (e.g. MnmE and dynamin), which, like trGTPases, directly couple the GTPase reaction to 
their biological function in the cell [230].  
The proposed universality of M+-dependency among canonical trGTPases is particularly 
interesting from the evolutionary perspective, as it points toward a common origin in an ancestral 
M+-dependent trGTPase. At the same time, usage of M+ ions as structural and catalytic cofactor 
constitutes a functional link to other known M+-dependent GTPases that – like trGTPases – usually 
belong to particularly ancient lineages of the TRAFAC class, associated with basic cellular functions 
such as tRNA modification or ribosome assembly [22, 255]. It is therefore conceivable that M+-
dependency might represent the primordial form of catalysis of GTP hydrolysis in GTPases of the 
TRAFAC class that antedates the convergent occurrence of arginine-finger-dependent catalysis.  
 
7.4 Materials and Methods 
Protein purification, crystallization and structure determination 
C. thermophilum eIF5B constructs containing residues 517-858 (cteIF5B(517-858)) were purified as 
previously described [220]. E. coli EF-Tu was prepared essentially as described in [256]. E. coli EF-Ts 
was prepared using standard procedures (see Expanded View for details). 
Crystallization trials were performed by sitting-drop vapor diffusion method using either  
self-made optimization screens for the original crystallization condition for cteIF5B⋅GTP (0.1 M 





Mg2+ and varying concentrations of guanine nucleotides. Crystals of cteIF5B(517-858)⋅GTP used for 
structure determination grew over night at 20 °C in 100 mM HEPES (pH 7.25), 12% PEG 4000 and 
100 mM NaOAc with 10 mg/ml of protein in the presence of 2 mM GTP. Crystals of cteIF5B(517-
858) bound to GTPγS grew over night at 20 °C under similar conditions (100 mM HEPES (pH 7), 13% 
PEG 4000 and 125 mM NaOAc) with 12 mg/ml protein and 2 mM GTPγS. The crystals for both 
proteins grew in space group P21.  
Crystals of cteIF5B(517-858)·GTPγS with a potassium ion bound in the active site were 
obtained after two weeks at 20 °C in 11% PEG 8000, 6% glycerol, and 50 mM KCl. The best 
diffracting crystals grew when using 10 mg/ml protein in the presence of 2 mM GTPγS. The crystals 
grew in space group P41212. 
Crystals of the AspMC mutant cteIF5B(517-858)D533N were obtained with 8 mg/ml protein 
and 3 mM GTP at 20 °C in a condition containing 100 mM HEPES (pH 7), 13% PEG 4000 and 125 
mM NaOAc. As for the wild-type protein crystals that were obtained under similar conditions, the 
crystals of cteIF5B(517-858)D533N belonged to space group P21. Initially, no crystals were obtained 
for the mutants D533A and D533R. However, high-quality crystals for both mutants could finally be 
obtained by repeated microseeding experiments (see Expanded View for details).  Crystals of 
cteIF5B(517-858)D533A (with 15 mg/ml protein and 6 mM GTPγS) grew in space group P21 in a 
condition containing 0.1 M HEPES/NaOH (pH 7.3), 15% PEG 4000, and 150 mM NaOAc. Crystals of 
cteIF5B(517-858)D533R (with 15 mg/ml protein and 4 mM GTPγS) grew in space group P41212 in a 
condition containing 100 mM MES (pH 6.7), 13% PEG 8000, 225 mM NaOAc. 
X-ray diffraction data were collected using synchrotron radiation. For all structures, the 
phase problem was solved by molecular replacement using the program PHASER [115]. Structures 
were refined to reasonable R-values and stereochemistry using the program PHENIX [117]. Data 
collection and refinement statistics for the structures of wild-type eIF5B(517-858) and for the three 
AspMC mutants are summarized in Tables 1 and E2, respectively. See Expanded View for details. 
 
Isothermal Titration Calorimetry 
The thermodynamic parameters of eIF5B binding to GDP or GDPNP were measured using a 





[220] in ITC buffer (30 mM HEPES/KOH (pH 7.5), 100 mM KCl, 10% glycerol, 4 mM β-
mercaptoethanol, 0.01% tween 20, 2.5 mM MgCl2) at different temperatures (10, 15, 20, 25 or 
30°C). 14-µl aliquots of 200-400 µM ligand were injected into the 1.42 ml cell containing 10-30 µM 
cteIF5B(517-858). The heat of dilution was measured by injecting the ligand into the buffer 
solution without protein; the values were then subtracted from the heat of the individual binding 
reactions to obtain the effective heat of binding. The final titration curves were fitted using the 
‘Origin’ based MicroCal software, assuming one binding site per protein molecule. For each 
isotherm the binding stoichiometry (N), enthalpy changes (∆H) and the association constants (Ka), 
were obtained by a nonlinear regression fitting procedure. These directly measured values were 
used to estimate the Gibbs energy (∆G) from the relation ∆G = - R⋅T⋅lnKa and the entropy changes 
(∆S) through ∆G = ∆H – T⋅∆S. 
In order to estimate the change in heat capacity (∆Cp) upon complex formation between 
eIF5B and guanine nucleotides, the measured ∆H values were plotted against the temperature, 
where the slope of the fitted line directly represents the ∆Cp of the binding reaction [178, 179]. See 
Expanded View for details about the correlation between ∆Cp and the change in solvent accessible 
surface area (ΔASA). 
 
Analysis of the GTPase reaction of eIF5B and EF-Tu by HPLC 
The intrinsic GTP hydrolysis of C. thermophilumeIF5B(517-858) and E. coli EF-Tu was analyzed by 
HPLC (GE Healthcare). Nucleotides were separated on a NUCLEOSIL 4000 PEI (Macherey Nagel) in 
10 mM Tris/HCl (pH 8.0) with a linear gradient from 0-1 M NaCl. For EF-Tu, the reactions were 
followed under single-turnover conditions, for which 25 µM EF-Tu⋅GTP was incubated at 30 °C in 
25 mM Tris/HCl (pH 7.5), 7 mM MgCl2, 2 mM DTT and alkali salts at different concentrations. At 
various time points, 50 µl aliquots were taken and incubated at 96 °C for 2 min to stop the 
reaction. Denatured protein was removed by centrifugation and the supernatant applied to the 
HPLC.  
For eIF5B, the reactions were followed under multiple-turnover conditions, for which 25 µM 





MgCl2, 2 mM DTT and alkali salts at different concentrations. 50 µl aliquots were taken at various 
time points and treated as described above. 
 
Multiple sequence alignments 
Multiple sequence alignments were done using the iterative alignment program MUSCLE [214]. 
 
Coordinates 
Coordinates and structure factors have been deposited in the PDB: 4TMW(ct5B(517-858)·GTP·Na+); 
4TMV (ct5B(517-858)·GTPγS·Na+); 4TMZ (ct5B(517-858)·GTPγS·K+); 4TMT (ct5B(517-
858)D533A·GTPγS); 4TMX (ct5B(517-858)D533N·GTP·Na+); 4TN1 (ct5B(517-858)D533R·GTPγS). 
 
Expanded View 
Expanded View information is available at The EMBO Journal Online and includes six figures, two 
tables and extended Materials and Methods. 
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7.5 Expanded View 
Expanded View Materials and Methods 
Protein purification  
The purification of Chaetomium thermophilum eIF5B(517-858) was done as previously described 
[220]. The plasmid for the expression of N-terminally His-taggedcteIF5B(517-858) (comprising G 
domain and domain II) was transformed into E. coli BL21(DE3) cells (Stratagene) by heat shock. 
Transformed cells were grown in 1 l cultures of 2YT medium at 37 °C to an OD600 of 0.6-0.8, 
followed by the induction of protein expression with 0.5 mM isopropyl-β-D-thiogalactopyranoside 
(IPTG). Cells were grown for an additional 18 h at 16 °C before harvesting. Harvested cells were 
resuspended in buffer A (40 mM HEPES/KOH (pH 7.5), 500 mM KCl, 10% glycerol, 30 mM 
imidazole, 2 mM β-mercaptoethanol), lysed using a Microfluidizer (Microfluidics) and clarified by 
30 min ultracentrifugation at 30,000 xg. The supernatant was loaded onto two HisTrap columns 
(GE Healthcare), equilibrated in buffer A. After the elution of bound proteins with a linear gradient 
of imidazole (30-300 mM), eIF5B-containing fractions were pooled and desalted in buffer B (20 mM 
HEPES/KOH (pH 7.5), 200 mM KCl, 10% glycerol, 30 mM imidazole and 2 mM β-mercaptoethanol) 
for subsequent TEV-protease cleavage at 4 °C over night to remove the His-Tag. Uncleaved protein 
was removed by a second HisTrap in buffer B and the flow-through was pooled and concentrated 
for the final size exclusion chromatography step on a Superdex 200 column (GE Healthcare), 
equilibrated in buffer C (10 mM HEPES/KOH (pH 7.5), 50 mM KCl, 3 mM MgCl2 and 1 mM DTT). The 
absence of copurified guanine nucleotides was confirmed by HPLC. The purified apo eIF5B was 
pooled, concentrated to 15-20 mg/ml, and finally stored at -80 °C. 
Mutant constructs of cteIF5B, in which Asp533 (AspMC) was substituted by alanine (D533A), 
asparagine (D533N) or arginine (D533R), respectively, were generated by site-directed 
mutagenesis according to the QuikChange protocol (Stratagene, Instruction Manual, 2006). All 
mutants were expressed and purified according to the above described protocol for wild-type 
cteIF5B(517-858) [220].  
For ITC experiments cteIF5B(517-858) was purified according to the above protocol with the 
difference that ITC buffer (30 mM HEPES/KOH (pH 7.5), 100 mM KCl, 10% glycerol, 4 mM β-
mercaptoethanol, 0.01% tween 20, 2.5 mM MgCl2) was used in the final gelfiltration step. 
For GTPase activity assays under different salt conditions, purified cteIF5B(517-858) (wild-type or 
mutant) was desalted in the desired buffer (Tris/HCl (pH 7.5), 3 mM MgCl2, 2 mM DTT and alkali 
salts at different concentrations) prior to the experiment (see below). 
E. coli EF-Ts was expressed with an N-terminal His-tag in E. coliBL21(DE3)pLysS cells (Stratagene). 
Transformed cells were grown in 1 l cultures of LB medium at 37 °C to an OD600 of ~0.8, followed by 
the induction of protein expression with 0.5 mM IPTG. Cells were grown for an additional 4 h at 37 
°C before harvesting. Purification of EF-Ts (including the removal of the His-tag) was performed 





Superdex 75 column (GE Healthcare), equilibrated in a buffer containing 25 mM Tris (pH 7.5), 30 
mM KCl, 70 mM NH4Cl and 7 mM MgCl2, was used in the final size exclusion chromatography step. 
Purified protein was flash-frozen in liquid nitrogen and stored at -80 °C. 
E. coli EF-Tu was prepared essentially as described previously [256]. The final gelfiltration buffer 
contained 20 mM Tris/HCl (pH 7.5), 50 mM KCl, 7 mM MgCl2 and 2 mM DTT. GTP-bound EF-Tu was 
prepared by incubating 100 µM purified EF-Tu with 3 mM GTP, 3 mM phosphoenolpyruvate 
(Roche), 0.05 mg/ml pyruvate kinase (Roche) and 0.04 µM EF-Ts for 1 h at 37 °C. To remove excess 
GTP and phosphoenolpyruvate, GTP-bound EF-Tu was desalted on a HiTrap Desalting column (GE 
Healthcare) at 4 °C in the desired buffer (25 mM Tris/HCl (pH 7.5 at 25 °C), 7 mM MgCl2, 2 mM DTT 
and alkali salts at different concentrations).   
 
Crystallization and structure determination 
The first crystallization trials with cteIF5B(517-858) were performed in an optimization screen for 
the condition under which the original crystals of GTP-bound cteIF5B(517-860) had been obtained 
using a fragment comprising residues 517-970 (0.1 M HEPES/NaOH (pH 7); 13% PEG 4000; 0.1 M 
NaOAc) [220]. 8, 10 or 12 mg/ml of protein were mixed with GTP, GTPγS or GDPNP at final 
concentrations of 1, 2 or 3 mM (up to 10 mM for GDPNP in the presence of 10 mM MgCl2) of the 
respective guanine nucleotides. Crystallization was performed at 4 and 20 °C by vapor diffusion 
using a 1:1 or 2:1 ratio of protein to reservoir solution. For cteIF5B(517-858)⋅GDPNP no crystals 
were obtained under any of the tested conditions. Crystals of cteIF5B(517-858)⋅GTP and 
cteIF5B(517-858)⋅GTPγS grew over night in most conditions, irrespective of the temperature or 
used guanine nucleotide concentration. In both cases the best diffracting crystals that were finally 
used for structure determination grew at 20 °C in primitive monoclinic space group P21. 
To find a crystallization condition for cteIF5B(517-858) in the presence of potassium, crystallization 
trials with 10 mg/ml protein were performed in the presence of 2 mM GTPγS using standard 
screens. Diffraction quality crystals were obtained after two weeks at 20 °C in a condition 
containing 11% PEG 8000, 6% glycerol, and 50 mM KCl. The crystals used for structure 
determination grew in space group P41212 and contained two protein-GTPγS complexes per 
asymmetric unit. 
Initial crystallization trials for the AspMC mutants of cteIF5B(517-858) (D533A, D533N and D533R) 
were performed with 8 mg/ml protein in the presence of 3 mM GTP or GTPγS using fine-screens 
around the two conditions described above. Only for the D533N mutant high quality crystals in 
space group P21 grew over night that could be directly used to determine the structure of 
cteIF5B(517-858)D533N bound to GTP and a Na+ ion. No crystals were initially obtained for the 
other mutants D533A and D533R. We then performed microseeding experiments for both 
mutants, in which crystals of the wild-type protein were destroyed and used as crystallization 
nuclei to induce crystallization. At protein concentrations of 15 mg/ml and 6 mM guanine 





0.1 M HEPES/NaOH (pH 7.3), 15% PEG 4000, and 150 mM NaOAc. These were then used in an 
additional round of microseeding, finally yielding large enough crystals for structure determination. 
As the wild-type protein, the D533A mutant crystallized in space group P21 and the structure was 
finally solved at a resolution of 1.58 Å. In contrast to D533A, no crystals were obtained for D533R 
in the initial microseeding experiments but only small spherolite-like aggregates which could not 
be used as seeds. We therefore performed new crystallization trials for the D533R mutant in 
various commercially available grid screens, in combination with microseeding. This yielded thin, 
plate-shaped crystals in a condition containing 100 mM MES (pH 6.5), 11% PEG 8000, and 150 mM 
NaOAc. Using these crystals as microseeds in an optimized screen, we were finally able to obtain 
cteIF5B(517-858)D533R crystals in the presence of GTPγS suited for structure determination. 
Despite the fact that the D533R mutant crystals were obtained in the presence of Na+ ions, they 
grew in space group P41212 as did those obtained in the presence of K
+. The structure of 
cteIF5B(517-858)D533R could finally be solved at a resolution of 2.75 Å. 
Based on the observations for the cteIF5B mutants, additional crystallization trials were performed 
with wild-type cteIF5B(517-858) in the presence of GDPNP and microseeds. In the fine-screens, 
microseeding resulted in the formation of large spherolytes, which, however, did not yield any 
crystals when used as seeds themselves. 
For the structures of wild-type cteIF5B(517-858) bound to GTP or GTPγS and Na+, X-ray diffraction 
data were collected at P13 beamline at PETRA III (EMBL, Hamburg). For the structures of wild-type 
cteIF5B(517-858) bound to GTPγS and K+ and all AspMC mutants, X-ray diffraction data used for 
structure determination were collected at beamline ID23-1 at ESRF (Grenoble). For all structures, 
the phase problem was solved by molecular replacement using the program PHASER [115] with the 
original structure of cteIF5B⋅GTP as search model. Structures were refined to reasonable R-values 
and stereochemistry using the program PHENIX [117]. Data collection and refinement statistics are 
summarized in Table 1 and Table E2. 
Structure factors and coordinates for the two aEF1A structures were obtained from the protein 
data bank (PDB: 3AGJ, 3VMF). The structures were refined using the program PHENIX [117]. 
Manual model rebuilding was performed against electron density maps in Coot [116]. Figures were 
prepared using Pymol (http://www.pymol.org). 
 
Isothermal Titration Calorimetry 
The thermodynamic parameters of eIF5B binding to GDP or GDPNP were measured using a 
MicroCal VP-ITC instrument (GE Healthcare). Experiments were carried out as previously described 
[220] in ITC buffer at different temperatures (10, 15, 20, 25 or 30°C). 14-µl aliquots of 200-400 µM 
ligand were injected into the 1.42 ml cell containing 10-30 µM cteIF5B(517-858). The heat of 
dilution was measured by injecting the ligand into the buffer solution without protein; the values 
were then subtracted from the heat of the individual binding reactions to obtain the effective heat 





assuming one binding site per protein molecule. For each isotherm the binding stoichiometry (N), 
enthalpy changes (∆H) and the association constants (Ka), were obtained by a nonlinear regression 
fitting procedure. These directly measured values were used to estimate the Gibbs energy (∆G) 
from the relation ∆G = - R⋅T⋅lnKa and the entropy changes (∆S) through ∆G = ∆H – T⋅∆S. 
In order to estimate the change in heat capacity (∆Cp) upon complex formation, the measured ∆H 
values were plotted against the temperature [178, 179]. The slope of the fitted line directly 
represents the ∆Cp of the binding reaction. ∆Cp can be used as an estimate for the change in 
solvent accessible surface area (∆ASA) upon complex formation as it was found to be proportional 
to the size of the area which is either exposed to (associated with a positive value for ∆Cp) or 
removed from (negative value for ∆Cp) the aqueous environment during the binding event [177, 
180-182]. ∆Cp and ∆ASA are connected by the empirically determined relation ∆Cp = ∆cap ⋅ ∆ASAap + 
∆cp ⋅ ∆ASAp where ∆cap (0.45) and ∆cp (-0.26) are the area coefficients in cal⋅K
-1⋅(mol⋅Å2)-1  for the 
contributions of apolar or polar side chains to ∆ASA, respectively [177, 182, 184]. As previously 
described [220], we use two values for the area coefficients to estimate the change in surface area 
upon ligand binding: ∆cmax = 0.24 (= 0.7⋅∆cap + 0.3 ⋅ ∆cp) as the upper limit case and ∆cmin = 0.45 as 
the lower limit case in which all involved residues are apolar. 
 
Analysis of the GTPase reaction of eIF5B and EF-Tu by HPLC 
The intrinsic GTP hydrolysis of C. thermophilumeIF5B(517-858) and E. coli EF-Tu was analyzed by 
HPLC (GE Healthcare). Nucleotides were separated on a NUCLEOSIL 4000 PEI (Macherey Nagel) in 
10 mM Tris/HCl (pH 8.0) with a linear gradient from 0-1 M NaCl. For EF-Tu, the reactions were 
followed under single-turnover conditions, for which 25 µM EF-Tu⋅GTP was incubated at 30 °C in 
25 mM Tris/HCl (pH 7.5), 7 mM MgCl2, 2 mM DTT and alkali salts at different concentrations. At 
various time points, 50 µl aliquots were taken and incubated at 96 °C for 2 min to stop the 
reaction. Denatured protein was removed by centrifugation and the supernatant applied to the 
HPLC.  
For eIF5B, the reactions were followed under multiple-turnover conditions, for which 25 µM 
nucleotide-free eIF5B was incubated with 300 µM GTP at 35 °C in 25 mM Tris/HCl (pH 7.5), 3 mM 
MgCl2, 2 mM DTT and alkali salts at different concentrations. 50 µl aliquots were taken at various 
time points and treated as described above.    
 
Steady-state fluorescence measurements 
Fluorescence measurements were carried out on a Fluoromax-3 spectrophotometer (Jobin Yvon 
Inc.) using a 1 ml quartz cuvette with magnet stirrer. Titrations of eIF5B constructs with mant-GTP 
were performed at 20 °C in buffer containing 25 mM Tris/HCl (pH 7.5), 200 mM KCl, 3 mM MgCl2 
and 2 mM DTT. Binding of mant-GTP to eIF5B constructs was monitored by tryptophan Foerster 
Resonance Energy Transfer (FRET) using an excitation wavelength of 290 nm and an emission 





eIF5B constructs and mant-GTP, 2 µM of the protein was titrated with increasing amounts of the 
mant-nucleotide (dilution was less than 1%). The resulting signal was corrected for the contribution 
of unbound nucleotide by titrating mant-GTP into buffer and subsequently subtracting these 
values from the signals obtained with protein. The titration data were analyzed using a quadratic 
binding model:  
          
(      )  √(      )     
  
 
whereF is the fluorescence signal of the mant-nucleotide in the presence of eIF5B, F0is the initial 
fluorescence signal, ΔFmax is the maximum fluorescence signal, X is the total concentration of eIF5B, 










Figure E1. The GTPase center of eIF5B bound to GTP or GTPγS. A-C)Fo-Fc omit maps for GTP and Na
+ (A), 
GTPγS and Na+ (B) or GTPγS and K+ (C) bound to eIF5B (contoured at 3𝜎). P-loop, switch 1 and switch 2 are 
colored in cyan. The electron density maps for GTPγS clearly indicate that the sulfur atom of the γ-
phosphate is oriented outward and interacts with the respective M+ ion. D) Overview of the active site of 
eIF5B bound to GTPγS and Na+ (purple sphere). The pentameric coordination sphere is indicated by purple 
lines. GTP, AspMC, GlyMC and Hiscat are shown as balls and sticks; P-loop, switch 1 and switch 2 are colored in 
cyan; the Mg2+ ion and water molecules are shown as spheres in light brown and grey, respectively. E) 
Superposition of eIF5B·GTP·Na+ (coloring as in D) and dynamin (brown) bound to GDP, AlF4 and Na
+ (PDB: 
2X2E). The M+ ions are coordinated by both proteins in nearly identical positions, despite differences in the 
ligands forming the coordination shell: AspMC is replaced by a Ser residue and two backbone oxygens from 









Figure E2. A-C) Titration curves (upper panels) and binding isotherms (lower panels) of eIF5B(517-858) 


















Figure E3.Analysis of M+ ion coordination in structures of GTP-bound aEF1A.A) 2mFo-DFc map (blue mesh) 
and mFo-DFc difference map (green mesh) for GTP and its surrounding in aEF1A molecule E of the 
aEF1A/Pelota complex (PDB: 3AGJ) (contoured at 3σ). The coloring is the same as in Fig. 4. In the original 
structure a water molecule is modeled into the pentameric coordination sphere between AspMC and GlyMC 
and the phosphates of the GTP molecule with coordination distances of ∼2.45 Å. Despite its solvent 
exposed position, the electron density for this water molecule is significantly stronger than that for the 
catalytic water (Wcat) or the water molecules coordinating the Mg2+ ion in the center of the active site. The 
positive difference electron density for the supposed water molecule (green mesh) indicates a higher 
density of electrons in this position than provided by H2O. B) The GTPase center in EF-Tu in its GDPNP 
conformation is virtually identical to that of aEF1A⋅GTP. With the exception of the β-γ-bridging oxygen of 
GTP EF-Tu⋅GDPNP provides all structural elements that are involved in M+ coordination in the archaeal 
ortholog. The M+ ion is indicated as semi-transparent blue sphere. Some universally conserved residues 
involved in GTP/GDPNP binding or GTP hydrolysis are shown as sticks. C and D)Fo-Fc omit maps for GTP and 
Na+ (C), or GTP and NH4
+ (D) bound to aEF1A (contoured at 3σ). P-loop and switch regions are colored 







Figure E4.GDPNP and GDPCP prevent the coordination of the M+ ion, which results in their inability to 
stably induce the conformational switch in trGTPases.A) Detailed view on the nucleotide binding pocket in 
a superposition of eIF5B⋅GTP (P-loop and switch regions in cyan) and aIF5B⋅GDPNP (P-loop and switch 
regions in yellow). GDPNP provides the γ-phosphate oxygens, the Mg2+ ion (light brown sphere) and its 
water ligands (red sphere; W1) in the identical positions as GTP for interactions with switch 2 and the stable 
association of switch 1 through Glu552 and Thr557 (C. thermophilum numbering). However, in contrast to 
the GTP-structure switch 1 and switch 2 remain in their GDP-like conformation in GDPNP-bound aIF5B and 
the position of Thr39 (corresponding to Thr557) is instead occupied by an additional water molecule (red 
sphere; W2). The only significant difference between GTP and GDPNP is the inability of the latter to 
coordinate the M+ ion (purple sphere), resulting in the loss of its contribution as structural cofactor to 
stabilize the GTP-conformation of switch 1 through the interaction with GlyMC (purple dashed line). (It is 
important to note that in the originally downloaded structure file for aIF5B⋅GDPNP (PDB: 1G7T), W1 (red 
sphere) is interpreted as the Mg2+ ion, whereas a water (number 844) was modeled in the position which is 
here indicated as Mg2+ ion (light brown sphere). Our reinterpretation is based on the coordination geometry 





for water 844 and between 2.6 and 3.4 Å for the supposed Mg2+ ion). This reinterpretation is consistent with 
previously reported values for the coordination of Mg2+ ions [257]. As the structure factors are not 
deposited in the PDB, we were unable to examine whether our reinterpretation is consistent with the 
experimental data). B) Surface presentation of the G domain in free EF-G⋅GDPCP (PDB: 2J7K). As for 
aIF5B⋅GDPNP, switch 1 (orange) and switch 2 (blue) remain in their ‘off’ state conformation despite the 
presence of the GTP analog. Like in the case of GDPNP, the coordination of the M+ ion is prevented by the β-
γ-bridging CH2 group instead of the required oxygen ligand. C) In SelB⋅GDPNP switch 2 (blue) interacts with 
the γ-phosphate in the canonical way. Switch 1 as well undergoes a conformational change, resulting in the 
canonical direct contact between Thr46 (corresponding to Thr557 in cteIF5B) and the Mg2+ ion (inset). 
However, despite the stabilization of Thr46, the preceding regions including the residues corresponding to 
the MC-loop in eIF5B and aEF1A remain flexible and are not defined in the electron density, most likely due 
to the loss of the M+ ion as stable interaction partner. D) Surface presentation of GDPNP-bound eRF3. As in 


























Figure E5.Crystalstructures of eIF5B AspMC (D533) mutants bound to GTP or GTPγS. The coloring is the 
same as in Figure E1. A) Nucleotide binding pocket of eIF5B-D533A bound to GTPγS. Due to the replacement 
of AspMC by Ala, one of the key ligands and thus the pentagonal coordination sphere for the M+ ion is lost. 
Accordingly, a water molecule (H2O) is now asymmetrically coordinated by four ligands provided by Gly
MC in 





the α-phosphate) and 3.2 Å (to GlyMC) to the oxygen ligands and ~3.3 Å to the sulfur atom. These distances 
to the oxygen ligands are significantly too large for a Na+ ion (~2.42 Å [156]). The Fo-Fc omit map is shown for 
GTPγS and the water molecule, contoured at 3𝜎. B) The nucleotide binding pocket of eIF5B-D533N bound to 
GTP and Na+. Unlike the D533A mutant, Asn in lieu of AspMC still provides the oxygen ligand required for the 
coordination of the M+ ion, analogous to the P-loop Asn in MnmE (see Figure 1D). Consistently, the crystal 
structure of eIF5B-D533N was found to coordinate a Na+ ion virtually identically to the wild-type protein 
(see Figure 1A). The coordination distances in the pentameric coordination shell lie between 2.22 Å (to 
GlyMC) and 2.45 Å (to the α-phosphate), consistent with the expected values for a Na+ ion [156]. The Fo-Fc 
omit map is shown for GTP and the Na+ ion, contoured at 3𝜎. C) The nucleotide binding pocket of eIF5B-
D533R bound to GTPγS. In both eIF5B molecules of the asymmetric unit, the side chain of Arg533 is oriented 
toward the nucleotide and forms a hydrogen bond to GlyMC (in one of the eIF5B molecules, Arg533 adopts a 
second (alternative) conformation, in which the guanidino group is oriented away from the nucleotide (not 
shown)). As expected from the disruption of the coordination sphere, no M+ ion is bound in the active site. 
Moreover, no water molecule seems to be bound in lieu of the M+ ion as seen in the D533A mutant (A). 
Although the guanidino group in this structure does not form a direct contact to the phosphate moieties of 
GTPγS, it is conceivable that – particularly at low salt concentrations – Arg533 may transiently adopt a 
conformation similar to that observed for Arg48, the cis-acting arginine-finger, in the GTPase hGBP1 (D) 
[258], to allow the observed slightly stimulating effect on the intrinsic GTPase activity (see Fig. 2F). The Fo-Fc 
omit map is shown for GTPγS, contoured at 3𝜎. D) The nucleotide binding pocket of hGBP1 (with P-loop and 
switch 1 in brown) bound to the transition state mimic GDP/AlF3 (PDB: 2B92). Several hydrogen bonds to 
switch 1 stabilize Arg48 in its active conformation, in which the guanidino group forms direct contacts to 
GDP and AlF3. E-H) Steady-state fluorescence measurements for the affinity of wild-type eIF5B(517-858) and 
AspMC mutants to mant-GTP. Increasing amounts of mant-GTP were titrated to 2 µM wild-type eIF5B (E) or 
the AspMC mutants D533A (F), D533N (G) and D553R (H) at 20 °C in buffer containing 25 mM Tris/HCl (pH 
7.5), 200 mM KCl, 3 mM MgCl2 and 2 mM DTT. Under these conditions, wild-type eIF5B(517-858) bound 
mant-GTP with a Kd of 1.7 ± 0.09 µM. A similar value was obtained for the D533N mutant (Kd of 1.5 ± 0.05 
µM), while D533A and D533R showed slightly lower Kd values of 1.08 ± 0.05 µM and 0.97 ± 0.06 µM, 

















Figure E6. Comparison of the effect of different species of M+ ions on the intrinsic GTPase activity of the E. 
coli EF-Tu D21A mutant (black and white) and wild-type EF-Tu (red and blue). The intrinsic GTPase activity 
was determined in the presence of 200 mM of the indicated salts under single turnover conditions. The 
order in which the combinations are given on the right corresponds to the relative rates of GTP hydrolysis. 
Experiments were repeated two to three times; standard deviations are given by error bars (in some cases 


















Table E1. Thermodynamic parameters of cteIF5B(517-858) binding to GTPγS, GDPNP and GDP at 
different temperatures. 










 GTPγS  10 0.58 -5.06 -8.06 3.0 
 GTPγS  20 0.67 -9.67 -8.27 -1.4 
 GTPγS  25 0.82 -12.93 -8.83 -4.1 
 GTPγS  30 0.92 -15.81 -8.41 -7.4 
 GDPNP  10 10.67 -5.89 -6.44 0.55 
 GDPNP  15 12.3 -7.31 -6.48 -0.83 
 GDPNP  20 15.47 -8.09 -6.49 -1.6 
 GDPNP  25 15.0 -9.58 -6.68 -2.9 
 GDPNP  30 20.8 -9.67 -6.47 -3.2 
 GDP  10 3.37 -6.94 -7.09 0.15 
 GDP  20 5.85 -9.06 -7.76 -2.3 
 GDP  30 10.4 -11.51 -6.91 -4.6 
Measurements were performed two to three times. 
Kd, dissociation equilibrium constant; calculated as 1/Ka. 
Ka, association equilibrium constant; standard deviation did not exceed ±15%. 
ΔH, standard enthalpy change; standard deviation did not exceed ±15%. 
ΔG, Gibbs energy; calculated from equation ΔG = − R⋅T⋅lnKa. 


















Table E2. Crystallization, X-ray data collection and refinement statistics for structures of 
eIF5B(517-858) mutants 




100 mM HEPES (pH 7.3), 
15% PEG 4000, 150 mM 
NaOAc 
100 mM MES (pH 6.7), 
13% PEG 8000, 225 mM 
NaOAc 
100 mM HEPES (pH 7), 13% 
PEG 4000, 125 mM NaOAc 
Temperature (°C) 20 20 20 
Data Collection 
Space Group P21 P41212 P21 
Unit Cell 
 
a = 55.6 Å 
b = 115.8 Å 
c = 65.9 Å  
 
α = 90° 
β = 102.3° 
γ = 90° 
a = 115.7 Å 
b = 115.7 Å 
c = 119.8 Å  
 
α = 90° 
β = 90° 
γ = 90° 
a = 55.4 Å 
b = 115.9 Å 
c = 66.1 Å  
 
α = 90° 
β = 101.4° 
γ = 90° 
Molecules/asym. 
unit 
2 2 2 
Resolution (Å) 1.58 (1.68-1.58) 2.75 (2.92-2.75) 1.5 (1.59-1.5) 
Observed 
reflections 
374970 (60270) 154138 (23582) 542902 (84681) 
Unique reflections 110416 (17665) 21704 (3403) 131458 (20989) 
Completeness (%) 98.8 (98.0) 99.8 (99.1) 99.2 (98.2) 
<I>/𝜎 17.7 (2.2) 19.35 (3.11) 24.4 (2.9) 
Rsym (%) 3.9 (51.5) 7.8 (56.8) 3.0 (46.3) 
CC(1/2) (%) 99.9 (73.9) 99.9 (86.1) 100 (82.8) 
Refinement 
Rwork (%) 16.9 20.6 15.5 
Rfree (%) 19.4 25.7 18.2 
Rmsd from Standard  
Stereochemistry 
Bond length (Å) 0.012 0.005 0.014 
Bond angles (°) 1.5 1.0 1.6 
Ramachandran Plot  
Statistics 
Most favored (%) 98.7 98.2 98.5 
Allowed regions 
(%) 
1.3 1.8 1.5 
Disallowed regions 
(%) 
0 0 0 
Values in parentheses refer to the highest resolution shell. 
Rwork and Rfree factors are calculated using the formula R = Σhkl‖F(obs)hkl| − |F(calc)hkl‖/Σhkl |F(obs)hkl|, where F(obs)hkl and F(calc)hkl are observed and measured 
structure factors, respectively. Rwork and Rfree differ in the set of reflections they are calculated from: Rfree is calculated for the test set, whereas Rwork is calculated 










Translation is an intriguing problem from two different perspectives: the mechanistic aspect of the 
translation apparatus as a biochemical process, and the evolutionary aspect of translation as the 
result of selective historical constellations. Necessarily, both aspects are inseparably connected 
with each other, with the accumulated mechanistic details being relicts of the former selective 
constellations under which the translation apparatus emerged. Hence, the problem to understand 
translation as an evolved mechanism, the relationship between the different stages of the 
translation process and the emergence of domain-specific variations cannot be derived from 
sequence-based phylogenetic analysis alone but must be based on an understanding of its 
structural and functional details, which, moreover, remain an intriguing problem in themselves. In 
turn, a full understanding of the mechanistic details and the underlying principles that govern 
translation in extant cells is not possible without simultaneously treating it as an evolutionary 
problem. This intersection is exemplified by translational GTPases, an ancient protein family with 
common evolutionary descent, whose members became involved in a variety of steps in the 
translation process.  
The principle aim of this thesis was the structural and functional characterization of eIF2 and 
eIF5B, the two translational GTPases involved in eukaryal translation initiation, which, in 
comparison with their homologs from bacteria and archaea or from other stages of the translation 
process, provide two disparate examples for the intersection between mechanistic and 
evolutionary aspects of translation.  
The first part of this thesis (chapters 2-4) was dedicated to the structural and functional 





perform essential and opposing roles during the guanine-nucleotide cycle of eIF2. On the one 
hand, a refined model for the intricate interaction network in the eIF2⋅eIF5 complex could be 
derived using a combination of complementary structural and biochemical approaches, which 
included the first crystal structure of a complex between the eIF5-CTD and the eIF2β-NTT. This 
model suggests that eIF5 uses three distinct binding interfaces with the eIF2 complex, two of which 
are formed by the eIF5-CTD that becomes clamped between the eIF2β-NTT and eIF2γ and the third 
formed between the eIF5-NTD and eIF2γ, which might become relevant at overlapping stages of 
the initiation process (chapter 2). On the other hand, an analogous interaction model could be 
derived for the complex between eIF2 and the catalytic subdomain of its GEF eIF2Bε (chapter 3), 
which provided insight into the mechanism by which the isolated eIF2Bε (outside the structural 
context of the eIF2B holo-complex) binds its substrate to promote GDP release from eIF2 and its 
exchange against GTP. The comparison between the two proposed binding models for the 
interactions between eIF2 and its effector proteins finally gave rise to the hypothesis that the 
structurally similar C-terminal domains of eIF5 and eIF2Bε share a common evolutionary descent 
from an ancestral form which has already been engaged in eIF2 binding and the modulation of its 
nucleotide-binding properties (chapter 3). 
Both binding models are currently based on a number of complementary biochemical and 
structural approaches used in this work as well as previous biochemical and genetic studies. 
However, several conclusions or suggestions presented in the two chapters only form the vantage 
point for further studies. In this context, interesting future aims would be the model-based 
introduction of additional Bpa-sites in the various proteins and the identification of additional 
crosslinking sites (e.g. the crosslinking target of eIF2Bε(524-712)N569Bpa on eIF2α) or a structural 
confirmation of the proposal that the DWEAR-motif forms part of the C-terminal domain of eIF5 by 
solving a crystal structure with helix α1 accommodated in the hydrophobic cleft as suggested in 
figure 5 of chapter 2. The ultimate goal, however, remains the structural analysis of the entire 
eIF2⋅eIF5 and eIF2⋅eIF2Bε complexes either in isolation or in the structural contexts of pre-ICs or 
the eIF2⋅eIF2B complex by means of X-ray crystallography or cryo-EM, in order to correlate 





structure of a 43S pre-IC containing the TC as well as eIF5 to test the hypotheses presented in 
chapter 2 concerning the location and involvement of its C-terminal domain.  
Chapter 4 presented the vantage point to solve the problem of eIF2B function with the in 
vitro reconstitution of the eIF2Bαβδ regulatory subcomplex and the determination of the first 
crystal structures of eIF2Bβ and eIF2Bδ from the thermophilic fungus C. thermophilum. Unlike the 
usually used S. cerevisiae system, all three subunits can be purified recombinantly in large amounts 
and like in other known cases, the thermophilic origin of the source organism appears to result in 
structural properties of the proteins that are favorable for crystallization. It would thus be an 
interesting scheme for future studies to obtain a high-resolution structural model for the eIF2B 
regulatory subcomplex. Necessarily, the next step would be the reconstitution of the eIF2B holo-
complex including eIF2Bε and eIF2Bγ, which is, however, currently hampered by the insolubility of 
eIF2Bγ when expressed recombinantly in E. coli. 
 
The fist two chapters of the second part of the thesis (chapters 5 and 6) were dedicated to 
the structural and functional characterization of eIF5B. Specific aspects of the findings for eIF5B 
subsequently served as the basis to develop the hypothesis of universal monovalent cation 
dependency among trGTPases, which was presented in chapter 7.  
The initial question at hand was the specific function of eIF5B in the process of subunit 
joining and its relation to the functional characteristics of the archaeal and bacterial orthologs. The 
starting point for this study was the observation that previously proposed structural and functional 
models for eIF5B were incompatible with the classical concepts of G protein function, at odds with 
the universal conservation of the nucleotide-binding motifs within a/eIF5B/IF2 homologs and 
finally incompatible with most available biochemical and structural data. The structural and 
biochemical studies presented in chapter 5 revealed that the activation mechanism of the eIF5B G 
domain for ribosomal subunit joining indeed follows the classical paradigms of G protein function 
as molecular switches. Moreover, this mechanism was found to be coupled to a so far 
unprecedented mode of overall activation of eIF5B, called domain release mechanism, which 





requirement of stabilizing interactions with the unique P site bound initiator tRNA (chapters 6) to 
promote the formation of an elongation competent 80S IC (chapter 5).  
Chapter 7 was finally dedicated to the hypothesis of M+ ion-dependent conformational 
switching and GTP hydrolysis among trGTPases. This hypothesis is so far based on biochemical and 
structural studies on the canonical trGTPases eIF5B, aEF1A and EF-Tu, the common descent of 
trGTPases as reflected in the high degree of sequence and structural homology in their G domains, 
as well as the immense explanatory power of M+ dependency for previously unresolved problems 
concerning the function of trGTPases. It is clear however that the claim of universality for this 
hypothesis, although in agreement with the available data, will have to be confirmed by structural 
and biochemical studies on the various trGTPases it has been proposed for. In this context, a 
number of additional projects were initiated in the course of this thesis, which included attempts 
to crystallize the GTP/GTPγS-bound forms of T. thermophilus IF2 and EF-Tu, aIF2γ and aEF2 from S. 
solfataricus, as well as eRF3 from C. thermophilum either in isolation or in a complex with eRF1 
(data not shown). Up to now, none of the desired structures could be determined. However, for 
several of the projects crystallization conditions could be identified as promising starting points for 
future studies. Moreover, future work will have to comprise mutational analyses, in particular of 
the key P loop aspartate (AspMC) in terms of its influence on the intrinsic and ribosome-dependent 
GTPase activity of the various trGTPases. However, as for the work concerning eIF2 function, the 
ultimate goal would be to provide high-resolution structural evidence for M+ coordination by a 
trGTPase in the context of the ribosome, which, due to the limitations of nonhydrolyzable GTP 
analogs as discussed in chapter 7, would require the usage of GDP in combination with transition 
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